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1We are very excited to
welcome you to T2019,
the 22nd conference of
the International Council
on Alcohol, Drugs and
Traﬃc Safety (ICADTS) in
Edmonton, Canada.
ICADTS has been
organizing these triannual
meetings since 1950, and
after Toronto (1953, 1974)
and Montreal (2002), this
is the 4th time in Canada.
The arrival of the T2019 meeting is very timely, as the
Canadian legalization of cannabis in October 2018 has
had a huge impact on society and raised a range of public
health issues including cannabis impaired driving. The
ICADTS conferences are the premier international
meetings on impaired driving and attract scientists and
policy makers from around the world. We are delighted
that you can be here to share your expertise.
With our partner, the City of Edmonton, we have put
together a rich and stimulating scientiﬁc program. The
formal goal of our meetings is to collect, disseminate and
share information, among professionals in the ﬁelds of
law, medicine, psychology, forensic toxicology, public
health, economics and public policy. But we also hope
that you will take this opportunity to meet colleagues old
and new, and develop long lasting relationships.
We very much look forward to your contributions and are
conﬁdent that T2019 will be yet another interesting and
exciting ICADTS meeting. We hope that you will enjoy this
conference, the hospitality of the City of Edmonton and
the beautiful setting.
Kind regards,
Jan Ramaekers
President, ICADTS 
It is with great pleasure
that we welcome you to
T2019, the 22nd
International Council on
Alcohol, Drugs and Traﬃc
Safety (ICADTS)
Conference in Edmonton,
Alberta, Canada. Since
1950, ICADTS conferences
have served as the
foremost international
gathering on alcohol and
drug impaired road use for
researchers, policy makers and practitioners, and all of
those striving for a safer world. We are honoured to be
hosting this very prestigious conference in our city.
Thanks to the incredible work of our distinguished
Scientiﬁc Committee we have created a program that we
hope you will ﬁnd both vibrant and comprehensive. The
goal of ICADTS is to eliminate alcohol and drug related
traﬃc fatalities and injuries and as such, the Council
sponsors conferences to share the most recent research
and best practices with delegates from a variety of
disciplines ranging from law enforcement to medicine, to
public health and education. With this goal as our north
star, T2019 features ﬁve exceptional keynote speakers,
diverse concurrent sessions, specialized workshops,
dedicated poster sessions and a wide array of exhibits.
More than 100 presenters from around the world will
share with you their knowledge, experience and insights.
Our time together provides an opportunity to meet with
friends and colleagues and to build new relationships that
will span the miles and the years. We are so pleased that
you could be with us and we hope that you will enjoy the
conference and your leisure time in Edmonton.
With warm regards on behalf of the T2019 Organizing
Committee.
Laura Thue
Chair, T2019
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Conference Chair:  Laura Thue |  City of
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Dennis Tetreault |  City of Edmonton
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Gary Dyck |  City of Edmonton
Robyn Robertson |  Traﬃc Injury Research
Foundation 
Ward Vanlaar |  Traﬃc Injury Research
Foundation
Laura Marshall |  Laura Marshall
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City of Edmonton in collaboration with
BUKSA Strategic Conference Services 
SCIENTIFIC COMMITTEE
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Coordinator, City of Edmonton, Traﬃc Safety
Section
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Departments of Family Medicine and
Epidemiology & Biostatistics, Western
University
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Oakland, California, USA
Barry Watson |  Professor, Centre for Accident
Research and Road Safety - Queensland
(CARRS-Q), School of Psychology &
Counselling, Queensland University of
Technology (QUT)
Jim Fell |  Principal Research Scientist,
Economics, Justice & Society, National Opinion
Research Center (NORC) at the University of
Chicago 
Flavio Pechansky |  Professor and Director of
the Center for Drug and Alcohol Research,
Federal University of Rio Grande do Sul, Porto
Alegre, Brazil
Brad Holland |  Director of Programs and
Research, Canadian Council of Motor Transport
Administrators (CCMTA)
Jeﬀ Brubacher |  Associate Professor,
Department of Emergency Medicine,
University of British Columbia 
Corporal Brian Sampson |  Provincial Impaired
Driving Coordinator, British Columbia, Royal
Canadian Mounted Police (RCMP)
Scott MacDonald |  Scientist, Centre for
Addictions Research of British Columbia
Wendy Doyle |  Executive Director, Oﬃce of
Traﬃc Safety, Alberta Transportation,
Government of Alberta
Kathy Belton |  Associate Director, Injury
Prevention Centre, School of Public Health,
University of Alberta
Kwei Quaye |  Assistant Vice President, Traﬃc
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Insurance
Amy Porath |  Director of Research and Policy,
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Department of Psychology, University of
Montreal
Marie Claude Ouimet |  Professeure agrégée,
Faculté de médicine et des sciences de la
santé, Université de Sherbrooke 
Mark Asbridge |  Associate Professor,
Department of Community Health and
Epidemiology, Dalhousie University 
Bruna Brands |  Professor, Department of
Pharmacology and Toxicology, Program
Director, Collaborative Program in Addiction
Studies, University of Toronto
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Traﬃc Safety Supervisor, City of Edmonton,
Traﬃc Safety Section
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Sunday, August 18, 2019
9:00 – 10:00 am  |  Meeting Level Foyer
Refreshments and Light Breakfast
9:00 am – 4:00 pm  | Salons 8, 9, 10
Exhibit Hall
10:00 am – 3:30 pm  | Salon 11
YOUNG AND NEW SCIENTISTS SPECIAL SESSION
Promising Minds, ICADTS and the Impaired Driving
Field Working Together
• Introduction, and a brief overview of the education committee
concept, and means to be involved | Flavio Pechansky
• An introduction to ICADTS; who we are, what we have to oﬀer,
how they can become involved and beneﬁt from the
organization | Jan Ramaekers
• An overview of the history of the ﬁeld | Kathy Stewart
• Research methodology for determining the relationship
between alcohol/drug use and driving impairment, including
crash risk and opportunities to join | Hallvard Gjerde
• Practical tools for who is new in the ﬁeld: How do I ﬁnd my
match? Mentoring, opportunities and navigation on DWI
research and practice | Juliana Scherer
12:00 noon – 1:00 pm | Salons 8, 9, 10
Young Scientists Workshop Attendees Grab-n-Go Lunch
• Determinants of prolonged length of stay at the hospital
among victims of road traﬃc injury: A retrospective cohort
study |  Jinky Leilanie Lu
• Cannabidiol and driving: A simulation-based clinical trial
|  Stefan Lakämper
• State of Texas ignition interlock laws |  Jena Prescott
• An explorative approach to observing the impairing eﬀects of
chronic benzodiazepine use on driving in a clinical population
| Frederick Vinckenbosch
• Psycho-cognitive factors associated with severe injury after
crashes of light motorcycles: A multi-center study in Taiwan
| Carlos Lam
• Aggression does not moderate risky driving behaviours
among stimulant drug users | Amie Hayley
• A review of MADD Canada’s training program for frontline staﬀ
of cannabis retail outlets | Eric Dumschat
12:00 noon – 1:00 pm | Salon 4
SCHOLAR'S LUNCH
(invitation only)
11:30 – 12:00 noon | Salons 8, 9, 10
Drug Driving Workshop Lunch and Networking
12:00 noon – 3:30 pm | Salon 12 
DRUG DRIVING AND THE LEGALIZATION OF
RECREATIONAL CANNABIS IN CANADA 
The Impact on Policing, Challenges for Enforcement
and What We Have Learned So Far
A special session sponsored by the City of Edmonton
• Opening remarks and introductions | Inspector Chris
Narbonne and Shewkar Ibrahim
• Introduction to Vision Zero | Shewkar Ibrahim
• History and overview of impaired driving In the Canadian
context |  Corporal Richard Nowak 
• The RCMP experience | Corporal Richard Nowak 
• The Edmonton police service experience |  Detective
Braydon Lawrence
Coﬀee Break
• What can other countries learn from the Canadian
experience? | All speakers
• Closing remarks | Inspector Chris Narbonne and
Shewkar Ibrahim
5:00 – 7:00 pm  | Chateau Lacombe
WELCOME RECEPTION 
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7:30 – 8:30 am  | Hall D Foyer
Refreshments and Light Breakfast 
8:30 – 9:15 am  | Hall D
OPENING CEREMONIES
9:15 – 10:00 am
OPENING PLENARY SESSION
Charterland: A Socio-Legal Perspective of Traﬃc
Safety and Canada’s Unique Legal Culture
Keynote Speaker: Robert Palser
10:00 – 2:45 pm  | Salons 8, 9, 10
Exhibit Hall
10:00 – 10:30 am  | Salons 8, 9, 10
Coﬀee Break, Exhibits and Posters
10:30 – 11:45 am
CONCURRENT SESSIONS
Salon 4
Roadside Drug Testing – Part I
• Oral ﬂuid roadside drug testing and deterrence: 
Australia’s second generational national strategic approach 
| Michael Keating
• New South Wales police force – roadside drug testing
program  | Robert Toynton
• Oral ﬂuid drug screening equipment standards for Canada 
| Amy Peaire
Salons 5, 6
Alcohol, Drugs and Crashes
• Involvement of alcohol and drugs in fatal traﬃc crashes: 
A report from autopsy and police data 2013-2017 in Chiba,
Japan  |  Kazuko Okamura
• Alcohol and drug use among road traﬃc crash victims in
Norway  | Benedicte Joergenrud
• In-Person versus distance delivery of the back on
track remedial program: A pilot study comparison 
| Jeﬀrey Brubacher
• Alcohol and drug use among fatally injured drivers in
Norway during 2005-2015  | Hallvard Gjerde
Salon 11
Evaluation of Intervention Programs – Part I
• Development and initial validation of a measure of 
within-session change for impaired drivers participating in
remedial programs  | Christine Wickens
• Study Protocol: Assisting clinical assessment of ﬁtness to
drive following drug or alcohol misuse, using the schuhfried
vienna test system ﬁtness to drive (standard) battery
| Natalie Gastin
• Cannabis and motor vehicle crashes: A Canadian culpability
study  | Christine Wickens
Salon 12
Vias and TIRF Present the E Survey on Road Users'
Attitudes – Part I
A special session sponsored and co-chaired by AAAFTS
• ESRA: Cross-national monitoring of road users’ attitudes
and performance  | Uta Meesmann
• ESRA thematic report on driving under the inﬂuence (DUI)
of alcohol and drugs: International comparison of 32
countries  | Yvonne Achermann  Stürmer
• Medication and driving: A comparison between Canada,
Europe and the United States  | Heather Woods-Fry
• Is BAC per se law related to drivers’ perceived
attitude, acceptability, and behaviors regarding DUI?
| Tara Kelley-Baker
11:45 am – 1:00 pm  | Hall D
Lunch 
51:00 - 2:15 pm
CONCURRENT SESSIONS
Salon 4
Impaired Driving and Other Risky Behaviours
• Driver-related risk factors for fatal road traﬃc crashes
associated with alcohol or drug impairment  |  Stig Tore
Bogstrand
• Risk behaviors of Brazilian drivers according to
sociodemographic characteristics  | Luana Gross
• Impaired driving and co-occurring problem behaviours
among adolescents: Results from the Ontario student drug
and health survey (OSDUHS)  | Jane Seeley
• Association between proﬁles of cell phone use, driving under
the inﬂuence, and other risk behaviors in ﬁve Brazilian
capitals  | Marcelo Rocha
Salons 5, 6
Ask the Experts: Legalization of Cannabis and
Impaired Road Use In Canada
• Join our distinguished speakers for an opportunity to ask
your questions and have a more in depth and open
discussion about the impacts of the legalization of cannabis
on impaired road use in Canada  | Robert Palser, Corporal
Richard Nowak and Detective Braydon Lawrence     
Salon 11
Drug Driving Policy – Part I
• Polish limits for drugs of abuse in whole blood deﬁning
driving under the inﬂuence and their consequences in
expert opinions issuing  | Wojciech Lechowicz
• The harms and costs of impaired driving in Canada
| Pamela Kent
• Cannabis use and THC involvement in fatal crashes
in Washington State before and after legalization  
| Lindsay Arnold
Salon 12
Vias and TIRF Present the E Survey on Road Users'
Attitudes – Part II
A special session sponsored and co-chaired by AAAFTS
• Validation of the theory of planned behaviour in diﬀerent
cultural settings: International comparison of drunk-driving
across 5 countries  | Uta Meesmann
• ESRA - Country comparison of drink-driving typologies  
| Gerald Furian
• Alcohol related accidents in Europe from the perspective of
legislation and road users’ attitudes  | Pavlina Skladana
• Analyses of changes in drink driving behavior, attitudes and
norms during a period with reduced drink driving enforcement
in Sweden: Results based on the ESRA study  | Anna Vadeby
2:15 – 2:45 pm  | Salons 8, 9, 10 
Coﬀee Break, Exhibits and Posters
2:45 pm
Exhibit Hall closed
2:45 – 3:45 pm
CONCURRENT SESSIONS
Salon 12
Evaluation of DUI Enforcement
• A comprehensive examination of driving-under-the-inﬂuence
(DUI) in a large U.S. community  | James Fell
• Intensiﬁed drunk driving enforcement in a Swedish region:
An evaluation of a pilot study  | °Asa Forsman
Salons 5, 6
Perceptions and Behaviour: Preventing Impaired
Driving – Part I
• Perceptions of those who drive after cannabis use: 
Exploring concepts from the social cognition literature  
| Christine M. Wickens
• Associations of perceived harm from regular cannabis use
with cannabis-related driving and passenger behaviours
among Canadian youth  | Mark Asbridge
• In-vehicle alcohol feedback, low subjective response to
alcohol and decision to drive after drinking  | Marie Claude
Ouimet 
Salon 11
Mental Health and Impaired Driving 
• The association between depression, anxiety and stress
on self-reported drink- and drug-driving behaviour 
| Sara Liu
• Depressed mood and alcohol in risky driving  | Nevicia Case
• The relationship between attention deﬁcit hyperactivity
disorder (ADHD) and impaired driving: Results from the
Ontario student drug and health survey (OSDUHS) 
| Evelyn Vingilis
Salons 8, 9, 10
Dedicated Poster Session
• Come view and hear from poster presenters, check out the
list of posters at the end of the program. 
4:00 – 5:00 pm  | Hall D
PLENARY SESSION
MADD 
Allison Tatham
Vision zero perspectives in a middle-income country:
How to move forward on this road
Keynote Speaker: Juliana Scherer
5:15 – 6:15 pm  | Salon 12
ICADTS MEMBERS GENERAL MEETING
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8:30 – 9:00 am  | Hall D Foyer
Refreshments and Light Breakfast
9:00 – 9:15 am  | Hall D
WELCOMING REMARKS
MADD
Elaine Arnold
9:15 – 10:00 am  | Hall D
PLENARY SESSION
Drink-driving in middle and low income countries:
A huge room of progress to improve road safety 
Keynote Speaker: Benacer Boulaajoul 
10:00 - 2:45 pm | Salons 8, 9, 10
Exhibit Hall
10:00 – 10:30 am  | Salons 8, 9, 10
Coﬀee Break, Exhibits and Posters
10:30 - 11:45 am
CONCURRENT SESSIONS
Salon 5, 6
Prevalence of Alcohol and Drugs in Drivers Around
the World
• Illicit drugs now more common than alcohol among crash
involved drivers and riders  | Matthew Baldock
• The prevalence and pattern of drugs detected in injured
drivers in four Canadian provinces  | Jeﬀrey Brubacher
• Estimating the prevalence of psychoactive substances among
random drivers in the artic counties of Murmansk (Russia) and
Finnmark (Norway)  | Ragnhild Jamt
• Roadside surveys of alcohol and drug use in Canada's North
| Doug Beirness
Salons 4
Drug Driving Policy – Part II
• Innovating the legal system of drugs detection 
| Armin Kaltenegger
• Canada's new federal drug-impaired driving provisions:
challenges in enforcement and prosecution  
| Erika Chamberlain
• Drug driving strategic innovations in policy and practice
following the introduction of per se and preliminary drug
testing legislation: Ireland and international context 
| Denis Cusack
• Association between Uruguay’s cannabis law and drivers’
fatalities variation: An assessment of two outcomes 
| Marie Claude Ouimet
Salon 12
Cannabis and Driving Performance
• A Meta-analytic protocol for determining the eﬀects of
cannabis on driving performance  | Sarah Simmons
• Brain activity and cognition of recreational and daily cannabis
users that are positive for THC concentrations below and
above a per se limit  | Jan Ramaekers
• Eﬀects of cannabidiol (CBD) content in vaporized cannabis on
tetrahydrocannabinol (THC)-induced impairment of driving
and cognition  |  Thomas Arkell
• Synthetic cannabinoid’s acute eﬀect on psychomotor,
cognitive and subjective experience in intoxicated participants
| Eef Theunissen
Salon 11
Evaluation of Intervention Programs – Part II
• Evaluation of alcohol countermeasure: analysis of recidivism
among primary oﬀenders having been referred to the
program to assess and reduce the risk of driving while
impaired  | Maxime Brault
• Evaluating individual psychological rehabilitation of oﬀenders
Part 2: Recidivism rate after intervention and assessment  |
Joachim Seidl
• Ethnolinguistic variability among remedial program
participants in Ontario  | Christine Wickens
11:45 am – 1:00 pm  | Salons 8, 9, 10
Lunch 
71:00 – 2:15 pm
CONCURRENT SESSIONS
Salon 12
Drink Driving Policy
• Evaluating the impacts of Canada’s minimum legal drinking
age (MLDA) laws on patterns of severe motor vehicle collision
injuries in Canada’s national trauma registry, 1999-2013 
| Marcos Sanches 
• Tools for implementing environmental approaches to impaired
driving: Helping communities adopt eﬀective strategies 
| Kathryn Stewart
• The long-term trend in alcohol-related crashes and associated
policy responses in Queensland, Australia  | Barry Watson 
Salon 11
Innovative Impaired Driving Interventions
• The role of technology in monitoring impaired driving oﬀenders
| Tara Casanova Powell
• The ‘one for the road’ group intervention for repeat impaired
drivers: Evaluations and development  |  Alex and Kilisitina
Dawber
• Development of a web-based drugs and alcohol unit as part of
the traﬃc oﬀender intervention program in New South Wales,
Australia  | Ian Faulks
• Evaluation of a physician communication tool to educate
patients on driving risks when prescribing pain medication
| Robyn Robertson
Salons 5, 6
Diﬀerent Types of Impairment and Driving
Performance
• Analgesic doses of ketamine with dexmedetomidine but not
fentanyl produce postoperative driving impairment equivalent
to a BAC of 0.05%  | Amie Hayley
• The eﬀects of cannabis and cocaine on driving related tasks of
perception, cognition, and action  | Michelle Tomczak
• Eye tracking data assessment: A non-intrusive approach to
detect drowsiness in drivers  | Shahidi Zandi
Salon 4
Special Session: Impaired Driving in Low and Middle
Income Countries – Part I 
• Ergonomic factors in road crash in Metro Manila
| Jinky Leilanie Lu
• Alcohol-impaired driving and speeding in Sao Paulo, Brazil:
Findings from the bloomberg initiative for global road safety
(BIGRS) 2015-2018  | Gabriel Andreuccetti
• Clusters of driving risk behaviors among Brazilian drivers 
| Juliana Scherer 
• Road traﬃc injures in Malawi: The role of alcohol 
| Asbjorg S. Christophersen
2:15 – 2:45 pm  | Salons 8, 9, 10
Coﬀee Break, Exhibits and Posters
2:45 pm
Exhibit Hall Closed
2:45 – 3:45 pm
CONCURRENT SESSIONS
Salon 5, 6 
Perceptions and Behaviour: Preventing Impaired
Driving – Part II
• Alternatives to drunk driving in the United States: Attitudes
and behaviors of drivers  | Carl Wicklund
• Community attitudes towards sanction- and therapeutic-
based countermeasures to address drug-driving in Victoria,
Australia  | Michael Fitzharris
• Investigation of women and engagement in drink driving
behaviour  | Kerry Armstrong
Salon 11
Ask the Experts: Skating to Where the Puck Will Be
• The landscape of impaired road use is changing. This session
will reﬂect on shifts in demographic, psychological, social,
cultural, political, environmental and scientiﬁc factors and
consider the Impact on future research.  Join our renowned
panelists for a stimulating conversation on the next big issues
and challenges for researchers in the ﬁeld. What are the trends
that will aﬀect alcohol, drugs and traﬃc safety in the future
and what are the research questions we should be asking
now?  | Evelyn Vingilis, Gabriel Andreuccetti, Richard Maguire
and Matthew Baldock 
Salons 8, 9, 10
Dedicated Poster Session
• Come view and hear from poster presenters, check out the list
of posters at the end of the program. 
Salons 4
Special Session: Impaired Driving in Low and Middle
Income Countries – Part II
• The criminal justice system of Pakistan: Deterrent impacts for
drug and alcohol use among road drivers  | Ahsan Ul Haq
Kayani
• Applying the traﬃc safety culture concept to drink driving in
low and middle income countries: Retrospective case studies
and an outline of a prospective approach  | Mark King
• A psychological insight into the driving behaviour of traﬃc
oﬀenders  | Mark King
4:00 – 5:00 pm | Hall D
PLENARY SESSION
Driving Baked: Creating a Recipe to Avoid Disaster
Keynote Speaker: Chief Neil Dubord
7:00 – 11:00 pm  | Hall D
ICADTS GALA DINNER
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8:30 – 9:00 am  | Meeting Room Foyer
Refreshments and Light Breakfast
9:00 – 10:30 am
CONCURRENT SESSIONS
Salon 5, 6
Toxicology
• Analytical reliability of four oral ﬂuid-point-of-collection
testing devices for drug detection in drivers  | Juliana Scherer
• A toxicological review of DUID case work, prior to, and since
the introduction of roadside drug testing and per se drug levels
in Ireland  | Richard Maguire
• The value of comprehensive toxicology testing in driving
under the inﬂuence of drugs (DUID) investigation casework
| Ayako Chan-Hosokawa
• An eﬀort to determine a time-frame on last marijuana use
by quantitation of minor blood cannabinoids 
| Ayako Chan-Hosokawa
• Kava inﬂuence on driving skills: A case study  | Shuang Fu
Salons 4
Roadside Drug Testing – Part II
• Roadside oral ﬂuid drug testing in Queensland Australia: 
A review of testing and fatality data  | Jeremy Davey
• Enhancing the standardized ﬁeld sobriety test to detect
cannabis impairment  | Doug Beirness
• The eﬀects of recent drug driving legislation in Great Britain
| Ean Lewin
• Appraising the eﬀectiveness of the standardized ﬁeld sobriety
test scoring criteria for discerning blood alcohol concentration
limits above and below 0.08  | Troy Walden 
Salon 11
Young Scientists from Across the Globe
• Developing provincial and territorial cannabis-impaired driving
countermeasures in Canada  | Eric Dumschat
• Reviewing a decade of changes in swiss traﬃc medicine:
Repercussions/ramiﬁcations on future challenges 
| Stefan Lakämper
• Cortisol, alcohol misuse and impaired driving in male ﬁrst-time
oﬀenders: A 3-year follow-up | Hamzah Bakouni
Salon 12
Special Session: Research on Trends of Alcohol and
Other Drug Involvement in Fatally Injured Drivers
Working Group
• Alcohol and other drug involvement in drivers in the United
States: 1982-2016  | James Fell
• Prevalence and trends of drugged driving in Canada 
| Steve Brown
• An assessment of Δ9-tetrahydrocannabinol concentrations
in exhaled breath and plasma in medical cannabis patients
| Phillip Olla
• Drug-involved driving has overtaken alcohol in fatal crashes:
The New Zealand experience with a vexed public health and
road safety problem  | Nils vann Lamoen
10:30 - 11:00 am | Hall D Foyer
Coﬀee Break
11:00 - 12:30 pm  | Hall D
CLOSING PLENARY SESSION 
AND CLOSING CEREMONIES
MADD
Lynda McCullough
History of ICADTS
Kathy Stewart
Cannabis and Driving: Current issues and Future
Perspectives
Johannes Ramaekers 
Invitation to T2020 and Closing Remarks
12:30 – 1:30 pm | Hall D Foyer
Lunch: Grab-n-Go
1:30 pm | Edmonton Convention Centre Main Entrance 
POST CONFERENCE TOURS DEPART
9Presenter Poster Title
Matt Webster High-risk behavior among rural female impaired drivers
Bob Voas Evaluating the eﬀectiveness of an electronic educational intervention for drivers on
alcohol ignition interlocks
Tom Nochajski Impact of a traumatic experience for DWI oﬀenders on substance use, driving
behavior, risk, alcohol and mental health problems
Amy Manning An examination of factors inﬂuencing the decision to not install an alcohol 
ignition interlock
Joris Verster Eﬃciency of eﬀort and motivational involvement in task performance during 
alcohol hangover
Joris Verster Performance eﬃciency and motivational involvement when driving under the
inﬂuence of oxycodone/paracetamol
Leticia Fara Drug use and diﬀerent risk behaviors between men and women on Brazilian highways
Don Voaklander Injuries and restriction in hours of alcohol sales in Wetaskiwin, Alberta: A comparison
with the central zone of Alberta
William Pan The eﬀect of Acetaldehyde in breath alcohol analysis
Henrique Bombana Psychoactive substances in non-fatal road traﬃc victims: Preliminary results from an
emergency room study in São Paulo, Brazil
POSTERS
22nd International Council 
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YOUNG SCIENTIST STIPEND DESCRIPTION
AND WINNERS 
These awards were created to encourage young scientists
and those embarking on a career in traﬃc safety to develop
their knowledge base and experience in diﬀerent areas of
alcohol, drugs and traﬃc safety, with ﬁnancial support for
eligible individuals to attend T2019 in Edmonton. 
Thank you to City of Edmonton and ICADTS for their
generous support in creating these stipends. 
Winners
Amie Hayley, Swinburne University of Technology,
Australia
Stefan Lakamper, University of Zürich, Switzerland 
Natalie Gastin, Swinburne University of Technology,
Australia
Marcelo Rocha, Universidade Federal do Rio Grande
do Sul, Brazil
Michelle Tomczak, University of Alberta, Canada
Nevicia Case, McGill University, Canada
LMIC STIPEND DESCRIPTION AND WINNERS 
These awards were created to encourage researchers from
low-or middle-income countries to develop their
knowledge base and experience in diﬀerent areas of
alcohol, drugs and traﬃc safety with support with ﬁnancial
support for eligible individuals to attend T2019 in
Edmonton. 
Thank you to City of Edmonton and ICADTS for their
generous support in creating these stipends. 
Winners
Ahsan Ul Haz, Government of Pakistan, Pakistan
Jinky Lu, National Institutes of Health, University of the
Philippines Manila, Philippines 
Gabriel Andreucceti, University of Sao Paulo Medical School
WORKING PAPER AWARDS 
Best Working Paper by a Young Scientist
A $500.00 award will be granted to the author of the best
working paper submitted by a Young Scientist based on the
quality, relevance and scientiﬁc usefulness of the work.
Best Working Paper by a Researcher from a
Low-or Middle-Income Country
A $500.00 award will be granted to the author of the best
working paper submitted by a Researcher from a Low-or
Middle-Income Country based on the quality, relevance and
scientiﬁc usefulness of the work. 
BEST POSTER AWARD
A $500.00 award will be granted for the best poster
submission.
ICADTS AWARDS 
The Widmark Laureates
The Widmark Award was established in 1965 at Indianna
University in honour of Professor Erik M P Widmark,
whose comprehensive research during the ﬁrst half of
the twentieth century touched on all aspects of the
pharmacology of alcohol.
Widmark Awards honour those who have made an
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A Comprehensive Examination of Driving-Under-The-Influence in a Large 
Community in the United States 
James C. Fell, M.S., NORC at the University of Chicago. 
 
Abstract 
 
Background: Across Miami-Dade County, Florida, driving-under-the-influence (DUI) arrests have 
decreased substantially.  
Aim: The objective of this research was to provide a comprehensive examination of DUI in the county and 
determine why DUI arrests have declined.  
Methods This was accomplished via analysis of (1) existing DUI arrest and crash data; (2) a telephone 
survey of Miami-Dade drivers (3) roadside surveys of alcohol and drug use conducted in Miami-Dade 
County; (4) information from focus group discussions with police and prosecutors in Miami-Dade County; 
and (5) a comprehensive review of the best impaired driving prevention practices.  
Results DUI arrests decreased 64% between 2009 and 2016 in Miami-Dade County while the decrease that 
occurred in the State of Florida as a whole was down 34% and in the United States was down 29% over the 
same time period. Alcohol-impaired driving related fatal crashes increased from 66 in 2010 to 100 in 2015 
(up 52%) and 76 in 2016 (up 15%). The percent of drivers on Miami-Dade County roads on weekend nights 
with illegal blood alcohol concentrations (BACs >.08 g/dL) increased from 1.5% in 2007 to 3.0% in 2017 (a 
100% increase). The percent of drivers on the county roads with marijuana in their systems increased from 
2.9% in 2007 to 11.5% in 2017 (a 300% increase).  
Discussion Discussions with police and prosecutors in the county revealed police apathy toward DUI 
enforcement, lack of DUI enforcement training, and a lack of leadership from the police chiefs.  
Practical Applications: An action plan with 10 recommendations were made to change the culture in 
Miami-Dade County and get DUI enforcement back on the public safety agenda.  
Key Words: driving-under-the-influence (DUI) arrests; DUI crashes; roadside surveys; focus groups; 
telephone survey.  
Financial Disclosure: This study was funded by the Miami Foundation in partnership with the Miami-Dade 
County State Attorney’s Office.  
Conflict of Interest: None.  
 
Introduction 
Driving-under-the-influence (DUI) arrests have been declining over the past 30 years in the United States 
(US). In 1989, there were 1.94 million DUI arrests while in 2017 there were fewer than 1.0 million DUI 
arrests (FBI, 2017). This decline in DUI arrests has been occurring in many states and US communities.  
 
The current research explored the recent trend reported in Miami Beach, Florida, and across the Miami-
Dade County that DUI arrests have decreased over a five year period. In a recent media announcement 
(Ovalle, 2016) it was noted that County police statistics indicated that 3,609 DUI arrests were made in 2015 
(13.4 DUI arrests per 10,000 population), a 57% drop from 2010 when 6,321 DUI arrests were made (25.2 
DUI arrests per 10,000 population). Several reasons are cited for this including lack of police staffing and 
training as well as the introduction of ridesharing programs such as Uber and Lyft. The Miami-Dade County 
State Attorney’s Office wanted to know why DUI arrests have decreased so dramatically. Was it due to 
commensurate decreases in impaired driving in the county? Or was it due to barriers and issues related to 
DUI enforcement? 
 
Methods 
DUI Arrests and DUI Crashes: 
The Miami-Dade State Attorney’s Office provided the DUI arrest data from all police agencies in the county 
for the years 2010-2016. The State of Florida provided the Florida Integrated Report Exchange System 
(FIRES) Crash Records System for the years 2010-2016. Crashes were characterized by time of day and a 
ratio of single vehicle nighttime (6:00 pm to 5:59 am) crashes to multiple vehicle daytime (6:00 am to 5:59 
pm) crashes was used as a surrogate for alcohol-impaired driving crashes since very few drivers in these 
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crashes were tested for a BAC. Data from the National Highway Traffic Safety Administration’s Fatality 
Analysis Reporting System (FARS) were analyzed for the years 2010-2016, isolating those fatal crashes that 
occurred in Miami-Dade County and calculating the fatalities that had a driver with a BAC > .08 g/dL. The 
FARS alcohol imputation file was used for this purpose (Subramanian, 2002) so that BAC data on drivers 
was estimated when it was missing using an imputation methodology.  
 
Telephone Survey: 
The objective of the telephone survey was to gather driver characteristics (those who report DUI and those 
who do not), and to assess community awareness of DUI prevention and enforcement strategies. A total of 
787 interviews were completed with Miami-Dade County residents from May-July 2017.  The final response 
rate was 28.1 percent based on the American Association of Public Opinion Research (AAPOR) Response 
Rate 3 method. The sample design is best described as a single frame cellular random digit dialing (RDD) 
survey supplemented with a targeted list of cell phone numbers of residents in Miami-Dade County. The 
sample size of 787 drivers was sufficient to draw reasonable conclusions. For example, a finding of 40% 
responding “Yes” to a question had an error of + or – 4% at the 95 percent confidence level so that the true 
value was somewhere between 36% and 44%. We conducted bivariate analyses to determine significant 
differences between drivers who self-report DUI and those who self-report not driving under the influence.  
Roadside Surveys: 
Roadside surveys were conducted on four weekend nights in the Fall of 2017 to meet a minimum goal of 
200 drivers. Surveys were conducted on both Friday and Saturday night of each weekend at one location 
between 10:00 p.m. and 12:00 a.m. and again at a different nearby location from 1:00 a.m. to 3:00 a.m, for a 
total of four survey locations per weekend. The locations were randomly chosen within the boundaries of 
cooperating local law enforcement agencies in Miami-Dade County and were the same locations used in the 
National Roadside Surveys (NRS) of 2007 and 2013/2014. Although there were practical considerations in 
selecting these locations in 2007 in Miami-Dade County, such as sufficient traffic flow and a safe area to 
pull vehicles over, the locations were randomly selected from eligible grids on a map of the streets of 
Miami-Dade County. The objective of this roadside survey was to estimate the alcohol and other drug 
prevalence of all drivers on the roads in Miami-Dade County during the given time periods.  
 
In this 2017 roadside survey, 339 drivers were directed into the bay for initial screening, 252 drivers were 
eligible and consented to the survey, and 215 drivers completed the survey. Out of the 215 participating 
drivers, 197 drivers (91.6%) provided a breath sample for measuring their BrAC and 183 drivers (85.1%) 
consented to providing a saliva sample for drug testing.   
 
Categories of drugs tested included: marijuana, opioids, sedatives, stimulants, antidepressants, and narcotic 
analgesics. Oral fluid was used because it can be analyzed to indicate recent cannabis use by identification 
of the psychoactive substance, delta9-tetrahydrocannabinol (THC). The oral fluid was tested using 
immunoassay for an initial screening test with a cut-off of 4 nanograms per milliliter (ng/mL) and, if 
positive, quantitatively confirmed using liquid chromatography with tandem mass spectral detection (LC-
MS-MS) at a cutoff level of 2 ng/mL. The results from this roadside survey provided objective biological 
information on the prevalence of impaired driving on Miami-Dade County roads on weekend nights and the 
prevalence rates of DUI by alcohol, THC, other drugs, and by a combination of drugs. This information was 
needed to determine whether DUI on the roads has decreased over the time period in which DUI arrests have 
decreased. The results of the 2017 survey were compared to the results of the roadside surveys conducted in 
Miami-Dade County in 2007 and 2013/14 as part of the National Roadside Surveys (NRS) conducted in 
those years (Kelley-Baker, et al., 2017).  
 
Focus Groups: 
Recruitment of law enforcement officers for the focus groups was accomplished via e-mail. Some very 
proficient DUI arrest officers were selected along with not so proficient officers. The goal of the focus 
groups was to talk with 5-7 participants at the same time to discuss the problem and to ask general and 
specific questions about the issue. The common agreed upon focus group remarks were translated into 
constructive recommendations. In two different sessions, focus group discussions were held with Miami-
Dade police officers and Miami-Dade DUI prosecutors. 
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Results 
DUI arrests reported by all police departments in Miami-Dade County, DUI arrests reported by all police 
departments in the state of Florida, and DUI arrests reported to the Federal Bureau of Investigation (FBI) for 
the Nation for the years 2009-2016 are shown in Table 1 below: 
TABLE 1: DUI ARRESTS FOR 2009-2016 
Year Miami-Dade 
County 
Florida United States 
2009 5,410 53,004 1,440,409 
2010 4,339 52,346 1,412,223 
2011 3,490 43,784 1,215,077 
2012 3,142 44,894 1,282,957 
2013 2,656 41,994 1,166,824 
2014 2,620 42,745 1,117,852 
2015 2,222 31,783 1,089,171 
2016 1,974 35,042 1,017,808 
 
DUI arrests declined from 5,410 in the county in 2009 to 1,974 in 2016, a 64% decline. This decline was 
statistically significant (p<0.001). The coefficient for the trend line was -39.735. The decline in DUI arrests 
in the State of Florida went from 53,004 in 2009 to 35,042 in 2016, a 34% decline. The difference in 
differences analyses shows a 4.64% decrease in the overall DUI arrests made in Miami-Dade County 
relative to the state of Florida, which was statistically significant (p-value=0.002). Nationally, DUI arrests 
decreased from 1,440,409 in 2009 to 1,017,808 in 2016, a 29% decrease. There was also a 4.04% decrease 
in the overall DUI arrests made in Miami-Dade County relative to the rest of the United States, which was 
also  statistically significant (p-value=0.001). DUI arrests in Miami-Dade County dropped significantly from 
the period 2009-2016 for all offenders: males and females, young and older, White and African American. 
 
The ratio of single vehicle nighttime (SVN) crashes (6pm-6am) to multiple vehicle daytime (MVD) crashes 
(6am-6pm) (serving as a surrogate measure of impaired driving crashes to account for underreporting of 
impaired drivers by police) decreased significantly in the other counties of Florida but was flat for Miami-
Dade County. In the difference in differences analyses, there was a significant difference over time in the 
ratio of SVN crashes to MVD crashes in Miami-Dade County (flat) relative to the rest of the state of Florida 
(decreasing trend), which was statistically significant (p-value<0.001). 
 
The FARS data for Miami-Dade County fatal crashes and fatalities for the years 2010-2016 are shown in 
Table 2.The percent of total traffic fatalities involving an intoxicated driver (BAC> .08) has ranged from 
28% in 2010 to 35% in 2012 to back down to 27% in 2016. So about one-third of traffic fatalities in Miami-
Dade County involve an intoxicated driver over the past 7 years with no significant change in the trend line.  
 
TABLE 2. MIAMI-DADE FARS ANALYSES 
 
2010 2011 2012 2013 2014 2015 2016 
Fatal crashes 227 223 217 212 268 316 279 
Fatal crashes BAC >= 0.08 66 
(29%) 
77 
(35%) 
73 
(34%) 
63 
(30%) 
81 
(30%) 
100 
(32%) 
76 
(27%) 
Traffic fatalities 246 247 235 225 280 340 294 
Traffic fatalities BAC >= 0.08 69 
(28%) 
89 
(36%) 
82 
(35%) 
65 
(29%) 
90 
(32%) 
111 
(33%) 
80 
(27%) 
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Telephone Survey of Attitudes and Reported Behaviors: 
Of a total of 406 respondents who reported that they drink alcohol, 31% (139) said they had driven a motor 
vehicle less than 2 hours after drinking within the past 12 months. See Table 3. 
 
Table 3.  Driven motor vehicle <2 hours after drinking alcohol in the past 12 months. 
Category N Percent (%) 
Male 107 39% 
Female 32 24% 
Latino 78 30% 
Non-Latino 55 47% 
18-24 years old 15 29% 
25-34 years old 42 43% 
35 to 39 years old 14 33% 
40 to 49 years old 32 38% 
50 to 54 years old 4 11% 
55 to 64 years old 24 44% 
65 years or older 8 22% 
 
Only 54% (422) of the sample thought it was very likely or likely that marijuana impairs a person’s ability 
to drive safely while 14% (107) said it was not likely at all.  
 
Roadside Surveys in 2007, 2013-2014 and 2017: 
In the 2017 Miami-Dade roadside survey conducted in this study, 197 nighttime drivers were tested for 
alcohol. A total of 28 (14.2%) had some alcohol in their systems (BrAC>.01), 15 (7.6%) drivers were 
impaired by alcohol (BrAC>.05), and 6 (3.0%) drivers had illegal BrACs (>.08). These trends in 
percentages from 2007 to 2013-2014 to 2017 can be seen in Table 4. 
 
Table 4:  Percent Drivers in Miami-Dade Roadside Surveys with Alcohol by Year 
 2007 2013-2014 2017 
Some Alcohol (BrAC>.01) 10.8% 15.5% 14.2% 
Impairment (BrAC>.05) 3.1% 6.2% 7.6% 
Illegal (BrAC>.08) 1.5% 2.3% 3.0% 
 
Other Drugs: 
A total 183 respondents voluntarily provided an oral fluid sample in the 2017 survey, which was tested for 
52 different drugs. A total of 31 (16.9%) drivers tested positive for at least one drug, 21 drivers tested 
positive for THC (11.5%).  
 
Figure 1:  Percent of Nighttime Drivers in Miami-Dade Roadside Surveys with Marijuana by Year 
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The trends for marijuana are shown in Figure 1. The percent of nighttime drivers from roadside surveys with 
marijuana in their oral fluid in the 2017 roadside survey has increased from 2007, though there was a slight 
non-significant decrease from the 2013-2014 survey.  Almost four times as many drivers had marijuana in 
their systems (11.5%) in 2017 than drivers who were intoxicated by alcohol (3.0%).  
 
Focus Groups: 
Regarding reasons for the decline in DUI arrests, police officers during focus groups offered the following: 
• Law enforcement apathy 
• No leadership from the top 
• Lack of DUI investigation training 
• The “Ferguson” effect (reluctance to make traffic stops which derives from a traffic stop incident 
where a White law enforcement officer ultimately shot and killed an unarmed African American 
driver in Ferguson, Missouri) 
• Lack of the number of police officers in each agency 
• Change in strategy from being “proactive” to “reactive” 
• Lack of well-trained and up-to-date drug recognition experts (DREs) who have completed several 
weeks of intensive training on recognizing drugged drivers 
• Lack of federal and state grant funding 
• Lack of confidence in the DUI arrest process 
• Perception by officers that the “Back on Track” DUI diversion program is a mere “slap on the wrist.” 
The prosecutors felt more like lack of police training, officer apathy, the dislike of the “Back on Track” 
program, and the attitudes of jurors played a key role. Jurors reportedly identified with the offenders, had 
sympathy for them, and tended to vote “not guilty” in less than clear cut cases. 
 
Discussion 
This study focused on DUI enforcement in one large community. It is clear that the number of drivers 
arrested for DUI has declined in Miami-Dade County. The reasons for this are numerous. Focus group 
discussions with Miami-Dade County police officers indicate that several factors could be contributing to 
the DUI arrest decline: (1) experienced officers with high DUI arrest rates have retired from several Miami-
Dade police departments; (2) young inexperienced officers are not confident in all the procedures that must 
be followed for a DUI arrest; (3) police chiefs are not emphasizing DUI enforcement; (4) there has been no 
refresher training given to Miami-Dade police officers on DUI detection and proper arrest procedures; (5) 
the “Back on Track” diversion program given to many DUI offenders serves as a disincentive to some police 
officers to make a DUI arrest since the offenders who complete the education program are not officially 
charged with DUI; (6) the paperwork involved in a DUI arrest is massive and cumbersome for police 
officers. 
 
The data collected from roadside surveys suggests that driving while impaired by alcohol and marijuana is 
increasing in Miami-Dade County. Traffic fatalities involving impaired driving have also increased in recent 
years, indicating that impaired driving is a significant public health problem in Miami-Dade County. 
Increasing the detection and arrest of impaired drivers has been associated with decreases in impaired 
drivers on the roads (Fell et al., 2015) and impaired driving crashes (Fell, et al. 2014; Beck, et al., 2017).  
 
Conclusions 
From the data analyses and the roadside surveys, there is no evidence that ridesharing has reduced impaired 
driving in Miami-Dade County. Impaired driving is actually increasing. Therefore, the decrease in DUI 
arrests is not due to fewer impaired drivers out on Miami-Dade County roads or involved in crashes. 
 
Focus group discussions with law enforcement officers and prosecutors indicated that four factors played a 
role in the substantial decrease in DUI arrests since 2009: (1) lack of priority and leadership from the police 
chiefs regarding enforcing DUI; (2) law enforcement apathy toward making DUI arrests; (3) a lack of DUI 
arrest procedures training; and (4) reluctance of police to make traffic stops (the “Ferguson effect”).  
 
Practical Applications: 
An Action Plan was recommended to officials in Miami-Dade County: 
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1. Police chiefs need to direct their traffic enforcement officers to be proactive rather than reactive when it 
comes to impaired driving. If DUI arrest rates can increase 10%, there is evidence that DUI crashes can be 
decreased 1% (Fell et al., 2014). 
2. To help overcome the reluctance of police to make traffic stops, police agencies in Miami-Dade County 
should join forces to conduct more sobriety checkpoints. Checkpoints are safer for both the police and the 
drivers going through them. The checkpoints are also better general deterrents to impaired driving than 
traffic stops or saturation patrols.  
3. Since many police officers in Miami-Dade County are not familiar with the DUI detection and arrest 
process, offer training on DUI enforcement to all traffic enforcement officers in the proper procedures. As 
officers gain more confidence in their DUI enforcement abilities, more drivers will be detected and arrested 
who drive impaired. The “Visual Detection of DWI Motorists” pamphlet can help in this regard (NHTSA, 
2010). 
4. If DUI enforcement is going to increase significantly in Miami-Dade County, then drivers who do drink 
are going to need better and more convenient alternatives. Support policies and programs that increase the 
availability, convenience, affordability and safety of transportation alternatives for drinkers who might drive 
otherwise. This includes transportation ride sharing (e.g., Uber and Lyft), enhancing other public 
transportation options (especially during nighttime and weekend hours) and boosting or incentivizing 
transportation alternatives in the densely populated bar districts of the county.  
 
In summary, DUI arrests have decreased 64% in Miami-Dade County since 2009. This is a significantly 
larger decrease than has occurred in the State of Florida as a whole (34%) and in the United States (29%) 
over the same time period. This decline is not due to any decline in DUI behavior in the county. In fact, the 
data indicate an increase in impaired driving on county roads, in crashes, and in fatal crashes. Discussions 
with police and prosecutors in the county reveal police apathy toward DUI enforcement, lack of DUI 
enforcement training, and lack of leadership from the top. Police officers need to become proactive rather 
than reactive toward DUI in the county. The above actions, if implemented, have the potential to change the 
culture in Miami-Dade County and get DUI enforcement back on the public agenda. 
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A Psychological Insight into the Driving Behaviour of Traffic Offenders 
Guneet Assi, Infotrans Engineers Pvt. Ltd. 
Abstract 
There is a dearth of literature from psychological perspective on road safety and this study was first of its 
kind in Indian context. Given the fact that India holds a dubious distinction for being at the top for road 
crash victims and fatalities, there is a dire need to address all the possible perspectives that could uncover 
and provide possible solutions to this growing public health issue. The objective of this study was to look at 
some of the psychological imperatives like driving anger, vengeance, sensation-seeking, impulsiveness, and 
dangerous driving that could possibly demarcate and distinguish any pattern amongst both male and female 
traffic offenders. The research also aimed at identifying predictors of dangerous driving using 
aforementioned variables. For this study, the respondents were randomly selected from amongst both male 
and female offenders over a period of six months, at the traffic police station where they would pay the fine 
and collect driving license of their vehicle. Out of 460 traffic offenders who were administered the 
questionnaire, a final sample of 100 male and 100 female traffic offenders in the age group of 18-23 years 
was selected for the study. Using the statistical technique of t-test and step-wise multiple regression 
equation, the results revealed significant differences among male and female traffic offenders on dangerous 
driving, sensation-seeking, and impulsiveness parameters. However no significant difference was found on 
the variables of driving anger and vengeance. Step-wise multiple regression equation found impulsiveness as 
a top predictor for dangerous driving among both the groups. There is a need for remediation program for 
the offenders for their sensitization and to be made more responsible about the implications of their actions. 
Majorly challenges encountered was non-availability of literature in Indian context and retrieving 
information from the participants. For future research, self-report measures together with the observational 
data and conducting similar research in bigger context like metros can be done. 
Keywords: Traffic offenders, driving behaviour, dangerous driving, India 
 
Introduction 
More than a million people die in road crashes globally. Road traffic fatalities are the eighth leading cause of 
death globally and it is estimated, that it would become the fifth leading cause of death by 2030, with ninety 
percent of road traffic deaths occur in low-income and middle-income countries (WHO, 2009). Road safety 
researchers have tried to enlist certain contributory factors to road traffic crashes and have classified them 
into behavioural, environmental and vehicular failures (Sabey & Taylor, 1980). Looking into the driver 
behaviour, specifically the driver’s personality which has long been recognized as a significant predictor of 
dangerous driving (Arthur, Barret, & Alexander, 1991; Fine, 1963; Tillman & Hobbs, 1949), this study was 
designed to have a psychological insight into the driving behaviour of young drivers primarily the young 
traffic offenders. The variables studied in this research were driving anger, vengeance, sensation-seeking, 
impulsiveness and their influence on dangerous driving. Driving anger reflects one's propensity to become 
angry while driving (Deffenbacher et al., 1994). Vengeance on the other hand, is a feeling of retaliation for a 
perceived injustice or harm. Vengeful drivers have been observed as overreacting to minor infractions and 
experiencing anger or irrational thoughts (Gibson & Wiesenthal, 1996; Stuckless & Goranson, 1992). As per 
the research studies done, the most consistent and stable personality traits found in relation to risky driving 
practices and dangerous driving is sensation-seeking (Iversen & Rundmo, 2002; Sumer, 2003; Roth et al., 
2007; Waylen & McKenna, 2008). Impulsiveness has also been associated with dangerous driving due to its 
relationship with drunk driving, impaired driver behaviour, reduced ability to perceive traffic signs, reduced 
seatbelt use, and accident rates (Hansen, 1988; Loo, 1978; Stanford et al., 1996) , and therefore, it was 
considered crucial to include this variable in the study as well. 
 
For the purpose of this study, a sample of drivers in the age group of 18-23 years living in tri-city area in 
northern India included Chandigarh, Mohali and Panchkula, were selected over a period of two to three 
years. Only those drivers were included in the sample who were challaned/obtained tickets for a traffic 
offense (i.e. the moving violations, which refers to any traffic violation when the vehicle is in motion) for at 
least two times or more by the traffic police, including drivers who were driving without a driving license. 
Selection of traffic offenders for the study was used, due to the fact that intentional violations are most 
strongly related to crashes and dangerous driving (Parker, Reason, Manstead, & Stradling, 1995; Reason 
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et al., 1990). Since the attitude of the driver and other psychological attributes make a great contribution to 
driving violations (Forward, 2009), it was felt imperative to study the traffic offenders only for the purpose 
of this study. 
 
Hypothesis 
For the present study, following hypothesis were formulated: 
1. It is expected that male traffic offenders will be higher than female traffic offenders on: (H1): dangerous 
driving; (H2): driving anger; (H3): vengeance; (H4): sensation-seeking; (H5): impulsiveness. 
2. It is expected that (H6): driving anger; (H7): vengeance; (H8): sensation-seeking; (H9): impulsiveness 
will emerge as predictors for dangerous driving in male and female traffic offenders 
 
Method 
Sample 
The research was undertaken at the ticket branch of the traffic police where offenders come to submit their 
fine for traffic violation. For this study a questionnaire was administered to 460 traffic offenders (both male 
and female) out of which the final sample of offenders was drawn which included 100 male and 100 female 
traffic offenders in the age range of 18-23 years with the following inclusion and exclusion criteria. 
Inclusion criteria 
• Only those drivers were included in the sample who were issued the ticket and challaned 
for a traffic offense (i.e. the moving violations, which refers to any traffic violation when 
the vehicle is in motion) for at least two times or more by the traffic police, including 
drivers who were driving without a driving license. 
• The sample included drivers of the age group of 18-23 years and only those drivers who 
either drove two-wheeled or four-wheeled vehicle. 
Exclusion criteria 
• Traffic offenders who have received only one challan or ticket for traffic offence. 
• Any youngster undergoing any kind of psychological treatment. 
• Youngsters who were not financially dependent on their parents, i.e. Individuals who were earning 
and doing a job. 
• Drivers who were using both type of vehicles for commuting, i.e. two-wheeler and fourwheeler. 
Further, a flow chart depicts the constitution of the sample 
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Tools 
Following standardized measures to assess the variables were used: 
• Driving Anger Scale (Deffenbacher et al., 1994) 
• Driving Vengeance Questionnaire (Wiesenthal et al., 2000). 
• Sensation-seeking scale (Indian adaptation) (Basu et al., 1993) 
• Baratt’s Impulsiveness Scale (BIS-11) (Patton et al., 1995) 
• Dula Dangerous Driving Index (DDDI) (Dula & Ballard, 2003) 
 
Procedure 
The questionnaires were administered to the individuals personally and it took 45 minutes to an hour to 
record their responses. The participation was voluntary and full confidentiality was assured. 
 
Results 
For analysis, t-test and multiple regression equation was applied on the data and results were computed. 
 
The t-test analysis 
The t-test analysis found significant difference among male and female traffic offenders on dangerous 
driving (t =3.47, p < 0.01); sensation-seeking (t=3.64, p < 0.01) and impulsiveness (t =2.22, p < 0.01) (Table 
1) while no significant differences among male and female traffic offenders emerged on driving anger and 
vengeance. The mean scores were found to be higher among group of male traffic offenders (M =70.89), (M 
=18.36), (M =70.47) as compared to the female traffic offenders (M =61.96), (M =15.54), (M =67.64). on 
dangerous driving, sensation-seeking and impulsiveness respectively (Table 1). 
 
 
 
Regression Analysis 
Among male traffic offenders, four variables turned out to be significant and were retained as predictors, as 
they explained 48 % (R2 = 0.48) (Table2) of the variance in the criterion variable i.e. dangerous driving. The 
predictors which emerged significant were impulsiveness (β = 0.30), driving anger (β = 0.30), sensation-
seeking (β = 0.27) and vengeance (β = 0.19). Among female offenders, the results found that two variables 
turned out to be significant and were retained as predictors, as they explained 12% (R2 = 0.12) (Table2) of 
the variance in the criterion variable i.e. dangerous driving. The predictors which emerged significant were 
impulsiveness (β = 0.26) and sensation-seeking (β = 0.20). 
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Discussion 
 
The results revealed significant differences among male and female traffic offenders on dangerous driving, 
sensation-seeking and impulsiveness while no significant difference was found on driving anger and 
vengeance. Step-wise multiple regression equation found impulsiveness as a top predictor for dangerous 
driving among both the groups. 
 
The hypothesis (H1) which expected male traffic offenders will be higher than female traffic offenders on 
dangerous driving was aptly supported. Considering the driving style of both the gender, males are more 
likely to be involved in road accidents and traffic violations such as speeding, drinking and risk-taking than 
the females (Storie, 1977) and hence were supported in the present study as well. The hypothesis (H2) and 
(H3) which expected males to be higher than female traffic offenders on driving anger and vengeance 
respectively was not supported. Certain research studies also support the findings of the present study. Like, 
no gender differences were observed on driving anger and aggression by Wickens, Mann, Stoduto, Butters, 
Ialomiteanu and Smart (2012). Also, a study among Japanese undergraduates did not reveal any gender 
effect on dispositional vengeance and anger (Sawada & Hayama, 2012). The hypothesis (H4) and (H5) of 
the present study which expected male traffic offenders will be higher than female traffic offenders on 
sensation-seeking and impulsiveness respectively was supported. Several studies on gender and sensation-
seeking support the current findings (Amirfakhraei et al., 2013; Arnett, 1990; Franken, 1988; Ulleberg & 
Rundmo, 2002; Zuckerman, 1979) with no gender differences on impulsiveness also being supported 
(Farnell, 2011). 
 
The hypothesis (H6) and (H7) which expected driving anger and vengeance to be predictors for dangerous 
driving respectively in male and female traffic offenders were not fully supported as they emerged as 
predictors only among male and not female traffic offenders. Perhaps, anger or feeling to retaliate might not 
be a motivating factor behind dangerous driving for female offenders. The hypothesis (H8) and (H9) which 
expected sensation-seeking and impulsiveness to be a predictor for dangerous driving respectively in male 
and female traffic offenders was supported among both the groups. Sensation-seeking along with 
impulsiveness was found to be a good predictor for crash-related conditions, risky driving, driving anger 
expression and self-reported driving violation (Dahlen et al., 2005; Iversen & Rundmo, 2002; Schwebel et 
al., 2006). 
 
The present study found male traffic offenders scoring high on dangerous driving, sensation-seeking, and 
impulsiveness, while driving anger and vengeance were also found significant in predicting dangerous 
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driving among them. However, impulsiveness and sensation-seeking were common key predictors of 
dangerous driving among male and female offenders. The fundamental limitation at the moment in India is 
the need for much larger sample sizes in diverse social and cultural milieu, and need for more extensive 
observational studies, as also administering a comprehensive questionnaire to study the driving behavior in 
larger context to obtain a holistic perspective. 
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A Toxicological Review of DUID Case Work, Prior to, and Since the 
Introduction of Roadside Drug Testing and Per Se Drug Levels in Ireland 
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Abstract 
Background: The 2016 Road Traffic Act in Ireland enabled An Garda Síochána (AGS) to conduct roadside 
and station-based drug testing using oral fluid. Per se drug levels were also introduced for Cocaine, 
Cannabis and Heroin. This review looks at the impact of these measures.  
Objective(s): As well as reviewing the toxicological casework prior to the introduction of the new 
legislative measures this review considered the available data from April 2017 to date including enforcement 
activity and laboratory findings. Significant trends where identified will be discussed.  
Method: Data from the roadside and station-based testing, as well as laboratory screening and confirmation 
testing was reviewed to evaluate the newly introduced measures. Roadside and station-based testing is 
conducted using the Drager DT5000 to detect Cannabis, Cocaine, Opiates and Benzodiazepines. Lab 
screening is by immunoassay/LC-MS-MS. Laboratory confirmation is conducted using GC-MS-MS and 
LC-MS-MS.  
Results: Before the enactment of the new measures the driver had the option to provide either blood or 
urine. When a specimen of oral fluid is collected and found to be positive for cannabis, cocaine or opiates 
the driver is compelled to provide a blood specimen. Since the introduction of the new measures there has 
been a marked increase in the number of blood specimens collected relative to urine.  The Drager DT5000 is 
working well and has performed satisfactorily. There is good agreement between the oral fluid testing 
system and the laboratory findings. Cannabis and Cocaine are the most prevalent drugs detected using the 
oral fluid testing system. Opiate and benzodiazepine prevalence are lower. Most cases are in excess of the 
per se levels stated in legislation for Cannabis and/or Cocaine.  
Conclusion: The new measures are effective at detecting drugs in drivers. Ongoing review is required in 
order to fully evaluate the impact of the legislative changes.  
Keywords: Drugs, Oral fluid, Per se, LC-MS-MS, GC-MS-MS  
Disclosures: None 
Background: 
Drug driving is a known problem in Ireland (Fitzpatrick, Daly, Leavy, & Cusack, 2006) and the mainstay of 
the legal measure has been where the presence of an impairing drug is confirmed and impairment is proven 
the driver has committed an offence (Oireacthas, 2010). In practice this has proven difficult to enforce and 
so alternative measures which would detect and deter driving under the influence of drugs were necessary. 
The 2016 Road Traffic Act in Ireland (Oireacthas, 2016) brought in a number of new measures to tackle the 
problem of driving under the influence of drugs. One important measure was the introduction of per se drug 
levels for Cocaine, Cannabis and Heroin and their metabolites. (see table 1) 
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Another important measure was the introduction of random roadside drug testing. This new measure would 
give An Garda Siochana (Irish Police Force) the power to stop, demand an oral fluid specimen and to test a 
drivers oral fluid for the presence of drugs. While the specific drugs which the police could test for are not 
specified in legislation, Cannabis, Cocaine, Opiates and Benzodiazepines, were included in the first testing 
system rolled out in April 2017. The system which was chosen, following competitive tender, was the 
Draeger Drugtest 5000 (DT5000). In order to be in a position to use the per se legislation, the requirement 
for blood to be provided on foot of a roadside positive drug test, was also included in the new legislation. 
Previously and in the absence of this particular measure, the driver had the option of providing a urine or 
blood specimen. At the same time, a new form was also introduced which was called the ‘information form’ 
which while not legally required/prescribed, was to be completed by the arresting officer where oral fluid 
drug testing occurred and returned with the blood specimen to the lab. The main purpose of this form was to 
enable a review of the performance of the oral fluid drug testing system, a requirement under the Road 
Safety Authorities strategy (RSA, 2013). These new measures complemented, rather than replaced the 
existing drug presence and impairment law that had been in place for many years. The laboratory of the 
Medical Bureau of Road Safety is responsible for the approval supply and testing of the oral fluid testing 
device. In addition, the laboratory is also responsible for subsequent testing of blood and urine specimens 
collected following a positive drug test under the Road Traffic Act. These two responsibilities enable the MBRS 
to comment on the toxicology of DUID case work.  
Objective(s):  
The main objective of this work was to review the available data to determine whether there were any 
significant changes or impacts since the introduction of the aforementioned new measures. The DT5000 was 
initially rolled out to 87 Garda Stations and were fixed and immobile, while an additional 50 were made 
available for mobile use. Where the police complete the information form indicating the roadside test, the 
laboratory results can be compared. The main areas of interest arising from the existing and newly 
introduced measures, and considered here, are: 
 
• Performance of the DT5000 in detecting drugs in oral fluid compared to the results of laboratory 
tests of specimens of blood taken following a positive oral fluid drug test.  
• The frequency of drug positives resulting from police enforcement and if there were any changes 
since the introduction of the new enforcement measure mentioned above.  
• The types of drugs being detected and if there were any changes since the introduction of the new 
enforcement measure mentioned above.  
 
The new measures came into force on the 13th of April 2017. Data from the 1st of January 2016 up the 12th 
of April 2017 (pre new measures period) was compared with all available date from 13th of April 2017 to 
the end of 2018 (post new measures period). Where significant trends were identified these are discussed 
below.  
Method 
Data provided by police enforcement activity was provided and reviewed. The laboratory data prior to the 
change in the legislation was extracted and broken down based on the specimen type and the drugs 
detected.. The performance of the DT5000 was evaluated by comparing its results as provided with the 
information form with the labs results. This screening data is compared for the two periods to see in broad 
terms how the drugs use patterns in drivers changed between the two periods. Lab screening is by 
immunoassay/LC-MS-MS (since 29/09/18). This was done using sensitivity and specificity calculations 
(Blencowe et al., 2011) where:  
 
Sensitivity = true positives/true positives + false negatives.  
 
Specificity= true negative/true negative + false positive.  
Laboratory confirmation is conducted using GC-MS-MS (Cannabis) and LC-MS-MS (Cocaine, 
Benzodiazepines, Opiates, Methadone, Amphetamines and Methamphetamines including MDA and 
MDMA).  
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Results 
Activity information provided by the police for 2018 show that the number of drugs tests carried out at 
random mandatory intoxicant checkpoints increased steadily over the year. The enforcement activity 
steadily increased during 2018 and the positivity rate was ca 13%. Additional effort over the Christmas and 
New Year holiday period is reflected in the graph below. A decrease to pre-Christmas activity is noted for 
January 2019. 
 
During 2018 608 information forms indicating the results of roadside testing using the DT5000 were 
received. Of these 49 were not positive for any of the four drugs Cannabis, Cocaine, Opiates and 
Benzodiazepines in oral fluid. Of the remaining, 559 were positive for at least one drug on roadside 
screening. Single and polydrug use was indicated based on the DT5000 results. The percentage positives 
were 72% for Cannabis, 41% for Cocaine, 8% opiates and 7% for Benzodiazepines. Polydrug use indicated 
the most prevalent combination was Cannabis and Cocaine at 17.2% (n=559, 2018). There were 15 (2.7%) 
cases where 3 drugs were detected and (0.7%) where all 4 were detected.  
 
The new requirement which compelled a suspected drug driver to provide a blood specimen had a 
significant impact on the specimen type being provided.  
 
Between the beginning of 2016 and the introduction of the new measures the specimen type was 46% urine 
and 54% blood. Since the introduction of the new measures up to the end of 2018 the ration has changed to 
30% urine and 70% blood. This is an indication that the per se legislation has had an impact on the types of 
specimens being collected.  
 
The number of specimens received for drug testing has also increased significantly. Specimens per day 
before the introduction of the new measure was 3.5/day however this has increased over the period to 5.1 
which is a 46% increase in specimens received for drug testing.  
 
There is good agreement between the oral fluid testing system and the laboratory findings (Drug, Sensitivity, 
Specificity; Cannabis, 82.5%, 77.2%; Cocaine, 77.3%, 77.8%: Opiates, 85%, 97%; Benzodiazepines, 30.9%, 
98.4%, 2018 data). The low sensitivity for the benzodiazepine class can be explained by a combination of 
differential cross reactivities for the many analytes in this class (Draeger, 2017) and the high protein binding 
and acidic pKas of the benzodiazepines which reduces the available free benzodiazepine in the oral fluid 
(Spiehler, 2004).  
It is noteworthy that confirmatory analysis of blood is carried out in duplicate and then the lower of to the 
duplicate results has an uncertainty measurement deduction applied (30%) before reporting. Most cases 
consist of Cannabis and/or Cocaine, with only 4 cases in 2018 that contained 6-am in excess of the limit.  
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When the data is considered raw without deduction this shows the relationship between the cut-offs used in 
the DT5000 and the laboratory.  
 
In the case of Cannabis the cut-off in oral fluid on the DT5000 is 10ng/ml. Where the DT5000 indicates a 
positive above this cut-off in almost in 83% of cases ( n=844, 2018) the lab will confirm that THC is above 
the per se level 1ng/nl. For 11-nor-9-carboxy-Δ 9 -tetrahydrocannabinol 96% of cases (n=844, 2018) will be 
confirmed above the per se limit. The fact that the metabolite is included in Irish law has meant that 
cannabis user is more likely to be confirmed by the lab. It is worth noting that inclusion of the metabolite 
does increase the detection time of cannabis use, quantitation of the metabolite also improves the 
interpretation in the case of a passive smoking defence (Berthet et al., 2016) and finally in almost all cases 
certified as positive there was a detectable level of THC (99%, n=844, 2018).  
 
Again looking at raw data, in the case of Cocaine the cut-off in oral fluid on the DT5000 is 20ng/ml. Where 
the DT5000 indicates a positive above this cut-off, Cocaine was confirmed in 74% of cases (n=366, 2018) 
above the per se level 10ng/ml. For Benzoylecgonine 92% of cases (n=366, 2018) will be confirmed above 
the per se limit of 50ng/ml. Again, the inclusion of the metabolite increases the detection of Cocaine use 
significantly.  
 
Overall drug patterns before and after the introduction of the new measure still show that Cannabis is the 
most prevalent drug (55% positive before, 57% positive after) after alcohol, however before the new 
measure Benzodiazepines (29% before, 21% after) were second followed by Cocaine (20% before, 23% 
after). This has changed and now Cocaine is more prevalent in drivers than Benzodiazepines. This may be a 
combination of road safety education efforts bearing fruit in the case of Benzodiazepines and in the latter 
case increased availability of high purity lower cost Cocaine in the EU(EMCDDA, 2019).  
 
Conclusion 
Oral fluid drug testing is being used in enforcement of road traffic law and this use has increased throughout 
2018. The new per se law has had a big impact on the specimen type being collected as evidenced by the 
significant increase in blood specimens being collected compared to urine and is borne out of the fact that a 
prosecution can proceed without hard to prove impairment. Cannabis and Cocaine are the most prevalent 
drugs detected using the oral fluid testing system. Benzodiazepine prevalence is lower and the current 
system will detect limited number of the benzodiazepine family. There is good correlation between the 
roadside and the lab results. The new measures are effective at detecting drugs in drivers, however ongoing 
review is required in order to fully evaluate the impact of the legislative changes.  
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Alcohol and Other Drug Involvement in Drivers in the United States: 1982-
2016 
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Abstract 
Since 1982, the United States has been tracking the blood alcohol concentrations (BACs) of drivers fatally 
injured in traffic crashes.  
Aim: Using the U.S. Fatality Analysis Reporting System (FARS) and five National Roadside Surveys of 
U.S. drivers, we (a) examined the trends from 1982 to 2016 for BACs in fatally injured drivers and (b) 
examined the trends of alcohol and other drugs in drivers on U.S. roads on week-end nights. Method In 
2016, 61% of driver fatalities were tested for BAC with a known result. When BAC data are unavailable, the 
estimated BAC is statistically imputed using crash, driver and other characteristics to obtain more complete 
and accurate alcohol data.  
Results In 2016, 30% of fatally injured drivers had impairing BACs (≥ .05 grams per decilitre [g/dL]); 28% 
were at or above the illegal BAC limit in the United States (BAC ≥ .08g/dL); and 12% had very high BACs 
(≥ .20g/dL). These percentages are a vast improvement over 1982 when the percentages were, respectively, 
52% (≥ .05g/dL), 49% (≥ .08g/dL), and 22% (≥ .20g/dL). However, the 2016 percentages of fatally injured 
drivers with the above BACs have been similar to the percentages found since 1997. While the number of 
drivers killed in crashes has decreased 4% between 1997 and 2016, the proportion with impairing BAC 
levels (> .05 g/dL) has ranged from 36% in 2008 and 2009 to 30% in 2016. In contrast, according to 
National Roadside Surveys (NRS) in the U.S., 13.7%, 8.4%, 7.7%, 4.5% and 3.1% of drivers out on the 
roads on week-end nights had BACs> .05g/dL in 1973, 1986, 1996, 2007 and 2013-2014, respectively. The 
2007 NRS and 2013-2014 NRS indicated 16% and 22% of drivers on the roads had drugs in their system 
with 9% and 13% showing marijuana, respectively. Therefore, the prevalence of drugs among week-end 
night time drivers on US roads was much higher than drivers with BACs>.05 g/dL. Drugs other than alcohol 
are not consistently tested for in FARS so we did not include that data in our analyses.  
Conclusions Evidence-based strategies have been credited for the substantial decline in alcohol-impaired 
driving between 1982 and 1997 and include: (1) the adoption of stronger impaired driving laws in the states; 
(2) increased enforcement of impaired driving laws; (3) raising the minimum legal drinking age to 21 in all 
states; (4) a reduction in per capita alcohol consumption; and (5) specific socioeconomic factors (e.g., 
recessions, unemployment rates, fewer young drivers). A Committee from the National Academies of 
Science, Engineering and Medicine (NASEM) assessed the alcohol-impaired driving status in the United 
States in 2018 and made a number of recommendations for getting to zero alcohol-impaired driving 
fatalities.   
Key Words: alcohol-impaired drivers; blood alcohol concentrations (BAC); fatally injured drivers; Fatality 
Analysis Reporting System (FARS); United States. 
 
Background: 
In 2015, over 35,000 people were killed in traffic crashes in the United States (US) (NHTSA, June 2017). 
That accounted for 1.3% of all deaths from all causes in the US that year (Sivak & Schoettle, 2017). That 
may seem like a small percentage, but European countries and Australia had much lower percentages as a 
comparison (e.g. United Kingdom - 0.3%; Germany – 0.4%; Switzerland – 0.5%; France – 0.6%; Australia – 
0.8%). About a third of the US traffic crash fatalities are due to speeding (NHTSA, July 2017), another third 
are due to alcohol-impaired driving (NHTSA, June 2017), while almost half of the drivers and passengers in 
cars who were killed were not wearing their seat belt (NHTSA, February 2017). Many countries around the 
world are committed to the vision of eliminating fatalities on their Nation’s roads. The Zero Deaths vision is 
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a way of describing how a combination of strategies is going to affect safety: Toward Zero Deaths. The goal 
was first adopted by Sweden in 1997 and “Vision Zero” has evolved across the world and in many US 
states. The approach uses a data-driven multidisciplinary approach involving highway design, vehicle safety 
features and the integration of education, enforcement, engineering and emergency medical services 
(www.TowardZeroDeaths.org).  
Since 1899, 3.5 million people have died in traffic crashes in the United States, with an estimated 1.6 million 
killed in crashes involving alcohol-impaired driving (National Center for Statistics and Analysis/NCSA, 
2004). Of the 37,461 people killed in traffic crashes across the United States in 2016, almost one third 
(10,497) were killed in crashes involving an alcohol-impaired driver (BAC > .08 g/dL)(NCSA, 2017 
October). In addition, between 1994 and 2010, approximately 1.4 million drivers have been arrested 
annually for driving while intoxicated (DWI) or driving under the influence (DUI). This has decreased in 
between 2010 and 2016 to 1.0 million DWI arrests (-28%) (Federal Bureau of Investigation, 2016). DUI 
arrests between 1983 and 2016 have decreased 47%. See Figure 1.  
 
Figure 1: DUI Arrests in the U.S. 1982-2016 
Aims: 
The aims for this study were: (1) examine the trends from 1982 through 2016 (the latest year for which we 
have fatality data at the time the study was conducted) for the BACs in fatally injured drivers; and (2) 
examine the trends of alcohol and other drugs in drivers on U.S. roads on week-end nights from National 
Roadside Surveys (NRS). 
Methods 
The Fatality Analysis Reporting System (FARS) is a census of all fatal crashes (defined as a death of a 
participant within 30 days of the crash event) occurring on U.S. public roadways and reported to the police. 
FARS analysts are stationed in each of the 50 States, the District of Columbia, and Puerto Rico. They collect 
data in more than 100 categories from several state data sources (including state crash report records, driver 
records, death certificates, vehicle registration files, and other sources), which they enter into a local 
computer database. Alcohol involvement is documented through BAC test results collected by police or 
coroners. Where such data are not available, the BACs of drivers, pedestrians, and cyclists are statistically 
imputed using crash characteristics (such as a police report of driver impairment) to obtain more complete 
and accurate alcohol data [Subramanian, 2002]. This imputation is available in FARS for each year from 
1982 through the current year. It provides a BAC value for every driver, pedalcyclist, and pedestrian in the 
FARS file (NHTSA, 2018). Drugs other than alcohol are not consistently tested for in FARS so we did not 
include that data in our analyses. National Roadside Surveys (NRS) of alcohol prevalence in drivers on U.S. 
roads on week-end nights have been conducted in the U.S. in 1973, 1986, 1996, 2007 and 2013-14. 
Beginning in 2007, in addition to breath tests for alcohol, oral fluid and blood samples were collected for 
drug analyses. These surveys involved randomly stopping drivers at 300 locations across the 48 contiguous 
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states in the U.S. Data were collected during 2-hour Friday daytime sessions (9:30 a.m. to 11:30 a.m. or 1:30 
p.m. to 3:30 p.m.) at 60 locations and during four 2-hour nighttime periods (10 p.m. to midnight and 1 a.m. 
to 3 a.m. on Fridays and Saturdays) at 240 locations. Both self-report and biological measures were taken. 
Biological measures included breath-alcohol measurements on about 9,000 drivers, oral fluid samples from 
about 7,000 drivers, and blood samples from about 3,000 drivers (Berning, Compton and Wochinger, 2015). 
Results 
For fatally injured drivers, Figure 2 shows the proportion of drivers who had any alcohol in their system at 
the time of the crash (BAC>.01 g/dL) for each year from 1982-2016. Those proportions decreased from 55% 
in 1982 to 36% in 1997, a 36% decrease in those proportions. But since 1997, the proportions have ranged 
from 33-38% with slight yearly variations.  
 
 
Figure 2: Proportion of Fatally Injured Drivers with BACs>.01 g/dL, 1982-2016, United States 
Figure 3 shows the proportion of fatally injured drivers who were impaired (BAC>.05 g/dL) from 1982-
2016. Once again, those proportions decreased from 52% in 1982 to 34% in 1997 (35% decrease) and then 
remained relatively level from 1998-2016 at 30-36%. Figure 4 shows the proportions of fatally injured 
drivers who were intoxicated (BAC>.08 g/dL). Those proportions decreased from 49% in 1982 to 32% in 
1997, a 35% decrease, then showed little progress from 1998-2016, ranging from 28-33%. Finally, Figure 5 
shows the proportions who had very high BACs (>.20 g/dL). In similar fashion, the proportions decreased 
from 22% in 1982 to 14% in 1997 (36% decrease) and then remained fairly stable ranging from 12-15% for 
the years 1998-2014. 
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Figure 3: Proportion of Fatally Injured Drivers with BACs>.05 g/dL 
 
Figure 4: Proportion of Fatally Injured Drivers with BACs>.08 g/dL 
 
Figure 5: Proportion of Fatally Injured Drivers with BACs>.20 g/dL 
Contrary to the driver fatalities, the NRS data of drivers on U.S. roads paints quite a different picture, with a 
continual decrease in the proportion of drivers on the roads with positive BACs. In 1973, more than one out 
of three drivers (36%) on the roads on week-end nights had been drinking (BAC> .01 g/dL) according to the 
breath test data. That proportion dropped to one out of four (26%) drivers with alcohol in their system in 
1986, one out of six (17%) in 1996, one out of eight (12%) in 2007, and even further to one out of twelve 
drivers (8%) in 2013-2014. The proportions of drivers with impairing BACs (> .05 g/dL) showed a similar 
pattern: 1973 – 13.7%; 1986 – 8.4%; 1996 – 7.7%; 2007 – 4.5% and 2013-14 – 3.1%.  
 
Percent Drivers with BACs > .05 g/dL 
                                                          1986            1996            2007           2014           1986-2014 Change 
National Roadside Survey 
Drivers 
8.4% 7.7% 4.5% 3.1% -63% 
Fatally Injured Drivers 46.3% 35.7% 34.9% 32.9% -29% 
Table 1: Percent Drivers with BACs > .05: Roadside Drivers vs. Fatally Injured Drivers  
The pattern for drivers with BACs> .08 g/dL: 1973 – 7.5%; 1986 – 5.4%; 1996 – 4.3%; 2007 – 2.2% and 
2013-14 – 1.5% was similar. However, regarding drugs other than alcohol, the 2007 NRS indicated 16.3% 
while the 2013-14 NRS showed an increase to 20.0%. Regarding the proportion of drivers with marijuana 
(THC) in their systems, that also increased from 8.6% in the 2007 NRS to 12.6% in the 2013-14 NRS. 
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Discussion 
In the United States, proven effective strategies have been substantially underutilized. The reasons for this 
vary, but public complacency is a major factor. For example, the following strategies could substantially 
reduce traffic fatalities: 
1. Sobriety Checkpoints 
Checkpoints are highly effective in deterring drinking and driving (Shults et al., 2001; Elder et al., 2002; 
Fell et al., 2004; Voas et al., 2005). Checkpoints are safer for both police and the public than individual 
traffic stops. Widespread use of checkpoints could reduce fatalities by at least 8%. Only 38 states use 
sobriety checkpoints. Only 12 states conduct them on a weekly basis. Using passive alcohol sensors at the 
checkpoints to detect drinking drivers would increase detection of drinking drivers by 50% (Ferguson et al., 
1995). 
2. Lowering the BAC limit for driving to .05 g/dL 
Studies in Australia and Europe show that lowering the BAC to .05 could reduce traffic fatalities by 11% 
(Fell & Scherer, 2017). Administrative sanctions (license suspension, fine) could be used for drivers with 
BACs=.05-.07 (highly effective in Canada) (Fell et al., 2016). 
3. Alcohol Ignition Interlock Installations 
All states have alcohol ignition interlock device (IID) laws. Studies show that all offender laws are 
associated with a 16% reduction in drinking driver fatal crashes (Teoh et al., 2017). Yet in the best states, 
only 50% of eligible offenders actually install the device on their car. Loopholes in the laws must be closed. 
4. Oral Fluid Screening for Drugged Driving 
Roadside surveys on week-end nights indicate that about 16-20% of drivers have impairing drugs in their 
systems (Kelley-Baker et al., May 2017). Australia uses an oral fluid drug screening device that can detect 
drug presence in about 3 minutes (Pathtech Drugwipe 2). These need to be approved for use in the states in 
order to detect and reduce drugged driving.   
Conclusion 
While substantial progress has been made in reducing alcohol-impaired driving in the United States, 
progress has levelled off since 1997. There has been a slight decrease in alcohol-impaired driving between 
2009 and 2016, however, much more can be done to accelerate progress. It is possible that the recent 
decrease in DUI arrests nationwide (Figure 1) is making impaired driving less risky. 
In January 2018, the National Academies of Sciences, Engineering, and Medicine released the most 
comprehensive report on accelerating progress to reduce alcohol-impaired driving fatalities in the United 
States to date (National Academies of Sciences, Engineering and Medicine (2018); see also Teutsch and 
Naimi, 2018). The report (written by a prestigious committee assembled to review the impaired driving 
problem) provides a blueprint to solving the problem by identifying evidence-based and promising policies, 
programs, strategies and system changes to increase nation progress in reducing alcohol-impaired driving 
traffic fatalities.  
Among many other recommended strategies, those pertinent to this study include: 
■ Local governments should adopt and/or strengthen laws and dedicate enforcement resources to stop 
illegal alcohol sales (i.e., sales to already intoxicated adults and sales to underage persons). 
■ Local law enforcement agencies should conduct sobriety checkpoints in conjunction with widespread 
publicity to promote awareness of these enforcement initiatives. 
■ Municipalities should support policies and programs that increase the availability, convenience, 
affordability and safety of transportation alternatives for drinkers who might drive otherwise. This includes 
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permitting transportation network company ride sharing, enhancing public transportation options (especially 
during night time and weekend hours) and boosting or incentivizing transportation alternatives in rural areas.  
■ Every state should implement DWI courts and these courts should include available consultation or 
referral for evaluation by an addiction trained clinician. 
■ All states should enact all offender alcohol ignition interlock laws. To increase effectiveness, states 
should consider increased monitoring periods based upon the offender’s BAC at the time of arrest and past 
recidivism. 
■ States should enact per se laws for alcohol-impaired driving at 0.05 BAC and accompany enactment 
with media campaigns and robust and visible enforcement efforts.   
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Abstract 
Background: In many countries, alcohol is one of the main factors contributing to road accidents. Alcohol 
has adverse effects on driving performance, such as longer reaction time, reduced alertness or visual 
impairment. In some countries, the share of alcohol-related fatal road accidents exceeds a quarter or even a 
third of the total.  
Objectives: The objective of this presentation is to describe the relationship between the proportion of 
alcohol related accidents in selected European countries and background aspects such as legal BAC limits, 
enforcement approaches, drinking habits and patterns, and attitudes of drivers and other road users to drink 
driving issues.  
Methods: The data to be analysed will derive primarily from the second E-Survey of Road users’ Attitudes 
(ESRA2) and the European Commission CARE database (alcohol-related road accidents). European 
countries meeting the following conditions are selected: carrying out of alcohol tests in all road crashes the 
police attend or at least in road crashes with (serious) injuries or fatalities, and participation in ESRA2.  
Results: Results based on the first edition of ESRA (ESRA1; N=38,738) show a link between the proportion 
of alcohol-related road deaths and drivers’ attitudes and reported behaviour, such as driving after drinking 
alcohol, acceptability of drunk driving, support to zero tolerance for alcohol, or the perception of alcohol as 
a risk factor. The setting of legal BAC limits also seems to play an important role.  
Discussion, Conclusions and Implications: One limitation of the study is under-reporting of the presence 
of alcohol in accidents. Moreover, the extent of under-reporting differs by country. Suggestions for road 
safety policy will be given taking this limitation into account.  
Keywords: Alcohol; road accidents; attitudes  
Disclosure: No relevant affiliations or conflicts of interest exist. 
 
Introduction 
Background 
Alcohol has adverse effects on driving performance, such as longer reaction time, reduced alertness or visual 
impairment. In many countries, alcohol is one of the main factors contributing to road accidents. In some 
countries, the share of alcohol-related fatal road accidents exceeds a quarter or even a third of the total.  
The extent of drink-driving, the perception of danger of alcohol in traffic or the support for policy measures 
are associated with the general drinking culture in a given country (frequency and amount of drinking, alcohol 
beverages preferred, occasions and purpose of drinking – i.e. intoxication or social and gastronomic 
complement). They are also related to economic regulations (taxes, prices, availability and marketing of 
alcoholic beverages) and, last but not least, to political and legislative regulations such as the blood alcohol 
concentration (BAC) limits for driving.  
Objectives 
The objective of the paper is to describe the relationship between various aspects of drink-driving such as 
legal BAC limits, enforcement approaches, drinking habits, and attitudes of drivers to drink-driving issues. 
These aspects are examined in relation to the proportion of alcohol-related accidents in a limited number of 
countries, In addition, the association between a “zero tolerance” approach and attitudes and behaviours are 
analysed.    
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Methods 
In this working paper, we describe the background factors supposed to be associated with alcohol-related road 
deaths. The data regarding attitudes, behaviours and enforcement experiences of drivers derive from the E-
Survey of Road users’ Attitudes (ESRA), the data regarding legal BAC limits as well as drinking habits and 
patterns derive mostly from WHO publications.  
In the presentation at the ICADTS conference, we will also show the results regarding the association between 
the factors mentioned above and alcohol-related road accidents for the countries with sufficient data available. 
The source for the accident data is the European Commission CARE database. 
Drinking data sources 
The data used for the purpose of this paper are extracted from the "Global status report on alcohol and health 
2018" and from the "European Report on Alcohol Policy 2016" which is based mostly on WHO data plus 
some other sources. (WHO, 2018; European Alcohol Policy Alliance, 2016).We extracted yearly per capita 
consumption (including unreported) of alcohol, financial and marketing regulation, sale restrictions and legal 
BAC limits for driving.  
The ESRA survey 
The ESRA project (E-Survey of Road users’ Attitudes) is a joint initiative of road safety institutes, research 
organisations, public services and private sponsors. The aim is to collect comparable data on road users’ 
opinions, attitudes and behaviours with respect to road traffic risks. 
The first edition of the ESRA survey (ESRA1) was carried out in 2015-2017. Data was gathered from almost 
40,000 road users in 38 countries across five continents. (Meesmann, Torfs, Nguyen, & Van den Berghe, 
2018). In the second edition (ESRA2), which was conducted in 2018, data from more than 35,000 road users 
were collected across 32 countries. In each country, an online survey was conducted using access panels of 
the national adult populations (≥18 years old).  More detailed information about the ESRA2 results on drink-
driving can be found in the ESRA thematic report ‘Driving under the influence of alcohol and drugs’ will be 
released shortly before ICADTS conference (Achermann Stürmer, Meesmann & Berbatovci, 2019). 
Data analysis 
The European countries participating in ESRA2 that carry out alcohol tests in at least those crashes with 
(serious) injuries or fatalities were selected (OECD/ITF, 2017).  
Descriptive analyses based on ESRA2 data were conducted for car drivers regarding self-reported alcohol-
related behaviours, the perception of alcohol as a cause of a road traffic accidents, acceptance of legal 
measures and the experience with enforcement. SPSS 24.0 was used for all analyses (IMB corp, 2016). 
Results 
The following 13 countries met inclusion criteria and were included for analyses: Austria (AT), Belgium (BE), 
Czech Republic (CZ), Finland (FI), France (FR), Greece (GR), Hungary (HU), Ireland (IE), Poland (PL), 
Portugal (PT), Serbia (RS), Sweden (SE), and Switzerland (CH).  
Drinking characteristics 
Approximately half of the selected countries apply excise duties on all types of alcoholic beverages (CZ, FI, 
FR, IE, PL, SE), in other countries (AT, BE, GR, HU, PT, CH), wine is not included. All employ some sale 
restrictions, at least age limitations. In most countries, alcohol is not sold to intoxicated persons. In some 
countries (BE, FI, FR, IE, PT, SE) alcoholic beverages cannot be sold at petrol stations. Another important 
indicator that differs substantially between countries is yearly alcohol per capita (15+) consumption (see table  
Table 1: Overall alcohol consumption in 2016 including unrecorded alcohol 
Up to 11 litres Finland, Greece, Sweden 
11,1 – 13 litres Austria, Belgium, France, Hungary, Ireland, Poland, Portugal, 
Serbia, Switzerland 
More than 13 litres  Czech Republic 
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In the selected countries, four different levels of legal BAC limits are in force (see table 2); in addition, most 
countries apply specific limits for novice drivers and/or professional drivers.  Although generally we can 
expect more restrictive measures in societies with negative value given to alcohol, typically northern and 
Baltic countries (Allamani, 2008), in traffic it seems to be true only partially, as absolute ban of alcohol is 
applied in two countries with rather Mediterranean patterns of drinking (Popova et al. 2007). 
Table 2: General legal BAC limits 
Zero tolerance Czech Republic, Hungary 
0,2 g/l Poland, Sweden 
0,3 g/l Serbia 
0,5 g/l Austria, Belgium, Finland, France, Greece, Ireland, Portugal, Switzerland 
 
Opinions, attitudes and behaviours of car drivers (ESRA2-analyses) 
As mentioned above, the results regarding self-declared behaviours of car drivers, their attitudes towards 
alcohol-related issues, their acceptance of legal measures and experience with enforcement are obtained 
thanks to ESRA2. The selected 13 countries include 15'000 respondents. 
Overall, the proportion of car drivers reporting that they have driven after drinking alcohol at least once over 
the last 30 days was 21% (table 3). The analysis shows that the proportion of self-reported drink-driving varies 
considerably from country to country. The highest proportions were found in Switzerland and Portugal (34%), 
the lowest in Hungary (5%), the Czech Republic and Poland (both 7%). 15% of car drivers reported that they 
had been driving at least once over the last 30 days when they may have exceeded the legal BAC limit. The 
highest proportions were found in Belgium (24%), Switzerland and France (both 22%), the lowest in Finland 
and Hungary (both 4%).  
Overall, 7% of the car drivers believe that most of their friends would drive after having drunk alcohol. In 
both Greece and Serbia, a considerably higher proportion of car drivers agreed with this statement (both 15%) 
A large proportion of car drivers think that alcohol is a relevant cause of a road crash involving a car. 82% 
attributed the scores 4, 5 or 6 on a 6-point scale from 1 “never” to 6 “(almost) always” to the question “How 
often do you think alcohol is the cause of a road crash involving a car?” The countries with the highest 
percentages are Finland (91%) and Czech Republic (89%) and the ones with the lowest, Ireland (70%) and 
Greece (76%).  
The three legal measures related to drinking and driving included in the survey have high support among the 
car drivers: between 60% and 79% were (rather) in favour of these three measures (table 3). The degree of 
support for these legal measures differs widely between countries. The measure “Install an alcohol “interlock” 
for drivers who have been caught drunk driving on more than one occasion” is much less well accepted in 
Switzerland (65%) and Austria (68%) than in Finland (89%), Sweden or Serbia (both 88%). The measure 
“Zero tolerance for alcohol (0,0 ‰) for novice drivers” is least supported in Finland (68%) and France (74%). 
This measure is particularly well accepted by car drivers in Serbia (91%) and Hungary (88%). 
Table 3: Answers of car drivers to various questions about drink-driving in ESRA2, by country, 2018 
 
AT BE CH EL FI FR IE PL PT SE CZ HU RS
Having driven after drinking alcohol 31% 33% 34% 28% 9% 29% 12% 7% 34% 8% 7% 5% 19% 21%
Having driven when you may have been 
over the legal BAC limits
15% 24% 22% 19% 4% 22% 11% 6% 14% 7% 12% 4% 11% 15%
Most of my friends would drive after 
having drunk alcohol
6% 13% 8% 15% 1% 6% 7% 6% 13% 2% 4% 3% 15% 7%
How often do you think alcohol is the 
cause of a road crash involving a car?
80% 82% 80% 76% 91% 80% 70% 83% 85% 82% 89% 85% 84% 82%
Install an alcohol “interlock” for drivers 
who have been caught drunk driving on 
more than one occasion
68% 76% 65% 85% 89% 74% 83% 86% 83% 88% 78% 81% 88% 79%
Zero tolerance for alcohol (0,0 ‰) for 
novice drivers
82% 78% 75% 84% 68% 74% 83% 79% 79% 82% 85% 88% 91% 79%
Zero tolerance for alcohol (0,0 ‰) for all 
drivers
49% 56% 48% 66% 58% 51% 74% 64% 65% 71% 69% 83% 73% 60%
Alcohol as a cause of car accidents (% of  frequencies : scores 4, 5 and 6 on a 6-point scale from 1 (never) to 6 ((almost) always))
Acceptance of legal measures, by country (% of acceptance: scores 4 and 5 on a 5-point scale from 1 (oppose) to 5 (support))
Countries
Total
Self-declared behaviour as a car driver, by country (% at least once over the last 30 days)
Level of agreement for different statements, by country (% of agreement: scores 4 and 5 on a 5-point scale from 1 (disagree) to 5 (agree))
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Note. (1) Reference population: car drivers. (2) Weighted means were applied. (3) For each question, the 
two lowest and two highest values are highlighted, green reflecting a “safer” and red, a “riskier” 
behaviour/attitude level. 
The proportion of car drivers in favour of the measure “Zero tolerance for alcohol (0,0 ‰) for all drivers” is 
considerably lower. In Switzerland and Austria, the majority of car drivers are against it (48% and 49% in 
favour). In Hungary and Ireland the support for this measure is the highest (74% and 83%).  
Overall, more than a quarter of the car drivers in the 13 European countries considered it (rather) likely that 
they would be subject to an alcohol test. In Poland, Serbia, the Czech Republic and Hungary, this proportion 
is markedly higher than in the other countries (figure 1). There is a strong association between the perceived 
likelihood of being checked for drink- driving and the level of enforcement. Finland is an exception, as the 
proportion of car drivers expecting an alcohol control is low (15%), while 42% have been checked for 
alcohol in the last 12 months. 
Alcohol related accidents 
Analyses of alcohol-related road accidents are based on the CARE database (common EU database on road 
accidents). Only the number of active participants involved in an accident (drivers and pedestrians) who 
were killed and tested for alcohol was taken into account (in the years 2015 - 2017). France, Portugal, 
Poland, Hungary and the Czech Republic are included in this analysis. Unfortunately, the quality of data for 
other countries is insufficient: for a large proportion of active road users killed, there is no information on 
BAC test results. 
In the first step (A) fatality numbers for BAC level 0, 0.01-0.5 and more than 0.5 g/l were compared, in the 
second step only the results (negative/positive) were compared.  
The analyses show that most of the victims have a BAC = 0 (50 - 90 %), 1-5% a BAC below 0.5  and 8-
40%, a BAC above 0.5 In France, 60% have a BAC=0, 4% a BAC below 0.5 and 27% a BAC above 0.5.  
(for 9 %, the alcohol level was unknown). 
 
Figure 1 Relationship between the perceived likelihood to be checked for alcohol and the alcohol 
checks in the 13 European countries 
Conclusions 
The study describes the complex relationship between drinking habits, legal measures and users’ attitudes to 
drink-driving issues. Though the drinking habits of given country seems to play an important role, two 
factors seems to rectify both attitudes and behaviours of drivers relatively successfully – BAC limits and 
intensity of enforcement. 
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The lowest proportion of self-reported driving after consumption of alcohol was recorded in Hungary, the 
Czech Republic and Poland, while Hungary appears among countries with the lowest percentage of driving 
with BAC above limit. Respondents from Finland and Sweden, but also from Hungary, the Czech Republic 
and Poland seldom believe that their friends would drive after having drunk alcohol. While Finland and 
Sweden belong to countries with the lowest consumption of alcohol, the results of Poland, Hungary and 
namely the Czech Republic (the highest per capita consumption among selected countries) can be rather 
explained by strict legal BAC limit (zero tolerance in HU and CZ) and relatively high level of enforcement. 
This assumption is also supported by a percentage above average of drivers perceiving alcohol as risky 
factor in road traffic in Finland and again in the Czech Republic, where the approach to alcohol is otherwise 
tolerant.  
The results of analysis of alcohol-related accidents, though limited regarding the number of countries with 
data of sufficient quality,  seem to speak for zero tolerance of alcohol in road traffic. Although the limit 0.0 
g/l is problematic and even the abstainer might have BAC up to 0.2 g/l, the strenght of such limit seems to 
lie in clarity of complete ban. 
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Abstract 
Background: Declines in alcohol-impaired driving in the United States seemed to have plateaued since 
2010.  
 
Objectives: To help characterize the current state of alcohol-impaired driving and alternatives.  
 
Methods: Data from the Road Safety Monitor (RSMs 2015-2018), an annual public opinion survey 
maintained by the Traffic Injury Research Foundation USA, Inc. (TIRF USA), were used (N=16,586 U.S. 
drivers). Data were analyzed using two sample tests of proportions and logistic regression analysis.  
 
Results: There has been little change from 2015 to 2018 when it comes to alcohol-impaired driving 
behavior and attitudes, even though a clear majority of drivers are concerned about alcohol-impaired driving 
and view it as a serious problem. In 2018, approximately 12% of drivers reported driving when they thought 
they were over the legal limit and 3.4% indicated they drove impaired often or very often. While the overall 
level of familiarity with, and access to, alternative options to alcohol-impaired driving remains high, actual 
use of the substitutes have not significantly changed, and some alternatives remain under-utilized. Results 
showed varying characteristics with respect to gender and age among self-reported drunk driving and users 
of alternatives.  
 
Discussion, Conclusions and Implications: Given the high levels of familiarity with campaigns and 
alternatives to alcohol-impaired driving but the limited use of these alternatives, there is great potential to 
increase the reliance on, and the usage of, these alternative solutions.  
 
Keywords: alcohol-impaired driving, alcohol-impaired driving campaigns, alcohol-impaired driving 
alternatives.  
Disclosure: Data used for the analyses in this research have been collected with financial support from 
Anheuser-Busch. The authors declare no ethical conflict of interest.  
 
Introduction 
Progress was made in reducing the alcohol-impaired driving problem in the past decade in the United states. 
To illustrate, the number of fatalities per 100 million vehicle miles traveled (VMT) has been reduced by 26.7% 
from 0.45 in 2005 to 0.33 in 2011 (NCSA 2016). The number of alcohol-impaired driving fatalities decreased 
by 27.4% from 13,582 in 2005 to 9,865 in 2011. However, after years of progress, declines in alcohol-impaired 
driving in the United States seemed to have plateaued in recent years. Fatality rates in alcohol-impaired driving 
crashes per 100 million VMT have been oscillating between 0.33 and 0.35 since 2011 to 2017 (NHTSA 2018) 
and the number of fatalities in these crashes is not decreasing (10,874 in 2017). These recent data demonstrate 
that continued action is needed.  
One solution to help address the problem is to encourage more people to use alternatives to alcohol-impaired 
driving such as safe ride home programs, public transportation, and designated drivers. Safe ride home 
programs provide alternative transportation options such as taking taxi services or public transportation to get 
home (Sarkar et al. 2005); they include both for-profit (e.g., Uber and Lyft) and non-profit safe ride home 
programs (for a review of the literature on safe ride home programs, see: Barrett, Vanlaar and Robertson 
2017). Safe ride home programs have evolved from the concept of a “designated driver” which is defined as 
one person within a group who refrains from the consumption of alcohol so that they can transport passengers 
home safely.  
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Methods 
Data Sources 
Data on alcohol-impaired driving behaviours and attitudes have been collected as part of the Traffic Injury 
Research Foundation USA, Inc. (TIRF USA) series of Road Safety Monitors (USA RSM) since 2015. The 
survey is administered annually to a sample of U.S. drivers aged 21 years or older. A total of 1,500 participants 
completed the poll in 2018; 5,027 in 2017; 5,050 in 2016 and 5,009 in 2015.  
 
Data Analysis 
All analyses were conducted using Stata 14.2 (StataCorp., 2015). The data from the RSM were analyzed, 
considering the stratified and weighted sampling design to avoid bias. Two-sample tests of proportion, linear 
regressions and logistic regression analyses were conducted to evaluate statistical significance of results and 
possible trends. 
Results 
3.1 Alcohol-impaired driving behaviors as reported by U.S. drivers  
Self-reported alcohol-impaired driving behavior by U.S. drivers is shown in Figure 1. Respondents were asked 
two questions. First, they were asked how many times in the past 12 months they had driven when they thought 
they were probably over the legal limit. Results on the left-hand side show the percent of drivers who reported 
doing this one, or more times. Second, respondents were asked how often they drive impaired on a scale from 
1 (never) to 6 (very often). The results on the right-hand side show the percent of those who chose 5 or 6 on 
this scale. 
The percent of respondents that reported driving when they thought they were over the legal limit increased 
to 11.6% in 2018 up from 9.2% in 2017. This percent was highest in 2016 with 11.7% and lowest in 2015 
with 8.0%. The percent of respondents that indicated they drive impaired often or very often also increased in 
2018 to 3.4% up from 2.7% in 2017 (but this increase was not statistically significant, p>0.05). Although this 
3.4% in 2018 represents a significant decrease with respect to the 5.5% in 2016, it is not significantly different 
from the 4.0% in 2015. 
 
Figure 1: Percent of U.S. drivers self-reporting alcohol-impaired driving in 2015-2018 
 
Data were analyzed to determine if there were any relationships between drivers’ behaviours and their age, 
sex, the distance they drive, the number of tickets issued, whether they had previously been injured in a 
collision, and their marital status (see Table 1). 
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Table 1: Percentage and odds ratios (OR) for drivers reporting alcohol-impaired driving in the past 
12 months: 2015-2018 by sex and age. *p-value<0.05 
  Sex Age 
  Female Male 21-29 30-39 40-49 50-59 60-69 70+ 
Over the legal 
limit 
6.3* 
(1.0) 
13.7* 
(1.9*) 
18.0* 
(1.0) 
16.6* 
(0.8) 
7.9* 
(0.5*) 
6.5* 
(0.4*) 
4.5* 
(0.3*) 
3.4* 
(0.2*) 
Often or very 
often 
2.0* 
(1.0) 
6.1* 
(1.7*) 
7.7* 
(1.0) 
8.4* 
(1.2) 
2.9* 
(0.7*) 
1.5* 
(0.4*) 
1.3* 
(0.4*) 
1.2* 
(0.3*) 
Overall, 13.7% of male drivers versus 6.3% of female drivers reported driving when probably over the legal 
limit at least once in the previous 12 months. Regarding driving impaired often or very often, 6.1% of male 
drivers versus 2.0% of female drivers reported this behaviour.  
Drivers aged 21 to 29 years, were more likely to report driving when probably over the legal limit at least 
once in the previous 12 months in comparison to older age groups. Furthermore, the prevalence of this 
behaviour decreased with age. Similarly, drivers aged 21 to 39 years were more likely than older drivers to 
report driving impaired often or very often.  
Logistic regression models controlling for sex and age confirmed the above results. 
 
3.2 Alternatives to Alcohol-Impaired Driving 
Drivers in the U.S. were polled about alternative solutions to alcohol-impaired driving. Figure 2 provides an 
overview of the different questions about designated drivers and responses. 
Respondents were informed that a designated driver is the person who agrees to do the driving and won’t be 
drinking alcoholic beverages when going out with others who will be drinking alcoholic beverages. Each year 
a majority of respondents reported that they have ever used or have been a designated driver; 74.7% in 2015, 
77.4% in 2016, 78.0% in 2017 and 75.7% in 2018. The increase from 2015 to 2016 was significant (3.6% 
change, p=0.02) but then this percentage remained nearly unchanged and the changes were not significant. 
 
Figure 2: Percent of U.S. drivers who self-report using alternatives to alcohol-impaired driving in 
2015-2018 
 
Another alternative to alcohol-impaired driving is the use of a taxi or any type of public transportation, such 
as a subway or bus that provide a safe ride home. A minority of respondents reported ever having obtained a 
ride home after drinking alcohol beverages by any of these public transportation options. The increase from 
27.5% in 2015 to 30.9% in 2016 was significant (12.4% change, p=0.01) but the subsequent changes were 
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not: 31.3% in 2017 and 33.5% in 2018. Overall there is a significantly increasing trend for this percent from 
2015 to 2018 (coef.=1.9, p=0.04). 
In 2016, respondents were asked for the first time if they had ever used a ride share service (i.e., private 
transportation) that you pay for, such as Uber or Lyft, after drinking alcohol beverages. The percent of drivers 
using this alternative has significantly increased from 18.7% in 2016, to 22.1% in 2017 and 26.4% in 2018 
(trend: coef.=3.9, p=0.04). 
Safe ride home programs were defined as “offering to drive impaired drivers home or drive both the impaired 
driver and the driver’s vehicle home, such as businesses, bus or taxi agencies, or volunteer groups”. The 
percent of respondents who answered they always or sometimes used these programs when available increased 
from 9.2% in 2015 to 12.6% in 2016, 14.0% in 2017 and 20.1% in 2018 (trend: coef.=3.4, p=0.03).  
Analyses of RSM data from 2015 to 2018 revealed significant sex and age differences in the use of different 
alternatives to DWI (see Table 2). 
 
Table 2: Percentage and odds ratios (OR) for drivers reporting use of alternatives to DWI, 2015-2018 
by sex and age. *p-value<0.05 
  Sex Age 
  Female Male 21-29 30-39 40-49 50-59 60-69 70+ 
Designated driver 
(ever used or been)  
77.3 
(1.0)  
75.8 
(0.9*) 
85.2* 
(1.0) 
86.7* 
(0.9) 
82.0* 
(0.6*) 
77.2* 
(0.5*) 
66.9* 
(0.3*) 
52.9* 
(0.2*) 
Public transportation 
(e.g., taxi, bus, 
subway) 
25.3* 
(1.0) 
35.7* 
(1.5*) 
49.2* 
(1.0) 
48.7* 
(1.04) 
33.5* 
(0.6*) 
22.8* 
(0.4*) 
12.1* 
(0.2*) 
7.2* 
(0.1*) 
Ride share service 
that you pay for (e.g., 
Uber, Lyft)  
16.9* 
(1.0) 
25.7* 
(1.3*) 
45.9* 
(1.0) 
37.9* 
(0.7*) 
17.7* 
(0.3*) 
11.1* 
(0.2*) 
5.3* 
(0.1*) 
3.0* 
(0.04*) 
Safe ride programs 
(always / sometimes) 
11.5* 
(1.0) 
27.5* 
(2.1*) 
38.1* 
(1.0) 
43.9* 
(0.9) 
11.9* 
(0.3*) 
9.0* 
(0.2*) 
2.6* 
(0.1*) 
2.5* 
(0.1*) 
 
Overall, older and female drivers were less likely to report using any of the different alternatives to impaired 
driving. The only exception was that female drivers were more likely than males to report using or being a 
designated driver. 
Conclusions 
The analysis revealed increases in both measures of self-reported alcohol-impaired driving in 2018. The 
increase in one indicator related to frequency of this dangerous behavior was not statistically significant, but 
the increase in the other indicator related to driving when probably over the legal alcohol limit, was significant. 
The most common reason that drivers reported for this behavior was that they believed they were okay to 
drive (approximately 50% of drivers reported this belief; see Wicklund et al. 2018 for more detail). This 
suggests they may not recognize the impairing effects of alcohol after they have been drinking or understand 
how their driving abilities may be affected. Encouraging people to use alternative solutions can help alleviate 
this behavior.  
The use of a designated driver seems to be the most commonly used alternative to alcohol-impaired driving, 
with approximately 76.6% of drivers reporting ever using or being one. However, this percent remained nearly 
unchanged in the four years of data. The results related to the use of public transportation, revealed a slight, 
ongoing increase from 27.5% in 2015 to 33.5% in 2018. Still, a significant majority of respondents indicated 
they do not use public transportation as an alternative to operation of a vehicle after consuming alcoholic 
beverages. There were also increases in the use of safe ride programs and ride share services, but these remain 
the less common of the alternatives with approximately only one in five of the respondents using these options.  
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Overall, there have been increases in the use of these alternatives from 2015 to 2018. Furthermore, when 
combining all alternatives, safe ride home programs or rideshare, using public transportation, or being/using 
a designated driver, an overwhelming majority of respondents reported using them in occasions when drinking 
occurred; 77.0% in 2015, 80.1% in 2016, 80.1% in 2017 and 81.2% in 2018. In terms of licensed drivers, this 
represents 183 million drivers using alternatives to alcohol-impaired driving in 2018, compared to 168 million 
in 2015 (based on an estimated 225 million drivers holding a valid license in the U.S in 2017 and 218 million 
in 2015*). 
The survey also gleaned respondent profiles of those who used alternative solutions and compared them to 
those who did not use them. These profiles help provide insight into possible strategies to encourage increased 
utilization of alternatives. For example, younger (21-39 years-old) respondents were much more likely to 
utilize safe ride home programs and public transportation than older drivers (40-70+ years-old). Additionally, 
males were more likely to use these alternatives than females. Yet, females were more likely to use a 
designated driver than males.  
In conclusion, this study indicates that there is significant opportunity for growth in the utilization of 
alternatives to alcohol-impaired driving, particularly because many U.S. drivers are aware of alternatives, and 
have used them at least once in their life. Where most gains can be made is probably in terms of encouraging 
U.S. drivers to use these alternatives more often, in addition to also convincing non-users to rely on them.  
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Abstract 
Cannabis research is important for establishing legislation, policies, and determining effective benchmarks 
for law enforcement in order to preserve public health and safety. The legalization of cannabis brings many 
challenges to Canadian healthcare and judicial landscapes. Due to the variability in the effects of cannabis on 
different populations and demographics, our research aims to explore the impact of Tetrahydrocannabinol 
(THC) on frequent users such as medical cannabis patients, and determine how this population would be 
impacted by the Canadian drug impaired driving law (formally Bill 46). Our objective is to explore the 
immediate and short-term impacts of THC concentration in blood plasma, breath levels, and neurocognition 
over a 5-hour period. We captured the subjective-effects of Cannabis using a visual analog scales (VAS), a 
series of 100-mm-long lines labeled with either a mood or a physical symptom. The blood and breath samples 
were captured over a 5-hour period and measured using liquid chromatography-tandem mass spectrometry 
techniques. For neurocognitive testing, we used a battery of teststhat comprised of executive functioning, 
visuomotor processing, visual scanning, visualsequencing, cognitive flexibility, and other cognitive tests.  
Afterwards, we developed models using artificial neural networks for data analysis to determine the length of 
time a participant’s blood / breath levels returned to baseline and became lower than the legal per se limits. 
Our findings indicate that breath THC concentrations rise much more rapidly than blood levels. The blood 
THC concentrations were higher for males compared to females, however the breath THC levels did not differ 
by gender. The peak blood and breath THC levels showed a decreasing trend as the age of the subjects 
increased. We are in the process of utilizing our research data and findings to develop an artificial intelligence-
based framework for detecting cannabis impairment. 
Keywords: Medical Cannabis, Pragmatic Clinical Trial, THC, Blood, Breathalyzer 
Introduction 
The use of medical cannabis has been widespread following decriminalization around many parts of the world 
(Lucas & Walsh, 2017). The effectiveness of cannabis use to relief pain for patients with various types of 
maladies has been established, while the physiological effects and its variances in terms of impairment caused 
by THC across different populations have not been fully explored (Schwope, Bosker, Ramaekers, Gorelick & 
Huestis, 2012; Sznitman & Room, 2018). This has severe implications for legislative and policy development 
purposes, where presently, blanket zero-tolerance policies in conjunction with alcohol impairment are the 
norm regards to the operation of vehicles and road safety. Studies of the long-term effects of cannabis use on 
impairment have been limited in their study design and sample size due to a variety of factors including the 
legal status of cannabis. Furthermore, studies of long term cannabis use conducted between 2004 to 2015 
show a large degree of variability in their results (Curran, Freeman, Mokrysz, Lewis, Morgan & Parsons, 
2016). Reviews of the long-term effects of cannabis on cognition performed during this time indicate that long 
term heavy cannabis use leads to deficits in motor function, executive function, and memory (Ganzer, 
Broning, Kraft, Sack & Thomasius, 2016; Solowij & Battisti, 2008; Wrege, Schmidt, Walter, Smieskova, 
Bendfeldt & Radue, 2014). Some of the most compelling recent evidence among these include impairment in 
episodic memory (Crane, Schuster, Fusar-Poli & Gonzalez, 2013).  In fact, abstinence time, age of onset, 
compensatory mechanisms, sex differences, and other confounding factors may alter the measured effects of 
long term cannabis use on cognition. Therefore, additional well designed and higher powered studies would 
be necessary to determine the correlation between long term cannabis use and cognition. (Curran, Freeman, 
Mokrysz, Lewis, Morgan & Parsons, 2016; Ganzer, Broning, Kraft, Sack & Thomasius, 2016; Crane, 
Schuster, Fusar-Poli & Gonzalez, 2013). Peak drug levels and peak levels of subjective intoxication are 
experienced approximately 2 hours after administration (Chesher, Bird, Jackson, Perrignon & Starmer, 1990; 
Curran, Brignell, Fletcher, Midddleton & Henry, 2002). 
Breath analysis has the potential to foster the development of new non-invasive diagnostic devices, an interest 
for both, forensic and medical science. Techniques to detect drugs cannabis and exhaled breath, similar to 
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breath alcohol tests, are highly desirable as an alternative to blood, urine and saliva urine analysis in situations 
such as police controls for drugged driving. 
Previous research has investigated exhaled breath and drugs of abuse and successfully detected 28 nonvolatile 
drugs of abuse in the breath (Ullah, Sandqvist, Beck, 2018).  
Human breath may contain approximately up to 3000 compounds, which comprise of volatile and nonvolatile 
compounds.  The non-volatile compounds carry in the aerosol particles could be collected as exhaled breath 
collection device, which typically takes about 2 to 3 minutes to perform. The detection window of cannabis 
in breath after smoking one cannabis cigarette in occasional and chronic smokers was at least 3h. Only THC 
was detected, and not the metabolite. The THC concentration in exhaled breath was related to the 
physiological changes that occur over time. (Coucke, Massarinin, Ostijin, Beck & Verstraete, 2014).   
Compounds from exogenous origin are also detected in exhaled breath, especially with regard to THC since 
it was administered through inhalation (Beck, Sanqvist, Dubbelboer & Franck 2011). The possibility to detect 
drug use by using exhaled breath is intriguing when considering that alcohol testing technology has been 
developed to the point that on-site breath testing with legally defensible results using infrared spectroscopy 
can be performed and also used for vehicle alcolocks (Beck, Sanqvist, Dubbelboer & Franck 2011).  
Identification of recent cannabis smoking and intoxication or impairment is critical to drug testing in the 
workplace, drug treatment facilities, and in driving under the influence of drugs (DUID)3 programs. 
SensAbues breath collection devices and a validated liquid chromatography–tandem mass spectrometry (LC-
MS/MS) method has been used to quantify breath cannabinoids in chronic and occasional cannabis smokers 
following controlled smoked THC administration. Detection of recent cannabis smoking is important for 
documenting accompanying impairment. Here we describe cannabinoid concentrations in exhaled breath 
following controlled smoked cannabis administration; these data characterize breath cannabinoids, the 
duration of detection, and peak concentrations. Breath collection is noninvasive and easily observed, and 
samples can be collected roadside. Breath alcohol tests are widely employed by law enforcement to provide 
evidence of recent alcohol consumption during roadside stops. Exhaled breath analysis also is evolving as a 
new frontier in lung and cardiovascular disease testing (Himes, Scheidweiler, Beck, Gorelick, Desrosiers & 
Huestis, 2013).  
THC in oral fluid can be detected for 48 h in chronic smokers during sustained abstinence; therefore, exhaled 
breath may offer a cannabinoid detection alternative and better coincide with impairment 1–2 h after smoking 
(Himes, Scheidweiler, Beck, Gorelick, Desrosiers & Huestis, 2013).Oral fluid (OF) is an accepted alternative 
biological matrix for drug treatment, workplace, and DUID (driving under the influence of drugs) 
investigations, but establishing the cannabinoid OF detection window and concentration cutoff criteria are 
important. 
Δ9-Tetrahydrocannabinol (THC) was the most commonly detected drug in oral fluid (OF) among drivers 
testing positive for potentially impairing drugs. Research has also established that THC can be detected in the 
breath and blood levels cannabinoid concentrations following controlled cannabinoid smoking detectable 
from 1 – 4 hours (Himes, Scheidweiler, Beck, Gorelick, Desrosiers & Huestis, 2013).  Governments and law 
enforcement agencies are interested in finding alternatives to urine and blood for identifying recent drug use 
Huestis (2013) . In Canada, the current approved matrix for DUID programs is saliva. THC is still detectable 
in oral fluid for 48 hour after consumption. Exhaled breath testing may be an alternative to oral fluid testing 
as cannabinoid detection in this matrix may correspond with impairment (Himes, Scheidweiler, Beck, 
Gorelick, Desrosiers & Huestis, 2013). 
 The purpose of this research is to provide further insight to aid legislators in establishing policies and laws 
that take medical cannabis users into greater account, as their characteristics and outcomes with regards to 
cannabis use greatly differ from recreational users. For our pragmatic clinical trial, we recruited 23 medical 
cannabis patients out of a pool of 300 verified research subjects through a random selection process. Our main 
goal was to evaluate any potential relationship between exhaled breath and blood plasma concentrations, along 
with any changes in neurocognition.  In the sections to follow, we will outline our experimental methodology, 
followed by our results, and finally a brief discussion on the significance of our findings. 
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Materials and Methods 
The criteria we used to screen participants were: 24 years of age or older, native speakers of English, medical 
marijuana license issued for a chronic health condition, medically stable, and peripheral veins suitable for 
repeated venipuncture. Exclusion criteria include pregnancy, and allergy to any cannabinoid or marijuana 
smoke.  At the time of this study, cannabis consumption was illegal in Canada, the ethics approval stated that 
only medical cannabis patients could be used in the study, and conduct a medical intake interview with a 
medical practitioners. The most common reason for the medical marijuana prescription was a psychiatric 
disorder (n = 15 or 68.2%), followed by musculo-skeletal (n = 4 or 18.2%), (auto)immune (n = 2 or 9.1%) 
and respiratory (n = 1 or 4.5%) illnesses. The majority of the sample (n = 12 or 54.5%) identified pain 
management as one of the reasons for which medical marijuana was prescribed. One patient withdrew from 
the study early due to experiencing adverse effects after exposure. Average self-reported cannabis 
consumption was 3.2 grams/day (SD = 1.5, range: 1-14).  The study was conducted on a single day, from 8:30 
AM to 3:00 PM. Patients’ breath collection was achieved using the SensAbues exhaled breath collection 
device, which is a plastic tube consisting of a filter that traps the aerosols containing the drug particles for 
effective for rapid collection according to previous research [4]. The subjects were asked to breath into the 
device for a count of 25 breaths. The devices are then stored at -25C until processing. Participants were asked 
to provide a baseline neural assessment and provide blood and breath samples. They consume 20% THC via 
vapes, dabs or by smoking a joint for 10 minutes, asked to report their subjective sense of intoxication on a 
visual analogue scale. After a 30-minute wait period, they provided biological samples and performed 
cognitive testing. The biological samples were then collected every hour for the following 3 hours. 
Neurocognition tests were administered at baseline, after consumption, and prior to the conclusion of the 
experiment. The tests included executive function, language and processing speed, visuomotor processing 
speed, Object naming, and executive function tests. 
To each breath collection device, 1 ng of internal standard (THC-d3) was added. A standard curve (0.001 – 
5,000 ng) was prepared by pipetting the appropriate amount of standard on blank breath pods. Standards and 
samples were treated to the same extraction conditions. Each device was placed on a conical glass tube and 2 
mL of methanol was gently added to each pod and allowed to saturate the pod for 5 min. After 5 min, 5 mL 
of methanol was added to each pod and an empty syringe was used to apply pressure to elute residual 
methanol. The tubes were then centrifuged for 2 min at 500 x g. The supernatant was removed to a 1.5 mL 
Eppendorf tube and centrifuged at 20,000 x g for 45 min at 4°C. The supernatant was transferred to an 
autosampler vial with a glass insert and analyzed by Liquid Chromatography-Tandem Mass Spectrometry 
(LC-MS/MS), following previous research methodologies [5]. 
To a series of 1.5 mL Eppendorf tubes 1 ng of internal standard (THC-d3) was added to each. A standard 
curve (0.001 – 5,000 ng) was prepared by pipetting the appropriate amount of standard into the Eppendorf 
tube along with 100 µL of matrix. Samples had 100 µL of patient plasma added. Standards and samples were 
treated to the same extraction conditions. Each tube was extracted as follows: 1 mL of 0.1% formic acid in 
methanol was added, vortex for 1 min, centrifuge at 20,000 x g for 10 min at 4°C, and the supernatant was 
removed to a conical glass tube which was then evaporated to dryness under a gentle flow of nitrogen at 35°C. 
The supernatant was transferred to an autosampler vial with a glass insert and analyzed by LC-S/MS. THC 
was measured by liquid chromatography-tandem mass spectrometry using a QTRAP 5500 triple-quadruple 
mass spectrometer (Sciex, Framingham, MA) in positive electrospray ionization mode by MRM data 
acquisition with an Agilent 1200 HPLC (Agilent Technologies: Santa Clara, California, USA). 
Chromatography was performed by automated injection on a Kinetex Biphenyl column, 50 x 2.1 mm, 2.6 µm 
particle size) (Phenomenex, Torrance, CA). The HPLC flow was maintained at 400 µL/minute with mobile 
phases consisting of: A= 0.1% formic acid in water, and B = 0.1% formic acid in acetonitrile. Initial conditions 
were 50% A and the gradient was ramped to 5% A by 2.5 min and then returned to 50% A. Total run time 
was 7 minutes. Data acquisition and quantification was performed with Analyst 1.6.2 software (Sciex, 
Framingham, MA).  
Data Analysis 
For data analysis of the breath – blood correlation, we used artificial intelligence-based deep neural network 
analysis to develop models for identifying patterns between the breath and blood plasma THC concentrations. 
Table 1 provides a summary of the biosamples data. The clinical trial data variables used to develop the deep 
learning models included the following: 
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• Time Elapsed since cannabis consumption 
• Breath THC concentration 
• Gender of the participant 
• Age of the participant 
• Dosage consumed 
• Body Mass Index (BMI) of the participant 
In the future, statistical analysis will be conducted on the full data set to explore the relationship between the 
subjective data collected and the bio samples. 
Results 
Our analysis revealed that THC blood concentrations increased less rapidly relative to breath concentrations 
in medical cannabis patients. For majority of participants, the blood concentration levels did not exceed 
5ng/ml, even as breath levels reached their peak values. Breath THC concentrations reached a peak value after 
0.5 hours of consumption on average. Breath concentration levels reached baseline levels after up to 2 hours. 
It was also observed that the peak breath concentrations showed a decreasing trend as the participants’ BMI 
increased, with the peak breath concentrations exceeding 100ng for the participants with a BMI less than 30. 
When comparing both the breath and the blood THC concentration levels between our participants, we found 
that males generally had higher concentrations relative to females. The blood plasma and breath concentration 
peak levels exhibited a decreasing trend as the age of the participants increased. When conducting the baseline 
THC concentration tests at the beginning of the study, Figure 1 reveals that less that 20% of the participants 
had equivalent blood concentration levels below the lower legal limit of 2 ng/ml at baseline, which is the 
minimum concentration required to be considered impaired according to the Canadian Federal Impaired 
Driving Act legislation. We used a plasma – blood conversion model used in the literature (Heustis, Barnes 
& Smith, 2005; Desrosiers, Himes, Scheidweiler, Concheiro-Guisan, Gorelick & Huestis, 2014) to estimate 
blood levels for per se limits comparison. 29% of participants exceeded the estimated blood concentration 
level of 5 ng/ml legal limit at baseline, which is the higher per se limit under the Canadian legislation.  While 
38% exceeded 10 ng/ml. When tested 30 minutes after consumption, 100% of the study participants had 
estimated blood THC concentrations above the 5 ng/ml maximum Canadian legal per se limit. At 150 minutes 
after consumption 100% of the participants were still over the 2ng level, with 85% over the 5 ng limit. The 
subjective data illustrated in Figure 2 was collected as baseline prior to consumption. The mid point was 
survey was collected 30 minutes after consumption, and the final survey was collected prior to discharge 
which would have been 210 minutes after consumption. This data revealed that the subjects reported only 
being moderately high an average of 5/10, pain levels reduced from an 3.7 to 2.8 after consumption.  There 
was an increase in alertness being reported after consumption from 5.4 to 9.2. More analysis is required to 
statistically analyze the subjective  data and explore the relationship with the neurocognitive data.  
Future Research 
The research conducted with medical patients will be replicated with a larger sample size using recreational 
cannabis users.  At the time of this study, it was illegal to consume cannabis and we were restricted by our 
ethics protocol to only use medical patients and they were only allowed to consume for 10 minutes, future 
research will allow longer consumption times and include non-medical patients. The results from the 
recreational cannabis study will be used to train and improve the AI neural network to determine patterns of 
how the breath and blood are related to research subjects  
Conclusion 
The pilot study observed that certain patients had a persistent blood THC concentration level above the legal 
limit even at baseline when the plasma results are converted to blood equivalence. Other research subjects had 
a blood concentration level well below legal limits, even though their THC breath levels was high as illustrated 
in Figure 2. Given this small sample size, there appears to be no direct correlation between blood and breath 
tests.  There are no guidelines in the literature regarding THC breath levels.  The sample of patients in our 
study self reported as being only moderately high (average 5 of 10) following their exposure to THC.  More 
analysis is required to statistically correlate the neurocognitive tests with the blood levels to determine if blood 
levels above the legal limits correlate to impairment. There could be implications for law enforcement in 
regard to generating false positive and false negative impairment tests as tolerance is more likely to develop 
in chronic users (Hartman & Heustis, 2013). When considering the implications, the limitations of our 
research needs to be considered. Some major limitations of our study are the sample size and the scope, which 
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is a challenge present in many clinical trials due to resource constraints. For future studies, it will be necessary 
to increase the sample of the study and increase the number of variables to account for additional factors. In 
summary, our findings validate existing research, and provide additional evidence for using exhaled breath 
testing as an effective means of THC impairment and field sobriety detection (Beck, Sandqvist, Dubbelboer 
& Franck, 2011; Beck, Stephanson, Sandqvist & Franck (2012). 
Appendix 
 
 
Figure 1 : Visual Analysis Scale results for research subjects. 
 
 
Figure 2: Research subjects Blood levels compared to Canadian Per Se limits 
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Abstract 
Background: Point-of-collection testing (POCT) devices for psychoactive substance detection through oral 
fluid samples are used in several countries for traffic enforcement. However, the reported reliability of such 
devices is quite heterogeneous among studies - and evaluating and comparing their analytical performance is 
paramount in order to guide enforcement policies focused on local needs. 
Aim: To evaluate the analytical reliability of four POCT devices for the detection of cocaine and cannabinoids 
using oral fluid samples of Brazilian drivers. 
Method: 168 drivers were recruited during standard roadblock procedures in Southern Brazil. Subjects were 
screened using one of the following POCT devices: the DDS2™, the DOA MultiScreen™, the Dräger 
DrugTest 5000™ and the Multi-Drug Multi-Line Twist Screen Device™ (MDML). Split oral fluid samples 
for confirmatory analysis were also collected, and stored in a -80°C freezer. Results of the screening tests 
were compared with chromatographic assays in order to obtain the reliability parameters. 
Results: The prevalence of confirmed positive samples for cocaine and cannabinoids were 9% and 4.4%, 
respectively. Sensitivity, specificity, and accuracy for cocaine detection were, respectively: DDS2™ = 100%, 
100%, and 100%; MDML™ = 86%, 100% and 98%; Dräger™ = 100%, 100% and 100%; and DOA™ = 83%, 
100% and 97%. Sensitivity, specificity and accuracy for the detection of cannabinoids were, respectively: 
DDS2™ = 75%, 100% and 78%; MDML™ = 29%, 100% and 89%; Dräger™ = 100%, 100% and 100%; and 
DOA™ = 0%, 94% and 100%, 
Conclusion: We observed a high prevalence of drivers testing positive for cocaine and cannabinoids. The 
evaluated POCT devices achieved reliability measures greater than 80% for cocaine detection, which is 
considered appropriate by international guidelines. However, the reliability for cannabinoid detections did not 
achieve the desired parameters in three of the four devices tested. Difficulties in detecting cannabinoids at the 
roadside should be better evaluated before the implementation of such tests.   
Introduction 
The impact of illicit psychoactive substance use in driving performance is being broadly studied in the last 
years. Although there is still no clear evidence on the dose-effect relationship for other substances as there is 
for alcohol, the literature highlights that drug use can impact driving skills in different ways and intensities 
(Busardo et al., 2017; Strand et al., 2016). Besides that, a high prevalence of drug-positive drivers at the 
roadside and involved in traffic collisions are reported worldwide (Christophersen et al., 2016; Lipari et al., 
2013; Penning et al., 2010). In this sense, there is an international effort in applying public policies and new 
technologies aiming the detection and the deterrence of drug use by drivers.  
The use of point-of-collection testing (POCT) devices for psychoactive substance detection was first 
implemented in Australia, and now they are being used for traffic enforcement in several countries (Verstraete, 
2005). The main advantages of POCT devices are the ease of use, the possibility of quick results at the 
roadside, and the screening for multiple substances at the same time using an alternative and non-invasive 
biological matrix, such as oral fluid (Drummer, 2005). On the other hand, the reported reliability of these 
devices seems to vary in different studies, especially for cannabinoids and opioid detection, as shown in a 
recent meta-analysis of our research group (Scherer et al., 2017a). 
In Brazil, despite the fact that drugged driving is prohibited, there is no approved device to test drivers at the 
roadside. Therefore, it is important to evaluate and compare the analytical performance of different POCT 
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devices according to local needs in order to guide public policies. Knowing that cannabinoid and cocaine are 
the most prevalent illicit substances consumed in Brazil (Laranjeira, 2014), this study aimed to evaluate the 
analytical reliability of four POCT devices for the detection of these substances using oral fluid samples from 
Brazilian drivers stopped in roadblocks. 
Method 
A total of 168 drivers were recruited during 37 standard roadblock procedures in Southern Brazil. Data 
collection occurred between 11 PM to 5 AM on different days of the week, according to the traffic patrols 
availability. This study was performed in collaboration with the Department of Transportation of the state of 
Rio Grande do Sul (DETRAN-RS) and the Federal Highway Police (PRF-RS). All data was collected in the 
metropolitan area of Porto Alegre, Brazil, in days and locations chosen by convenience for the police 
department as part of standard operating procedures. Inclusion criteria included being 18 years old or above 
and presenting any condition that would prevent the driver from returning driving to the road (e.g.: positive 
breathalyzer test, no driving license, etc). In this sense, only drivers who were not allowed to return to the 
road were included in this study. Moreover, the last criterion was used to ensure the ethical responsibility to 
avoid a potential positive subject in the drug screening test. All subjects participated voluntarily in the 
research, and sign the informed consent.  
Subjects were screened by trained traffic agents, and saliva samples were tested using a single device. The 
following POCT devices were tested: the DDS2™ (n=50), the DOA MultiScreen™ (n=42), the Dräger 
DrugTest 5000™ (n=23) and the Multi-Drug Multi-Line Twist Screen Device™ (MDML, n=49). The main 
characteristics of each device are presented in Table 1. All screening procedures were performed according 
with the manufactures. Split oral fluid samples for confirmatory analysis were also collected using microtubes 
free of additives and stored in a -80°C freezer.  
The confirmatory analyzes were carried out by the Immunalysis Corporation (California, USA), using the 
standard protocols established by that company, which are based on international recommendations for 
toxicological analysis. Initially, all samples were analyzed by ELISA (Enzyme-Linked Immunosorbent 
Assay). After this step, all samples that tested positive in the ELISA assay - as well as the samples with 
discordant results between the ELISA test and the device screening test - were analyzed again by 
chromatographic methods. 5% of the negative samples (7 for cocaine and 7 for cannabis) were randomly 
chosen to be analyzed by the chromatographic assays as well. The cutoff used for cannabinoids detection 
(THC) was 4ng / mL in the ELISA and 2ng/ mL in the gas chromatography-mass spectrometry (GC-MS) 
analysis. For cocaine, the cutoff was 20 ng/mL in the ELISA and 8ng/ mL in the liquid chromatography 
tandem mass spectrometry (LC-MS/MS). Samples that presented THC and cocaine/benzoylecgonine 
concentrations equal to or greater than 2 ng /mL and 10 ng /mL, respectively, in the chromatographic analyzes 
were considered positive samples, as recommended in the Walsh´s International Guideline.  
 
Table 1. POCT devices used in the study and their main characteristics.  
Device DDS2 Mobile Test 
System 
DOA MultiScreen Draeger DrugTest 
5000 
Multi-Drug 
Multi-Line Twist 
Screen Device 
Manufacture 
(country) 
Alere Inc (United 
Kingdom) 
Ulti Med Products 
(Germany) 
Drägerwerk AG & 
Co. (Germany) 
Alere Inc (USA) 
Drug panel 
(cutoff 
ng/mL) 
Amphetamines 
(50), 
benzodiazepines 
(20), cannabinoids 
(25), cocaine (30), 
opioids (40), 
Methamphetamines 
(50) 
Amphetamines 
(50), 
benzodiazepines 
(10), cannabinoids 
(12), cocaine (20), 
opioids (40), 
Methamphetamines 
(50), Ecstasy (50), 
Oxycodone (40) 
Amphetamines 
(50), 
benzodiazepines 
(15), cannabinoids 
(5-25), cocaine 
(20), opioids (20), 
Methamphetamines 
(35) 
 
Amphetamines 
(50), 
benzodiazepines 
(20), cannabinoids 
(100), cocaine (20), 
opioids (40), 
Methamphetamines 
(50), Phencyclidine 
(10) 
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Interpretation 
of results 
Automatized 
(reader) 
Automatized 
(reader) 
Automatized 
(reader) 
Visual 
     
Legend: the cutoff values for each substance are within parenthesis and are presented as ng/mL. 
 
Results 
Cocaine 
From the 168 subjects that were screening for cocaine during data collection, a total of 160 obtained a valid 
screening result. Of those, 156 were tested in the confirmatory analysis (4 samples were lost due to the small 
volume collected). A total of 14 samples (9% of the 156) were confirmed positive for cocaine. The reliability 
measures of the devices showed a general sensitivity of 87.5%, specificity of 100.0% and accuracy of 98.7%. 
All the evaluated devices obtained reliability measurements for cocaine detection greater than 80%* (Figure 
1).  
* International recommendation from the DRUID project. 
 
Figure 1. Reliability measures for cocaine detection among the four tested POCT devices. PPV = positive 
predictive value; NPV = negative predictive value. 
Cannabinoids 
From the 160 subjects that obtained valid results in the cannabinoids screening tests, 158 were tested in the 
confirmatory analysis (2 samples were lost due to the small volume collected). A total of 7 samples (4.4% of 
the 158) were confirmed positive for cannabis. The reliability measures of the devices showed a general 
sensitivity of 41.2%, specificity of 98.6% and accuracy of 92.4% for the detection of cocaine. Just one device 
devices obtained reliability measurements for cannabinoids detection greater than 80% (Figure 2). 
 
 
Figure 2. Reliability measures for cocaine detection among the four tested POCT devices. PPV = positive 
predictive value; NPV = negative predictive value. 
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Discussion 
The present study allowed the initial analytical evaluation and comparison of four POCT devices for cocaine 
and cannabinoid detection using samples from Brazilian drivers. Our findings corroborate previous studies 
that suggest a significant prevalence of Brazilians drivers with positive results for the detection of drugs other 
than alcohol. Besides that, the reliability analysis of the devices for cocaine detection showed values of 
sensitivity, specificity and accuracy within the internationally recommended parameters (>80% according to 
DRUID project) for all evaluated devices. On the other hand, just one device achieved acceptable reliability 
measures for cannabinoids detection. However, it is important to point out that this same device had a lower 
number of evaluations when compared to the others, which may influence the presented results. 
Studies that evaluated cocaine detection in roadside studies usually show good analytical reliability, with 
accuracy ranging from 63 to 100% (Scherer et al., 2017a). Due to its basic properties, cocaine and their 
metabolites are likely to be found in oral fluid, especially after the first hours of administration (Cone and 
Huestis, 2007; Ellefsen et al., 2016a). Recently, two studies evaluating DDS2™ using oral fluid sample of 
drivers found an accuracy of 99% (Edwards et al., 2017) and 85.7% (Veitenheimer and Wagner, 2017). Other 
devices, although less evaluated in the literature, also presented acceptable reliability measures in recent 
studies (Ellefsen et al., 2016b; Scherer et al., 2017b). By the other hand, the reliability measures of POCT 
devices for cannabinoids detection are very heterogeneous among studies, especially because of its 
hydrophobic properties and its complex pharmacokinetics (Bosker and Huestis, 2009; Choo and Huestis, 
2004; Cone and Huestis, 2007). In our meta-analysis, we found accuracies ranging from 41 to 100%, with a 
summarized AUC of 85% (Scherer et al., 2017a). According to Newmeyer et al. (2017), the analytical 
accuracy of  the DT5000 ranged between and 84.0%–92.0% in studies using oral fluid samples with low 
confirmatory cutoff. For DDS2™, similar results were obtained (Moore et al., 2013; Newmeyer et al., 2017; 
Veitenheimer and Wagner, 2017).  
It is important to note that the great variability among different studies could be due to several methodological 
approaches, involving aspects from oral fluid collection until confirmatory analysis protocols. This highlight 
the need for evaluating each device according to local polices and local needs. In our study, the reliability for 
cannabinoid detections did not achieve the desired parameters in three of the four devices tested. Therefore, 
difficulties in detecting cannabinoids in the Brazilian context should be better evaluated before the 
implementation of these tests. Moreover, further studies should be performed in order to evaluate the 
reliability of the detection of other drugs, expanding the sample size and including other Brazilian locations.  
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Abstract 
Context: Although drug-impaired driving has been prohibited in Canada since 1925, there were no drug-
specific enforcement provisions until the Criminal Code was amended in 2008 to authorize standardized 
field sobriety testing and Drug Recognition Evaluation (DRE). While these provisions improved 
enforcement somewhat, they had little, if any, deterrent effect. DRE evidence was routinely challenged, and 
courts were sceptical about the link between the presence of a drug and impairment of driving-related skills. 
With the de-criminalization of cannabis in 2018, there will be even greater need to identify and prosecute 
drug-impaired drivers.  
Objectives: This paper examines key drug-impaired driving provisions of Bill C-46, which received Royal 
Assent in June 2018. Among other things, it authorized Parliament to create per se drug-impaired driving 
offences, and authorized police to demand bodily samples (most likely oral fluid) if they reasonably suspect 
that a driver has drugs in his body. These are important provisions, but will still pose challenges for the 
enforcement and prosection of drug-impaired driving.  
Key Outcomes: The challenges posed by the legislation are: (1) it will be difficult for police to prove that 
they had the requisite reasonable suspicion that a driver had drugs in his body; (2) due to limitations in the 
technology, the THC threshold of screening devices will be set much higher (25ngs) than the per se limits 
(2-5ngs and 5+ngs); (3) the cost and time delay associated with the devices will limit the feasibility of 
roadside screening tests for cannabis.  
Discussion and Implications: Without a quick, simple, inexpensive, and accurate means of screening for 
drugs at roadside, this new legislation is unlikely to have a deterrent effect, and the incidence of driving after 
cannabis use is likely to increase, particularly among youth.  
Disclosure: Chamberlain is on the MADD Canada Board of Directors; Solomon is Director of Legal Policy 
for MADD Canada. 
 
Introduction 
Although drug-impaired driving has been prohibited in Canada since 1925, there were no drug-specific 
enforcement provisions until the Criminal Code was amended in 2008 to authorize standardized field 
sobriety testing (SFST) and Drug Recognition Evaluation (DRE). While these provisions improved 
enforcement somewhat, they had little, if any deterrent effect (Solomon & Chamberlain, 2014). Recent 
survey and roadside screening data indicate that driving after cannabis use continues to increase (Robertson 
et al., 2017; Beirness & Porath, 2017), and that the percentage of drivers testing positive for drugs exceeds 
the percentage testing positive for alcohol, particularly among young people (Beasley & Beirness, 2014; 
Beirness & Beasley, 2018). Further, while the percentage of fatally-injured drivers testing positive for 
alcohol has been decreasing, the percentage testing positive for drugs has been increasing (Solomon, Ellis & 
Zheng, 2018, p. 1). The number of cannabis-positive, fatally-injured drivers increased more than 230% from 
2000 to 2014 (Traffic Injury Research Foundation, 2017, p. 1).  
 
With the de-criminalization of cannabis in Canada in 2018, there will be even greater need to identify and 
prosecute drug-impaired drivers. Unfortunately, the enforcement measures introduced in Bill C-46 (2018) 
are likely to prove challenging in their implementation, and will not allow enforcement to keep pace with the 
inevitable increase in cannabis use in Canada (Solomon, Chamberlain & Vandenberghe, 2018).  
 
 
The Pre-Existing Law 
Prior to 2008, police in Canada had no specific authority to gather evidence related to drug-impaired driving. 
The relevant criminal offence was simply driving while one’s ability was impaired by alcohol or any drug 
(Criminal Code, s. 253(1)(a), now s. 320.14(1)(a)). This meant that the prosecution of drug-impaired driving 
was typically based on an officer’s testimony about the accused’s driving and other behaviour (e.g. erratic 
driving, lack of coordination, slurred speech, admission of drug consumption). However, even when a driver 
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had consumed drugs and was obviously impaired, the Crown usually needed to introduce expert evidence to 
prove that the drug was the cause of the impairment. Obtaining a conviction based on the testimony of a 
non-expert patrol officer was described by the Department of Justice as “nearly impossible” (Department of 
Justice, 2003, p. 4).  
 
In light of these challenges, the Criminal Code was amended in 2008 to add two drug-impaired driving 
enforcement tools. First, police were authorized to demand that a driver participate in SFST if they had 
reasonable grounds to suspect that the driver had any alcohol or drugs in his or her body (Criminal Code, s. 
254(2)(a), now s. 320.27(1)(a)). This low threshold test is based on the same grounds as demanding breath 
tests on approved screening devices (ASDs). As with ASD tests, the results of SFST can only be used to 
screen drivers and provide grounds for demanding an evidentiary breath test or DRE.  
 
Second, police were given authority to demand DRE from a driver who they had reasonable grounds to 
believe had, within the preceding three hours, committed the offence of driving while impaired by drugs or 
by a drug in combination with alcohol (Criminal Code, s. 254(3.1), now s. 320.27(2)(a)). The results of the 
DRE were admissible in evidence at trial, if the DRE was conducted in accordance with the stringent 
regulatory requirements and the driver was afforded the right to counsel. Refusal to participate in either 
SFST or DRE, without a reasonable excuse, is a criminal offence.  
 
While these amendments were an improvement, they raised challenges of their own. With respect to SFST, 
research suggests that police may fail to detect many drug-positive drivers, and may never even demand a 
screening test (Brubacher et al., 2018). Research also suggests that SFSTs are not an especially valuable 
screening tool when it comes to assessing impairment caused by cannabis or other drugs (Stough et al., 
2006). DRE tests, in turn, are time-consuming and cumbersome, and the training of evaluating officers is 
expensive (Solomon & Chamberlain, 2014). This means that the number of qualified DRE officers in 
Canada is relatively low, and their distribution across the country is uneven. For instance, it may be difficult 
to secure an evaluating officer in a rural community late at night within the prescribed three-hour time limit.  
Further, DRE is primarily an indication that the driver has a specified drug in his or her system; it does not 
focus on driver impairment. As a result, DRE evidence was routinely challenged by accused, and judges 
were sceptical about the link between the presence of a drug and impairment of driving-related skills 
(Solomon & Chamberlain, 2014; R. v. Abbasi-Rad, 2016). Moreover, it was not until 2017 that the Supreme 
Court of Canada ruled that DRE evidence was admissible in court without having to independently qualify 
the evaluating officer as an expert through a special voir dire hearing (R. v. Bingley).  
 
These difficulties help to explain why, in spite of the increase in driving after drug use, drug-impaired 
driving charges accounted for only 3.9% of total impaired driving charges in 2016 (Statistics Canada, 2018). 
Even when drivers are charged, the conviction rate for drug-impaired driving is significantly lower (61%) 
than for alcohol-impaired driving (81%) (Perreault, 2015). In short, enforcement methods were not keeping 
up with the increasing rates of driving after drug use.  
 
The 2018 Legislative Amendments 
Bill C-46 was a major revision of the Criminal Code’s impaired driving provisions, including the 
introduction of mandatory (i.e. random) alcohol screening and a restriction on several problematic defences. 
It also confirmed that DRE evidence is admissible without having to independently qualify the evaluating 
officer as an expert. In terms of new drug-impaired driving provisions, two changes were critical: Parliament 
was given authority to establish per se drug-related driving offences (Criminal Code, s. 320.14(1)(c)); and 
police were authorized to demand roadside drug screening tests (s. 320.27(1)(c)) and evidentiary blood tests 
(s. 320.28(2)(b)) in specified circumstances.  
 
The Per Se Offences  
Pursuant to Bill C-46, Parliament has enacted three new cannabis-related per se driving offences:  
i. having 2 but less than 5 nanograms of THC per ml of whole blood (a summary conviction offence 
punishable by a fine of up to $1000);  
ii. having 5 or more nanograms of THC per ml of whole blood (a hybrid offence, with the same 
penalties as the alcohol-impaired driving offences);  
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iii. having 2.5 or more nanograms of THC per ml of whole blood and a BAC of 0.05% or higher (a 
hybrid offence with the same penalties as the alcohol-impaired driving offences).  
 
Testing of Bodily Fluids  
 
Bill C-46 maintained the police power to demand SFST and DRE in specified circumstances, and added two 
other powers to collect evidence of drug-impaired driving. First, police are authorized to demand “a sample 
of a bodily substance” for testing on “approved drug screening equipment” from a person if they have 
reasonable grounds to suspect that the person has a drug in his or her body and has driven within the 
preceding three hours. For the foreseeable future, this power will be limited to requiring oral fluid samples 
on a roadside oral fluid test kit.  
 
Second, Bill C-46 authorizes police to demand that a person provide a blood sample (Criminal Code, s. 
320.28(2)(b)) or submit to DRE (s. 320.28(2)(a)) if they have reasonable grounds to believe that the person 
has driven while his or her ability to do so was impaired to any degree by a drug, or a drug in combination 
with alcohol, or has committed the offence of driving with a blood-drug concentration equal to or greater 
than the proscribed limit.  
 
The Challenges Raised by the 2018 Enforcement Provisions 
While the new per se offences and police powers will strengthen drug-impaired driving enforcement, there 
are significant limits on their effectiveness, particularly in regard to THC. There are three obvious 
challenges.  
 
First, it may be difficult for officers to meet the threshold requirement for demanding an oral fluid sample, 
namely, that they had reasonable grounds to suspect that the driver had drugs in his or her body. This test 
has already proved to be a significant hurdle in alcohol-impaired driving cases: a national survey indicated 
that defence counsel often successfully challenged the basis for the officer’s belief that the driver had 
alcohol in his or her body and, thus, the legality of the demand for a breath screening test or SFST 
(Robertson, Vanlaar & Simpson, 2009, pp. 68-70). This would, in turn, result in the evidentiary breath tests 
being excluded from evidence and, ultimately, in the accused’s acquittal. We can expect that officers will 
have even more difficulty establishing the requisite grounds in drug-related cases, since the signs and 
symptoms of drug use are not as widely recognized.  
 
Next, based on the Canadian Society of Forensic Science’s recommendation, the THC threshold for testing 
positive on the roadside oral fluid screening devices was set at 25 nanograms per millilitre of oral fluid 
(Canadian Centre of Forensic Science, 2017, p. 4). This threshold is obviously under-inclusive, in that 
drivers with 2 to 24 nanograms/millilitre of oral fluid will evade detection and will not be required to submit 
to DRE or evidentiary blood testing, even though many of them may be above the Criminal Code per se 
limit at roadside. (This high threshold was adopted because THC levels in blood peak during or immediately 
after use, and fall an estimated 80% to 90% within 30 minutes. A lower threshold could result in some 
drivers failing the roadside test, only to be cleared on an evidentiary test after having been brought to the 
police station, given the opportunity to contact counsel, etc.)  
 
Finally, the current cost of oral fluid drug testing is substantial, ranging anywhere from $12-$45 per test kit, 
depending on the manufacturer (Hildrebrand et al., 2008; Asbridge & Ogilvie, 2015). The time it takes to 
obtain the test result also varies depending on the manufacturer, ranging from 3 to 12 minutes. Moreover, 
the cost of an evidentiary blood-drug test kit appears to be in the range of several hundred dollars, and it can 
take months to obtain the results. This is troubling, since drug-impaired driving cases already require more 
court appearances and take about twice as long to complete as alcohol-impaired driving cases (median 
length 227 days vs 121 days) (Perreault, 2016, pp. 15-16). By comparison, a roadside or evidentiary alcohol 
breath test costs pennies and the results are available in a minute.  
 
Unfortunately, there is no inexpensive, quick, simple, and accurate means of screening large numbers of 
drivers for cannabis at roadside. Given the costs and wait times, it is not feasible to conduct the large 
number of roadside drug screening and evidentiary blood tests necessary to substantially decrease the 
prevalence of drug-impaired driving.  
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Conclusion 
Like the 2008 amendments, the 2018 amendments should be viewed as a positive development, in that they 
will moderately strengthen enforcement and increase detection, charge and conviction rates for cannabis-
impaired driving. The deterrent impact of these new provisions will depend in part on whether the provinces 
and territories enact complementary drug-related roadside administrative licence suspension provisions, and 
whether federal and provincial governments are willing to make the very substantial financial commitments 
necessary to maintain relatively high rates of roadside oral fluid drug screening. However, it remains to be 
seen whether the new cannabis-related driving provisions will halt, let alone reverse, the increasing 
incidence of driving after cannabis use.  
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Abstract 
 
Background: Risky drivers present heterogeneous profiles and personality traits. No data regarding the 
identification of these clusters exist in Brazil; therefore, deterrence efforts will be less focused and effective. 
Objective: To identify driving risk behavior (DRB) clusters in Brazilian drivers and examine differences in 
drug use. 
Methods: A total of 6,392 drivers were recruited by convenience in public spaces (e.g. supermarkets, gas 
stations, shopping malls) of five Brazilian cities. A Knowledge, Attitudes, and Practices survey was 
conducted via face-to-face interviews between 4:00 and 10:00 PM in order to collect information regarding 
driving behaviors. All recruited drivers were 18 years old or above, and were residents of the interventions 
cities. An optimal number of clusters for DRB was determined by average silhouette width. A Partition 
Around Medoids (PAM) algorithm was used to identify groups of car drivers in relation to the following 
DRB: driving without a seat belt (SB), exceeding the speed limit (SPD), using a cell phone while driving 
(CELL), and driving after drinking alcohol (DUI). After these clusters were identified, we conducted a 
descriptive analysis of sociodemographic and drug use profile of each group.   
Results: The sample comprised mostly men (63,4%), with a mean age of 43 years, and a mean of 13 years 
of education. More than 22% of the sample presented episodes of binge drinking in the previous year, and 
7,6% reported drug use other than alcohol. Five clusters of DRB were identified. In cluster 1 (20.1%), 
subjects presented history of CELL; in cluster 2 (41.4%) drivers presented no DRB; in cluster 3 (9.3%), all 
drivers presented SPD; in cluster 4 (12.5%) drivers presented high percentage of all DRB, and in cluster 5 
(16.6%) all drivers presented DUI, with low prevalence of the other DRB. Clusters with DUI (4 and 5) 
comprised more men (82 and 79%, respectively), with binge drinking (51 and 46%) and drug use in the 
previous year (13.5 and 8.6%). Cluster 1 had more education years (mean=14.4) and the highest personal 
income (mean=US$1,335). Cluster 2 had older drivers (mean=46.6 years), and fewer bingers (11%). Cluster 
4 had the youngest drivers (mean=34.4 years). 
Conclusions: We could classify drivers with different DRB. Overall, alcohol-related clusters are associated 
with young who frequently binge. This supports behavior heterogeneity among drivers, calling for targeted 
interventions for these clusters. 
 
Introduction 
It is well established that most road traffic injuries (RTI) are consequences of human factors, in particular 
driving behaviors. According to the World Health Organization, the human behaviors that lead to most RTI 
are: driving above the speed limit; using cellphone while driving; not using safety devices such as child 
restraint, helmet and seat belt; and driving under the influence of alcohol and other psychoactive substances 
(PAS) (WHO, 2019). In this sense, recent evidence suggests that there is a high heterogeneity among risky 
drivers, and the different combination of these risky behaviors may imply very different profiles of drivers 
(Brown et al., 2016). Thus, interventions aimed at risky drivers would benefit from a better understanding of 
the particularities of these individuals - especially in low- and middle-income countries, where evidence is 
scarce and mortality due to RTI are among the highest.  
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Due to the fact that traffic behavior is a multifactorial component with non-linear relationships between 
different variables, the use of complex methods of analysis, such as Machine Learning (ML), could be 
useful to identify patterns of risks that are difficult to recognize when using traditional methods. Among ML 
methods, cluster analysis (Xu & WunschII, 2005) is a clinically relevant method because it detects inter-
individual differences and the existence of multiple groups, breaking a unidimensional classification (Bora, 
Veznedaroğlu, & Vahip, 2016; Lee et al., 2017). Thus, the use of this kind of analysis could favor the 
identification of the clusters of drivers who present different and overlapping patterns of risky behaviors, 
facilitating the development of more specific and effective interventions. Therefore, we aimed at identifying 
clusters of driving risk behavior (DRB) in a sample of Brazilian drivers using ML algorithms, and at 
verifying their differences concerning sociodemographic characteristics and drug use profile. 
Method 
Data collection, sampling, and procedures 
Data presented in this study were collected as part of the Global Road Safety Program Brazil/“Vida no 
Trânsito” project. In the present analysis, we used secondary data from the interview of Brazilian drivers at 
public places to understand their knowledge, attitudes, and practices (KAP survey) concerning alcohol/drug 
use and other behavioral risk factors. The KAP survey was conducted in five Brazilian capitals once 
between March and May 2014, and again between August and November 2014. While the survey was 
explicitly designed to better understand drink driving, questions regarding other risk behaviors were also 
embedded. 
The sampling occurred in two stages: 
1. Intervention cities were divided into regions along existing municipal divisions. The regions were 
selected with the assumption that the distribution of drivers therein was equal to that of the 
general (city-wide) driving population. The number of regions that were sampled varied 
according to the size of the intervention city. 
2. In each of the regions, the data collection teams identified sites in which they could safely 
approach drivers. Consistent with methods employed in other Global Road Safety Program 
countries, these sites included: supermarkets, gas stations, shopping malls, fairs, plazas, and 
public parks. Where needed, the team requested authorization from business owners to conduct 
the surveys in parking lots or near the entrances/exits of a given establishment. The same data 
collection sites were maintained for all rounds. 
The target population for the KAP survey was drivers registered in each intervention city. Anyone reporting 
not having driven in the last 12 months, or being a tourist, i.e. from another city, was excluded. Individuals 
under 18 years were also excluded. The KAP surveys were conducted via face-to-face interviews and all 
data were entered into an ODK-based structured questionnaire, which was accessed via tablet. Data were 
collected during five consecutive days, by two different teams, between 4:00 and 10:00 PM - although 
adjustments were made due to the specificities of each city (i.e. climatic conditions). Data collection teams 
were comprised of four interviewers and a manager, who in addition to overseeing the data collection 
process also provided a brief intervention to drivers who reported drinking immediately prior to the 
interview, and especially if they reported intending to drive after the interview. This intervention consisted 
of explaining the risks associated with drink driving and offering to the participant the possibility of a safe 
ride home via a friend or family member, or a taxi voucher.  
A total of 12,231 persons were approached during the KAP survey data collection. Of those, 1,308 reported 
not having driven in the previous 12 months and 1,199 did not accept to participate in the study, ending in a 
final sample of 9,724 participants.  
This study was approved by the Institutional Review Board at the Hospital de Clínicas de Porto Alegre 
(under N. GPPG 10-0477 - CAAE/CONEP-Brazil:22108813.6.0000.5327). All subjects included in the 
study signed informed consent.  
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Data pre-processing  
 
For the present analysis, we selected just the participants who referred to being cars or truck drivers 
(n=7,439). From those, we excluded 1,045 participants who have not finished the interview and, for that 
reason presented missing information. Therefore, the final number of participants included in the present 
analysis was 6,392 drivers. The following variables were used to perform the cluster analysis: a) Driving 
without seat belt; b) Exceeding the speed limit; c) Using the phone while driving; and d) Driving after 
drinking alcohol.  
  
Data analysis 
 
We used the algorithm Partition Around Medoids (PAM) (Kaufman & Rousseeuw, 2005) to identify groups 
of car drivers in relation to behavior risk, using as input the variables presented in the previous section. PAM 
is a realization of a k-medoids clustering algorithm that groups a set objects into a given number k of 
clusters. This machine learning technique attempts to minimize the sum of dissimilarities between data 
points labeled to be in a cluster and its medoid. PAM starts randomly selecting k of the n data points as the 
medoids. Then, the algorithm repeats the following steps: assigning each data point to the cluster with the 
closest medoid; for each medoid, randomly select a point, compute the cost of swapping it with the medoid; 
if the cost decreased, select this new configuration of medoids. PAM ends the computation when there is no 
change in the assignments. 
 
We have used the Gower’s distance to perform the dissimilarities (Gower, 1971). The best number of 
clusters was determined by analyzing the average silhouette width and the practical interpretation of the 
clusters. Another internal validation measures were performed to verify the quality of clustering as Dunn 
and Person-Gamma Indexes (Hassani & Seidl, 2017).  
 
Results 
 
The PAM algorithm returned five clusters of drivers. In Cluster 1 (n=1282, 20.1% - “unsafe cellphone 
users”) all subjects presented a history of cell phone use while driving. Cluster 2 (n=2649, 41.4% - “safe 
drivers”) was comprised of subjects who do not exhibit driving risk behaviors. In Cluster 3 (n=595, 9.3% - 
“speeders”) all drivers presented a history of exceeding the speed limit. In Cluster 4 (n=802, 12.5% - “high-
risk drivers”), drivers presented a high percentage of all driving risky behaviors analyzed. Cluster 5 
(n=1064, 16.6% - “drunk drivers”) was comprised of drivers with history of driving after drinking alcohol, 
with a low prevalence of other driving risk behaviors. The socio-demographic characteristics, drug use 
profile and other traffic infractions of each cluster are shown in Table 1.  
Table 1. Sociodemographic characteristics, drug use profile and traffic infractions among the five clusters of 
DRB.  
  Cluster 1 
Unsafe 
cellphone 
users 
Cluster 2 
Safe 
Drivers 
Cluster 3 
Speeders 
Cluster 4 
Risky 
drivers 
Cluster 5 
Drunk 
drivers 
  n=1282  
(20.1%) 
n=2649  
(41.4%) 
n=595  
(9.3%) 
n=802  
(12.5%) 
n=1064  
(16.6%) 
Sex ¹           
..Male 714 (55.7) 1446 
(54.6) 
398 (66.9) 657 (81.9) 838 (78.8) 
..Female 568 (44.3) 1203 
(45.4) 
197 (33.1) 145 (18.1) 226 (21.2) 
Age (years) ² 39.8 ± 12.5 46.6 ± 15 43 ± 15.4 34.4 ± 11.4 40.5 ± 12.7 
Years of 
Education ² 
14.4 ± 3.4 12.8 ± 3.9 12.7 ± 3.9 13.7 ± 3.2 13.8 ± 3.4 
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Monthly income 
(R$) ³ 
3000 
[2000-5000] 
2450  
[1400-
4000] 
2500 
[1500-
4000] 
3000  
[1700-
5000] 
3000  
[2000-
5500] 
Proportion of 
driving years in 
life (%) ² 
43.2 ± 19 41.6 ± 
21.9 
41.9 ± 
21.2 
41.1 ± 18.1 43.8 ± 18.6 
Binge drink ¹           
..Binge drinker 177 (13.8) 288 (10.9) 79 (13.3) 408 (50.9) 486 (45.7) 
..Don't binge drink 397 (31) 823 (31.1) 154 (25.9) 326 (40.6) 578 (54.3) 
..Don't drink 708 (55.2) 1538 
(58.1) 
362 (60.8) 68 (8.5) 0 (0) 
Believes alcohol 
impair driving ¹ 
1132 (88.3) 2405 
(90.8) 
534 (89.7) 530 (66.1) 677 (63.6) 
Lifetime accident 
involvement after 
dinking 
60 (4.7) 66 (2.5) 20 (3.4) 112 (14.0) 89 (8.4) 
Drug use¹* 98 (7.6) 153 (5.8) 35 (5.9) 108 (13.5) 91 (8.6) 
Drugged driving¹* 51 (4.0) 59 (2.2) 11 (1.8) 71 (8.8) 57 (5.3) 
Fined for 
cellphone use 
while driving ¹* 
152 (11.9) 23 (0.9) 15 (2.5) 99 (12.3) 62 (5.8) 
Fined for not using 
seat belt while 
driving ¹* 
61 (4.8) 54 (2) 23 (3.9) 84 (10.5) 47 (4.4) 
Fined for speeding 
¹* 
278 (21.7) 282 (10.6) 142 (23.9) 284 (35.4) 219 (20.6) 
¹Frequency (%); ²Mean ± standard deviation; ³Median [Q1-Q3]. *In last year. 
Conclusion 
The cluster analysis identified five subgroups of drivers with different profiles of DRB engagement. These 
subgroups differed both on sociodemographic characteristics and drug use profile. In line with international 
evidence (Brown et al., 2012; Dotta-Panichi, Wagner, & Sarriera, 2013; Flowers et al., 2008; Sanna et al., 
2015; Stephens, Bishop, Liu, & Fitzharris, 2017), our study showed that drunken driving-related clusters are 
associated with male young drivers who frequently binge. They also presented the highest prevalence of 
PAS use, history of drugged driving in the previous year, and lifetime history of road traffic crashes when 
compared with the other clusters.  
Despite the fact of some limitations, including the reliance on self-report data and the use of a convenience 
sample, this study offers for the first time an evaluation of multiple DRB in a big sample of Brazilian 
drivers. Even though cluster results are usually difficult to replicate, this method is being consistently used 
to identify clusters of drivers with different profiles in order to provide a foundation for public policies. In 
addition, our results endorse the hypothesis that lower awareness of impairment is correlated with the higher 
frequency of drunken driving behavior and that in Brazil there is still a lack of traffic enforcement – which 
can be affirmed by the low prevalence of fines among the clusters with different risky behaviors. In 
conclusion, the heterogeneity of DRB among our sample highlights the need to develop and evaluate 
different strategies in order to deter drivers according to cluster profiles.  
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Abstract 
Background: Remedial programs have shown value on several measures, including reduced recidivism and 
substance use.  These findings have involved lengthy, complex studies that are typically not feasible for 
monitoring effectiveness on an ongoing basis, or for quality assurance purposes.  We describe here 
development and preliminary validation of a brief, within-session measure of change to monitor program 
impact on an ongoing basis.  
Objectives: We constructed a 13-item instrument reflecting content areas shown in previous research or 
suggested by theory to be related to program outcomes:  drinking-driving knowledge, attitudes, negative 
affect, behavioural intentions, and perceived self-efficacy in avoiding future drink-driving.  We conducted 
preliminary validation studies to determine if these measures capture within-session change, and if that 
change predicts substance use at 6-month follow-up.  
Methods: A sample of 1,647 participants in Ontario’s Back on Track (BOT) program completed the 13–
item scale immediately before and immediately following participating in their assigned 8-hour Education or 
16-hour Treatment program.  Another sample of 394 Warn Range offenders completed the scale 
immediately before and after completing their Education (n=363) or Treatment program (n=31).  Using 
probabilistic matching procedures, pre and post data are being matched to 6-month follow-up data to assess 
the relationship of within-session change to longer-term behaviour change.   
Results: The scale appears sensitive to change immediately following program completion, with beneficial 
changes for nearly all measures across both Education and Treatment programs.  Preliminary results from 
the probabilistic matching data suggest that some measures of within-session change are predicting change 
in substance use at 6-month follow-up, with changes in negative affect and self-efficacy being most 
consistently related.  Confirmation with a larger sample is ongoing.  
Discussion: The scale can identify positive change immediately following participation in a brief remedial 
measures program. Preliminary results suggest that this within-session change predicts change in self-
reported substance use at 6-month follow-up. 
Introduction 
The strongest evidence for the beneficial effects of remedial program participation among impaired driving 
offenders comes from large scale studies assessing the medium to long-term impact of remedial program 
participation on substance use, recidivism and health outcomes (e.g., Brown et al, 2010; Ma et al, 2015; 
Mann et al, 1988, 1994; Stoduto et al, 2014; Wells-Parker & Williams, 2002; Wickens et al, 2013). Early 
evaluations also reported short-term effects of remedial program participation on attitudes and related 
measures but these measures were criticized for not being related to longer-term outcome measures (Mann 
et al, 1983). A validated measure of within-session change that is predictive of long-term outcomes would 
be useful for clinical and evaluation purposes in cases where longer-term follow-ups are not feasible. 
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However, no validated or standardized measures of within-session change have been reported in the 
literature.   
We report here the development and preliminary validation of a within-session measure of change in 
remedial programs for drink-driving offenders guided by previous research and theoretical considerations. 
Items were developed reflecting five general areas: (1) knowledge related to drink-driving; (2) attitudes 
towards driving after drinking and traffic safety in general; (3) behavioural intentions; (4) self-efficacy, and; 
(5) negative affect. Measures of knowledge and attitudes have long been used as measures of the immediate 
impact of programs for drinking drivers, and more generally to assess impact of psychoeducational program 
participation (Mann et al, 1983, 1988). Previous studies have shown that knowledge and attitude measures 
will change with remedial program participation (Mann et al, 1983). Behavioural intentions are an 
individual’s plans or expectations of performing a behaviour at some time in the future, and these are 
important components of Ajzen and Fishbein’s influential theory of behaviour change (Ajzen & Fishbein, 
2000). Behavioural intentions have also been shown to be useful predictors of future behaviour, and change 
in behavioural intentions are related to behavioural change (Webb & Sheeran, 2006). Self-efficacy is the 
belief that one can successfully complete tasks or achieve goals, and is a central construct in Bandura’s 
prominent model of behavioural change (Bandura, 1977). Self-efficacy measures have been identified as 
important predictors of future behaviour in drink-driving and related programs (Wells-Parker et al, 2000). 
Negative affect consists of negative feelings or emotional states such as depression and anxiety and has been 
linked theoretically to the impact of remedial measures programs for convicted drinking drivers (Wells-
Parker et al, 2009). Research confirms that negative affect is significantly related to program outcomes 
(Mann et al, 2009; Wells-Parker & Williams, 2002).  
The measures of within-session change used in early evaluations of remedial measures programs typically 
included measures of knowledge and attitudes, which had only modest theoretical justification for linking to 
longer-term change. Our inclusion of measures of change in behavioural intentions, self-efficacy and 
negative affect have stronger theoretical justifications for being linked to measures of longer-term change. 
We describe here change in these measures over the course of participating in an 8-hour or 16-hour remedial 
intervention. We also present a preliminary assessment of how change over the course of participating in the 
remedial intervention is associated with change in the number of drinking days reported between assessment 
and 6-month follow-up. The number of drinking days has been found previously to be an important indicator 
of successful remedial program outcome (e.g., Flam-Zalcman et al, 2013; Wickens et al, 2018). 
Method 
Setting and Samples 
This work was conducted as part of the ongoing evaluation of Back on Track (BOT), Ontario’s remedial 
measures program for impaired driving offenders. Individuals who attend BOT as a result of a Criminal 
Code conviction must complete an assessment, then either an 8-hour Education or 16-hour Treatment 
workshop depending on their risk category as determined by the assessment, followed six months later by a 
follow-up interview. Individuals who attend BOT as a result of a roadside Warn Range offence must either 
complete the Education program (second-time offenders) or the Treatment program (third-time offenders).   
The BOT participants included in the first analysis were the 1,647 individuals (Criminal Code and Warn 
Range offenders) from whom matched pre- and post-workshop questionnaires were collected between 
September 2011 and October 2012. Of these respondents, 853 completed the Education workshop and 794 
completed the Treatment workshop. Ethical concerns regarding anonymity of respondents led to the use of 
probabilistic matching procedures for linking pre- and post-workshop forms, that involved use of a restricted 
identifier code for each participant that included only first initial and initial of birth month. As well, it is 
made clear to all participants that completion of the questionnaires is not mandatory.  During this time 
period, approximately 11,317 individuals completed the BOT program, suggesting that 15 percent of 
participants completed both pre- and post-workshop forms and their forms were successfully matched. The 
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participants included in the second analysis were a subsequent sample of 8,300 Criminal Code offenders 
who participated between 2012 and 2017, for whom matched pre- and post-workshop questionnaire data 
were available, and whose data were also able to be matched to their assessment and 6-month follow-up data 
using probabilistic matching procedures. 
Pre- and Post-Workshop Questionnaires 
Administration of the brief evaluation instrument at the beginning and at the end of each Education and 
Treatment workshop was incorporated as standard procedure into BOT. Pre- and post-workshop 
questionnaires were identical and presented participants with a total of 13 items, as summarized in Table 1. 
All participants were informed that these questionnaires were not part of the official BOT program, and that 
completion of the questionnaires was completely voluntary. 
Statistical Analysis 
Data were analyzed using SAS. To assess within-session change, paired-sample t-tests were conducted on 
all 13 items, contrasting pre- and post-workshop scores. Analyses were conducted for the total sample, as 
well as for Education and Treatment workshop participants separately. To assess how within-session change 
related to change in drinking days between assessment and 6-month follow-up, simple regression analyses 
were conducted for each of the 13 items. The outcome measure was the difference in the number of drinking 
days between assessment and six months follow-up and the independent measure was the difference 
between pre- and post-workshop questionnaire scores. Table 2 shows the regression parameter estimates 
(beta), t and p-values of the model for each item. 
Results 
Within-Session Change - All Workshop Participants 
Table 1 presents the pre- and post-workshop scores for each item for all respondents, Education and 
Treatment workshops combined. Separate analyses were conducted for participants in the Education 
Workshop and the Treatment Workshop, with very similar results.  In terms of participants’ drink-driving 
knowledge, significant improvement was demonstrated. Participants’ mean estimate of the number of drinks 
an average person can have in two hours and still drive safely went from 1.06 before BOT workshop 
completion to 0.71 following BOT workshop completion. 
Improved affect was also demonstrated by the full sample of participants following program completion. 
Participants reported feeling less sad or blue and less nervous after BOT completion. Participants also 
expressed changes in attitudes toward drink-driving, acknowledging the behaviour as dangerous and as 
representing a major safety problem. Results for the full sample showed improved behavioural intentions to 
avoid driving after consuming three drinks at a party, as well as just one drink at a party. Interestingly, there 
was no change in participants’ intentions to reduce how much they drink to avoid driving after drinking. The 
full sample’s ratings of both self-efficacy items increased following BOT workshop completion, 
demonstrating increased confidence in their ability to avoid driving after drinking. 
Within Session Change Predicting 6-Month Change in Drinking Days 
Table 2 presents preliminary analyses relating within-session change to change in the number of drinking 
days in the preceeding 90 days between assessment and 6-month follow-up. As can be seen, five of the 13 
measures of change between the beginning and the end of the 8 or 16-hour programs showed significant 
associations with measures of change in the number of drinking days between assessment and 6-month 
follow-up. Interestingly, no significant relationships between change in knowledge and change in attitudes 
and change in drinking days were observed. Change in one of the behavioural intention measures, and in 
one of the self-efficacy measures was significantly associated with change in drinking days. Changes in 
three of the four measures of negative affect were significantly associated with change in number of 
drinking days between assessment and follow-up.  
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Table 1 – Means, standard deviations, and t-tests of pre- and post-workshop questionnaire scores 
(n=1,647) 
Items Pre- 
Workshop 
Mean (SD) 
Post- 
Workshop 
Mean (SD) 
t p 
Knowledge     
The number of drinks an average person can 
have in two hours and still drive safely is1: 
1.06 (0.85) 0.71 (0.63) 14.44 <.001 
 
Affect2 
    
I often feel sad or blue 1.54 (0.80) 1.46 (0.75) 4.54 <.001 
I am feeling sad or blue now 1.43 (0.78) 1.24 (0.62) 9.58 <.001 
I often have feelings of nervousness 1.62 (0.85) 1.52 (0.79) 5.42 <.001 
I am feeling nervous now 1.51 (0.81) 1.21 (0.58) 15.34 <.001 
Attitude2     
Driving after drinking is a dangerous behaviour 3.83 (0.56) 3.95 (0.35) -7.77 <.001 
Driving after drinking is a major safety problem 3.83 (0.57) 3.92 (0.42) -6.22 <.001 
Road safety is a major problem in Ontario 3.35 (0.79) 3.58 (0.73) -11.96 <.001 
 
Behavioural Intention2 
    
Once I get my license back, I would probably 
drive if I had only three drinks at a party 
1.21 (0.63) 1.14 (0.53) 3.96 <.001 
Once I get my license back, I would probably 
drive if I had only one drink at a party 
1.82 (1.06) 1.65 (1.01) 6.34 <.001 
I plan to reduce how much I drink to avoid 
driving after drinking 
3.53 (0.88) 3.56 (0.87) -1.12 0.26 
Self-Efficacy2     
I am confident that I can avoid driving after any 
drinking in the future 
3.82 (0.60) 3.91 (0.43) -5.28 <.001 
I will be successful in my efforts to avoid 
driving after drinking in the future 
3.88 (0.52) 3.91 (0.45) -2.49 0.01 
1 Response options ranged from 0-8+ 
2 Responses rated on a 4-point Likert-type scale with the labels “1-Strongly Disagree”, “2-Somewhat 
Disagree”, “3-Somewhat Agree”, and “4-Strongly Agree” 
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Table 2 – Regression of within-session change measures on change in number of days of 
alcohol use between assessment and follow-up: Regression parameter (beta) estimates 
Pre-post session  items 
Beta 
(Std. Error) 
t p 
1. The number of drinks an average person can have in two 
hours and still drive safely is: 
0.25 ( 0.23) 1.09 0.27 
2. Driving after drinking is a dangerous behaviour. 0.06 ( 0.30) 0.21 0.83 
3. Driving after drinking is a major safety problem. -0.10 ( 0.29) -0.35 0.73 
4. Once I get my license back, I would probably drive if I had 
only three drinks at a party. 
0.47 ( 0.24) 1.92 0.05 
5. Once I get my license back, I would probably drive if I had 
only one drink at a party. 
0.15 ( 0.17) 0.86 0.39 
6. I plan to reduce how much I drink to avoid driving after 
drinking. 
-0.09 ( 0.16) -0.54 0.59 
7. Road safety is a major problem in Ontario. 0.06 ( 0.22) 0.25 0.80 
8. I often feel sad or blue. 0.01 ( 0.29) 0.05 0.96 
9. I am feeling sad or blue now. 0.52 ( 0.25) 2.08 0.04 
10. I often have feelings of nervousness. 0.74 ( 0.26) 2.83 <0.01 
11. I am feeling nervous now. 0.67 ( 0.23) 2.95 <0.01 
12. I am confident that I can avoid driving after any drinking 
in the future. 
0.07 ( 0.25) 0.26 0.80 
13. I will be successful in my efforts to avoid driving after 
drinking too much in the future. 
0.75 ( 0.30) 2.47 0.01 
  
Discussion 
The results of this preliminary evaluation provide support for the use of these pre- and post-workshop 
questionnaires in assessing the impact of participation in remedial programs for impaired driving offenders, 
and are consistent with the expectation that the BOT program would exert a beneficial impact on 
participants. The pre-post results for all 1,647 respondents combined showed that responses to 12 of the 13 
items included in pre- and post-workshop questionnaires showed statistically significant change in a positive 
direction. Only for one question (i.e., “I plan to reduce how much I drink to avoid driving after drinking”) 
was there no significant change. Overall, participants improved in their knowledge of drink-driving, their 
assessment of how dangerous drink-driving is in Ontario, in how well they expected to be able to avoid 
driving after drinking, and whether they felt sad or blue or nervous. Very similar results were found for 
respondents who took the Treatment and Education workshops when viewed separately. These data provide 
convergent evidence that BOT program participation can exert a beneficial impact on participants, which is 
consistent with evidence obtained from evaluations that have evaluated change in Criminal Code 
participants from baseline assessment to 6-month follow-up (Flam-Zalcman et al, 2013; Sharpley et al, 
2007; Stoduto et al, 2014; Wickens et al, 2018), as well as evidence from a province-wide assessment of the 
impact of the introduction of the program on recidivism rates (Ma et al, 2015).  
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Our preliminary results provide no indication that changes in knowledge and attitude measures are related to 
longer-term change in drinking days. However, change in measures of negative affect, self-efficacy and 
behavioural intentions showed relationships with 6-month change in drinking days.   
Negative affect measures have been theorized to reflect a dissonance-related state in participants that can 
motivate behavioural change (Wells-Parker et al, 2009). Negative affect states may also motivate continued 
drinking and thus relief of these states may be an important goal of interventions (Dill et al, 2007). Previous 
research suggests that negative affect may signal receptiveness to interventions, can predict 6-month follow-
up substance use measures, as well as post-program recidivism rates (Mann et al, 2009; Wells-Parker et al, 
2009). The present results provide further support for the significance of negative affect in understanding 
participants’ responses to remedial program participation. 
The significance of self-efficacy in behavioural change processes has long been recognized (Bandura, 1977). 
Wells-Parker et al (2000) observed that drink-drivers participating in a remedial program with higher levels 
of self-efficacy showed lower recidivism rates over a follow-up interval. Behavioural intentions are 
considered to be the pathway between attitudes and behaviour change (Ajzen & Fishbein, 2000; Webb & 
Sheeran, 2006). In a recent meta-analysis of intention-behaviour investigations, Webb and Sheeran (2006) 
observed that a medium to large change in reported intentions was associated with a small to medium 
change in behaviour.   
While the results of this study provide evidence of program success and validity of the pre- and post-
workshop assessment measures, several limitations need to be kept in mind in interpreting these findings. 
Data are based on self-report, and thus may be subject to associated forms of bias. The number of successful 
matches of pre- and post-workshop forms was around 15 percent, similar to that observed in other studies 
involving drink-driving offenders (e.g., Sheehan et al, 2012). Since the match between pre-and post-
workshop forms was based on a key provided by the clients, inconsistent use of a key would also have 
resulted in lower observed participation rates. Other important limitations include the lack of a comparison 
group, and the use of only one measure of long-term outcome (drinking days).   
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Development of a Web-Based Drugs and Alcohol Unit as Part of the Traffic 
Offender Intervention Program in New South Wales, Australia 
Ian J. Faulks, B.A. (UNSW), M.Sc.(Qual.) (ANU), Centre for Accident Research and Road Safety. 
Abstract 
Background: The NSW Traffic Offender Intervention Program (TOIP) is a pre-sentencing intervention for 
driver offenders, offered in face-to-face classes only.  
Objective: TOP ONLINE is a web-based traffic offender intervention developed in desktop, tablet and 
smartphone applications. TOP ONLINE overcomes some of the obstacles to high fidelity program 
implementation concerning content, accessibility, and self-paced learning. This paper details the 
development and pilot testing of the TOP ONLINE: Drugs and Alcohol Unit.  
Method: An existing accredited Drugs & Alcohol session was adapted into the Moodle open-source 
educational platform (https://moodle.org/). The online unit was field tested with offenders, and was also 
critiqued by independent assessors with relevant experience. A usability survey and interviews were 
conducted with offenders and the independent assessors. Usage data captured by the Moodle platform was 
also reviewed.  
Results: Pilot testing of the TOP ONLINE: Drugs & Alcohol Unit was conducted over January 2017-
January 2018: 351 offenders were offered the program, 217 (62%) registered, and 158 (45%) commenced 
the program. Most (148, 94%) offenders who started, completed. Offenders enjoyed the control of when and 
how they accessed the Unit. The independent assessors approved the content and presentation of the online 
unit. The Moodle platform logs enabled usage by offenders to be reviewed. Unless unit segments were 
mandated by the program logic some offenders would skip sections, and focus on assessment items only.  
Discussion, Conclusions and Implications: The TOP ONLINE: Drugs & Alcohol Unit shows that web-
based learning can be integrated into a traffic offender intervention program successfully. It does not suit all 
offenders. There can be intervening reasons why even those offenders who express an interest do not access 
the resource. It is noted that online learning for TOIP, as discussed here, was offered in the context of 
blended learning opportunities integrating face-to-face, group discussion, home study and online learning.  
 
Background 
The NSW Traffic Offender Intervention Program (TOIP) is a major pre-sentencing intervention for drivers 
who have been caught for driving offences (Faulks, Siskind & Sheehan, 2018). Until recently, the pogram has 
been offered in face-to-face classes only, and is a fixed program of study regardless of the offences committed. 
The curriculum is the same for young speeding offenders, for drink drivers, for drug drivers, or for offenders 
who have driven while suspended or disqualified. As well, up to 1 in 5 offenders attending the program will 
miss a class, resulting in delays in sentencing and increased costs associated with further adjournments, or 
else sentencing without prior completion. 
Objective 
TOP ONLINE is a web-based traffic offender intervention developed to augment and extend TOIP, in desktop, 
tablet and smartphone applications. The aims of TOP ONLINE are: first, the need to better target traffic 
offender rehabilitation measures to engage offenders; and, second to address inefficiencies in program 
delivery and the operation of the Local Court-based Traffic Offender Intervention Program in NSW. TOP 
ONLINE has been designed to overcome some of the obstacles to high fidelity program implementation 
concerning content, accessibility, and self-paced learning. This working paper summarises the development 
and pilot testing of the TOP ONLINE: Drugs and Alcohol Unit.  
Method 
An existing accredited Drugs & Alcohol face-to-face session was adapted into the Moodle opensource 
educational platform (https://moodle.org/). The adaptation incorporated the accredited lecture-based 
curriculum and assessment. The lectures were organised into eleven segments, typically between 4-8 minutes. 
The accredited curriculum was extended to include additional material, including: an introductory video 
lecture that described the learning platform and key features; an AUDIT assessment (Allen, Litten, Fertig & 
Barbor, 1997); an interview with a drugs and alcohol counsellor; examples of public service advertising 
targeting drink driving and drug driving; a PDF file of the Powerpoint presentation slides used in the Drugs 
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& Alcohol Unit; and links to resources and relevant information. The online unit was field tested with 
offenders who were offered the unit as an alternative to attending a face-to-face class. Offenders registered 
in-class in the week prior to the scheduled drugs and alcohol presentation. They were asked to complete the 
online unit prior to the face-to-face class, otherwise they had to attend the class as scheduled.  
The online unit was also critiqued by independent assessors with relevant road safety, drug and alcohol, legal, 
or educational experience. A usability survey and interviews were conducted with both offenders and with the 
independent assessors. Usage data routinely captured by the Moodle platform was also reviewed. 
Results 
Lesson content 
Table 4 shows the lesson content of the Drugs and Alcohol Unit that is offered online. The content differs 
from many alcohol and other drug interventions, as it is accepted that the offenders attending the program are 
adults and have experience (or at the least exposure) to alcohol and other drug use. The focus is not on drug 
and alcohol use prevention, but rather on harm minimisation (cf, e.g., Vogl, Teesson, Newton & Andrews, 
2012, for a description of a school-based alcohol use prevention intervention). 
 
Pilot testing 
Pilot testing of the TOP ONLINE: Drugs & Alcohol Unit was conducted over January 2017- January 2019. 
A total pool of 416 offenders were offered the online program, 255 (61%) registered to participate, and 193 
(46%) actually commenced the program. For those offenders who logged in and started, the trial was highly 
successful: almost all offenders completed (181, 94%), and those who did not complete attended the face-to-
face session subsequently. 
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Table 2 shows some results from the usability study. While about half of the offenders had not undertaken 
online study before, almost all indicated that they would take further online study if available. The Moodle 
platform was seen as being easy to understand and use, and the material presented within the Drugs & Alcohol 
Unit was well regarded.  
Offenders reported that they enjoyed the control of when and how they accessed the Unit, including options 
such as re-running lecture segments regarding material they did not at first understand fully, being able to 
assess the unit anytime and anywhere, and the use of smartphones, tablets and desktops as available. The 
material presented in the online unit was more extensive than that presented in a face-to-face session, but 
many offenders perceived the time to complete the unit to be shorter. 
The offenders’ reasons for not accessing the online unit were practical: work, family or social activities 
intervened or there were problems with accessing the internet. The alternative  availability of the face-to-face 
class as scheduled also influenced the offenders’ decision to access the online unit. 
The independent assessors approved the content and presentation of the online unit, although one assessor felt 
that editing was required for the interview with the drug and alcohol counsellor. The logs created by the 
Moodle platform enabled patterns of use by offenders to be reviewed. The logs showed that unless unit 
segments were mandated by the program logic some offenders would skip both required lecture sections and 
other optional sections (the drug and alcohol counsellor interview, examples of public service advertisements), 
and focus on the assessment items only. 
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Discussion, Conclusions and Implications 
Online interventions to address alcohol and/or other drug use are now common (White, Kavanagh, Stallman, 
et al., 2010). The development and implementation of the TOP ONLINE: Drugs & Alcohol Unit has 
demonstrated that web-based learning can be integrated into a broader traffic offender intervention program 
successfully (see also Wilson, 2015, for a demonstration of a standalone drink driving intervention). However, 
while TOP ONLINE provides an innovative new platform for the delivery of drug and alcohol education, it 
does not suit all offenders, and there can be intervening reasons why even those offenders who express an 
interest do not access the resource. 
The development of TOP ONLINE enabled several opportunities to be identified. For example, it may be 
more appropriate to reorganise the online intervention into separate a Alcohol (Drinkdriving) Unit and a Drugs 
Other Than Alcohol (Drug driving) Unit to better target the specific offence category of offenders attending 
TOIP, as no offenders had been charged with both a drink driving and drug driving offence. Another challenge 
is to ensure that the curriculum is fully delivered to offenders, and thus the settings for the online intervention 
must require all segments to be viewed (i.e., no ‘extension’ or discretionary segments). The AUDIT 
assessment was conducted as a research tool only and the results were not communicated to the offenders. It 
could be appropriate to provide the AUDIT assessment results to offenders, as this is an oportunity for 
intervention with those who report their drinking to be at risky or harmful levels (Wilson, 2015). 
It is concluded that online learning is a feasible option for traffic offender interventions. It is noted that online 
learning for TOIP, as discussed here, was offered in the context of blended learning opportunities integrating 
face-to-face, group discussion, home study and online learning. Importantly, there is an additive effect to the 
online Drugs & Alcohol Unit, as offenders are required to attend a series of seven face-to-face lecture sessions 
and group discussions. Drug and alcohol issues are addressed in many other sessions, including sessions 
addressing policing, managing risks on the road, insurance, and legal aspects. 
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Abstract 
Context: The Road Traffic Act 2016 legislated for per se blood levels for drugs driving and police 
preliminary drug testing in oral fluid.  
Objectives: To assess the results of an integrated approach to driving under the influence of drugs (DUID) 
from medical, scientific, legislative, enforcement and prosecutorial perspectives to harmonise closely these 
areas of activity and expertise for successful road safety strategy in DUID and to review measurables over a 
two-year period.  
Key Outcomes: Evidence on review of data since April 2017 shows that the level of detection of DUID has 
increased. The number of specimens for laboratory confirmation for cannabis and cocaine has risen 
significantly. Collaboration with the regulatory authority for medicines and with pharmacy and medical 
practice remains essential. Medical exemption provisions for medicinal cannabis have not been availed of by 
drivers to any significant extent. Prosecutions under the new measures have been successful but have 
generated new questions. The uptake of testing of oral fluid while significant is lower than anticipated. This 
information has fed back into police operational practice; medical and pharmacy practice; medicines 
regulations; medical fitness to drive assessment criteria; and to the parliament to improve the road safety 
strategy on DUID.  
Discussion: DUID remains an international evidence-based road safety measure. Initiatives against DUID 
are considered in the holistic context of enforcement and medical fitness to drive. The responsibilities of the 
driver are part of safe driving initiatives. Recent court judgements have so confirmed. Education of 
healthcare professionals remains essential. Strategic integrated intoxicant testing includes preliminary 
alcohol and drug testing; standardised impairment testing; and evidential and forensic laboratory 
confirmatory testing. Scientific methodology innovations and outcomes are reviewed in parallel. There are 
strengths and weaknesses in the impact of the legislative measures on road safety particularly in police 
enforcement arising from this outcome review with policy makers, strategists, police service and the forensic 
laboratory.  
Keywords: DUID, preliminary testing, legislative changes, road safety strategy 
Disclosures: None 
 
Introduction: The Road Traffic Act 2016 in Ireland includes per se legislation for Cannabis, Cocaine and 
Heroin in whole blood. This new measure and the roadside and an Garda Siochana (the Irish national police 
force) station-based preliminary drug testing of oral fluid were introduced in April 2017. This was as a direct 
result of the actions set out in the national strategy for Ireland, Road Safety Strategy 2013-2020. Action 78 
was to “Legislate for the 
implementation of chemical roadside testing for drugs”. Action 124 required the National DUI Forensic 
Laboratory (the Medical Bureau of Road Safety/”MBRS”) to “Evaluate on an ongoing basis the use of 
roadside drug screening devices”. 
 
Objective: To assess, with international comparisons, the results of an integrated approach to DUID from 
medical, scientific, legislative, enforcement and prosecutorial perspectives in recognition of the necessity to 
have these areas of activity and expertise in a close harmony as is achievable for successful road safety 
strategy in DUID. Recent developments in various jurisdictions in the decriminalisation of cannabis for 
medicinal purposes and for personal use has brought this debate into focus with the overlap between road 
safety strategy and law, criminal law, forensic science and public health considerations. 
 
Methods: DUID Data for Ireland of the National DUI Forensic Laboratory (the MBRS) from the newly 
introduced roadside and Police station-based preliminary drug testing devices together with the confirmatory 
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laboratory (GC-MS-MS /LC-MS-MS) testing results and the national Garda data returns since April 2017 
are analysed to assess the outcome and efficacy of these wide-ranging measures. 
 
Results: There has been a significant increase in the number of blood specimens collected since the 
introduction of the new legislation. The number of specimens requiring laboratory confirmation for cannabis 
and cocaine has risen significantly. The uptake of testing of oral fluid while significant is lower than 
anticipated. 
 
The number of Mandatory Intoxicant Testing (MIT) roadside checkpoints (provided for in the update from 
Mandatory Alcohol Testing checkpoints in the road traffic legislation of 2016 to now include drug testing) 
in 2018 is presented in Figure 1. The figures for Garda activity in those MIT checkpoints for 2018 are 
presented in Table 1. 
 
 
Figure 1. 
 
Table 1. 
 
A total of 1,417 blood and urine samples were screened for DUID drugs in 2018 as presented in Table 2. 
These samples were then subject to confirmatory analysis. A total of 1,388 results were confirmed positive 
in blood (by GC-MS-MS /LC-MS-MS) for cannabis, cocaine and benzodiazepines (to November 2018) as 
set out in Table 3. A number of drivers were positive for more than one drug and the figures must be 
interpreted in this context. 
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Whilst there have been convictions, consolidated and tabulated information and statistics on 
prosecutions of DUID before the criminal courts since the implementation of the legislative 
changes in April 2017 are not yet available from the Garda, prosecution and Court authorities. 
 
Discussion 
Driving under the influence of drugs (DUID) must continue to be an evidence-based 
road safety measure internationally. This paper considers by comparative review recent 
developments internationally and nationally. In Ireland, preliminary drug testing in oral fluid 
for cannabis, benzodiazepines, cocaine and opiates and per se levels for cannabis, cocaine and 
heroin were introduced in significant legislative, scientific and enforcement reforms in 2017. 
The per se levels introduced are set out in Table 4. 
 
 
Different jurisdictions in Europe have opted for a variety of cut-off concentrations for blood 
levels of THC (Table 5). 
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As an example of recent DUID changes outside of Europe, the Federal Government of Canada legalised 
cannabis for sale and personal use in October 2018 under Bill C-45. The Manitoba Justice Minister had 
called on the Government not to proclaim the legislation until roadside screening was in place. The 
Transportation Provisions of the Criminal Code (Bill C- 46) in Canada set then introduced reform to set 
different per se levels for cannabis and driving with offences at 2 but less than 5ng THC per ml blood and 
greater than 5 ng THC per ml blood. It also introduced a hybrid offence for combined THC and alcohol. The 
legislation came into effect on December 18 2018. 
 
The road safety strategy in Ireland has as an aim a nationwide distribution of Preliminary Drug Testing 
(PDT) devices for both roadside use and for use in Garda stations. This is achieved by co-operation as 
between the MBRS and the national Garda force. A diagrammatic representation of the locations of PDT 
devices and Evidential Breath Testing (EBT) and PDT Garda stations is given in Figure 2. A total of 157 
PDT devices are available nationwide to the police which compares with 1,400 Preliminary Breath Testing 
devices. The number of roadside drug tests and of positive drug tests indicate an increase in the number of 
MIT checkpoints and in roadside drug testing but the latter remain much smaller in number and together 
with the very small number of PDT tests carried out in the Garda stations in 2018 show the potential for  
significant expansion of such testing as envisaged in the road safety strategy and by the facilitating 
legislative changes. 
 
 
 
The results from the PDT, screening and confirmatory results indicate that cannabis, cocaine and 
benzodiazepines are the three most prevalent drugs detected in DUID and that the population is 
predominantly young, male drivers. 
 
The road safety strategy in tackling the problem and dangers of DUID are linked to the medical fitness to 
drive requirements. These are now set out in the publicly available document: Sláinte agus Tiomáint on 
Alcohol and Drugs Misuse and Dependence; and also in the Information Leaflets: Medicines and Driving 
& Driving Under the Influence of Illicit Drugs and/or the Abuse of Prescription Drugs. This information is 
available to physicians, the driver patient and the general public. 
 
The Road Traffic Act 2016 included a novel medical exemption for medicinal cannabinoids, but only if the 
driver is not impaired (Figure 3). To date, there is no recorded case of the exemption being pleaded by any 
driver where the per se blood level for cannabis has been exceeded. Other jurisdictions are currently looking 
at similar issues around the legalisation of cannabis for medical and personal use. 
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Different jurisdictions have approached the setting per se DUID levels in a number of ways. England and 
Wales opted for levels based on a crash risk formula following a review in 2013 and in legal regulations 
introduced in 2015. Ireland opted for a zero-tolerance approach based on its 2012 report. It remains critical 
to safe driving that drivers continue to take their prescribed and over the counter medications in accordance 
with healthcare advice. Measures 
against DUID must be considered in the holistic context of medical fitness to drive over a spectrum of 
medical conditions. The role and responsibilities of the driver are a part of safe driving initiatives and recent 
court judgements, including the Supreme Court case of McGarvey v Barr (2009), have confirmed this 
responsibility. Education of healthcare professionals, particularly doctors and pharmacists, must form part of 
both undergraduate and postgraduate training. For Garda officers and doctors, impairment evidence remains 
an intrinsic part of enforcement and practical training of both doctors and police is a core requirement as the 
existing presence and impairment legislation runs in parallel with the newer per se prosecutable offence in 
all jurisdictions. Integrated intoxicant testing includes preliminary breath alcohol testing; preliminary drug 
testing; standardised impairment testing; evidential alcohol testing; and forensic laboratory confirmatory 
testing. This has now been achieved in Ireland with a stringent review of its impact and success or otherwise 
now underway. 
 
The Drager DrugTest 5000 Analyser was selected following a review of such devices in an MBRS report in 
2012 and a subsequent competitive tender within the European Union in 2014. The performance of the 
devices since their introduction in Ireland cannabis, cocaine, opiates and benzodiazepines (sensitivity and 
specificity) has been compared to laboratory screening and confirmatory data in the MBRS, the national 
DUID forensic laboratory, in 
2018. Figures show good agreement between the oral fluid testing system and the laboratory findings and 
these are presented in a Working Paper in the ICADTS T2019 toxicology session. Improvements have also 
been made in confirmatory analytical techniques (GC-MSMS /LC-MS-MS). 
 
Conclusions 
 
The level of detection of drug driving in Ireland has increased since the legislative changes of 2016 
introducing preliminary roadside and police station drug testing, per se levels for certain drugs in whole 
blood and expanded mandatory intoxicant checkpoint provisions. This has also increased the awareness in 
the driving population of the availability of detection and enforcement methods at the roadside. There is 
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potential to increase greatly the number of PDT tests at the roadside and police stations. The analysis of the 
DUID drug results allows for more targeted awareness road safety campaign strategies to the relevant driver 
populations. The linkage to medical fitness to drive fits into a more holistic approach to addressing the 
issues in DUID and road safety. 
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Abstract 
Background: The literature suggests that men and women have different risk behaviors in traffic. Despite 
that, there are few studies in Brazil that differentiate these behaviors, especially on the use of psychoactive 
substances.  
Objective: To compare psychoactive substance use and risk behaviors in Brazilian traffic between men and 
women.  
Methods: This is a secondary data analysis of a roadside cross-sectional study about driving behavior that 
consecutively recruited 2,262 drivers, from two Brazilian capitals. Binary regression analysis was performed 
for outcome prediction.  
Results: The sample consisted mostly of male (84.2%), young adults (33±10 years), who studied until higher 
education (40.1%). Binary logistic regression analysis showed that men were 1.7 greater chance to have 
speeding fines (CI: 1.027-2.979, p<0.001), 1.9 greater chance to binge drink (CI: 1.341-2.694, p<0.001), and 
1.8 times greater chance to drink and drive (CI: 1.302- 2.566, p<0.001) – having reported 4.5 times more 
history of accidentally under this condition (CI: 2.201-9.2580, p<0.001), with no difference in perceived risk 
between groups.  In addition, men had a 2.5 greater chance of not wearing a seat belt (CI: 1.387-4.522, 
p<0.002). On the other hand, women were 1.7 greater chance to use psychoactive substances (CI: 1.009-
3.189, p<0.004), of the type Prescription Drugs 15 (80.0). Also, women had 1.2 greater chance of being a 
passenger of a drunk driver (CI: 1.020-1.644, p<0.003).  
Conclusion: Our study shows that men and women provide different types of risk behavior. The greater 
chance of substance use by women is an alert for traffic safety, since the main focus is usually on male 
offenders. This evidence may contribute to the construction of more effective strategies in Brazil, as the 
detection of these substances on highways. 
Keywords: risk behavior, traffic, Brazil 
 
Introduction 
Traffic collisions (CTs) are among the main external causes of death in Brazil, affecting mainly young men 
(Malta et al., 2017). In the last decade, studies on traffic have reported risk behaviors responsible for fatal traffic 
collisions, such as driving under the influence, which enables more personalized interventions, especially 
amongst the male population (Korn and Bonny-Noach, 2017; Verstraete and Legrand, 2014). 
The male role in risky behavior in traffic is not new. It is known that the male population is more likely to engage 
in risk behaviors, and their representation on risky driving is well proven - not only in developed countries but 
also in low and middle countries (Brown, Ouimet, Nadeau, Tremblay, & Pruessner, 2015; Pechansky et al., 2012). 
Despite this, literature suggests that men and women are involved in different risk behaviors, which are important 
to differentiate. Studies have shown sex differences in driving behavior - women wear seatbelts more often and 
tend not to drive without a license. On the other hand, men tend to drink and drive and are more aggressive in 
traffic (Brown et al., 2015; Hennessy & Wiesenthal, 2001; Tsai et al, 2008; McKnight & McKnight, 2003). 
However, women are increasingly engaging in risky behaviors such as binge drinking and psychoactive 
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substances use in the last years (Wilsnack et al., 2018; UNODOC, 2016; Bertoni, et al., 2014; Fernandez-
Montalvo et al., 2014). In the same way, there has been a growth in women's involvement in fatal collisions, 
showing that women may also be risking more in traffic than before (Kostyniuk et al., 1998; Mayhew et al., 2003; 
Tsai et al, 2008), but little is known how this is being expressed in women driving behavior and how women 
differentiate themselves from men in this aspect. 
Because of the emerging evidence on female risk behaviors in traffic, and the notion that males express more risk 
when driving, enforcement becomes extremely skewed for the approach in males. There are no studies in Brazil 
that differentiate behaviors among sex, especially on the use of psychoactive substances. Studies exploring sex 
differences may contribute for the construction of effective and personalized intervention, especially in 
developing countries. In this study, we aimed at evaluating the use of psychoactive substances and other risk 
behaviors between men and women in a sample of Brazilian drivers. 
Methods 
Sample selection and procedures 
This is a secondary data analysis of a roadside cross-sectional study about driving behavior that consecutively 
recruited 2,650 drivers, from two Brazilian capitals – Teresina and Palmas. 338 drivers refused to participate in 
the study, totaling 2,262 subjects. From August 2011 to July 2013, our team conducted, with technical assistance 
from the Johns Hopkins International Injury Research Unit (JH-IIRU), five rounds of roadside interviews among 
drivers stopped at night between 10pm-4am, in sobriety checkpoints, organized by local transit authorities. The 
subjects were recruited, and individuals who had reported not driving in the past 12 months and under the age of 
18 were excluded from the study. The roadside interview covered socio-demographic information from 
participants such as sex, age, highest level of educational and contextual information from the vehicle as well as 
a range of items related to risky driving behavior as drug use, drinking and driving, no sit belt use, speeding, 
among others behaviors. Subjects were interviewed by trained and supervised data collectors and researches. 
Data analysis 
The variables of this study were purposely selected because they were risk factors for male drivers. The odds 
ratio of each variable was estimated by a Binary Logistic Regression analysis, for outcome prediction. The 
variables were analyzed separately as outcomes. Age was used as a quantitative measure. The categorical 
variables are presented in absolute and relative frequencies. All statistical analyses were completed using 
Statistical Package for the Social Sciences (SPSS) software version 18.0 (Chicago:SPSS Inc; 2009.). 
Results 
Sociodemographic characteristics 
Table 1 summarizes the sociodemographic characteristics of males (n=1,904) and females (n=358). The 
sample consisted mostly of male (84.2%), young adults (33±10 years), who studied until higher education 
(40.1%). 
 
Table 1 - Sociodemographic characteristics in a sample of drivers from 
Brazil 
Variables Total 
(n=2,262) 
Male 
(n=1,904) 
Female 
(n=358) 
p-value 
Age¹ 33 ± 10 33 ± 11 32 ± 9 <0.002 
Education: 12+ 
years² 
907 (40.1) 671 (29.7) 235 (10.4) <0.001 
¹ Means ± Standard Deviation. 
²Values expressed by absolute frequency (%). 
  
 
Table 2 summarizes the drug use and others risky behaviors among male and female drivers. Binary logistic 
regression analysis showed that men were 1.7 greater chance to have speeding fines (CI: 1.027-2.979, 
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p<0.001), 1.9 greater chance to binge drink (CI: 1.341-2.694, p<0.001), and 1.8 times greater chance to drink 
and drive (CI: 1.302- 2.566, p<0.001) – having reported 4.5 times more history of accidentally under this 
condition (CI: 2.201-9.2580, p<0.001), with no difference in perceived risk between groups.  In addition, men 
had a 2.5 greater chance of not wearing a seat belt (CI: 1.387-4.522, p<0.002). On the other hand, women 
were 1.7 greater chance to use psychoactive substances (CI: 1.009-3.189, p<0.004), of the type Prescription 
Drugs 15 (80.0). Also, women had 1.2 greater chance of being a passenger of a drunk driver (CI: 1.020-1.644, 
p<0.003). 
 
Table 2 – Drug use and risky behaviors among male and female in a sample drivers from Brazil 
Variables Total 
(n=2,262) 
Male 
(n=1,904) 
Female 
(n=358) 
OddsRatio  
(CI: 95%) 
p- value 
Lack of Self Belt Use 1,346 (59.5) 1,186 (62.3) 160 (44.8) 1.387-4.522 <0.002 
Speeding Fines 220(9.7) 198 (10.4) 22 (6.2) 1.027-2.979 <0.001 
Being a passenger of a drunk 
driver 
893(39.4) 733 (38.5) 160 (44.8) 1.644-1.020 <0.002 
Binge Drinking 1,051(47.4) 932 (49.0) 119 (33.5) 1.341-2.694 <0.001 
Drink and Drive 1,233 (47.0) 1.083 (56.9) 150 (41.9) 1.302-2.566 <0.001 
Traffic collision for drinking 
and driving 
204(7.7) 196 (10.3) 8 (2.5) 2.201-9.2580 <0.001 
Psychoactive Substances Use 
and Driving 
69(2.6) 47 (2.5) 22 (6.2) 3.189-1.009 <0.004 
Values expressed by ¹absolute frequency (%). Odds Ratio= Odds Ratio by Binary Logistic Regression 
Discussion and Conclusion 
This is the first Brazilian study to evaluate different risk behaviors in traffic between men and women, 
especially regarding substance use. Although men are currently the largest focus in national and international 
studies on traffic risk due to their prevalence of involvement in traffic collisions, our study shows that men 
and women provide different types of risk behavior, with female subjects presenting important attitudes to be 
evaluated. In our study, behaviors such as drinking and driving, seat belt use, speed fines, binge drinking and 
traffic collisions for drinking and driving remained predictive of males. However, regarding the use of 
substances and hitchhiking with drivers who had drunk, being a woman seems to predict these behaviors in 
Brazil. 
Increasingly, women are engaging in more types of risky behaviors, which may also be reflecting on their 
behavior in traffic. The literature corroborates our findings, showing that women are more exposed to traffic 
risks in recent years (Tsai, Anderson, & Vaca, 2008). The literature shows that substance use may be 
associated with practicing other risky behaviors (Korn & Bonny-Noach, 2013), suggesting that drug 
involvement may exacerbate involvement in risk taking, such as driving under the influence and being a 
passenger of a drunk driver, found in this study. The Involvement in different types of risk behavior in traffic 
may be explained by a combination of cognitive and personality factors such as impaired decision making, 
impulsivity and sensation seeking (Brown et al., 2016; Sloan, Eldred, & Xu, 2014). Despite the diversity of 
risk behavior in men, women's behaviors are highly impacted in terms of fatality in traffic collisions, given 
the high mortality in these circumstances. 
The greater chance of substance use by women compared to men is an alert for traffic safety, since the main 
focus is usually on male offenders. Future research focusing on personality traits and cognition in female 
drivers may assist in preventive measures for these behaviors in traffic. Thus this evidence may contribute to 
the construction of more effective strategies in Brazil, such as the implementation of detection of psychoactive 
substance usage amongst drivers on Brazilian highways. 
  
85 
References 
Bertoni N, Burnett C, Cruz MS, Andrade T, Bastos FI, Leal E, et al. Exploring sex differences in drug use, 
health and service use characteristics among young urban crack users in Brazil. Int J Equity Health. 
2014;13(1):70. DOI: 10.1186/s12939-014-0070-x 
Brown, T. G., Ouimet, M. C., Eldeb, M., Tremblay, J., Vingilis, E., Nadeau, L., … Bechara, A. (2016). 
Personality, Executive Control, and Neurobiological Characteristics Associated with Different Forms of 
Risky Driving. PloS One, 11(2), e0150227. https://doi.org/10.1371/journal.pone.0150227 
Brown, T. G., Ouimet, M. C., Nadeau, L., Tremblay, J., & Pruessner, J. (2015). Sex Differences in the 
Personality and Cognitive Characteristics of First-Time DWI Offenders. Journal of Studies on Alcohol 
and Drugs, 76(6), 928–934. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26562601 
Fernandez-Montalvo J, Lopez-Goñi JJ, Azanza P, Cacho R. Gender differences in drug-addicted patients in a 
clinical treatment center of Spain. Am J Addict. 2014;23(4):399-406. DOI: 10.1111/j.1521-
0391.2013.12117.x 
Hennessy, D. A., & Wiesenthal, D. L. (2001). Gender, Driver Aggression, and Driver Violence: An Applied 
Evaluation. Sex Roles, 44(11/12), 661–676. https://doi.org/10.1023/A:1012246213617 
Jessor, R., Turbin, M. S., & Costa, F. M. (1997). Predicting developmental change in risky driving: The 
transition to young adulthood. Applied Developmental Science, 1, 4–16. Reprinted in Lerner, R. M. 
(Ed.). Adolescence: Development, diversity, and context. Hamden, Connecticut: Garland 
Korn, L., & Bonny-Noach, H. (2013). Health risk and deviant behaviors among students in an academic 
institution in Israel. International Journal of Child & Adolescent Health, 6(2), 191–201. 
Kostyniuk L, Molnar LJ, Eby DW. (1998) Are women taking more risks while driving? A look at Michigan 
dirvers. In: Proceedings of the Second National Conference in Women’s Travel Issues. US Department 
of Transportation, Washington, DC, pp. 502– 516. 
Malta, D. C., Minayo, M. C. de S., Soares Filho, A. M., Silva, M. M. A. da, Montenegro, 
M. de M. S., Ladeira, R. M., … Naghavi, M. (2017). Mortalidade e anos de vida perdidos por violências 
interpessoais e autoprovocadas no Brasil e Estados: análise das estimativas do Estudo Carga Global de 
Doença, 1990 e 2015. Revista Brasileira de Epidemiologia, 20(suppl 1), 142–156. 
https://doi.org/10.1590/1980-5497201700050012 
McKnight, A. J., & McKnight, A. S. (2003). Young novice drivers: careless or clueless? Accident; Analysis and 
Prevention, 35(6), 921–925. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12971927 
Pechansky, F., Duarte, P. do C. A. V., De Boni, R., Leukefeld, C. G., von Diemen, L., Bumaguin, D. B., … 
Fuchs, D. F. P. (2012). Predictors of positive Blood Alcohol Concentration (BAC) in a sample of 
Brazilian drivers. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999), 34(3), 277–285. 
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23429773 Sloan, F. A., Eldred, L. M., & Xu, Y. (2014). 
The behavioral economics of drunk 
driving. Journal of Health Economics, 35, 64–81. https://doi.org/10.1016/j.jhealeco.2014.01.005 
Tsai, V. W., Anderson, C. L., & Vaca, F. E. (2008). Young Female Drivers in Fatal Crashes: Recent Trends, 
1995–2004. Traffic Injury Prevention, 9(1), 65–69. https://doi.org/10.1080/15389580701729881 
United Nations Office on Drugs and Crime. World Drug Report 2016 [Internet]. Viena; UNODOC; 2016. 
Available from: https://www.unodc.org/wdr2016 
Wilsnack, R., Wilsnack, S., Gmel, G., Wolfgang, K. (2018). Gender Differences in Binge Drinking. Alcohol 
Research, Jan; 39(1): 57–76. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104960/ 
  
86 
ESRA Thematic Report on Driving Under the Influence of Alcohol and 
Drugs – International Comparison of 32 Countries  
Yvonne Achermann Stürmer, Swiss Council for Accident Prevention. 
Uta Meesmann, Vias Institute; University of Liège (LEMA). 
Abstract 
Background: Driving under the influence (DUI) of alcohol and drugs constitutes a main cause of road 
casualties. Public attitudes, legislation, and enforcement measures influence the number of road accidents 
attributed to DUI. ESRA (E-Survey of Road users’ Attitudes) provides recent data on DUI for 32 countries.  
Objectives: The objective of this presentation is to give an overview of the ESRA thematic report ‘Driving 
under the influence of alcohol and drugs’, which will be released during this ICADTS conference. The 
report is based on the second edition of the survey (ESRA2), which is currently being conducted; the data 
and first round of analyses will be available in early 2019.  
Methods: Self-declared impaired driving, related attitudes and opinions as well as enforcement experiences, 
and support for policy measures - all variables collected in ESRA - are compared between countries, 
genders, and age groups. Logistic regression models explore underlying factors predicting self-declared 
DUI.  
Results: Results from the first ESRA edition (ESRA1; N=38,738) showed that drink-driving was reported 
by 30% of the drivers and 14% for drug-driving; driving after taking medication that carries a warning 
concerning the driving ability, by 25%. The national results differ substantially, ranging from 11-43% for 
alcohol, 3-24% for drugs, and 7-34% for medication. Different factors have been found to be associated with 
impaired driving, among others ‘gender’, ‘personal acceptability’ and ‘perceived likelihood of being 
checked for alcohol and drugs’.  
Conclusion: There are notable disparities in the behaviour and attitudes towards impaired driving between 
the countries and socio-demographic groups. The ESRA project aims at monitoring these differences.  
Keywords: driving under the influence; alcohol; drugs; attitude 
Disclosure: No relevant affiliations or conflicts of interest exist. 
Introduction 
Driving under the influence (DUI) of alcohol and drugs constitutes one of the main causes of road casualties. 
The consumption of impairing substances leads to increased reaction time, lower vigilance, poor judgement 
and can impair visual functions. Public attitudes, legislation, and enforcement measures influence the 
number of road accidents attributed to DUI. The ESRA2_2018 survey (E-Survey of Road users’ Attitudes) 
provides recent comparable data on opinions, attitudes, behaviours and enforcement experiences regarding 
DUI of alcohol and drugs across 32 countries.  
The objective of the associated ICADTS presentation is to give an overview of the ESRA thematic report 
‘Driving under the influence of alcohol and drugs’, which will be released shortly before the ICADTS 
conference (Achermann Stürmer, Meesmann & Berbatovci, 2019). The report is based on the second edition 
of the survey, which was conducted in 2018. The current paper focusses on the topics ‘self-declared DUI of 
alcohol, drugs and medicines’ and ‘support for policy measures related to DUI’.  
Methods 
ESRA2 survey  
The ESRA project (E-Survey of Road users’ Attitudes) is a joint initiative of road safety institutes, research 
organisations, public services, and private sponsors, aiming at collecting comparable international and 
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national data on road users’ opinions, attitudes and behaviour with respect to road traffic risks. The project is 
funded by the partners’ own resources and covers countries all over the world.  
ESRA is an extensive online panel survey, using a representative sample (at least N=1,000) of the national 
adult populations in each participating country. A common questionnaire was developed and translated into 
national language versions. The themes covered are e.g. ‘selfdeclared behaviour’, ‘attitudes and opinions on 
unsafe traffic behaviour’, ‘enforcement experiences’, and ‘support for policy measures’. The survey 
addresses different road safety topics (e.g. DUI of alcohol, drugs and medicines, speeding, distraction) and 
targets all types of road users. The first edition of the ESRA survey (ESRA1) took place in 2015-2017. Data 
were gathered from almost 40,000 road users in 38 countries and reports giving an overview on the results, 
including on DUI were published (Meesmann, Torfs, Nguyen, Van den Berghe, 2018; Achermann Stürmer, 
2016). As mentioned, the present paper is based on the second edition of the global survey (ESRA2_2018), 
which was carried out in 32 countries, and collected data from more than 35,000 road users (Meesmann, U., 
& Torfs. K., (2019).  
Data analysis  
For the purpose of this paper, descriptive analyses were conducted to compare ‘self-declared DUI’ and 
‘support for policy measures’ across countries, regions, gender and age. Proportions were compared across 
four regions (‘Europe20’, ‘AsiaOceania5’, ‘NorthAmerica2’, ‘Africa5’) to determine if there were 
significant differences between them. The same was done for the gender and age group* differences within 
each region. Note that a weighting of the data was applied to calculate national and regional means. This 
weighting took into account small corrections with respect to gender and six age groups, as mentioned in 
footnote 1. In addition, the regional weights took into account the population size of each country in the total 
set of countries in the given region (United Nations Statistics Division, 2019). SPSS 25.0 was used for all 
analyses (IMB corp, 2017). 
*6 age groups: 18-24y, 25-34y, 35-44y, 45-54y, 55-64y, 65y+ 
Results 
The results presented in this paper focus on self-declared DUI of alcohol, drugs and medicines as well as 
support for policy measures related to drink-driving. The presentation during the ICADTS conference will, 
furthermore, show results on other themes related to DUI (e.g. acceptability, attitudes, enforcement) as well 
as explorative analyses on predictors of selfdeclared DUI of alcohol and drugs, based on logistic regression 
models. 
Self-reported driving under influence of alcohol, drugs and medicines  
Within the ESRA2 questionnaire, respondents were asked to answer four questions on selfdeclared DUI (see 
Table 1). Car drivers had to answer on a five-point scale ranging from never to (almost) always. For the 
purpose of the analysis, the value of 1 was coded as never, and values 2 to 5 were coded as at least once. 
Table 1 shows the proportion of car drivers who reported DUI at least once in the last 30 days. The three 
lowest values are highlighted in green, and the three highest values in red.  
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The results indicate that the proportion of car drivers who report DUI of alcohol, drugs and medication 
varies across countries and regions. In Europe and North America, the psychoactive substance most 
frequently reported by car drivers was alcohol (more than 20% in both regions), followed by medication that 
carries a warning that it may influence driving ability (15% in both regions). Driving under the influence of 
drugs is clearly lower in these two regions, particularly in Europe (5% vs. 12% in North America). In Asian 
and African countries, DUI of medication seems to play a bigger role than alcohol and drugs (more than 
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20% regarding medication and between 14% and 19% regarding alcohol and drugs in both regions). Overall 
at country level, the highest prevalence rates are found for drink-driving, namely in Portugal (34%), 
Switzerland (34%) and Belgium (33%)*, and the lowest for drugdriving (without medication), in Finland 
(1.7%), Hungary (2.2%) and the Czech Republic (2.7%).  
In all regions, men report more often DUI of alcohol and of drugs (other than medication) than women. Only 
in Asia and Oceania, no significant gender difference was observed. The gender difference was particularly 
strong in Europe. The greatest difference was found for driving after drinking alcohol in the last 30 days, 
which was reported by 27% of all male drivers in Europe, compared to 13% of all female drivers (chi-square 
= 461.45; df = 1; pvalue < 0.001; Cramer’s V: 0.174). The association with age differs per substance and per 
region and is described in more detail in the ESRA2 thematic report on DUI (Achermann Stürmer, 
Meesmann & Berbatovci, 2019).  
Support for policy measures related to drink-driving  
Within the ESRA2 questionnaire, respondents were asked to answer three questions on policy measures 
related to drink-driving (see Table 2). They had to answer on a five-point scale ranging from oppose to 
support. For the purpose of the analysis, the values 4 to 5 were coded as support, and values 1 to 3, as 
oppose and neutral.  
Table 2 shows the proportions of the respondents who support a certain policy measure. The three lowest 
values are highlighted in green and the three highest values in red. In all regions, the three alcohol-related 
policy measures have high support among the respondents, particularly in Africa, as well as in Asia and 
Oceania. The highest support in all regions can be found for an obligation to install an alcohol ‘interlock’ for 
drivers who have been caught drink-driving on more than one occasion (between 79% and 85%). The least 
supported measure is ‘zero tolerance for alcohol (0.0‰) for all drivers’, particularly in Europe and North 
America (below 68% vs. slightly above 80% in the two other regions).  
 
*Note that in all three countries the general legal blood alcohol concentration (BAC) alcohol limit is 0.5 g/l. Thus, driving after 
drinking a small amount of alcohol is legally allowed (except for certain driver groups e.g. young/novice drivers). 
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Gender is significantly associated with the support for measures in most regions. No significant gender 
difference was observed only for the ‘interlock’ measure in Asia and Oceania and for a ‘zero tolerance for 
alcohol (0.0‰) for all drivers’ in Asia and Oceania as well as in Africa. The gender difference was 
particularly strong in Europe and North America. The biggest difference was found in North America, 
where 84% of all female drivers supported a ‘zero tolerance for alcohol (0.0‰) for novice drivers (licence 
obtained less than 2 years)’, compared to 76% of all male drivers (chi-square = 18.21; df = 1; p-value < 
0.001; Cramer’s V: 0.096). In all regions and for all proposed policy measures the results show significant 
associations with higher age, except for the highest age group (65+) in Africa. 
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Conclusion 
There are notable disparities in self-declared DUI and support for policy measures between the countries and 
regions, as well as between socio-demographic groups. The national results of self-declared DUI, for 
example, range from 4-34% for alcohol, 2-24% for drugs, and 7- 26% for medication. In all regions, women 
tend to report less often DUI of alcohol and of drugs (other than medication) and are more strongly 
supportive of alcohol-related policy measures than men. Moreover, the results show that in regions with 
higher proportions of self-declared drink-driving (Europe and North America), support for alcohol-related 
policy measures tends to be lower. At the country level, this association can also be observed.  
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Abstract 
Background. Trends in road safety performance and the success of policy measures can be monitored using 
road safety performance indicators based on accident statistics, road side surveys, or questionnaire surveys. 
However, results are seldom comparable across countries because of differences in aims, scope, or 
methodology.  
Objectives. ESRA (E-Survey of Road users’ Attitudes) is a global cross-national initiative in 46 countries, 
coordinated by Vias institute. Aim of this initiative is to provide scientific support to road safety policy by 
generating comparable national data on the current road safety situation. The use of a uniform sampling 
method and identical questionnaire allows comparisons across countries.  
Methods. ESRA is an online panel survey, using a representative sample (N=1,000) of the national adult 
populations in each participating country. A common questionnaire was developed and translated into 
national language versions. The themes covered are e.g. self-declared behaviour, attitudes and opinions on 
unsafe traffic behaviour, enforcement experiences and support for policy measures. The survey addresses 
different road safety topics (e.g. driving under the influence of alcohol, drugs and medicines, speeding, 
distraction) and targets all types of road users.  
Results. The first edition of the survey (ESRA1) was conducted in three waves (2015,2016,2017) in 38 
countries (N=38,738) and in December 2018 the second edition (ESRA2_wave1) will be launched in 32 
countries (expected N=32,000). This presentation is intended as an introduction for the special session on 
ESRA. Main outlines of the project, methodology and some key results will be described.  
Conclusions. The fast growth of the ESRA initiative shows the feasibility and added value of a joint data 
collection by a network of road safety organisations. The intention is to repeat the measurements on a 
triennial basis and to develop time series. Disclosure. No relevant affiliations or conflicts of interest exist.  
Keywords: international survey; road safety; safety culture; attitude 
 
Background 
Trends in road safety performance and the success of policy measures can be monitored using road safety 
performance indicators based on accident statistics, road side surveys, or questionnaire surveys. However, 
results are seldom comparable across countries because of differences in aims, scope, or methodology. 
Hence, in 2015, Vias institute (formerly the Belgian Road Safety Institute) launched the ESRA (E-Survey of 
Road users’ Attitudes) initiative to fill this knowledge gap. The current paper as well as the corresponding 
ICADTS presentation is intended to serve as an introduction for the special session on ESRA. Main outlines 
of the initiative, the survey methodology and some key results will be described.  
The ESRA Initiative 
The ESRA Network  
ESRA (E-Survey of Road users’ Attitudes) is a joint initiative of road safety institutes, research 
organisations, public services, and private sponsors, aiming at collecting comparable international and 
national data on road users’ opinions, attitudes and behaviour with respect to road traffic risks. ESRA is 
funded by the partners’ own resources and covers countries all over the world. Vias institute in Brussels 
(Belgium) initiated and coordinates ESRA, in cooperation with a core group of partner organisations from 
eleven countries (BASt, BFU, CTL, IATSS, IFSTTAR, ITS, KFV, NTUA, PRP, SWOV, TIRF). A first 
edition of the ESRA survey (ESRA1) was conducted in three waves between 2015-2017* (ESRA1; 
Meesmann, Torfs, Nguyen, & Van den Berghe, 2018). The current paper focusses on the second edition of 
the ESRA survey, which was conducted in 32 countries in 2018 (ESRA2_2018). 2 almost 40,000 road users 
in 38 countries across 5 continents  
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Objectives  
The objectives of the ESRA initiative are:  
• to provide scientific support for road safety policy at national and international levels; • to 
make internationally comparable data available on the current road safety situation in 
countries all over the world; 
• to develop a series of reliable, cost-effective and comparable road safety performance 
indicators; 
• to develop time series on road safety performance.  
The intention is to repeat this survey every three years and extend it to an increasing number of countries. 
*2 almost 40,000 road users in 38 countries across 5 continents  
Survey Methodology 
Data collection  
Online panel survey  
ESRA is an extensive online panel survey, using a representative sample (at least N=1,000) of the national 
adult populations in each participating country. More specifically, ESRA2 is based on a web survey using 
access panels. This approach has some advantages compared to other survey modes, especially given the 
international context of the study. These advantages are: (1) self-administered web surveys are less prone to 
social desirability in responses compared to interviewer-administered surveys, and (2) they also have some 
practical advantages such as the length of the survey, timing, and costs (De Leeuw, Hox, & Dillman, 2008; 
Baker, Blumberg, Brick, Couper, Courtright, Dennis, et al. 2010; Goldenbeld, & de Craen, 2013).  
Scope and questionnaire  
A common questionnaire was developed and translated into 42 national language versions. The survey was 
programmed in six different characters: Greek, Hebrew, Hindi, Japanese, Korean, and Latin. The main 
themes covered in the ESRA2 questionnaire are: ‘socio-demographic information’, ‘mobility and exposure’, 
‘self-declared unsafe behaviour in traffic’, ‘acceptability of safe and unsafe traffic behaviour’, ‘attitudes 
towards safe and unsafe traffic behaviour’, ‘subjective safety and risk perception’, ‘support for policy 
measures’, ‘enforcement’, ‘road crash involvement’, ‘vehicle automation’, and two bonus questions which 
were filled in by each national partner. The survey addresses different road safety topics: ‘driving under the 
influence of alcohol, drugs and medicines’, ‘speeding’, ‘protective systems (e.g. seat belt use, helmet use)’, 
‘distraction’ and ‘fatigue’.  
Sample and fieldwork  
The survey targets all types of road users. The aim is to cover a representative sample of the national adult 
population of at least 1000 respondents in each country. Hard quotas were used for gender and age 
distribution during the sampling procedure (United Nations Statistics Division, 2019). The geographical 
spread of the sample across the country was monitored (soft quota). Four market research agencies (INFAS, 
Ipsos (formerly GfK), Punto de Fuga, and SSI) organised the fieldwork under the supervision of the Vias 
institute. The fieldwork was conducted simultaneously in all countries in December 2018.  
 
 
 
 
 
 
 
In total the ESRA2_2018 survey collected data from more than 35,000 road users across 32 countries. Table 
1 shows the distribution of the sample by region, gender, and age group. Figure 1 shows the geographical 
coverage of the survey.  
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Data processing and reporting  
The cleaned data files of the market research companies were merged together into one, including the 
answers of all respondents in 32 countries. The statistical packages used were SPSS 25.0 (IMB corp, 2017) 
and R (R core team, 2018).  
Dichotomisation of the data  
The original data were dichotomized in order to minimize the number of answer categories in view of the 
analyses and dissemination. The dichotomization was done centrally by Vias institute and used in all 
descriptive analyses of the ESRA2 reports. The dichotomizations and reference categories for each question 
are indicated in the ESRA2 questionnaire in Meesmann & Torfs (2019).  
Regional groups  
Four groups were defined in order to compare the results on regional level: 
• Europe20: Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, 
Hungary, Ireland, Italy, Netherlands, Poland, Portugal, Serbia, Slovenia, Spain, Sweden, 
Switzerland, United Kingdom 
• NorthAmerica2: Canada, USA 
• AsiaOceania5: Australia, India, Israel, Japan, Korea 
• Africa5: Egypt, Kenya, Morocco, Nigeria, South Africa  
Weighting of the data  
Weighting of the data was applied to calculate national and regional means. This weighting took into 
account small corrections with respect to gender and six age groups: 18-24y, 25-34y, 35- 44y, 45-54y, 55-
64y, 65y+. Furthermore, the regional weights took into account the population size of each country in the 
total set of countries in this region (United Nations Statistics Division, 2019). 
Costs and external funding  
The costs for the ESRA initiative are kept as low as possible. The main principles to achieve this are: (1) 
using online panel services; and (2) sharing the analysis work amongst the ESRA partner organisations. The 
financial resources for the survey costs and the staffing resources for the analyses were secured by the 
ESRA2 partners own sources.  
In most countries, the cost for gathering the data was in the range between 5,000 and 10,000 € (for 1000 
respondents). Overall, the out-of-pocket costs for creating the ESRA2_2018 database (32 countries) 
amounted to around 160,000 €.  
The ESRA2 questionnaire was developed by Vias institute in collaboration with the ESRA2 core group 
partners. National partners were responsible for the translations of the master version into their national 
language version(s). Furthermore, they were responsible for the validations of the national results and 
provided contextual information necessary for the interpretation of the results. The analyses of the common 
data were a joint effort of ESRA2 core group in (BASt, bfu, CTL, IATSS, IFSTTAR, ITS, KFV, NTUA, 
PRP, SWOV, TIRF, Vias institute), who spent over 60 person months on analysing and producing the 
common ESRA2 output. 
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Results and Discussion 
ESRA2 output  
The results of the ESRA2_2018 survey will be published in a main report (Meesmann et al. 2019), a 
methodology report (Meesmann & Torfs, 2019), 15 thematic reports on different topics (speeding, 
distraction (mobile phone use), fatigue, seat belt, child restraint systems, unsafety feeling & risk perception, 
enforcement, vehicle automation, pedestrians, cyclists, moped drivers and motorcyclists, young road users, 
elderly road users, and gender aspects), and 32 country fact sheets. Furthermore, ESRA2 partners plan to 
publish national reports, scientific articles, and conference contributions. A final conference of the ESRA2 
project will be held in March 2020 (Paris, France). For more information see: www.esranet.eu . 
 
Example of ESRA2 results – self-declared unsafe traffic behaviour  
As an example of ESRA2 results, this paper will present self-declared unsafe traffic behaviour as a car 
driver. Within the ESRA2 questionnaire respondents were asked to answer 14 questions on self-declared 
behaviour as a car driver (see Table 2). Car drivers were asked to answer on a fivepoint rating scale ranging 
from never to (almost) always. For the purpose of the analysis, the value of 1 was coded as never, and values 
2 to 5 were coded as at least once. Table 2 shows the proportion of car drivers who reported a certain 
behaviour at least once in the last 30 days. The three lowest values are highlighted in green and the three 
highest values in red.  
The results show that in Europe and in North America, speeding offences were clearly the most frequently 
reported unsafe traffic behaviour (between 56% and 72%), while in Africa, Asia and Oceania, the use of a 
hands-free mobile phone was the most often reported unsafe driving behaviour (67% vs. 55% in Asia and 
Oceania) in this comparison. In all regions, the results show low percentages of drivers who reported driving 
under the influence of drugs or alcohol (above the legal limit). The percentage on self-declared driving after 
drinking alcohol are clearly higher. Note, that in most countries driving after drinking a small amount of 
alcohol is legally allowed.  
Furthermore, the results show big regional difference with respect to not using seat belts or child restraint 
systems (North America and Europa between 10-18%; Asia, Oceania and Africa between 35% and 48%). 
Note, that the Asian and Oceanian region is strongly dominated by the Indian sample.  
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For more results on driving under the influence, see other ICADTS presentation on ESRA and Achermann 
Stürmer, Y., Meesmann, U. & Berbatovci, H. (2019). 
Conclusion 
The fast growth of the ESRA initiative shows the feasibility and added value of a joint data collection by a 
network of road safety organisations. ESRA has become a global initiative which already conducted surveys 
in 46 countries across 6 continents (ESRA1, ESRA2). The intention is to repeat the measurements on a 
triennial basis and to develop time series of road safety performance indicators.  
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Abstract 
Background: In Ontario, Canada, impaired driving offenders are required to participate in the Back on Track 
(BOT) remedial program before they are eligible for licence reinstatement.  Ontario is one of the most 
ethnically diverse areas in the world; to effectively respond to the needs of BOT clients it is important to 
understand ethnic diversity and any language issues that might affect program success. 
Objectives: This exploratory work assessed the ethnolinguistic background of BOT participants, including 
their perceived comfort with participating in the program in English, and whether these factors differed for 
Criminal Code versus Warn Range participants, or by provider location.  
Methods: We present descriptive information on ethnolinguistic characteristics of a sample of 11,779 BOT 
participants who voluntarily completed an anonymous questionnaire at registration. 
Results: The BOT population reflects the ethnic diversity of Ontario. The largest proportion of participants 
overall are White-North American (62.4%), but substantial numbers of other ethnoracial groups are 
observed.  While most participants report being born in Canada, 24% were born outside of the country. After 
White-North American, the two largest ethnoracial groups are White-European (12.4%) and South Asian 
(7.0%). Each provider location appears to represent a community with a relatively unique ethnolinguistic 
make-up.  The large majority of respondents identify English as their primary language, and 98.9% report 
being completely, very, or moderately comfortable with English. Relative to Warn Range offenders, 
Criminal Code offenders are more likely to be White-North American, born in Canada, and report English as 
their primary language. 
Discussion: BOT participants are representative of Ontario’s ethnolinguistic variability.  While it appears 
that the large majority of BOT clients are comfortable with English, an important minority are not.  In 
response to these findings, BOT client workbooks have recently been translated into Punjabi and Tamil. 
Further monitoring of the ethnolinguistic characteristics of BOT clients is warranted. 
 
Introduction 
Back On Track (BOT) is Ontario’s remedial measures program for impaired drivers. The structure of the 
program is determined by Provincial guidelines.  Drinking drivers with a Criminal Code conviction are 
required to first complete an assessment that measures the severity of their substance-related problems.  
Individuals whose problems are determined to be less severe, as determined by the assessment, are assigned 
to an 8-hour Education workshop.  Those whose problems are determined to be more severe are assigned to 
a 16-hour Treatment workshop.  Finally, six months following completion of the 8-hour or 16-hour 
workshop, program participants must complete a 30-minute follow-up interview, typically by telephone.  
This structure is modified for those entering the program because of Warn Range offenses to exclude the 
assessment and follow-up interview requirements.   
Canada has over 200 ethnic groups and is one of the most ethnically diverse jurisdictions in the world (Chui 
et al, 2008).  Participants in the BOT program thus may represent a number of different ethnocultural 
groups.  As well, 28.5% of the province’s population was not born in Canada, and 26.6% of Ontarians are 
Allophones (people with a mother tongue other than English or French (Statistics Canada, 2013).  From its 
inception, BOT has followed other Provincial government programs in allowing program participants to 
bring their own interpreters with them when they attend programs.  This practice has proven successful in 
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allowing those with limited understanding of English to participate successfully in the program.  
Nevertheless, there is a need for more information about the ethnic background of BOT participants and 
their familiarity with the English language.   
New Canadians bring their cultural norms, beliefs and attitudes to Canada, including drinking practices and 
habits (Agic et al, 2011).  There is increasing recognition of the importance of language and culture in 
government services, including road safety programs (Mental Health Commission of Canada, 2012; Wray, 
Agic, Bennett-AbuAyyash, et al. 2013; Zeitoun and Al-Masri, 2010), and it is important to understand the 
cultural and language needs of populations served, including BOT participants. This report presents data 
from an initial investigation of language and ethnocultural identity among respondents participating in the 
BOT program.  The work is exploratory in nature, and was undertaken to provide insight into ethnocultural 
diversity among participants of the program, potential language barriers some program participants may be 
facing, and differences among program providers in the ethnocultural diversity of participants.   
Methods 
Beginning in November, 2010, all BOT participants were asked to voluntarily complete a brief questionnaire 
containing questions about language and ethnocultural identity.  The ethnicity and language questions were 
derived from similar questions employed by Statistics Canada and by CAMH in other contexts (e.g., CAMH 
Monitor telephone survey of the adult population, socio-demographic questions asked of treatment clients).  
The questions were designed to elicit information about language most comfortable speaking, a comfort 
level with speaking English, self-identified ethnocultural identity, and country of birth.   
Two methods were used to invite BOT participants to complete the ethnolinguistic survey.  First, as part of 
the online registration process, participants were asked if they would be willing to complete the 
questionnaire voluntarily and anonymously.  Those willing to do so could click a link that took them to the 
form.  Second, for those who received a mailed registration package, the ethnolinguistic questionnaire was 
included, along with an invitation to complete the forms voluntarily and anonymously.  These individuals 
were able to mail the forms back to the BOT office, or could hand in the forms at one of their contacts with 
program staff.   
This report is based on data provided by 10,652 Criminal Code participants and 1,127 Warn Range 
participants, who completed forms between November, 2010 and October, 2012.  While we cannot be 
certain of the exact total of individuals who had the opportunity to complete the questionnaire, we can 
estimate it based on the total number of individuals who completed the BOT program (about 22,000).  Based 
on this estimate, the proportion of BOT participants who volunteered to complete the questionnaire was 
about 50%.  This figure should be treated with caution because the exact number of individuals eligible to 
complete the form during this period was not available, but it nevertheless compares reasonably well with 
other estimates of participation rates in voluntary surveys (e.g., Mann et al, 2010).   
Data collected through participants completing online forms (n=10,682) were imported to a Microsoft Excel 
dataset.  These data were also able to be linked to basic demographic information (i.e., age, sex, program 
location).  This information was not available for data collected by returned paper forms (n=930).  Paper 
forms were scanned using Remark scanning software and imported to a Microsoft Excel dataset.  The two 
datasets were merged for analysis purposes. 
The large majority of participants were males (84.2% vs. 15.8% females).  Interestingly, in comparison to 
male respondents, a higher proportion of female respondents were more likely to be Criminal Code 
participants (16.5%) than Warn Range participants (9.4%).  The largest proportion of respondents fell into 
the 30-44 year-old age group (36.5%).  The next largest proportion was found in the under 30 year-old age 
group (34.4%), followed by those aged 45-59 years (23.6%).  Much smaller proportions were found in the 
60-74 year-old age group (5.4%) and the 75 years of age and over group (0.2%). In general, Warn Range 
participants were younger than Criminal Code participants.   
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Results 
Ethnocultural identity and country of birth 
Table 1 presents self-reported ethnocultural identity for Criminal Code and Warn Range participants.  
Overall, the largest proportion of participants identified themselves as White-North American (62.4%), 
followed by White-European (12.4%) and South Asian (7.0%). Aboriginal (2.8%), Indian-Caribbean (2.5%), 
and Latin Americans (2.2%) each constituted more than 2% of the sample, with the remaining groups 
(Black-Caribbean, East Asian, South East Asian, Mixed Background, Middle Eastern, Black-African, Black-
North American, and Other) each constituting less than 2% of the sample.  Some differences in ethnocultural 
identity between Criminal Code and Warn Range participants were also seen.  White-North American, 
Aboriginal, Latin American, and those who fell into the Other category appeared more likely to be Criminal 
Code than Warn Range participants, while those from all other groups appeared more likely to be Warn 
Range than Criminal Code participants.  
Table 1:  Ethnocultural identity by type of participant (data from online and 
paper forms) * 
 
Ethnocultural 
 Identity  
 Criminal Code 
Participants 
(N=10652) 
 Warn Range 
Participants 
(N=1127) 
 TOTAL 
 
(N=11779) 
White - North American 6600 ( 64.0%) 517 ( 47.4%) 7117 ( 62.4%) 
White – European 1277 ( 12.4%) 141 ( 12.9%) 1418 ( 12.4%) 
Asian – South 665 (  6.5%) 132 ( 12.1%) 797 (  7.0%) 
Aboriginal 307 (  3.0%) 15 (  1.4%) 322 (  2.8%) 
Indian – Caribbean 242 (  2.3%) 41 (  3.8%) 283 (  2.5%) 
Latin American 225 (  2.2%) 22 (  2.0%) 247 (  2.2%) 
Black – Caribbean 176 (  1.7%) 33 (  3.0%) 209 (  1.8%) 
Asian – East 131 (  1.3%) 55 (  5.0%) 186 (  1.6%) 
Asian - South East 134 (  1.3%) 37 (  3.4%) 171 (  1.5%) 
Mixed Background 147 (  1.4%) 20 (  1.8%) 167 (  1.5%) 
Middle Eastern 108 (  1.0%) 29 (  2.7%) 137 (  1.2%) 
Black – African 106 (  1.0%) 22 (  2.0%) 128 (  1.1%) 
Other 113 (  1.1%) 11 (  1.0%) 124 (  1.1%) 
Black - North American 79 (  0.8%) 16 (  1.5%) 95 (  0.8%) 
Total 10310 (100.0%) 1091 (100.0%) 11401 (100.0%) 
* - Pearson's chi-square test indicates significant differences among groups, p<.0001 
Table 2 summarizes information on country of birth in the sample.  Overall, the majority of participants 
were born in Canada (76.0%), but nevertheless a substantial proportion (24.0%) was born outside of the 
country.  Differences between Criminal Code and Warn Range participants in country of birth were also 
seen.  Criminal Code participants appeared more likely to be born in Canada than Warn Range participants 
(76.8% vs. 68.3%), while Warn Range participants appeared more likely to be born outside of Canada than 
Criminal Code participants (31.7% vs. 23.2%). 
Table 2: Birthplace by type of participant (data from online and paper 
forms) * 
 
Birthplace 
  
 Criminal Code 
Participants 
(N=10652) 
 Warn Range 
Participants 
(N=1127) 
 TOTAL 
 
(N=11779) 
Canada 8076 ( 76.8%) 753 ( 68.3%) 8829 ( 76.0%) 
Elsewhere 2434 ( 23.2%) 349 ( 31.7%) 2783 ( 24.0%) 
Total 10510 (100.0%) 1102 (100.0%) 11612 (100.0%) 
* - Pearson's chi-square test indicates significant differences among groups, p<.0001 
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Language and comfort with English 
Data on the language that participants reported being most comfortable speaking (referred to herein as 
primary language) is presented in Table 3.  The large majority of respondents reported English as their 
primary language (90.3%).  Primary languages identified by between 1 and 2% of participants were Punjabi 
(1.1%) and Other (1.7%; the footnote in Table 5 identifies the main ethnocultural identities of participants 
who responded Other on this question).  While some participants responded that each of the other 21 
languages represented in the question were their primary language, the proportions were all less than 1%.  
No significant differences between Criminal Code and Warn Range participants were seen in their self-
identified primary language.     
Table 4 presents data on the comfort level with English for Criminal Code and Warn Range participants.  
The large majority of respondents reported that they were completely comfortable with English (93.5%), and 
most of the rest reported being very comfortable (2.2%) or moderately comfortable (3.1%) with English.  
Only a very small proportion reported being only a little comfortable (0.7%) or not at all comfortable (0.4%) 
with English.  Differences in comfort level with English were observed between Criminal Code and Warn 
Range participants.  Criminal Code respondents appeared more likely than Warn Range respondents to 
report being completely comfortable (93.7% vs. 91.4%) with English, while Warn Range respondents 
appeared more likely than Criminal Code respondents to fall into the remaining categories.   
Table 3: Primary language by type of participant (data from online and 
paper forms) 
 
Primary Language 
  
 Criminal Code 
Participants 
(N=10652) 
 Warn Range 
Participants 
(N=1127) 
 TOTAL 
 
(N=11779) 
English 9288 (90.6%) 954 ( 87.7%) 10242 (90.3%) 
Other [a] 182 (  1.8%) 10 (  0.9%) 192 (  1.7%) 
Punjabi 123 (  1.2%) 7 (  0.6%) 130 (  1.1%) 
Tamil 90 (  0.9%) 17 (  1.6%) 107 (  0.9%) 
French 89 (  0.9%) 10 (  0.9%) 99 (  0.9%) 
Spanish 85 (  0.8%) 6 (  0.6%) 91 (  0.8%) 
Portuguese 67 (  0.7%) 7 (  0.6%) 74 (  0.7%) 
Chinese 49 (  0.5%) 21 (  1.9%) 70 (  0.6%) 
Russian 54 (  0.5%) 5 (  0.5%) 59 (  0.5%) 
Vietnamese 37 (  0.4%) 14 (  1.3%) 51 (  0.4%) 
Serbian 43 (  0.4%) 2 (  0.2%) 45 (  0.4%) 
Arabic 22 (  0.2%) 5 (  0.5%) 27 (  0.2%) 
Hindi 21 (  0.2%) 5 (  0.5%) 26 (  0.2%) 
Korean 20 (  0.2%) 4 (  0.4%) 24 (  0.2%) 
Persian/Farsi 17 (  0.2%) 4 (  0.4%) 21 (  0.2%) 
Urdu 12 (  0.1%) 7 (  0.6%) 19 (  0.2%) 
Gujarati 15 (  0.1%) 0 (  0.0%) 15 (  0.1%) 
Tagalog 9 (  0.1%) 3 (  0.3%) 12 (  0.1%) 
Albanian 7 (  0.1%) 3 (  0.3%) 10 (  0.1%) 
Ojibwa 8 (  0.1%) 2 (  0.2%) 10 (  0.1%) 
Greek 5 (  0.0%) 1 (  0.1%) 6 (  0.1%) 
Bengali 4 (  0.0%) 1 (  0.1%) 5 (  0.0%) 
Dari 5 (  0.0%) 0 (  0.0%) 5 (  0.0%) 
Somali 4 (  0.0%) 0 (  0.0%) 4 (  0.0%) 
Total 10256 (100.0%) 1088 (100.0%) 11344 (100.0%) 
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Table 3: Primary language by type of participant (data from online and 
paper forms) 
 
Primary Language 
  
 Criminal Code 
Participants 
(N=10652) 
 Warn Range 
Participants 
(N=1127) 
 TOTAL 
 
(N=11779) 
[a] ‘Other’ primary language corresponds to participants with the 
following ethnocultural identities: White-European languages (58.3%), White-North-
American(8.6%), Black-African (5.4%), Asian-South East(4.3%), and 
Middle Eastern (3.2%). 
 
 
Table 4:  Comfort with English by type of participant (data from online and 
paper forms)* 
 
Comfort with English 
  
 Criminal Code 
Participants 
(N=10652) 
 Warn Range 
Participants 
(N=1127) 
 TOTAL 
 
(N=11779) 
Completely 9743 ( 93.7%) 1004 ( 91.4%) 10747 ( 93.5%) 
Very 225 (  2.2%) 33 (  3.0%) 258 (  2.2%) 
Moderately 316 (  3.0%) 42 (  3.8%) 358 (  3.1%) 
A little 73 (  0.7%) 9 (  0.8%) 82 (  0.7%) 
Not at all 36 (  0.3%) 10 (  0.9%) 46 (  0.4%) 
Total 10393 (100.0%) 1098 (100.0%) 11491 (100.0%) 
* - Pearson's chi-square test indicates significant differences among groups, p=.0082 
 
 
Discussion 
BOT participants reflect the ethnic diversity of the Ontario population.  While the largest proportion of 
participants overall are White-North American (62.4%), substantial numbers of participants from other 
ethnocultural groups were observed.  As well, while most participants report being born in Canada, nearly a 
quarter (24%) was born outside of the country.  After White-North American, the two largest ethnocultural 
groups are White-European (12.4%) and South- Asian (7.0%).  Smaller proportions of respondents endorse 
other groups, most notably Aboriginal (2.8%), Indian-Caribbean (2.5%), and Latin American (2.2%).  While 
the number of individuals from specific ethnic groups are small, nevertheless they represent cultures with 
very different practices and attitudes, including those related to alcohol and driving (e.g., Agic et al, 2011).  
It is also the case that some of the broad categories used here, such as South-Asian, themselves represent 
several very distinct cultures and linguistic groups (Agic et al, in press).   
The large majority of respondents noted their primary language as English (90.3%).  While many other 
primary languages were also seen, the proportion of respondents endorsing these other languages was small.  
The most common primary language noted after English was ‘Other’ (1.7%) followed by Punjabi (1.1%), 
Tamil (0.9%), French (0.9%), and Spanish (0.8%).  This observation suggests that a large majority of 
program participants appear to be English speakers.  This is confirmed by the data on the comfort level with 
English, with 98.9% of respondents reporting being completely, very, or moderately comfortable with 
English.  Nevertheless, it is important to recognize that 1.1% of participants are only a little or not at all 
comfortable with English.  While this small percentage would seem to suggest that language accessibility is 
not a significant problem at present, nevertheless it does justify the continuation of the policy of allowing 
participants to bring personal interpreters.  Efforts to improve participants’ access to the program may 
consider identifying some of the major languages where translation of program information may be justified.  
As with ethnocultural group, there does not appear to be a consistent pattern of primary language group 
across service providers, other than English being the primary language of the large majority of participants.   
We also examined whether there were any differences in ethnocultural group or primary language between 
Criminal Code and Warn Range offenders.  In general, Criminal Code offenders were more likely to be 
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White-North American, to be born in Canada, to report English as their primary language, and to report 
higher levels of comfort with English than Warn Range participants.  Since Criminal Code offenses involve 
higher BACs and presumably involve more drinking on the occasion when the offense occurred, these 
findings are generally consistent with other studies that suggest that those born in Canada or who endorse 
‘Canadian’ as their ethnicity report heavier drinking and higher levels of risky drinking, on average, than 
those born in other countries or who report belonging to other cultures (Agic et al, 2016).   
While these results are of substantial interest, it is important to recognize important limitations in the way 
that the data were collected and thus in the strength of the conclusions that can be drawn.  The constraints 
that collection of the data could not be construed as program requirements, and also that collection of the 
data not intrude on time needed to fulfill program requirements, meant that the total number of individuals 
who were eligible to complete the questionnaire could not be specifically identified but only estimated.  
Also, the questionnaire was available only in English.  Because of this, individuals who are less familiar 
with English may be less likely to complete it.  This could result in an underestimate of the number of 
individuals who are not familiar with English, or who are from cultural backgrounds with less familiarity 
with the language.   
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Evaluating Individual Psychological Rehabilitation of Offenders.  
Part 2: Recidivism Rate After Intervention and Assessment. 
Joachim Seidl, Association for Education, Advanced Training and Further Education. 
Petra Feustel-Seidl, Verkehrspsychologische Praxis. 
Abstract 
Background: At the T2016 congress in Gramado (Brazil) we discussed the rehabilitation program and the 
follow-up assessment of clients attending our traffic-psychological therapy in the period of 2013 to 2015. 
Results regarding the rate of recidivism are available now.  
Aim: After the withdrawal of the driver’s license due to alcohol, drug or significant traffic offenses, the 
clients must prove their fitness to drive. Seeking counseling from a traffic psychologist is conducive to that 
end. Before driving privileges are reinstated, German offenders need to pass a medical psychological 
assessment (MPA) (“Medizinisch-Psychologische Untersuchung MPU”). If a client passes that assessment 
successfully, he is classified fit to operate a vehicle again and get back their unrestricted driver’s license. We 
would like to introduce the rehabilitation briefly and the result of the evaluation on the basis of MPA results 
between 2013 and 2017. We were able to evaluate the effectiveness of the rehabilitation program by 
examining the recidivism rate over a period of 3 years.  
Method:The AFN (Association for Education, Advanced Training and Further Education) developed a 
“traffic psychological therapy” based on Alfred Adler's individual psychology. The AFN's traffic 
psychological therapy comprises at least 10 hours over a period of at least 6 months. The therapy takes place 
in individual sessions or in small groups with a maximum of 4 participants and a duration of 18 hours. With 
the support of the Driving License Agency we were able to monitor former participants regarding any 
relevant recidivism within 3 years after completing the rehabilitation program.  
Results: In total, 384 clients completed the rehabilitation program between 2013 and 2017. Of all the 
therapy participants, 86 % obtained a positive result in the MPA, 8 % were recommended additional courses 
and 6 % obtained a negative result. Out of the 219 clients between 2013 and 2015, only 5 persons relapsed. 
4 persons, caught drunk-driving and 1 person that was caught under the influence of drugs, committed 
another alcohol offense. Clients, who were caught under the influence of drugs or clients with significant 
traffic offenses did not have a relapse within the 3-year period.  
Discussion and Conclusions: It became apparent that the overwhelming majority of offenders could restore 
their fitness to operate vehicles by means of traffic psychological therapy.  
After completing the rehabilitation program successfully, the rate of recidivism is 2,3 % within 3 years.  
Keywords: Rehabilitation program, recidivism, evaluation, assessment  
 
Background 
Germany has a long tradition of rehabilitating habitual traffic offenders. Penalties alone are inadequate 
protection against reoffending. Attitude and conduct must inevitably be changed permanently.  
 
The driver license will be revoked for  
(1) crimes committed under the influence of alcohol (from BAC 0.16 %),  
(2) multiple traffic offenses under the influence of alcohol,  
(3) consumption of controlled substances,  
(4) 8 points or more on the driver license (registered at the Driver Fitness Assessment System) and the driver 
will be classified as unfit for operating motor vehicles.  
 
The offenders shall restore their fitness to drive during the retention period. Seeking counseling from a 
traffic psychologist is conducive to that end. Before driving privileges are reinstated, German offenders need 
to pass a medical psychological assessment (MPA) (“Medizinisch-Psychologische Untersuchung MPU”).  
 
A medical psychological assessment is an interdisciplinary examination of a person´s driving fitness that 
renders of the current state of scientific knowledge relating to a specific situation which is completed by 
answering a given question.  
 
Every year about 100,000 medical psychological assessments are conducted in Germany, whereby with a 
total of about 50 million motorists only 0.2 % of the motorists are affected by this measure.  
 
The purpose of the MPA is to assess whether the offender is fit to operate vehicles again.  
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Aim 
 In this process, the offenders willing to restore their fitness can be expertly guided by a traffic psychologist. 
They have to realize the scope of their problems (alcohol, drugs, speeding, etc.) and implement changes in 
their attitude and behavior.  
 
A traffic psychological rehabilitation method has been developed and evaluated on the basis of MPA results. 
We would like to introduce the rehabilitation and the result of the evaluation between 2013 and 2017 and the 
recidivism rate over a period of 3 years.  
 
Method 
The AFN (Association for Education, Advanced Training and Further Education) developed a “traffic 
psychological therapy” based on Alfred Adler's individual psychology. Using the focal lifestyle analysis, 
each participant is working on the background of their own individual problem. The goal is to eliminate the 
breeding ground for the symptoms, thereby facilitating safe road use in the future.  
Essential parts of the “traffic psychological therapy” are the acquisition and extension of the participant’s 
knowledge, regarding the effect and risks of alcohol and drug consumption, legal regulations like the legal 
alcohol limit, different point systems or other information. The participants are given homework as well, to 
ensure that they keep on working on their own, too.  
 
The focal lifestyle analysis is based on the method of individual psychology (IP) founded by the Austrian 
psychotherapist Alfred Adler. The term “lifestyle” refers to the typical pattern of dealing with difficult tasks 
and life periods that individuals develop over the course of their lives. However, some persons are not 
capable of dealing successfully and healthily with disadvantages they experience in their life. They feel 
inferior and start to “over-compensate” for their problems by seeking power and dominance, losing their 
flexibility in thinking and coping in the process. Their problems will often increase instead of getting solved 
and they will experience exhaustion, dissatisfaction, low self-esteem and general a lack of success. The 
consumption of drugs and alcohol promises – and temporarily provides – a "solution" and relief.  
 
An Intervention can help the affected person address the problem and make their lifestyle clear to them as 
well as point out that change is possible. The Seminar leader, the individual and the other participants 
compile the typical lifestyle strategies of each individual and develop new objectives and effective strategies 
together that make previous consumption behavior redundant.  
The main aim is to help the participants of the traffic psychological therapy realize that their “sober 
behavior” was just as problematic as their “consumptive behavior” and that their offences are directly 
related to the whole person and their life story.  
 
The AFN's traffic psychological therapy comprises at least 10 hours over a period of at least 6 months. It is 
implemented in individual or small group (4 participants, 18 hours) therapy.  
We were able to evaluate the effectiveness of the rehabilitation program by MPA results and the recidivism 
rate.  
 
We decided to choose a three-year period after the end of the measure. We define a relevant relapse in the 
criterion of legal currency:  
 in the case of an alcohol question: another alcohol offense  
 in the case of a drug question: a new drug offence or alcohol offense  
 for questions relating to traffic law: renewed driving disqualification due to general traffic offenses.  
 
Results 
384 subjects took part in the evaluation. They completed the traffic psychological therapy between 2013 and 
2017. Distribution among the problematic groups: 72 % alcohol, 13 % drugs, 15 % traffic offenses. Of all 
the therapy participants, 86 % obtained a positive result in the MPA, 8 % were recommended additional 
courses and 6 % obtained a negative result.  
Of the 219 clients between 2013 and 2015, only 5 persons relapsed. 4 persons, caught drunk-driving and 1 
person that was caught under the influence of drugs, committed another alcohol offense. Clients, who were 
caught under the influence of drugs or clients with significant traffic offenses did not relapse within the 3-
year period.  
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Discussion and Conclusions 
It has become apparent that the overwhelming majority of offenders could restore their fitness to operate 
vehicles by means of the traffic psychological therapy.  
After completing the rehabilitation program successfully, the rate of recidivism is 2,3 % within 3 years. The 
next step will be to verify the results of the clients between 2016 and 2018 by relapses within the 3-year 
period (T2022).  
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Abstract 
Background: Alcohol ignition interlock devices (IID) have been effective in reducing alcohol-impaired 
driving. As drivers with IIDs maintain routine contact with installers, there is a prime opportunity to 
evaluate provider interventions designed to reduce rates of alcohol-impaired driving. Unfortunately, few 
studies to date have attempted to evaluate such interventions with this high-risk population.  
Objectives: In the current study, we evaluated the effectiveness of the Learn Your Limit (LYL) program for 
drivers with IIDs. The LYL is an educational intervention is delivered by provider texts and email to IID 
users to encourage the separation of drinking from driving. This study sought to contrast the performance of 
participants who received the supplemental LYL program with those in a treatment-as-usual condition.  
Methods: Participants (N = 313) were recruited via fliers and were randomly assigned to a treatment-as-
usual or LYL conditions. Demographics and measures of performance while on IID were collected and 
analyzed using a series of multivariate linear regression analyses.  
Results: Group assignment was non-significant when predicting total IID lockouts (β)= - .089, p = .251 
indicating that LYL participation did not significantly reduce total lockouts. However, when examining 
multiple high BAC lockouts, group assignment significantly predicted high lockout rates (β)= - .216, p = 
.005 indicating that those who participated in the LYL program were over 20% less likely to have multiple 
high BAC lockouts.  
Discussion and Implications: Although it did not achieve full success, the LYL program has shown 
enormous potential.  To realize its full potential efforts to improve the delivery of the program, to isolate the 
program from changes in IID legislation and IID market need to be developed. A partnership with 
manufacturing companies to ensure consistency of interlocks with use of blue tooth and Wi-Fi for real-time 
educational lessons and videos would provide a next step opportunity.  
Acknowledgement: The Small Business Innovation Research (SBIR) through the National Institute on 
Alcohol Abuse and Alcoholism grant funded the project under grant R44AA022853. 
 
Introduction 
Drivers convicted of Driving Under the Influence (DUI) are four times more likely to be involved in a fatal 
crash while impaired by alcohol than an average licensed driver [1].   Alcohol ignition interlock devices 
(IIDs) are tools that prevent a vehicle from starting when the drivers’ Blood Alcohol Content (BAC) is about 
a specified level.   Research has consistently shown that while on the vehicle of a DUI offender, IIDs are 
more effective than license suspension for controlling recidivism [2, 3] and reducing DUI rates [4-8].  As a 
result, all 50 U.S. states and Washington D.C. have enacted laws providing for IIDs as a sanction for DUI.   
Unfortunately, the efficiency of IIDs to prevent alcohol-related crashes is limited at least in part by the 
failure of the benefits of IIDs while on the offenders vehicles to persist after device removal [9].    
 
While installed on the vehicle, IIDs have been found to reduce recidivism by up to 65% [10]. The reduction 
in the incidence of recidivism while the IID is in place may indicate that drivers adapted their drinking 
behaviors to accommodate the IID. This suggests that such adaptive behavior could be potentiated through 
an integration of treatment with IID programs to minimize relapse after IID removal [9].  Recent 
developments in IID technology have the potential to provide targeted interventions to IID users, and 
therefore, to improve participants’ IID experiences as well as after the device is removed [11].   New 
technologies have potential for delivering information to interlock users that can help them in avoiding 
lockouts and violations and encourage adaptive behaviors while in the interlock program [12].  Despite this 
potential, however, to our knowledge, there has been no use of automated electronic technology to intervene 
with active interlock users.  
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Funded by NIAAA through a Small Business Innovation Research (SBIR) program, an Arizona interlock 
services provider, Axxess Unlimited, LLC, proposed to produce an intervention designed to expand their 
communication capability with their clients to transmit prevention and educational messages directly to 
interlock users via text messages and/or emails with imbedded short video links; these messages were designed 
to also be easily accessible via the existing client “Dashboard” account as well. The existing system was 
augmented to include more detailed structured feedback to clients on their behavior and provide educational 
information covering the technical aspects of using the interlock device, tools and resources to help prevent 
impaired driving, and behavioral strategies to separate drinking from driving.  PIRE independently evaluated 
the efficaciousness of the intervention to promote adaptive behaviors while on IID.  This report presents the 
outcome of that evaluation.  
The electronic intervention. 
Typically, interlock companies offer a brief training to their clients on the operational use of the interlock 
device via vendors at area installation centers. Prior to grant funding, Axxess Unlimited implemented an 
“onboarding” (enrollment) system that used three short introductory video presentations for all new clients 
at the time of registration focusing on how the interlock works and how to avoid violations, as well as 
information on their various service plans. 
 
With funding from the SBIR, this system was extended to allow clients to receive regular detailed prevention 
information and extended feedback on specific lockouts and violations. There were specific tailored messages 
for common violations while on IID.  
 Study Design and Analyses 
Phase I:   
 
Phase I of the SBIR program assessed the feasibility of the educational intervention.  Quantitative interlock 
data were collected and used to compare the experiences of the previous year (2014) interlock clients (N = 
971, our reference/comparison group) to the 538 enrolled in 2015.  Participants in the reference group were 
exposed to the pre-intervention, basic interlock plan with limited information provided upon enrollment. 
Comparisons were made on Arizona Motor Vehicle Department (MVD) defined violations (two .08 BAC 
lockouts) as well as on IID violations (lockouts > .02 BAC and missed retests). 
 
Web Survey to Determine Interest in an Electronic Intervention 
 
A 30-item, confidential web survey of clients was also employed to determine customer assessment of the value 
of the current Dashboard system and their views on the potential value of the hypothetical addition of 
educational text messages and emails with video links. Two hundred participants were invited via an email to 
complete a 10-minute web survey using Survey Monkey for an incentive of $20; 157 clients ultimately 
completed the survey. The web survey collected information in two key areas: (a) client-centered characteristics 
(demographics, priors, time in program, lockouts and other violations, fees paid, and reasons for choosing the 
interlock company); and (b) the extent to which clients used the current program features and Axxess 
Unlimited’s existing Dashboard system (and their reactions to these services—favorable, indifferent, 
unfavorable). The existing Dashboard system not only allowed clients to access information about appointments 
and invoices, but to view their interlock log data and contemporaneously record explanations related to any 
lockouts and violations 
 
Phase II: 
 
Phase II of the SBIR program was set to evaluate the intervention by conducting a random assignment study of 
clients receiving the electronic intervention with clients receiving basic interlock services. In Phase II, in 
addition to four introductory educational videos, a series of 12 short prevention and motivational messages, with 
most including video links (<1 to 3 minutes in length), were developed focusing on a variety of topics including 
information on how the interlock works, tools to help the customer while on the interlock program, educational 
pieces on preventing violations, and motivational pieces on separating drinking from driving.  These messages 
were automated and programmed to be delivered via text and/or email at specific times after interlock 
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installation (e.g., Day 1 after interlock installment, Day 10, Day 25, etc.) over the first 6 months on the 
interlock. All interlock users in the intervention group were set to receive at least two prevention messages per 
month (for a total of 12).     
The electronic system also delivered targeted prevention information and extended feedback when individual 
clients had lockouts and violations. There were specific messages for an early morning positive BAC test; an 
obvious mouth alcohol failure (a high positive test followed by a low or zero BAC test); and failure to take a 
running retest.   
The Phase II evaluation also included web-based entry and exit surveys to determine the level of 
participation and perception of the degree to which the intervention might elicit behavioral changes 
following its removal. Subjects received $30 (which was later increased to $50) for completing the entry 
survey and $70 for the exit survey. Participants (N = 313) were recruited via fliers and were randomly 
assigned to a treatment-as-usual or to the electronic intervention. Demographics and measures of interlock 
performance (MVD defined violations and IID violations) and program satisfaction while on IID were 
collected and analyzed using a series of multivariate linear regression analyses.  
 
Problems and Barriers 
 
A series of unexpected problems and barriers arose during Phase II, in particular the occurrence of market 
changes in Arizona which resulted in an increase in the number of interlock providers and subsequently, an 
increase in competition for the participating interlock company.  These developments delayed recruitment 
and resulted in a lower number of subjects for the study.  Between Phases 1 and 2, changes in the state 
required interlock specifications required a change in interlock devices for the study continuity. Further, the 
logistics of randomly assigning clients to the intervention or to the comparison group were complicated 
when judges required that some DUI offenders have access to their Dashboard interlock log information. In 
addition, despite having been trained, relying on interlock installation personnel to assist with the random 
assignment plan proved to be problematic.  Finally, participants who filled out the Phase II Exit surveys 
skipped many of the questions related to the intervention.  
 
Results 
Phase I:   
Table 1 shows that the interlock users in the experimental group had significantly fewer IID-defined (lockouts) 
and MVD -defined violations than did the interlock users in the comparison group.   Using the guidelines 
proposed by Cohen [13], the corresponding effect size was moderate (η2 = .0598) for IID violations and small 
for MVD violations (η2 = .0118).  This difference is logical as the requirements to meet an MVD violation are 
notably more stringent (i.e., BAC levels have to be much higher to count as an MVD violation) than they are to 
meet an IID violation.  
 
Table 1.  Mean number of IID-violations and MVD violations  
 Experimental Group  
(N=538) 
Reference Group  
(N=971) P value 
  Mean SD  Mean SD 
IID Violations  1.19 2.85  3.32 4.60 <.001 
MVD Violations  0.30 0.84  0.67 1.29 <.001 
Experimental and reference group indicate IID clients who in participated of the enhanced  program (in 2015), 
and those who did not (in 2014).  IID-violations and MVD-violations refer to violations as established by the 
settings of the interlock device (IID-violations; BAC ≥ .03) or by the Motor Vehicle Department (MVD-
violations; BAC ≥ .08). SD denotes standard deviation. 
 
The web surveys revealed that there was significant potential for several of the electronic intervention features.  
Participants reported that information placed on the Dashboard, or received via email or text would be useful.  
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Almost 50% of participants indicated they accessed the Dashboard via their cellphone. Performance incentives 
were viewed favorably including reduced monthly fees for potentially completing a brief education/treatment 
session with counselors. Though the treatment sessions were not implemented in the current study, these Phase I 
results indicated that drivers with IIDs would be receptive to such an intervention with a financial incentive like 
reduced interlock fees. 
Phase II:   
 
MVD-violations and IID-violations.   
 
Group assignment was non-significant when predicting total IID lockouts (β)= - .089, p = .251 indicating 
that intervention participation did not significantly reduce total lockouts. However, when examining 
incidents of high BAC lockouts (>.08), the intervention group reported about 14% fewer high BAC lockouts 
than the comparison group. Similarly, group assignment significantly predicted high BAC lockout rates (β)= 
- .216, p = .005 with those who participated in the intervention program were over 20% less likely to have 
multiple high BAC lockouts. 
 
Web-based process evaluation.  
  
We found no differences between the comparison and intervention conditions on the number of issues 
clients reported with the device, or the amount of the perceived financial burden. Nevertheless, there was a 
trend of those in the comparison condition reporting more issues related to having the IID than those in the 
intervention condition (p = 0.086).    
We also assessed indicators of self-reported future behavioral modifications in association with the intervention 
program.  Participants were asked a series of questions assessing whether they felt they needed to change their 
drinking behaviors, and how they might do so. Interestingly, though neither group was more likely to report 
problems with their drinking behaviors or express need to change their behaviors when the device was installed 
on their car, upon removal of the interlock, those in the intervention condition were significantly more likely to 
endorse items suggesting behavioral adaptations following removal of the device including: “Change where and 
when you drink?” and “Change who you drink with?” (t(-2.01), p<.05 and t(-2.20), p<.05, respectively). This 
may indicate that those in the intervention condition could be more likely to make meaningful changes 
following device removal. 
 
Discussion 
 
Despite facing multiple problems , the evaluation suggests that some elements of the electronic intervention 
implemented while the interlock units were on the offender’s vehicles were effective for reducing the most 
serious violations. We found that regular text and email messages with video links are viable methods for 
disseminating information to DUI offenders on IIDs – both in terms of getting information to drivers and 
potentially receiving information from them.  The web surveys revealed that the electronic intervention was 
generally well received, and there was notable interest in several of the program features.   
 
When taken together, results seem to indicate that though the intervention did not decrease the frequency of 
lockouts relative to the basic program, when participants in the intervention did lock out, fewer of their 
lockouts were above a legal BAC limit of .08 when compared to the basic condition.  
 
Thus, although it did not achieve full success partially due to the implementation problems and barriers 
described above, the electronic intervention has shown good potential.  To realize the full potential to 
improve the delivery of such a program, adding targeted electronic educational messages to improve 
interlock performance will have to be cost effective for interlock companies.  A partnership with 
manufacturing companies to ensure consistency of interlocks with use of blue tooth and Wi-Fi for real-time 
educational lessons and videos could provide a next step opportunity. Finally, developing brief therapeutic 
interventions designed to be delivered electronically to IID users may allow for the development of 
additional adaptive behaviors.  
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Abstract 
Context. In Canada, the minimum legal drinking age (MLDA) is 18 years in Alberta, Manitoba, and 
Québec, and 19 years in the rest of the country. Recently, a Canadian expert panel has recommended raising 
the MLDA across all provinces to at least 19 years of age or—ideally—to 21 years of age. 
Objective. To assess the impacts of current MLDA laws on severe motor vehicle collision (MVC) injuries 
seen in hospital-based trauma centres in Canada. 
Data source. Canada’s National Trauma Registry-Comprehensive Data Set (NTR-CDS, 1999-2013). 
Sample. NTR-CDS admissions of patients aged 14-23 years (total admissions, n = 7946; males = 5357) 
including major trauma (Injury Severity Score > 12) due to MVCs.  
Primary outcome. ICD-9/10-defined MVC injuries. 
Analytic plan. Regression-discontinuity analyses. 
Key findings. Males accounted for approximately 67.4% of all severe traffic-related MVC admissions to 
trauma centres during the study span. In comparison to young males slightly younger than the drinking age, 
those young men just older than the MLDA had significant and immediate increases of 26% (95% CI = 3%-
49%, p = 0.029) in trauma-centre admissions for injuries due to MVCs. There was no evidence of change 
across the MLDA for females 7.6% (95% CI = -14.5%-30%, p = 0.497). 
Discussion. Given that the MLDA appears to attenuate severe MVC-related injuries among young males 
still under MLDA constraints, it is reasonable to expect that raising the MLDA may reduce the overall 
societal burden of alcohol-related severe MVC trauma among newly restricted young adults. 
Keywords. Minimum legal drinking age laws; youth; alcohol consumption; motor vehicle collisions; 
hospital records. 
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Introduction 
Alcohol use is the largest contributor to the global burden of morbidity and mortality among adolescents and 
young adults aged 10-24 years old (Institute for Health Metrics and Evaluation, 2013; Gore et al., 2011; Lim 
et al., 2012), and road traffic crashes represent the second leading cause of disability-adjusted life years lost 
(DALYs) in this age group(Gore et al., 2011). Given the prominence of alcohol-related injuries among 
young people worldwide (The Management of Substance Abuse Team (MSB) in the Department of Mental 
Health and Substance Abuse (MSD) of the World Health Organization, 2011), especially those due to motor 
vehicle collisions (MVCs) (World Health Organization (WHO), 2015), many countries have established 
minimum legal drinking age (MLDA) restrictions regarding the purchase, use, and possession of alcohol 
products. The MLDA aims to reduce the burden that alcohol-related harms hold among young people. 
Canadian MLDAs are under provincial jurisdiction, and almost all provinces set their current legislated 
drinking ages in the mid-to-late 1970s. The MLDA is 18 years of age in Alberta, Manitoba and Québec, and 
19 years of age in the rest of Canada. Recently, the Canadian Public Health Association (Canadian Public 
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Health Association, 2011) and Canadian alcohol-policy experts have recommended raising the MLDA 
across all provinces to 19 years of age, with the expert panel also identifying 21 years as the ideal (Stockwell 
et al., 2019). 
A large majority of studies assessing the impacts of the MLDA on MVCs were conducted 20-40 years ago 
[for reviews, see (McCartt, Hellinga, & Kirley, 2010; Wagenaar & Toomey, 2002)], as most research relied 
on natural experiments involving legislative changes in the United States in the 1980s (Wagenaar & 
Toomey, 2002). It is reasonable to argue that the impacts of MLDA laws observed two to four decades ago 
might be substantially attenuated in the contemporary context due, in large part, to advances in both road 
and vehicle safety (Kahane, 2004; Waller, 2002), introduction of provincial graduated driver licensing 
(GDL) legislation (Dee, Grabowski, & Morrisey, 2005; Masten, Foss, & Marshall, 2011; Mayhew, Simpson, 
& Singhal, 2005; McCartt, Teoh, Fields, Braitman, & Hellinga, 2010), declining prevalence of past year 
drinking and past month binge drinking among adolescents and young adults (1999-2013) (Boak, Hamilton, 
Adlaf, & Mann, 2013), and increases in the severity of penalties for drinking and driving (Asbridge et al., 
2009; Mann et al., 2001; Vingilis, Blefgen, Lei, Sykora, & Mann, 1988).  
Over the last seven years, our research team has demonstrated that Canadian drinking age legislation has a 
significant impact on driving-related harms. For example, in comparison to youth slightly younger than the 
MLDA, those young people just older than the MLDA have significant and immediate increases in: motor 
vehicle collision fatalities [among males (Callaghan, Sanches, Gatley, & Stockwell, 2014)]; police-reported 
motor vehicle collisions [among males and females (Callaghan, Gatley, Sanches, & Asbridge, 2014)]; and 
alcohol-impaired driving crimes [among males and females (Callaghan et al., 2016)]. However, our program 
of research has shown some inconsistencies in relation to the impact of the MLDA on MVC injuries seen in 
hospital-based settings in Canada (Callaghan et al., 2013; Callaghan, Sanches, & Gatley, 2013). In a large, 
national study, we found that young men (but not young women) gaining the MLDA incur significant and 
immediate increases in severe motor vehicle collision injuries requiring inpatient hospital-based services 
(Callaghan, Sanches, & Gatley, 2013). However, in another study, we found that the MLDA was not 
associated with evidence of increases in inpatient or emergency department utilization for MVC injuries 
(Callaghan et al., 2013).  
The primary aim of the current study is to clarify the impacts of the MLDA on hospital-based service 
utilization due to motor vehicle collision injury among young people in Canada. Using Canada’s National 
Trauma Registry (NTR), we expected that there would be significant and immediate increases in severe 
MVC trauma episodes among young men and women who were just released from MLDA restrictions.  
Methods 
Data Sources.  
National Trauma Registry – Comprehensive Dataset (NTR-CDS) 
The NTR-CDS dataset includes only individuals who presented to a participating trauma centre with an 
injury severity score of (ISS) > 12 (Canadian Institute for Health Information, 2014). The ISS is an 
international system developed to allow comparisons of injury severity patterns across countries (Palmer, 
2007). This dataset captures demographic information, details of pre-hospital and hospital care, and patient 
outcomes at discharge and post-hospitalization. The NTR-CDS only contains information from designated 
trauma hospitals in provinces/territories with established trauma registries, or other participating trauma 
facilities. The NTR-CDS was decommissioned on March 31, 2014. 
The NTR currently uses the ICD-10-CA/CCI classification system, introduced in 2004-2005. Older NTR 
records used ICD-9-CCP and ICD-9-PM (Canadian Institute for Health Information, 2016).  
Data span. 
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The NTR-CDS includes the following data spans, by province/territory: 1999/2000-2012/2013 in Alberta, 
British Columbia, Manitoba, Ontario, and Nova Scotia; New Brunswick (2000/2001-2012/2013); 
Newfoundland and Labrador (2003/2004-2012/2013); Nova Scotia (1999/2000-2012/2013); Québec 
(2000/2001-2012/2013); and Saskatchewan (2009/2010-2012/2013). During the study span, there was 
variation in the number of facilities reporting to the NTR-CDS, ranging from 25 in 1999/2000 to 112 in 
2012/2013.  
Sample.  
The number of admissions of patients aged 14-23 years (total admissions, n = 7946; males = 5357) 
hospitalized with major trauma (Injury Severity Score > 12) due to motor vehicle collision injuries in 
participating trauma centre hospitals across Canada (excluding Quebec). Patients from Newfoundland and 
Labrador and Manitoba were excluded from analyses due to missing key information in the dataset (i.e., date 
of birth or date of admission) required for calculating the age-in-month variable. 
Construction of MVC outcomes. 
We used ICD-9 and ICD-10 codes for traffic-related collision injuries (Centers for Disease Control and 
Prevention, n.d.)– see Table 1. 
MVC injuries: count data.  
We defined the primary outcome in terms of monthly counts of NTR admissions for motor vehicle collision-
related injuries. 
Driver’s age.  
We calculated the age of the driver at the time of NTR admission in terms of age in months. 
Analytic plan.  
Regression-discontinuity. 
We employed a regression-discontinuity (RD) design(Shadish, Cook, & Campbell, 2002; Thistlethwaite & 
Campbell, 1960)—a quasi-experimental approach which can provide credible estimates of the causal effect 
of an intervention on a specified outcome (Lee & Lemieux, 2009). A detailed description of RD can be 
found in our prior publications (Callaghan et al., 2016; Callaghan, Sanches, Gatley, & Stockwell, 2014; 
Callaghan et al. 2013; Callaghan, Sanches, & Gatley, 2013).  
Primary RD analyses: Non-parametric local regression. 
In our primary nonparametric local regression analyses, we used a recent approach (Calonico, Cattaneo, & 
Titiunik, 2014b) implemented in the R package—rdrobust (Calonico, Cattaneo, & Titiunik, 2014a; R 
Development Core Team, 2014)—to fit the robust RD models with bias correction. We also used the 
triangular kernel weighting approach and a recently proposed strategy for identifying the optimum 
bandwidth in the local regression series (Calonico et al., 2014b). Local regression fits a piecewise weighted 
regression model to each data point by using a set of points in its neighborhood. To estimate the MLDA 
effect, two local regression models are adjusted, one on each side of the discontinuity, and the difference in 
their estimates at the discontinuity point is the estimated MLDA effect. An important strength of local 
regression is that the approach is relatively robust to non-linearities and allows for data modeling without 
making assumptions about the functional form of the model. This is a key advantage of local regression as 
compared to traditional parametric regression, where one usually needs to test higher order polynomial 
terms, a practice which recently has been criticized (Gelman & Imbens, 2014). 
Results 
Males accounted for approximately 67.4% of all severe traffic-related MVC admissions in the study. The 
RD analyses found that in comparison to young males slightly younger than the drinking age, those young 
men just older than the MLDA had significant and immediate increases of 26% (95% CI = 3%-49%, p = 
0.029) in trauma-centre admissions for injuries due to motor vehicle collisions (Figure 1). There was no 
evidence of change across the MLDA for females 7.6% (95% CI = -14.5%-30%, p = 0.497) (Figure 1).  
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Discussion 
The current study found that young men gaining the legal drinking age incurred a significant and immediate 
26% increase in national trauma centre admissions for severe motor vehicle collision trauma. There was no 
evidence of significant changes in patterns of MVC admissions across the MLDA for females. This finding 
dovetails with our prior work showing that release from MLDA restrictions is associated with significant 
increases in male (but not female) inpatient hospitalization admissions due to MVC injuries (Callaghan, 
Sanches, & Gatley, 2013, 2013). 
Recent work in the field also has shown that in comparison to their female counterparts, young men 
experience a substantially higher absolute number of driving-related harms appearing immediately after the 
MLDA, such as mortality due to MVCs ( Callaghan et al., 2014; Carpenter & Dobkin, 2009, 2017), police-
reported alcohol-impaired driving crimes (Callaghan et al., 2016), hospitalizations for injuries due to MVCs 
( Callaghan et al., 2013; Kypri et al., 2006), and population-based, police-reported MVCs (Callaghan et al., 
2014). This disproportionate burden of traffic-related harms among young men might be due to a number of 
factors, such as their relatively greater levels of binge drinking, driving after drinking, drinking while 
driving, and engaging in riskier driving behavior than females (Adlaf, Demers, & Gliksman, 2005; Harré, 
Brandt, & Dawe, 2000; Health Canada, 2014; Rhodes & Pivik, 2011). 
Study results should be interpreted in light of a number of potential limitations. The primary analytic 
strategy used a regression-discontinuity approach, which assumes that potentially confounding variables are 
smoothly distributed across the MLDA cutoff. If a factor differentially affected individuals on either side of 
the MLDA, then this might undermine the validity of the estimates. Even though a number of traffic-related 
policies changed during the study spans [e.g., reduced BAC limits and per se laws (Mann et al., 2001); more 
severe alcohol-impaired driving penalties (Asbridge et al., 2009; Vingilis et al., 1988)], it is unlikely that 
broad population-based policy changes would affect our results, as these policies would be unlikely to 
impact differently collisions for those slightly younger versus those just older than the MLDA. However, the 
implementation of GDL programs (which included 0% BAC restrictions) in some provinces may have 
affected the MLDA results (see Supplementary Table 1). For example, in British Columbia and Alberta, the 
minimum age of release from the GDL 0% BAC restrictions can occur at the same time as the provincial 
MLDA, although it is likely that the lifting of these restrictions (which occur after the successful completion 
of a final roadside exam at the end of the GDL program) would occur later than the MLDA for the bulk of 
young drivers because the final roadside exam pass rate in these two provinces is approximately 60%, and 
not all young drivers take the exam at the minimum age (Personal communication. 16th September 2015; 
Peters T. Office of Traffic Safety, Alberta Transportation. Personal communication. 21st September 2015; 
Fang M. Insurance Corporation of British Columbia (ICBC). Personal communication). Thus, the post-
MLDA effect in British Columbia and Alberta may be confounded by release from the 0% BAC restrictions 
in these two provinces. In some provinces, release from 0% BAC restrictions (as a result of GDL 
completion) can occur prior to the provincial MLDA, and this may have attenuated the MLDA effect by 
increasing the number of MVCs just prior to the MLDA.  
 Despite these limitations, the current study makes an important contribution to the ongoing Canadian and 
international debates by demonstrating that release from current Canadian drinking-age restrictions is 
associated with significant and immediate increases in severe motor vehicle collision trauma among male 
drivers. Raising MLDAs nationally to the recommended 19 or 21 years of age would likely result in a 
substantial reduction in alcohol-related MVCs in the newly alcohol-restricted age groups—particularly 
among young males. Study results also show that transition across the MLDA is an important phase of 
driving-related risk for young men, and it may be helpful for public health strategies to target this period 
with tailored, event-specific interventions. 
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Background. Some studies have assessed risk communication related to driving impairing medications between 
Health Care Practitioners (HCPs) and patients. However, further research is needed to support the development 
of an evidence-based educational resource to inform HCPs about effective ways to communicate to patients the 
risks associated with prescription pain medication use and driving.  
Objectives. The objective of this study was to develop and evaluate an educational resource for HCPs to 
effectively communicate with their patients about driving risks when prescribing pain medications.  
Methods. A literature review and focus groups with HCPs (N=27) at the Washington University medical campus 
in St. Louis, Missouri (MO) and patients (N=16) at the Rehabilitation Institute of St. Louis (TRISL) in MO were 
conducted in July 2017 to develop the educational resource which was a customized Smartphone App for HCPs. 
The beta version was pilot-tested with HCPs (N=9) in August 2018. An experimental design with patients 
exposed to the intervention with the App (N=23) and patients not exposed to the intervention (N=12) was used to 
evaluate the impact, and to assess: (1) if patients in the experimental group were better informed about impairing 
risks of their medication after the intervention; and (2) if patients in the experimental group planned to adapt their 
behaviour in accordance with increased knowledge.  
Results. Patients in the experimental group reported being more informed than those in the control group after 
the intervention (OR: 1.14 p=.91) and being less inclined to drive within two hours of taking prescribed pain 
medication (OR: 0.39 p=.42). These results were not significant.  
Discussion. Preliminary results are promising but not significant. More data are being collected to determine 
whether results are significant.  
Key-words. Prescription medication, risk communication, impaired driving.  
Disclosure. There are no ethical conflicts of interest to report. Financial support for this study has been received 
by TIRF USA from the US Food and Drug Administration (FDA). Ethical approval has been obtained from the 
New England Independent Review Board (IRB#: 120160541).  
 
Introduction  
While the issue of drug-impaired driving may have garnered increased attention in recent years, a greater focus 
has been placed on the issue of illegal drugs as compared to medicinal drugs. However, numerous medications 
have been identified as having the potential to impair driving including benzodiazepines, antidepressants, 
antihistamines and prescription pain medications (Emich, van dijk, & Monteiro, 2014; Smyth, Sheehan, Siskind, 
Mercier-Guyon, & Mallaret, 2013). Some work has focused on drug classification and labelling systems 
(Schulze, Schumacher, Urmeew, & Auerbach, 2012) or the use of pictorial aids in medication instructions (Katz, 
Kripalani, & Weiss, 2006; Emich et al., 2014) to help identify effective strategies to address driving risks 
associated with the use of prescription drugs. Nevertheless, few studies have been conducted to identify 
evidence-based strategies for Health Care Practitioners (HCPs) to effectively communicate with their patients 
about the effects of prescribed medications on driving abilities, notably in North America.  
To overcome this gap, the objectives of this study were to develop an educational resource for HCPs to help them 
communicate effectively with their patients about the risks associated with the use of prescription pain 
medication when driving. The resource also included related materials for use with patients to encourage patients 
to adopt protective behaviors with the ultimate goal to improve road safety and protect the public.  
This paper describes the methods adopted to develop and evaluate the educational resource as well as initial 
evaluation results.  
Methods  
Two focus groups with prescribing HCPs (N=27) at the Washington University medical campus in St. Louis, 
Missouri (MO) and two focus groups with pain medication patients (N=16) at the Rehabilitation Institute of St. 
Louis (TRISL) in MO were conducted in July 2017 to develop the educational resource. Participants in both 
groups were recruited using snowball sampling from a pool of subjects that served as a captive audience. 
Saturation was reached. The resource that was built using results from the focus groups consisted of a 
Smartphone App for HCPs, called the DiDRxChecker (i.e., Drug Impaired Driving Rx – or, medical prescription 
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– Checker). The beta version was pilot-tested with HCPs (N=9) in August 2018 to obtain process evaluation 
information. The focus groups and pilot test were organized and delivered according to Knowledge Translation 
(KT) theory to ensure necessary data would be obtained to inform the development of the App as to facilitate the 
efficient communication between HCPs and their patients. In particular, TIRF’s KT model served as a guiding 
paradigm for this purpose (Robertson, 2013).  
An experimental design with patients exposed to the intervention with the App (N=23) and patients not exposed 
to the intervention (N=12) was used to evaluate the impact, and to assess: (1) if patients in the experimental 
group were better informed about impairing risks of their medication after the intervention; and (2) if patients in 
the experimental group planned to adapt their behaviour in accordance with increased knowledge. Logistic 
regression analysis was used to analyze the data obtained with an in-person questionnaire and produce interim 
results. Different techniques were then used to assess the sample size needed to find significant effects given the 
preliminary results, including power analysis for two sample proportions test; power analysis for a Cochran-
Mantel-Haenszel test; and, power analysis for matched case-control studies (StataCorp., 2015). In each power 
analysis the alpha was set at 0.05 for the significance level and power at 0.80.  
 
Results 
Focus groups  
Focus groups with HCPs revealed that established operational practices for patient care did not facilitate 
discussion of the impairing effects of medication on driving. Notably, there was a considerable knowledge gap 
that impeded the ability of HCPs to determine the impairing effects of medication on the driving skills of 
individual patients. This gap reduced confidence among HCPs in identifying which patients required a 
conversation about this topic, key messages to include in the conversation, and strategies to conduct the 
conversation. Also, the main strategy followed by HCPs was to assist their patients to achieve the best outcomes 
and a return to baseline if possible, or to help them achieve a reasonable quality of life. In this regard, preventing 
them from driving or impeding their ability to drive was not perceived to be a realistic solution to manage health 
issues except in the most extreme circumstances.  
Focus groups with patients revealed that patients appeared to be most receptive to verbal information provided by 
physicians as well as other HCPs, and they were less likely to review written materials that exceed a page. The 
ability to personalize information was determined to be an essential requirement to increase usage of information 
by HCPs and patients. Further, results of the focus groups suggested that although HCPs may have explained 
some general impairing side effects related to prescription pain medication, rarely were the implications for 
driving skills explicitly highlighted. This was primarily due to the fact that HCPs assumed that patients are able 
to extrapolate general information about impairing effects to a wide range of activities, notably driving, when in 
fact they are not. It may also be an indication that HCPs are less familiar with skills needed for driving, and the 
way that these medications can contribute to unsafe driving. It could also be possible that HCPs assume this 
content will be covered by the pharmacist.  
Pilot-test  
Based on the literature review and results from the focus groups, an online Application was built that HCPs can 
use to guide their conversation with their patients about the impairing risks of prescription pain medication. It 
was pilot-tested with HCPs and further fine-tuned based on their feedback.  
The App, called the DiDRxChecker, can be downloaded from the Apple App Store or Google Play Store 
(currently not publicly available but only upon invitation for the remainder of the study). It consists of a user-
friendly interface enabling the HCP to answer a few key questions about the patient to determine applicability of 
further discussion about impairing effects (e.g., types of medication prescribed; driving needs of patients; new 
medications; other prescribed medications; patient characteristics). Based on the answers an indication of the 
level of risk and associated need for a conversation about impairing risks is provided (low need, moderate need, 
high need; see Figure 1 for an overview of the algorithm used by the App and Figure 2 for a screen caption of the 
App). Along with this indication a series of resources are provided that can easily be forwarded to the patient or 
printed if hard copies are preferred. Resources consist of a series of short, one-page documents that provide 
information about the impairing effects of prescription medications, the impact on driving skills, and guidelines 
for effective communication (resources not included in this paper but available upon request).  
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Figure 1: Graphical depiction of DiDRxChecker algorithm  
 
Figure 2: Screen caption of the DiDRxChecker App  
 
Outcome evaluation  
In examining the variable “How informed do you think you are on the side effects of your prescribed pain 
medication that may impact your driving abilities?”, an increase was observed from baseline to post-
measurement in the frequency of experimental group participants who stated they were informed (36.36 % to 
38.46 %). A small decrease from baseline to post-measurement was observed in the frequency of control group 
participants (45.45 % to 44.44 %). A logistic regression analysis examining the interaction effect of group by 
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time demonstrated that the odds of reporting that patients were more informed after receiving the intervention in 
the experimental group was 14% greater than participants in the control group (OR: 1.14 p=.91).  
In examining the variable “I will drive within two hours of taking my prescribed pain medication”, a decrease 
from baseline to post-measurement in the frequency of experimental group participants who stated they would 
drive within two hours of taking their prescribed pain medication was observed. At baseline, 43.48% of 
experimental group participants stated that it was likely that they would perform this behaviour. Post-
intervention, 23.08% of experimental group participants stated this. No change in frequency of this reported 
behaviour was observed in the control group (33.33% both at baseline and post-intervention). A logistic 
regression analysis that examined the interaction effect of group by time demonstrated that the odds of driving 
within two hours of taking prescribed pain medication decreased by 61% for participants in the experimental 
group when compared to those in the control group (OR: .39 p=.42).  
Power analysis  
Overall, there were positive results from the focus groups with patients and HCPs who liked the DiDRxChecker 
App and the information contained within it. Furthermore, the outcome evaluation findings suggest that there 
were positive effects of the DiDRxChecker intervention when comparing patients who were exposed to the 
resource versus a control group of patients who were not. However, these effects were statistically non-
significant. Given the small sample size used in the outcome evaluation (N=35), and the possibility to extend the 
study, a power analysis was conducted to estimate the sample size needed to find significant effects given the 
distribution of the preliminary results. The different analyses combined revealed that the sample size should be 
N>105.  
Conclusions 
In conclusion, the focus groups and questionnaire data demonstrated there is a need among HCPs and patients to 
be better informed about the impairing effects of prescription medication on driving. It also demonstrated HCPs 
and patients were receptive to using supporting tools to help them guide their conversation with patients about 
this issue to positively influence patient care. Based on the literature and input from HCPs and patients such an 
educational tool was developed, and pilot-tested. The tool is called the DiDRxChecker and is available as an 
App. It is easy to use and supports HCPs to have a meaningful conversation with patients who take potentially 
impairing medications and are driving. It also provides easy access to short documents (available electronically 
or for printing) that can be shared with patients to better inform them. Preliminary results from an outcome 
evaluation are promising and suggest that patients exposed to the resource feel better informed and are more 
inclined to adopt protective behaviors compared to patients not exposed to the App. However, these results were 
not significant, perhaps due to the small sample size. A power analysis was conducted to estimate the required 
sample size to find significant results. Based on these findings, additional data are being collected in 2019 for a 
more robust evaluation.  
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Abstract 
Recent research has highlighted the increasing number of females who are arrested for driving under the 
influence (Schwartz & Beltz, 2018) and involved in impaired driving crashes (Vaca et al., 2014), but little is 
known about rural women who drive under the influence and their other risk behaviors. The present study 
compares the past year risk behaviors of rural female impaired drivers to other rural female offenders. As part 
of a larger study on drug use and risk behaviour among rural women, 400 women from three rural jails were 
randomly selected, screened, and consented. During a baseline face-to-face interview, participants completed 
the NM-ASSIST and also provided information about impaired driving, drug, and sex risk behaviors. 
Participants reporting past year impaired driving (n=260) were compared to those who did not (n=131). Past 
year impaired drivers had significantly (p < .05) higher substance use involvement scores for cannabis, 
sedatives, and prescription opioids. Past year impaired drivers were also significantly more likely to have been 
the passenger of an impaired driver (78.1% vs. 53.4%), been an injection drug user (69.6% vs. 42.0%), and 
traded sex for drugs or money (31.2% vs. 15.3%) in the past year. Results highlight the high rates of 
concomitant risk behaviors among rural female impaired drivers, exceeding those of other high-risk offenders. 
These findings indicate the need for thorough clinical assessment of impaired drivers as well as the 
opportunity to intervene to reduce multiple risk behaviors. 
 
Introduction 
Driving under the influence (DUI) remains a significant public health problem and threat to public safety. 
Recent research has highlighted gender-specific DUI trends, including an increasing number of females who 
are arrested for DUI (Schwartz & Beltz, 2018) and involved in impaired driving crashes (Vaca et al., 2014), 
yet relatively little is known about women’s experiences with impaired driving. Although the observed 
increase in driving fatalities among women over time may be due, in part, to higher risk exposure as 
women’s use of personal vehicles has increased, other research suggests that risky driving behaviors have 
also become more common in certain female groups (including younger women; Romano et al, 2008). 
 
As demographic trends in DUI shift over time, it becomes increasingly important to examine populations at 
growing risk. For example, although national data show that arrest rates for DUI are higher in 
nonmetropolitan than metropolitan areas (FBI, 2018), few studies have examined differences between rural 
and urban impaired drivers (Malek-Ahmasi & Degiorgio 2015; Webster et al, 2010), and only one has 
examined these differences among female DUI offenders (Webster et al., 2009). This study found that rural 
female DUI offenders were more likely to be underage, have multiple DUIs, screen positive for drug 
problems, meet DSM-IV substance dependence and abuse criteria, and fail to meet requirements of their 
intervention referral compared to urban female DUI offenders (Webster et al., 2009); however, these 
analyses were based on DUI assessment data that were limited in breadth, generally containing only 
information directly related to the DUI offense. No studies have examined other characteristics and 
behaviors of rural female impaired drivers.  
 
One area for further study is the association between DUI and other risky behaviors. In adolescent 
populations, for example, impaired driving is associated with experiences of riding with intoxicated drivers 
(Li et al., 2014), as well as engaging in secondary tasks while driving (e.g., texting) and other risky driving 
behaviors (Li et al., 2013). Although such results may be attributed to social learning and normalization of 
risky or impaired driving, DUI also may be indicative of a broader construct of risk-taking, related to 
underlying traits such as impulsivity and low risk perception (Ryb et al., 2006). One study, for example, 
found that current methamphetamine users (compared to controls) scored higher on measures of impulsivity 
and antisocial personality disorder symptomology, and worse on measures of safe driving, even when 
controlling for acute intoxication or withdrawal symptoms, demographics, and driving experience 
(Bosanquet et al., 2013). 
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In light of these findings, it is possible that DUI may serve as a marker for other risky behaviors. The link 
between substance use and risky sexual behaviors, for example, although likely moderated by response 
inhibition or other factors (Nydegger et al., 2014), has been well-established (Ritchwood et al., 2015). 
Similarly, substance use related risk behaviors, such as injection drug use, have been associated with risky 
sexual practices (including use of drugs before sex, having more lifetime sexual partners, and having a main 
sexual partner who also injects drugs; Staton et al., 2017). Considering impaired driving as a risky decision 
related to alcohol or drug use, it would seem that exploring possible relationships between DUI and other 
high-risk behaviors may offer insight into important areas for assessment and intervention. 
 
Given the limited knowledge on rural female impaired drivers and the relationship between their impaired 
driving and other risk behaviors, the present study examines risk behavior in a sample of rural female drug-
involved offenders, comparing risk behaviors of women who have driven impaired in the past year to the 
those who have not. 
Methods 
Participants 
As part of a study on drug use and high-risk behavior among rural women, 400 women from three rural jails 
were randomly selected, consented, and screened. Eligibility criteria included: (1) moderate risk of substance 
abuse based on the NIDA-modified Alcohol, Smoking and Substance Involvement Screening Test (NM-
ASSIST) score of 4+ for any drug (NIDA, 2009); (2) self-reported sexual risk behaviors in the three months 
before arrest, based on five questions from the risk behavioral assessment (Wechsberg, 1998); (3) residing in 
a designated Appalachian county before incarceration; (4) anticipated release date between two weeks and 
three months from screening; (5) and willingness to participate. For detailed descriptions of the sampling and 
screening approach, see Staton et al. (2017; 2018).  
 
Procedure 
Individuals who provided consent and met screening criteria were scheduled for a baseline interview. 
Interviews were conducted face-to-face by a trained female interviewer in a private room at the jail; no jail 
staff were present for interviews. Participants responded to questions about their drug use and other risk 
behaviors prior to entering jail. Responses were recorded using Computer Assisted Personal Interview (CAPI) 
software. Participants were paid $25 for their time. All study screening and data collection procedures were 
approved by the university IRB and protected under a federal Certificate of Confidentiality. 
Measures 
Demographics. Demographic information collected from participants included their age, race, marital status, 
years of education, and employment status in the 6 months prior to incarceration. Given that the sample was 
recruited from jails, length of the current incarceration was also collected. 
Drug Use. The NM-ASSIST was used to measure participants’ drug use problem severity and level of risk 
(NIDA, 2009). At screening, participants were asked six questions related to intensity and frequency of use 
of cannabis, cocaine, prescription stimulants, methamphetamine, inhalants, hallucinogens, sedatives, street 
opioids, and prescription opioids. A risk score was computed using standard scoring procedures for each 
substance, which ranged from 0 to 39. Participants also completed the Substance Problem Scale (SPS) of the 
Global Appraisal of Individual Needs (GAIN-I version 5; Dennis, 1998). The SPS is a 16-item measure of 
problematic alcohol and drug use based on DSM-IV-TR criteria. Higher SPS scores indicate more severe 
substance use problems. For the current study, participants specifically responded to the SPS based on the 
year prior to incarceration. Injection Practices. Participants were also asked about their injection practices in 
the year prior to incarceration: whether they injected drugs, used dirty needles/works, and the number of 
people with whom they shared dirty needles. 
Sex Risk Behaviors. Participants provided information on their sex risk behaviors in the year prior to 
incarceration. Specifically, participants reported their number of sexual partners and casual sexual partners as 
well as whether they traded sex for money/drugs/food. Impaired Driving. Finally, participants were asked 
whether they had driven under the influence of drugs or alcohol in the year prior to incarceration. They also 
reported whether they were the passenger of an impaired driver during this time period. 
Data Analysis 
Nine participants from the original sample were removed due to missing data. Then, 
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participants reporting past year impaired driving (n=260) were compared to those who did not 
(n=131) on demographic characteristics using a series of t-test and chi-square analyses. The two 
groups were compared on their risk behaviors, controlling for demographic differences, using 
analysis of covariance and logistic regression analysis. Risk behavior differences were 
considered statistically significant at p < 0.05. All analyses were conducted using SPSS 24 (IBM 
Corp., 2016). 
Results 
Demographics 
The majority of the sample was white (99.0%) with an average age of 32.7 and less than 
a high school education (11.1 years). Less than a quarter (23.0%) of participants were employed 
at least part time prior to incarceration and 37.3% of participants were married or living as 
married. As shown in Table 1, age was the only significant demographic difference between 
impaired drivers and other drug-using offenders, with impaired drivers being significantly 
younger (31.9 vs. 34.4; t(226.6) = 2.734, p = .007). 
 
Drug Use 
Participants’ past year substance use severity varied across group (see Table 2). When 
controlling for age, impaired drivers reported significantly higher scores (F(16,363) = 4.90, p 
= .000) on the SPS compared to other drug-using offenders. Additionally, substance-impaired 
drivers had higher substance involvement scores on the NM-ASSIST for cannabis (F(36,353) = 
1.64, p = .014), sedatives (F(38,351) = 1.85, p = .002), and prescription opioids (F(36,353) = 
1.88, p = .002). 
 
Other Risk Behaviors 
Substance-impaired drivers were also more likely to report a number of additional past 
year risk behaviors compared to other drug-using offenders. Specifically, substance-impaired 
drivers were significantly more likely to report having injected drugs (AOR = 2.90; 95% 
Confidence Interval [CI] = 1.86, 4.55, p = .000) in the past year, having used a dirty needle 
and/or works (AOR = 3.05; 95% CI = 1.95, 4.77, p = .000) in the past year, and reported sharing 
dirty needles with significantly more people (F(15,374) = 1.93, p = .019). Compared to other 
drug-involved offenders, they were also more likely to report trading sex for drugs and/or money 
(AOR = 2.36; 95% CI = 1.37, 4.09, p = .002) in the past year and were more likely to report 
having been the passenger of an impaired driver (AOR = 2.85; 95% CI = 1.80, 4.52, p = .000). 
Discussion 
The present study compared the risk behaviors of drug-involved female offenders who 
self-reported impaired driving in the past year to those who did not. Overall, impaired drivers 
reported engaging in more drug use and other risk behaviors than non-impaired drivers. These 
findings add to the impaired driving literature in three important ways. 
 
First, this study is among the first to document drug use in rural female impaired drivers. 
Although the sample consisted entirely of drug-involved offenders, impaired drivers had higher 
SPS scores and significantly higher NM-ASSIST substance involvement scores for cannabis, 
sedatives, and prescription opioids. While this study did not examine the drugs involved in impaired driving, 
this finding is consistent with research showing that cannabis is the most frequently involved drug in impaired 
driving with prescription medications among the next most 
prevalent (NIDA, 2016). Furthermore, the drug use profiles are consistent with another study of 
rural convicted DUI offenders which reported cannabis, sedatives, and prescription opioids as the 
drugs most frequently involved in self-reported driving episodes (Webster et al., 2018). 
 
Second, the study adds to our understanding of other risk behaviors in which rural female 
impaired drivers engage. This included higher rates of drug injection and risky injection 
practices, higher rates of trading sex, and of riding with an impaired driver. The higher 
prevalence of riding with an impaired driver is consistent with previous research on adolescents 
(Li et al. 2014). However, to our knowledge, the association between impaired driving and 
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injection drug use and risky sex behavior found in the present study is a new finding, and one 
that future research should more carefully explore. Each of these risk behaviors have clear health 
implications for these women and point to the importance of comprehensive assessment of 
impaired drivers to identify and appropriately target intervention efforts. 
 
Finally, and more generally, these findings contribute to the small but growing literature 
on rural impaired drivers. A disproportionate number of DUI arrests and impaired driving 
fatalities occur in rural areas (FBI, 2018; National Center for Statistics and Analysis, 2017), yet 
rural impaired drivers remain largely unstudied (Webster et al., 2018). Future studies should 
continue to examine this population to gain a better understanding of how best to prevent future 
harm to themselves and others through targeted intervention. 
 
Limitations 
Study limitations should be considered when interpreting results. First, participants were 
recruited from three rural jails and were selected because they engaged in risky behaviors; 
therefore, findings may not generalize to other rural female impaired drivers. Second, only past 
year impaired driving and other risk behaviors were examined; as a result, the relationship 
between long-term patterns of risk behavior and impaired driving among rural females is 
unknown. Finally, data were self-reported and may be subject to recall bias. 
 
Conclusions 
Despite these limitations, the current study provides new information about rural female 
impaired drivers and their high rates of concomitant risk behaviors, which exceed those of other 
high-risk, drug-involved offenders. This consistent pattern may suggest an underlying cause, 
which future research could target. Furthermore, these findings indicate the need for thorough 
clinical assessment of impaired drivers so that appropriate interventions may target multiple risk 
behaviors. 
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Abstract 
Background: Although there has been an abundance of work looking at the impact of traumatic events and 
substance use and problems, there is little to none that have examined the impact of traumatic experiences in 
the DWI population.   
Aim: The current study considers convicted DWI offenders who indicated they had experienced at least one 
of the criteria listed in Criterion A of the DSM diagnosis for PTSD.  Comparisons are made between three 
groups: no trauma, less than 33 on the PTSD symptom assessment, and then 33 or more on the PTSD 
symptom assessment.   
Method: This effort is part of a larger study of convicted DWI offenders who have been mandated to install 
an Interlock in their vehicle.  Recruitment of offenders occurred in impaired driving programs, at the places 
where interlocks were installed, and from STOPDWI In Erie County. For the current report, the measures 
used included measures of substance use, risk, alcohol problems, PTSD Symptoms, and mental health 
problems.  
Results: Comparisons showed that relative to the no-trauma and low PTSD symptom groups, the group 
with high PTSD symptoms were more likely have had prior treatment, prior criminal history, to use a 
bicycle and public transportation, and to have been injured in a crash.  The high symptom group also 
showed higher means for drug use in the last year, number of total DSM 5 current alcohol use disorder 
criteria, problem risk, readiness to change, and all subscales on the Brief Symptom Inventory.  
Conclusions: Experiencing a traumatic event has an impact on convicted DWI offenders in terms of risk 
factors. However, the experience alone is not sufficient, there needs to high levels of symptoms for that 
influence to be evident.  This has implications for assessment of DWI offenders when they show up for 
treatment.  
Background 
Exposure to traumatic experiences and events is a known risk factor for negative outcomes for individuals 
and is a public health issue impacting families and communities (SAMHSA, 2014). Research indicates that 
upwards of 70% of the general population worldwide has experienced a traumatic event in their lifetime, and 
the average number of traumas that a person has been exposed to is 3 (Kessler, et al., 2017).  Exposure to 
trauma does not automatically cause post-traumatic stress disorder (PTSD), anxiety, depression or other 
mental health issues, although repeated or prolonged exposure to trauma increases the risk of long term issues 
(Atwoli, Stein, Koenen, & McLaughlin, 2015).  
There is no single act, action or activity that in and of itself constitutes trauma. Many things can be experienced 
as trauma by an individual, whether physical or psychological, and although trauma has been operationalized 
in the Diagnostic and Statistical Manual (DSM), there is not one exclusive list of events or experiences that 
define trauma or traumatic experiences (SAMHSA, 2014).  In addition, the experience of or exposure to a 
potentially traumatic event does not automatically create a long lasting negative impact on an individual, 
individuals interpret experiences uniquely.   
Diagnosis of PTSD in the DSM-V requires exposure to a traumatic event that includes actual or threatened 
death, serious injury or sexual violence (American Psychiatric Association, 2013).  An individual can be 
exposed to the trauma either directly through experience, or indirectly through witnessing something happen 
to another person, or learning about a trauma occurring to someone they are close to, or being exposed to 
details of traumatic events repeatedly (therapists and first responders). PTSD symptoms include repeated and 
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intrusive memories of the trauma that cannot be controlled or avoided; emotional numbness and avoidance of 
places, people and activities; and increased arousal.   
Considering that PTSD is an accepted diagnosis and listed in both the DSM-V and International Classification 
of Diseases-10 (ICD-10; Centers for Medicare & Medicaid Services, 2019), it is important to remember that 
mental health is a topic that continues to carry significant stigma in the United States (Corrigan & Watson, 
2002).  Stigma or the anticipation of stigma can prevent an individual or family from accessing mental health 
services  (Fox, Smith, & Vogt, 2018). In place of proper services and support, research finds that self-
medication with alcohol or other substances for mental health issues, such as PTSD, happens in around 20% 
of the population and self-medication leads to a higher risk of suicidality, and decreased mental health  (Leeies, 
Pagura, Sareen, & Bolton, 2010).  Self-medication for mental health issues is common and is seen as more 
prevalent among younger, single, white men; self-medication for mental health issues can lead to a substance 
use disorder (Turner, Mota, Bolton, & Sareen, 2018).   
Although exposure to trauma has some clear associations with alcohol and other substance use, little research 
has been done on the experiences of trauma in the alcohol impaired driving offender.  Some research has 
shown that for repeat alcohol impaired driving offenders, who are in treatment, those with PTSD experience 
a higher rate of alcohol impaired driving recidivism than those offenders without PTSD (Peller, Najavits, 
Nelson, LaBrie, & Shaffer, 2010).  This link between trauma, alcohol and impaired driving requires further 
examination.  
Methods 
Participants 
Participants were 276 Driving While Intoxicated (DWI)/Driving While Ability Impaired (DWAI) offenders 
from western New York state. They were in the post sentencing period and were serving license suspension 
or received a conditional driver’s license or hardship license at the time of recruitment.  Sentences for impaired 
driving may include fines, jail time, participation in a drinking driver program/impaired driver program 
(DDP/IDP), participation in a victim impact panel, license revocation or suspension, and for DWI offenders 
who violated Leandra’s Law, installation of the Ignition Interlock Device (IID) in their vehicles.    
Inclusion criterion for this study was having a recent DWI/DWAI conviction in Erie County, NY where the 
study interviews took place, and being over the age of 18.   Recruitment for this longitudinal study began in 
2015 and final interviews will take place in 2020. In this sample, the majority of participants were White, non-
Hispanic (78%), single (75.3%), male (62%), with at least some college (77.5%) and almost a third of 
participants hold a bachelor’s degree or higher (32.3%).  
Procedures 
This research is part of the Managing Heavy Drinking (MHD) research study, a study of IID users and DWI 
offenders. Participants were recruited using fliers and presentations specifically targeting locations where 
DWI offenders may frequent. These fliers were distributed in person at impaired driving classes by research 
assistants, and by community partners at victim impact panels, ignition interlock installation centers, 
substance abuse treatment facilities and health centers.   In addition, we created a website and a Google phone 
number for information and directions to the study location, and to accept calls, emails and text messages for 
questions and scheduling purposes.  
Participation in this longitudinal study included three interviews over the course of 12-18 months and 
consisted of a computer survey, biological sample collection (hair, blood/saliva) and a Timeline Follow-Back 
interview at each of the three time points. Interviews were conducted by trained research assistants at a 
research center or in a mobile office at a location convenient to the participant. Participants received cash 
payment at each of the three interview time-points for a total of $300-$375. A $25 per appointment incentive 
was offered for participants to provide a blood sample in lieu of a saliva sample.  In addition, each participant 
who arrived for their first appointment as scheduled received their selection of an additional gift card.  These 
gift cards varied throughout the study and ranged in value from $20-$30.  
Due to the fact that all participants were currently or recently court involved, we applied for and received a 
certificate of confidentiality to ensure that our data were protected from forced disclosure.  This was done so 
that our participants could be sure that their answers were private and could not be used against them in 
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continuing court procedures.  Even though the court process was finished for most participants, those who 
have IID devices are still connected to the courts, as their performance on the IID is actively monitored through 
STOP DWI, and positive tests are reported to court.  
Measures 
Data regarding trauma exposure and experience were collected during the computer survey. As a screening 
question, participants were asked to identify if they had ever witnessed or experienced an extremely traumatic 
event that included actual or threatened death or serious injury to themselves or someone else. Examples given 
with this question included rape, assault, someone dying in an accident, natural disasters, combat or any other 
upsetting event (MINI_Screen; Sheehan & Lecrubier, 2006).  If a participant said yes, they were directed to a 
list of 19 traumatic events from the DSM-IV definition of trauma.  Along with the pre-filled list, participants 
were able to indicate if their trauma experience was not covered by one of the items in the list.  All participants, 
regardless of endorsing trauma exposure or not, completed the PCL-C, which is the civilian version of the 
PTSD Checklist (PCL).   
In addition, all participants completed the RIASI, AUDIT, BSI, AUDADIS (abuse and dependence subscales) 
and a six-month Timeline Follow-back regarding drinking, driving and drug use behavior.  
Data were analyzed utilizing IBM SPSS Statistics 25. We looked at frequencies, cross-tabs and t-tests to 
identify response patterns among participants.  
Results 
Of the 276 participants, fifteen selected the option “Prefer not to respond” to the trauma screening question. 
From the remaining 261, forty-nine percent (n=127) endorsed the trauma screening question and fifty-one 
percent (n=134) did not endorse the trauma screening question.     
The mean number of specific traumas identified by participants was 2.3, with a range of 0-14.  Five of the 
traumas on the list were combat specific and were endorsed by 8 or fewer participants (<6%).  The most 
frequently endorsed trauma was the unexpected, sudden death of a close friend or relative (77%, n=97), 
followed by learning that one of the traumas in the list happened to someone close to you when you were not 
there (68%, n=86).  Serious injuries and accidents were reported by 49-52% of the respondents respectively.  
When looking at the PTSD Checklist (PCL-C), 256 participants responded to the questions about PTSD 
symptoms and severity.  Of these respondents, fifty-four percent (n=140) met the DSM-V criteria for PTSD 
based on their responses to this measure, which is 13 more participants than endorsed the trauma screening 
question. Over half of these participants (n=77) scored above 38 on the PCL-C, which is the cutoff score for 
probable PTSD in veterans (there is no consensus as to the cutoff score for civilians, but it is hypothesized to 
be lower than this score).  
We were interested in potential differences between those who experienced trauma and those who did not 
report experiencing trauma.  The groups were relatively similar in several areas as there was no difference for 
BAC at arrest, number of days drinking in a typical week, number of drinks on a typical drinking day, 
frequency of binge drinking (5 or more drinks (male) or 4 or more drinks (female) on a given drinking 
occasion).  There was also no difference in the rate of IID installation between groups, and no gender, race, 
education or marital status differences were found.   
A significant difference in income over $40,000 was identified between the trauma group and non-trauma 
group, (42.1 vs 55.9, p=.039), and unemployment was significantly higher in the trauma group (23.6%) vs the 
non-trauma group (13%, p=.027).  Those in the trauma group were more likely to have been injured in a crash 
(26.0 vs 11.9, p=.004), and more likely to have been in prior treatment for substance use (60.0 vs 48.5, p=.037) 
although there were no differences in prior DWI or prior suspension.  
We asked participants about additional substance use on both the computer survey as well as during the TLFB 
interview. Participants in the trauma group reported using significantly more types of drugs in the past year 
than the non-trauma group (5.09 (3.66) vs 3.84 (2.56), p=.004). The trauma group also scored higher on overall 
risk (RIASI) (21.31 (5.90) vs 18.53 (5.60), p<.001).  
Not surprisingly, there were significant differences on both the total score for the BSI (92.28 (43.32) vs. 70.37 
(25.49), p<.001), as well as on all of the individual subscales on the BSI.  
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Discussion 
Systemically, the stigma associated with being a DWI offender carries both social and financial consequences.  
Unemployment and poverty are two risk factors for mental health issues as well as alcohol and substance use, 
and these were seen significantly more frequently in the trauma group.  A DWI conviction carries financial 
cost that includes fines, fees (for IID, IDP, DMV etc), increased car insurance rates, legal fees and more.  In 
this study, participants are reporting total costs of their DWI at between $8,000-$15,000.  For those making 
$40,000/year, this represents 20-38% of their annual income before taxes.  If paying for the DWI puts a 
financial burden on an individual who is already experiencing financial issues, it may be unlikely that they 
engage fully with the interventions that are put in place, such as treatment (pay per session), IDP (pay per 
program) or the IID device (pay for install, per-month fee, reset fee for positive test, uninstall fee).  
For a person who is self-medicating for mental health issues prior to a DWI, the stigma of the conviction, 
coupled with the financial strain, may not set the stage for change. A trauma-informed framework that includes 
acknowledging and addressing the presence of trauma in DWI offenders may change the outcomes for 
offenders in court and in the sanction phase, when they are interacting with psycho-educational, interventional 
and treatment components.  A new perspective of being treated as someone who needs assistance, rather than 
someone who is just a criminal may reduce stigma, improve outcomes throughout the process, potentially 
mitigating the increased risk for alcohol and substance abuse that is associated with trauma, and in turn 
improving public health and traffic safety.  
Further research is needed to integrate trauma-informed perspectives into court and sanctions for DWI 
offenders. Reducing the stigma of mental health can start here.  
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Abstract 
Background: Back on Track (BOT) is a remedial program for impaired driving offenders. Currently, BOT 
is offered at 30 sites across Ontario. Although efforts have been made to enable equitable access, impaired 
driving offenders in more remote areas may face challenges in accessing the program. In light of recent 
evidence suggesting that internet-based psychotherapeutic interventions may be effective, distance 
participation in BOT is being considered. 
Objective: This pilot study was designed to provide a preliminary comparison of in-person versus distance 
delivery of the BOT program. 
Methods: Nine participants were randomly assigned to the in-person condition and ten participants to the 
distance condition. Distance participants watched live feed of the in-person group, presented via the Ontario 
Telehealth Network (OTN), with two-way audio and visual feed between groups. All participants completed 
pre- and post-workshop assessments of knowledge and attitudes relevant to impaired driving, as well as 
assessments of satisfaction, engagement, and presentation clarity. Facilitators completed a feedback 
questionnaire. 
Results: Only one difference in outcome between the two program delivery methods was identified; the in-
person group appeared to experience an improvement in knowledge about impaired driving, whereas the 
simulated distance group appeared to experience a decrease in knowledge (F(1,14)=8.40, p=0.012). Client 
Satisfaction (t(17)=-4.89, p<.001) and Participant Engagement (t(15)=-2.05, p=.058) were higher among in-
person than simulated distance participants. In-person participants found the workshop to be more clearly 
presented than did simulated distance participants (t(12.44)=-2.79, p=.016). Facilitator feedback cited 
challenges with the technology and identified the need for trained clinical staff at the distance learning site to 
deal with any client issues.  
Discussion, Conclusions and Implications: Recognizing sample size limitations, the current study found 
few differences in outcomes between groups, although both participant and facilitator data suggest concerns 
about the experience of distance participants. Results support further refinement and evaluation of distance 
delivery of BOT. 
Acknowledgments: This research was funded by Ontario's Remedial Measures Program. 
Introduction 
Back on Track (BOT) is a remedial program for drivers convicted of a Criminal Code impaired driving 
offence or drivers with two or more administrative driving suspensions; full reinstatement of driving 
privileges is contingent, in part, on successful program completion. Based on an initial assessment, program 
clients are assigned to either an 8-hour education or a 16-hour treatment intervention/workshop. Follow-up 
interviews are conducted six months following workshop completion. Developed and operated by the Centre 
for Addiction and Mental Health (CAMH), the program is currently offered at 30 sites across the province. 
Program content and procedures are manualized to safeguard consistency and quality of program delivery. 
The BOT program has received high participant satisfaction ratings (Smart et al., 2012), and been associated 
with reductions in alcohol and drug use and related problems following program participation (Stoduto et 
al., 2014; Wickens, Flam-Zalcman et al., 2013).  
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Although efforts have been made to enable equitable access to BOT across Ontario, impaired driving 
offenders in more remote areas of the province face challenges in accessing the program. In order to increase 
accessibility, distance participation through web-based and related technologies has been considered.  
 
Available research of distance therapy suggests that it can have beneficial effects for some participants. A 
meta-analysis of internet-based psychotherapeutic interventions showed a medium effect size for these 
interventions, and concluded that they were as effective as traditional face-to-face therapies (Barak et al, 
2008). However, distance therapy faces several challenges such as an absence of visual cues and 
spontaneous clarifications potentially impairing communication (Rochlen et al., 2004) or the need for 
technological literacy in order to manage the medium (Stofle, 2001). Other concerns in BOT’s regulatory 
context include verifying the identity of participants, determining if they are under the influence of alcohol 
or drugs, and determining that the participant has remained engaged during the program. 
 
Offering distance participation in BOT is an attractive option in that it may increase accessibility of the 
program, but it is important to understand how distance participation might affect the demonstrated 
beneficial impact of the program for in-person participants. Therefore, the purpose of this pilot study was to 
compare in-person with simulated distance BOT participants in changes in knowledge and attitudes about 
impaired driving and their levels of client satisfaction, program engagement, and perception of presentation 
clarity. 
 
Methods 
Study Design and Sample 
This pilot evaluation adopted a mixed between-within (pre-post) design. Recruitment began in April, 2017 
and continued until the sample of 20 participants was obtained. A total of 22 participants provided voluntary 
informed consent; 19 completed the study (17 males; 2 females). 
 
Participant Inclusion/Exclusion 
Individuals assigned to the Education workshop based on completion of the initial assessment were eligible 
to participate in the pilot study if they were: (a) 18 years of age or older; (b) planning to attend BOT at the 
Toronto site; (c) able to participate in the program without assistance (e.g., does not require an interpreter); 
(d) able to understand written English (as determined by self-report and the ability to read the informed 
consent form), and; (e) willing to provide informed consent to participate in either the control or distance 
participation conditions.  
Measures 
Impaired Driving Knowledge and Attitudes. Pre- and Post-Workshop Questionnaires were identical and 
consisted of 13 items that assessed Affect (4 items), Attitudes toward Drink-Driving (3 items), Behavioural 
Intentions (3 items), Self-Efficacy (2 items), and Knowledge (1 item). With one exception, all items were  
rated on a 4-point Likert-type scale with the labels “1-Strongly Disagree”, “2-Somewhat Disagree”, “3-
Somewhat Agree”, and “4-Strongly Agree”. The item assessing Knowledge asked: “The number of drinks 
an average person can have in two hours and still drive safely is:” with response options ranging from 0 to 
8+. Previous research has identified a significant improvement for 12 of the 13 items following workshop 
completion (Wickens et al., 2019). 
Client Satisfaction. The Satisfaction Questionnaire consists of 15 items that assess satisfaction with the 
service and facilitators. All items are rated on a 5-point scale with labels "1=Disagree" to "5=Agree". 
Overall Satisfaction was calculated for each client based on their average score across all 15 items. 
Negatively worded items were reverse-coded; thus, high scores denoted greater overall satisfaction.  
Participant Engagement Scale. Adapted for the current study from a measure of student engagement and 
disaffection with learning (Skinner et al., 2009), the 27-item Participant Engagement Scale included items 
targeting behavioural and emotional engagement and disaffection. Items were rated on a 5-point scale with 
labels “1-Strongly Disagree”, “2-Somewhat Disagree”, “3-Neither Agree nor disagree", “4-Somewhat 
Agree”, and “5-Strongly Agree”. Negatively worded items were reverse-coded, and all items averaged to 
create an Overall Engagement score.  
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Workshop Evaluation. The Workshop Evaluation divides the BOT program into 22 distinct curriculum 
components and asks participants to rate how clearly presented each component was using a 5-point Likert-
type scale ranging from “1 = not at all” to “5 = very”. Ratings were averaged across all 22 components. 
Facilitator Feedback. Facilitators were asked to provide written responses to open-ended questions 
assessing their experience with the simulated distance delivery of the program. 
Procedure 
When a BOT client was assigned to the Education workshop (at the Toronto site) based on the initial 
assessment, the staff member completing the assessment provided the client with a brief description of the 
study. Those individuals interested in participating were scheduled to attend the program on the day of the 
pilot evaluation. Upon arrival at the workshop location, potential participants were shown the Study 
Information and Informed Consent form. Those who voluntarily agreed to participate in the evaluation were 
randomly assigned, on a 1-to-1 basis, to participate in either the in-person (control, n=9) or simulated 
distance (experimental, n=10) delivery of the workshop. Clients in the in-person (control) condition 
experienced the BOT program as usual. Clients in the simulated distance (experimental) condition 
participated via interactive video technology, utilizing Ontario Telehealth Network (OTN) facilities. After 
ensuring valid and informed consent, participants in the experimental group were guided to a conference 
room where OTN equipment was located. The participants were able to view and interact audio-visually 
with the program facilitators and in-person participants. Prior to beginning the workshop, all participants 
completed a brief personal information form that requested some basic demographic information and the 
Pre-Workshop Questionnaire which took a baseline measure of knowledge and attitudes relevant to impaired 
driving. Upon completion of the workshop, participants completed the Post-Workshop Questionnaire, Client 
Satisfaction Questionnaire, Participant Engagement Scale, and Workshop Evaluation. At the end of the 
workshop, participants were provided with a Tim Horton’s gift card, worth $20, to thank them for 
participating in the study. 
Planned Statistical Analyses 
Initially, characteristics of the data, including normality and presence of outliers, were assessed.  
Subsequently, simple descriptive analyses were carried out (e.g., means, standard deviations, proportions). 
Finally, bivariate tests were conducted to compare the in-person and simulated distance groups on measures 
of change in knowledge and attitudes with program participation, client satisfaction, evaluation of program 
components, and self-rated program engagement (t-test, one-way ANOVAs). Missing values were treated 
listwise. 
Results 
Sample Characteristics 
Table 1 presents the characteristics of the in-person (control) and simulated distance (experimental) groups. 
Across the sample, there were 17 males and 2 females with ages ranging from 18 to 59 years (mean = 35.0, 
SD = 12.0). A series of independent-sample t-tests and chi-square analyses revealed no statistically 
significant differences between groups in age, sex, type of offence, or knowledge and attitudes about 
impaired driving before workshop participation. 
Change in Program Outcomes and Experiences 
Table 2 presents the means, standard deviations, and measures of internal consistency for each of the output 
variables. Based on ANOVA tests of program outcomes, a change in Knowledge about impaired driving 
from pre- to post-workshop differed across groups, with the in-person group increasing in knowledge but the 
simulated distance group decreasing in knowledge (F(1,14)=8.40, p=0.012). No significant interactions with 
Affect, Attitude, Behavioural Intent, or Self-Efficacy were found. Self-Efficacy remained constant pre- and 
post-session for both groups. There was a main effect pre- to post-workshop for Attitude (F(1,17)=6.96, 
p=.017), indicating that both groups demonstrated improved Attitude toward impaired driving following 
program participation. 
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Table 1: Sample characteristics 
Variable α / r In-Person 
(n=9) 
Distance 
(n=10) 
t / χ2 p 
Age (mean in years, SD) - 33.33, 11.16 36.50, 13.09 0.564 .580 
Sex      
Male - 9 8 2.012 .156 
Female - 0 2 
Type of Offence      
Criminal Code - 8 9 0.006 .937 
Highway Traffic Act - 1 1 
Pre-Workshop Questionnaire 
(mean, SD) 
     
Knowledge - 0.78, 0.67 0.90, 0.74 0.377 .711 
Affect .54 1.22, 0.34 1.50, 0.60 1.22 .239 
Attitude - a 3.78, 0.24 3.73, 0.34 -0.324 .750 
Behavioural Intent .55 1.78, 0.67 1.53, 0.45 -0.946 .357 
Self-Efficacy - a 4.00, 0.00 4.00, 0.00 - - 
a
At least one of the component variables has zero variance. 
 
Table 2:  Means, standard deviations, and measures of internal consistency by program 
type 
  In-Person (n=9) Distance (n=10) 
Variable α / r Mean SD Mean SD 
Post-Workshop Questionnaire      
Knowledge b - 1.13 0.35 0.75 0.71 
Affect .93 1.39 0.99 1.53 0.79 
Attitude - a 3.93 0.15 3.93 0.21 
Behavioural Intent - a 1.67 0.44 1.43 0.32 
Self-Efficacy - a 4.00 0.00 4.00 0.00 
Client Satisfaction .82 4.61 0.32 3.67 0.49 
Participant Engagement c .96 4.82 0.20 4.23 0.74 
Workshop Evaluation .93 4.81 0.27 4.20 0.62 
a 
At least one of the component variables has zero variance. 
b Due to listwise deletion of missing data, the reported means and standard deviations for both the in-person and simulated distance groups are 
each based on n=8. 
c Due to listwise deletion of missing data, the reported means and standard deviations for the in-person group is based on n=7. 
 
Independent-samples t-tests were performed to assess differences in how participants experienced the 
program. Client Satisfaction (t(17)=-4.89, p<.001) and Participant Engagement (t(15)=-2.05, p=.058) were 
significantly higher among in-person than simulated distance participants, although the latter effect only 
approached statistical significance. Participants in the in-person group found the workshop to be more 
clearly presented than those in the simulated distance group (t(12.44)=-2.79, p=.016). 
Facilitator feedback cited challenges with the technology used to implement distance delivery of the 
program and identified the need for trained clinical staff to be present at the distance learning site to deal 
with any client issues such as use of substances in contravention of BOT policy or emotional responses to 
the program content.  
Discussion 
Only one difference in outcome between the two program delivery methods was identified. Specifically, 
clients in the in-person group appeared to experience an improvement in knowledge about impaired driving, 
whereas the simulated distance group appeared to experience a decrease in knowledge. Despite the few 
differences in program outcomes, there was some indication that participants in the distance group 
experienced the program differently. Participants in the simulated distance group reported both lower 
engagement  and satisfaction with the program and described the curriculum as less clearly presented than 
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did the in-person participants. The distance group was watching the workshop through a camera focused on 
the facilitator and the screen. Challenges included the sound and video quality, which had to be adjusted 
when a video was switched on. Similarly, when curriculum relevant to impaired driving knowledge was 
presented, the distance participants had an informal group discussion which may have affected their uptake 
of the information and contributed to the divergent scores on the Knowledge component of the Post-
Workshop Questionnaire; however, the statistical difference is minimal and should not be extrapolated too 
broadly.  
The facilitators had concerns about the need for a trained individual at the distant site in case of any 
triggered reaction, acting-out behaviour, or alcohol intoxication/withdrawal among participants. They also 
requested training for managing technological aspects of the workshop.  
Limitations 
This pilot comparison was conducted with a small group of 19 participants. Results may not be 
representative of a larger population. In real life settings, the number of participants in the distant group 
might be as low as 1 to as high as 10 or more. Also, the settings might not be as controlled, e.g. the distant 
participant might do the workshop from home, from a community health centre, or a hospital. We excluded 
participants who would need interpreters, which might not be possible in real life settings. Also, these results 
are not transferable to more intense treatment workshops which are designed for more vulnerable drivers. 
Conclusion 
This pilot comparison of in-person versus distance participation in BOT showed that on many measures of 
program impact the two groups were similar. However, those in the simulated distance group did not show 
an increase in knowledge about impaired driving following the workshop similar to that demonstrated by 
participants in the in-person group. Client satisfaction, engagement, evaluation of the program’s clarity of 
presentation, and feedback from facilitators suggested areas where the experience of those in the distance 
group was not as positive as those who participated in-person. Results suggest that an expanded evaluation 
of distance participation that successfully addresses the concerns identified here is necessary before this 
option could be recommended for implementation. 
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Abstract 
A new way of organizing drink driving enforcement was tested in a pilot study in a Swedish police region. 
One of the goals of the pilot study was to increase the perceived risk of being stopped by the police to conduct 
a breath test. This paper shows preliminary results of the evaluation based on a questionnaire answered by 
respondents recruited from the police’s Facebook pages. A preliminary conclusion is that one (out of four) of 
the districts included in the pilot study showed an increased proportion of respondents who had been stopped 
by the police. The respondents had also noticed an increase of posts about drink driving controls on social 
media. However, no actual improvement in perceived risk of being stopped by the police could be detected. 
The results of the entire evaluation must be awaited before any final conclusions can be drawn. 
Keywords: Enforcement, drink driving, perceived risk, questionnaire 
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Introduction 
Drink driving is one of the major road safety problems in Sweden. In recent years, police enforcement in terms 
of the number of breath tests conducted has declined. Between 2010 and 2015, the number of tests were 
reduced by 53% (ETSC, 2016). This decline has led to great concern in the traffic safety community. In 2016, 
the police published a new strategy for traffic enforcement. One of the goals of this strategy is to increase the 
visibility of the police and thus increase the perceived risk of being stopped in a police control. The strategy 
also supports the use of rather short controls (around 20 minutes) based on the work by Koper (1995). 
As a result of the new strategy, a new way of organizing the drink driving enforcement was tested in a pilot 
study in one of the police regions in Sweden. The pilot was conducted during a 6 month period and included 
20-minute controls spread out over different times of the day and over different geographical locations. In 
addition, information about the controls was published on the police’s Facebook pages. 
The aim of the study presented in this paper was to evaluate the pilot study with respect to perceived risk of 
being stopped by the police. The evaluation also includes experiences from the police. However, because data 
collection is still underway, only a part of the evaluation is presented here. More results will be presented at 
ICADTS 2019 when the evaluation is finalized. 
Method 
The pilot study was conducted in four different districts: 
• Uppsala: a city with 150 000 inhabitants covering an area of 44 km2 
• Västerås: a city with 120 000 inhabitants covering an area of 48 km2 
• Enköping/Håbo: This district consists of two cities (about 13 000 and 23 000 inhabitants, respectively) 
and several smaller urban areas that in total covers an area of 35 km2 
• Heby: a rural district including several smaller urban areas (the police controls were conducted in or 
near the urban areas). 
The number of police controls per week and control locations in each district were calculated based on three 
criteria: 
• 20 h of random breath test (RBT) controls per 100 km2 per week (based on Cameron, 2013) 
• each control should last about 20 min 
• the number of control locations should be twice the number of controls per week 
This resulted in 27 controls per week in Uppsala, 30 controls in Västerås and 21 controls in Enköping/Håbo. 
In Heby, the prerequisites were different since it is a rural area with rather long distances from the police 
station. Therefore, the number was set to 7 controls per week which was assessed as a reasonable workload 
for the police. 
137 
The control locations were selected by the police, but also checked by the authors of this paper. Some small 
corrections were suggested to spread out the controls over the entire districts.  
Posts were published on the Police’s Facebook pages in order to increase the public’s attention to the controls. 
These posts were published irregularly and typically included information of where the control was conducted 
and the result, for example if any driver was caught drink driving. 
The pilot started in September 2018 (different starting dates in different areas) and was concluded on February 
28, 2019. The controls (location, time of day, number of breath tests) were documented in a web-based form. 
The central part of the evaluation was a questionnaire answered by a web-panel before and after the pilot 
study. This questionnaire was distributed both to residents in the pilot area and to residents in a control area. 
The questions most relevant for the evaluation concerned perceived risks, if the respondents had been stopped 
by the police to conduct a breath test or not and if they had noticed posts about drink driving controls on social 
media. As a complement to the web-panel, drivers were also asked to answer a short version of the 
questionnaire through a post on the police’s Facebook pages. This was also done before and after the pilot 
study, but only in the pilot area, not in the control area. In addition, each police district was asked to write a 
story of their experiences of the pilot study, which should contain both positive and negative experiences, as 
well as suggestions for improvement. 
This paper shows preliminary results of the evaluation based only on the Facebook-questionnaire. Results 
from the web-based questionnaire will be presented at ICADTS 2019. 
Results and Discussion 
According to initial feedback from the police, the new way of organizing police controls worked well, and 
they became more motivated to conduct drink driving enforcement. The police also plan to continue working 
according to this model, at least in the urban districts. However, they also reported difficulties to keep up with 
the prescribed number of controls per week during periods with high workload and adverse weather 
conditions. This initial feedback will be followed up with interviews and the police’s own stories regarding 
the experience. 
Information about the performed police controls during the pilot was received from the web-based form. None 
of the police districts reached the number of prescribed controls (Figure 1). In Uppsala, the police had some 
problems at the beginning of the period, but this improved over time. In Heby, which is rural district, the large 
distances became a problem and the method with 20-minute controls are probably not optimal. Overall (from 
October and onwards), Enköping/Håbo had the highest number of actual controls relative to the prescribed 
number (89%), followed by Västerås (71%) and Uppsala (69%). 
 
Figure 1 Number of controls per four-week period and district. The horizontal lines show the prescribed 
number of controls per district based on the area.  
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The respondents of the Facebook-questionnaire were assigned to the police district where they lived, and the 
number of respondents varied between districts, as well as before and after the pilot study. In Uppsala 265 
responses were recorded before the pilot study and 356 after. In Västerås the numbers were 164 before and 
405 after, in Enköping/Håbo 62 before and 96 after, and in Heby 22 before and 30 after. Results from Heby 
are not shown separately because of the small number of responses.  
In Enköping/Håbo, the proportion that reported that they had been stopped by the police to conduct a breath 
test during the last six months increased during the pilot study (significant difference on the 5% level), see 
Figure 2. No other statistically significant differences were found. This result is plausible since 
Enköping/Håbo was the district that conducted most police controls in relation to the prescribed number of 
controls.  
 
Figure 2 Proportion of questionnaire respondents who have been stopped at least once during the last six 
months. Based on the question: During the last six months, how many times have you been stopped by the 
police to conduct a breath test? 
 
Figure 3 shows the proportion of respondents who have noticed posts about drink driving enforcement on 
social media a few times a month or more often, before and after the pilot study. The proportion has increased 
in all districts (significant difference on the 5% level). This result is expected since respondents were recruited 
from the police’s Facebook pages and the police deliberately increased their number of posts as part of the 
pilot study. The result confirms that people visiting the police’s Facebook page also have noticed this increase.  
 
Figure 3 Proportion of respondents who have noticed posts on social media a few times a month or more 
often. Based on the question: How often have you, during the last six months, seen articles and/or posts about 
drink driving enforcement in newspapers or other media (answers for social media).  
0
10
20
30
40
50
60
70
80
90
100
Uppsala Västerås Enköping/Håbo All districts
P
ro
p
o
rt
io
n
 (
%
) 
th
at
 h
as
 b
ee
n
 
st
o
p
p
ed
 a
t 
le
as
t 
o
n
ce
Before After
0
10
20
30
40
50
60
70
80
90
100
Uppsala Västerås Enköping/Håbo All districts
P
ro
p
o
rt
io
n
 (
%
) 
th
at
 h
as
 n
o
ti
ce
d
 p
o
st
s 
a 
fe
w
 t
im
es
 a
 m
o
n
th
 o
r 
m
o
re
 o
ft
en
 
Before After
139 
An important aim of the pilot study was to increase the perceived risk of being stopped by the police and 
asked to conduct a breath test. However, this result could not be seen in the responses to the Facebook-
questionnaire. Even after the pilot, a majority of the respondents found it very unlikely that they would be 
stopped by the police (Figure 4). Combining the data from all districts, this proportion increased marginally 
from 73.1% to 74.9%. The perceived likelihood of being stopped differs somewhat between the districts but 
no clear changes seems to have taken place during the pilot study.  
 
Figure 4 The respondents’ perceived risk of being stopped by the police. Based on the question: On a typical 
journey, how likely is it that you (as a driver) get stopped by the police to conduct a breath test? 
 
Preliminary conclusions 
Only preliminary conclusions can be drawn since the evaluation is not yet finalized. The conclusions are 
mainly drawn based on responses from persons recruited from the police’s Facebook-pages. The results may 
therefore not be representative for the population living in the pilot area in general. However, comparisons 
between responses from the Facebook-questionnaire and responses from the web-panel in the before period 
showed consistent results. 
The preliminary conclusions are: 
• None of the districts in the pilot study reached the prescribed number of controls per week. 
Enköping/Håbo was closest with a rate of 87%. 
• The proportion reported to have been stopped by the police increased during the pilot study in 
Enköping/Håbo. In the other districts, the proportion was about the same before and after the pilot 
study. 
• The respondents in all districts noticed an increase in posts about drink driving controls on social 
media. This result was expected since respondents were recruited from the police’s Facebook pages 
and the police deliberately increased their number of posts as part of the pilot study. 
• No actual improvement in perceived risk of being stopped by the police could be detected. However, 
the results of the entire evaluation must be awaited before a final conclusion can be reached. 
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Abstract 
Background: Alcohol-impaired driving decreased dramatically in Japan during the early 2000s. However, 
little research has been conducted on the involvement of drugs other than alcohol in traffic crashes. 
Systematic drug testing is not an integral part of the crash investigation by traffic police and empirical data 
on drug use are missing in police crash records. Autopsies are conducted on a handful of fatally injured road 
users upon request from the police, and results of drug testing are compiled in the database. 
Purpose: To describe the characteristics of autopsy data including prevalence of drugs detected in fatally 
injured road users and to compare this with police data. 
Method: A retrospective data analysis using the two databases from Chiba Prefecture between 2013 and 
2017: autopsy data of Chiba University and the police crash data. Study protocol was approved by the ethics 
committees of participating institutions. 
Results: There were ca. 730 fatal injury crashes (deaths within 24 hours). Of 152 autopsied cases (25% 
women, mean age 62), 36% were pedestrians, followed by pedal cyclists (26%) and drivers of four-wheeled 
vehicle (20%). Medicinal drugs were detected from 54% of the cases after deleting medicinal drugs likely to 
be given for treatment. Most frequently detected agents included cough suppressants, antianxiety/sleeping 
pills, antihypertensives, antihistamines, antipsychotics, antidiabetics, and so on. Poly-medication was 
identified in 60% of the cases where medicinal drugs were detected. No illicit drugs were detected. Alcohol 
involvement was documented in 33% of police investigations, and alcohol was detected in 41% of the 
autopsied bodies. Socioeconomic and health factors surrounding the deceased will also be reported. 
Acknowledgements: We would like to thank Dr. Herbert Chan of University of British Columbia for 
providing support with drug categorization. This work was supported by JSPS KAKENHI Grant Number 
17K01813.  
Introduction 
Alcohol-impaired driving decreased dramatically in Japan in the early 2000s. Traffic crash statistics show 
that alcohol is involved in 6% of at-fault motor vehicle drivers involved in fatal crashes (National Police 
Agency [NPA], 2018). Little is known, however, about alcohol involvement of pedestrians and pedal 
cyclists, because alcohol involvement of drivers tends to be the focus of enforcement and of police 
investigation of crash-responsibility. Pedestrians and pedal cyclists account for 50% of fatally injured road 
users in Japan. Nearly 60% of all fatally injured road users in Japan, ―including drivers, passengers, 
bicyclists, and pedestrians, ―are 65 years and over (NPA, 2018). Given the high proportion of vulnerable 
road user fatalities, alcohol involvement of pedestrians and cyclists merits investigation. 
Furthermore, little research has been conducted on the involvement of drugs other than alcohol in traffic 
crashes. Systematic drug testing is not a routine part of the crash investigation and empirical data on 
involvement of licit and/or illicit drugs among injured road users are almost non-existent in Japan. The 
prevalence of illicit drug use in the general Japanese population is lower than in western countries (Wada, 
Funada, & Matsumoto, 2013), while the prevalence of use of licit psychotropic medication appears to be 
similar to that in European countries (Nakagawa, 2011). 
It is shown that Canadian police rarely identify drivers who had used impairing drugs or medications during 
course of crash investigation (Brubacher et al., 2018). This may be true for Japanese police, in which case 
crash statistics do not capture most drug-related crashes. Against this background, we investigated fatal 
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crashes where the deceased were autopsied and drug-tested. Autopsies are conducted on fatally injured road 
users upon request from police. In the early 1990s, 5-6% of fatally injured road users in Japan were 
autopsied (Fujita, 2009). The current figure may be higher and varies from region to region within Japan. 
Police request autopsies when they need to clarify cause of death or suspect involvement of more than one 
striking vehicle in a crash (e.g., suspected hit-and-run). This judgment is made by specially trained police 
officers. 
In the absence of epidemiological data regarding road user impairment due to drugs, the aim of this paper 
was to describe the characteristics of autopsy data of fatally injured road users and to compare this with 
police crash data. 
Materials and Methods 
We conducted a retrospective data analysis using information from the Chiba Prefecture (population 6.3 
million), situated east of Tokyo. Most autopsies are conducted in Chiba University. Two data sources were 
used: (1) autopsy data of Chiba University (April 2013 and March 2017), and (2) corresponding police crash 
data. Police data were retrieved from the National Research Institute of Police Science database. The study 
protocol was approved by the ethics committees of participating institutions. 
The extracted autopsy data (N = 152) included all types of road users who were fatally injured or found dead 
on the road or roadside. These 152 cases were autopsied and had toxicology testing using broad spectrum 
drug testing that screened for 273 substances. The toxicology panel included 
methamphetamine/amphetamine (the most abused illicit drugs in Japan), cannabis, and 10 other illicit drugs 
as well as various medicinal drugs. All detected drugs were confirmed and quantified in preserved blood 
(femoral and heart) and urine by mass spectrometric techniques (LC-MS/MS). We classified detected 
substances as inert or active depending on whether they were known to have psychotropic effects on 
humans. Active drugs were classified into the seven categories of the Drug Evaluation and Classification 
(DEC) system (Canadian Centre on Substance Use and Addiction, 2018). We also categorized drugs 
according to the Japanese drug warning system for consumers: ‘driving prohibition’, ‘drive with due care’, 
or no warning (Okamura, Fujita, Kihira, & Kosuge, 2018). 
From police crash data, we extracted 725 fatal crashes (death within 24 hours) and 76,464 “serious or slight 
injury” crashes. The latter included crashes resulting in death more than 24 hours after crash occurrence. The 
two databases were linked using date/time of crash, police jurisdiction, and age/sex of the deceased as key 
parameters (see Fig. 1).  
Alcohol > 0.1 mg/ml detected either in blood or urine was interpreted as cases where the deceased had 
consumed alcohol (Suzuki & Yashiki, 2002). The threshold of 0.1 mg/ml was set to eliminate potential post-
mortem alcohol production due to decomposition. Drugs likely given for post-crash resuscitation were also 
deleted (lidocaine, atropine, midazolam, pentazocine, and ketamine) after inspecting autopsy reports for 
record of hospitalization and treatment. 
Uni- or bivariate statistics were presented using t, chi-square or Fisher’s exact test to describe the data. 
Statistical significance was determined at p < .05 throughout this paper. 
 
 
 
 
 
 
Fig. 1. Schematic diagram of the data used in this study 
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Results 
Autopsy data: general characteristics 
Mean age of autopsied cases was 61.7 (standard deviation [SD]: 19.5, range: 18―99). Women accounted for 
25% of cases. Thirty-eight percent were pedestrians, 27% pedal cyclists, 19% car/truck drivers, 2% car 
passengers, and 15% moped/motorcycle drivers. Thirty percent were deemed to be the most at-fault party, 
68% were partially at fault (Police assign relative responsibility―the most at-fault and the second at-fault―to 
drivers, cyclists, and pedestrian). Typically, between one and several days had passed after death before 
autopsies were conducted. This may have affected drug detection. Various post-mortem factors may lead to 
reduction or increase in the drug concentration (Leikin & Watson, 2003; Skopp, 2009). The longer it took 
before the autopsy was conducted, the greater the change in drug concentration and this could result in false 
negative results (failure to detect drugs that were actually present before death). 
Sociodemographic information about the deceased was provided by investigating police. It was documented 
that 5% had criminal record(s) and 4% had a past traffic-related incident (imprisonment, crash involvement 
or citation). Some were known to have health problems such as one or more medical condition other than 
hypertension (27%), hypertension (15%), mental disorder other than dementia (11%), dementia (7%), 
walking difficulties (7%), history of falling (7%), and alcohol-related problems (6%). 
Autopsy data: involvement of alcohol and drugs 
Alcohol was detected in 32% of the autopsied cases (the mean femoral blood alcohol concentration [BAC]: 
1.3 mg/ml, SD: 0.8, range: 0.1―3.0), while police suspected that 27% of the deceased had consumed alcohol 
(BAC not provided). No illicit drugs were detected, although police documented detection of 
methamphetamine in one surviving at-fault striking driver but not from the deceased driver. 
Medicinal drugs were detected in 53% of the autopsied cases. Poly-medication was identified in 62% of 
drug-positive cases. Of these drug-positive cases, the mean number of active drugs per body was 1.7 (SD: 
2.2, range: 0―12); the mean number of drugs with driving-related warning per body was 2.6 (SD: 2.1, rage: 
0-12). Of detected 231 substances, 103 (45%) were central nervous system (CNS) depressants, followed by 
inert drugs (38%), CNS stimulants (14%), and narcotic analgesics (4%) under the DEC category system. 
Under the Japanese drug warning system, 73% of the detected drugs were classified as “driving prohibition” 
and 20% “drive-with-due-care” class, meaning that 92% of detected drugs had a driving-related warning. 
Examples of frequently detected drugs were antihypertensives, benzodiazepines or hypnotics of a similar 
type (e.g., zopiclone), antipsychotics, antihistamines, antitussives, antipyretic analgesics, and antidiabetics. 
Under the Japanese drug warning system, almost all hypnotics, antipsychotics, antidepressants, 
antihistamines and antitussives were labeled as “driving prohibition”, while antihypertensives and 
antidiabetics were labeled as “driving-with-due-care”. The latter class was classified into inert under the 
DEC category system. 
Involvement of alcohol and drugs were compared between types of road user. However, there was no 
statistically significant difference in percentage of alcohol and drug involvement, meaning that alcohol and 
drug involvement in pedestrians and cyclists did not differ from drivers of motorized vehicles. 
Next, age and sex were compared by involvement of alcohol and drugs. A significantly higher percentage of 
men had alcohol than women (38% vs 18%), but no significant difference was found as to age. There were 
some significant differences by involvement of drugs. First, significantly more women than men had used 
drugs with a driving-related warning (68% vs 42%). Also, those who had taken these drugs were older than 
those who did not (mean age 68.1 vs 55.1). 
Linkage to police crash data 
Of 152 autopsied cases, 122 (80%) could be linked to police crash data. Seventy-five percent of these had 
been registered as fatal crashes, 16% as serious injury crashes, and 8% as slight injury crashes in police data. 
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Causes of death for the 30 unlinked cases were: pathological/sudden deaths (47%), drowning (13%), 
physical trauma (10%), suicide (10%), and undetermined (10%).  
There were some statistically significant group differences between linked and unlinked cases. Fewer 
unlinked cases than linked cases were brought to hospital (62% vs 82%), suggesting that the deceased had 
been dead for some time. A significantly higher proportion of unlinked cases took active drugs compared 
with linked cases (52% vs 31%). Conversely, the mean BAC of unlinked cases was lower than linked cases 
(0.25 mg/ml vs 1.06 mg/ml) where detected, which could be due to longer time till drug testing. 
Involvement of alcohol and drugs within the linked autopsy data 
Among the linked cases, there was a statistically significant association between alcohol involvement and 
severity of crashes as registered by police. Alcohol was detected in 42% of the deceased bodies in crashes 
resulting in death within 24 hours, this figure was much lower (7%) in crashes that resulted in death after 24 
hours. This may represent alcohol metabolism following the crash or less frequent alcohol-testing. Second, 
there was a statistically significant association between alcohol involvement and type of crash. Alcohol was 
detected in 40% of deceased who were involved in single-vehicle crashes, but in fewer people who died in a 
pedestrian-vehicle crash (21%) or multiple-vehicle crash (11%). 
In contrast, we found no significant association between drug involvement and the severity or type of 
crashes.  
Comparison of autopsied and non-autopsied fatal crashes 
We studied crashes resulting in death within 24 hours (from police data) and compared autopsied cases (n = 
85) with police non-autopsied cases (n = 640).  
There were statistically significant differences in environmental conditions between autopsied and non-
autopsied fatal crashes. A higher proportion of autopsied crashes versus non-autopsied crashes occurred 
between 22:00-3:00 (40% vs 12%). Conversely, a significantly higher proportion of non-autopsied crashes 
occurred during daytime. A higher percentage of autopsied crashes occurred in the rain (18% vs 10%), 
whereas a higher percentage of non-autopsied fatal crashes occurred in good weather. Also, autopsied cases 
were more likely to occur between intersections and on narrower or undivided roads.  
There were also statistically significant differences in type of collision between autopsied and non-autopsied 
crashes. While 40% of non-autopsied crashes were multiple-vehicle collisions (e.g., angle/turning collision 
at intersection), 53% of autopsied crashes were pedestrian-vehicle collisions. While 29% of non-autopsied 
cases were collisions with a pedestrian who were crossing the road, 28% of autopsied crashes were collision 
with a pedestrian who were lying on the road, suggesting alcohol involvement or walking difficulties. Hit-
and-run and multiple-collisions in one crash were more prevalent in autopsied crashes. 
Age and sex of the deceased were comparable between autopsied and non-autopsied crashes. However, 
more autopsied crashes involved people of non-Japanese nationality compared with non-autopsied crashes 
(4% vs 1%). The proportion of alcohol involvement was significantly higher among autopsied than in non-
autopsied crashes (48% vs 14%). Involvement of drugs was not recorded at all in the police fatal crash data. 
Conclusion 
The autopsy data reported in this paper provided insight into general trends in Japanese fatal crashes, but 
some distinct characteristics were found in autopsied cases such as higher alcohol involvement not only in 
drivers but also in pedestrians and cyclists. Involvement of impairing medications was more prevalent than 
alcohol and particularly high in older or female road users. Unfavorable health or socioeconomic conditions 
could potentially be related to involvement in fatal crashes, but understanding these factors requires more 
accurate data and larger samples. Much more information is needed to understand the causal effects of 
alcohol and drug involvement on crash occurrence. 
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Abstract 
Context: Kava is not defined as a “drug” in traffic legislation in NSW Australia. Increasing use of kava by 
various community groups has resulted in more traffic offences. This presentation relates to two serious 
motor vehicle collisions, caused by the same driver being under the influence of kava.   
Objectives: This presentation alerts the public and law enforcement agencies to concerns surrounding traffic 
safety, after high dose kava ingestion.  
Key Outcomes: It is highly recommended that a high dose of kava ingestion should be avoided if driving or 
operating heavy machinery.  
Discussion: Mr A had two serious vehicle collisions in an 8-month period in the early hours of the morning, 
involving two parked vehicles and a road barrier, respectively. Based on witnesses’ observations after the 
collisions, he appeared to be seriously affected by alcohol and / or illicit substances. Roadside breath tests 
returned a negative reading for alcohol, and his initial blood / urine tests returned negative results for any 
drugs and alcohol. A witness stated that Mr A had consumed an unknown amount of kava shortly prior to 
the first collision. After the second collision Mr A’s blood sample was analysed again at a later date, and 
approximately 3 mg/L of kavain was detected in his blood. Mr A stated he had consumed12 cups of kava in 
the hours prior to this collision. Mr A had consumed approximately 60 times more than the medicinal dose 
of kavain in addition to an unknown amount of another five major kavalactones, shortly prior to the second 
collision. The signs and behaviours he displayed after both collisions were consistent with the effects of 
kava and it is concluded that he was under the influence of kava at the time of both collisions.    
Keywords: Kava, driving-skills.  
Disclosure: There are no financial and ethical conflicts of interest for this study. There was no funding 
provided for this study. The cases were routine NSW Police Force investigations relating to suspected DUI. 
The authors would like to express their appreciation to NSW Police Force and the NSW Forensic & 
Analytical Science Service.       
   
Content   
Kava (Piper methysticum) is a plant indigenous to the Pacific Islands. It is a psychotropic plant that has been 
used both recreationally and medicinally for centuries among Pacific Island populations (Lindstrom, 2004). 
People from the major Pacific Islands have developed kava as a beverage and it is commonly consumed 
much like alcohol in Western cultures (Steiner, 2001). In countries, such as Fiji, Samoa, Vanuatu and 
Australia, kava is popular for recreational usage amongst some communities (Clough, 2003; Mathews et al., 
1988).   
 
In recent years, motor vehicle collisions following kava ingestion have raised the concern of many scientists. 
Several studies have been performed to investigate the relationship between motor vehicle collisions and 
kava intake (Wainiqolo et al., 2012, 2015 and 2016; Sarris et al., 2011). These studies suggested that 
drinking kava in the six hours prior to driving was a major contributing factor in some motor vehicle 
collisions.  The cases we report on, were two motor vehicle collisions caused by one regular kava drinker. 
The driver consumed 12 cups of kava drink, finishing one hour before the second collision occurred.  The 
cases are the typical examples of motor vehicle collisions caused by kava ingestion in New South Wales, 
Australia and are consistent with the conclusions of the abovementioned studies.     
   
Objectives   
This article reports on two serious motor vehicle collisions, which were caused by one driver under the 
influence of kava. This case study demonstrates concern relating to traffic safety after high dose kava 
ingestion. The study also demonstrates the emergence of new problematic drug abuse in relation to traffic 
situations and recommends broadening the spectrum of drug analysis.     
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Key Outcomes    
In New South Wales, Australia, drivers suspected of driving whilst under the influence (DUI) are required to 
provide blood and urine samples for analysis. The range of drugs included in the analytical spectrum is 
defined by legislation. The result of the case studies presented, provided support for recommendations to 
broaden the drug analysis spectrum of blood samples taken from drivers suspected of DUI. Considering the 
increasing recreational use of kava by various communities in Australia, we highly recommend that high 
dose of kava ingestion should be avoided if driving or operating heavy machinery.   
   
Case Brief     
A middle-aged male, Mr A, had two serious motor vehicle collisions in an 8-month period, both of which 
occurred in the early hours of the morning.    
   
Case 1: The first incident happened at about 2.30 am, in a residential area of NSW, Australia. The vehicle 
being driven by Mr A collided with a parked vehicle, then continued to be driven a short distance where it 
collided with another parked vehicle. After the collisions, Mr A refused to exchange details with the owners 
of the parked vehicles and drove away. Witnesses reported to police that they believed that Mr A was 
significantly affected by alcohol or drugs due to his manner of driving and stated that he was “staring 
blankly ahead while he was driving his car and going nowhere”. Police stated that after being removed from 
his vehicle, Mr A appeared to be extremely affected by alcohol or a drug. He was unable to speak in 
sentences, slurred his words and was unable to stand unassisted.   
      
Mr A’s roadside alcohol breath test returned a negative result, and he was conveyed to a hospital for 
mandatory blood and urine sample collection.  The analysis of his blood and urine samples returned negative 
results for any drug or alcohol. At that time, there was no analysis for kavalactones (kava’s major 
constituents) performed on the samples at NSW Forensic and Analytical Science Service Laboratory. At a 
later date, one of Mr A’s family members stated to police that Mr A had consumed a lot of kava drinks 
shortly prior to the collisions.   
   
Case 2: Approximately 8 months after the first incident, Mr A had a single vehicle collision on a New South 
Wales highway at about 4.35 am. The vehicle driven by Mr A collided with a safety barrier and finally 
stopped in dense grassland after sliding about 100 meters from the point of impact.  Based on the signs Mr A 
displayed after the collision, witnesses formed the opinion that he appeared to be seriously affected by 
alcohol and / or an illicit substance. He was unable to stand, continually fell over on the grass, appeared very 
sleepy and mumbled when he spoke. His eyes were bloodshot, and he had trouble maintaining any 
conversation with police.  Mr A was assisted by police to walk from the grassland as he was unable to walk 
unassisted. He was subjected to a roadside breath test which returned a negative reading for alcohol.   
    
Mr A was conveyed to hospital for medical assessment and a blood sample was collected. Mr A stated to 
police that he had consumed 12 cups of kava drink approximately one hour prior to the collision and he did 
not consume alcohol, a drug or any other substance, nor was he suffering any medical condition.   
     
Mr A’s blood sample was analysed at a later date and reported approximately 3 mg/L of kavain (one of the 
six major kavalactones) was detected in his blood. There were no other common psychoactive substances 
found in his blood.     
  
Discussion   
Kava is the name of a beverage produced from the dried roots of the Piper methysticum shrub. Kava has 
mild psychoactive effects, similar to the effects of alcohol. Kava was first brought to northern Australia in 
the 1980s by Pacific Islanders who had settled in the country. They used the herb as an alternative to 
alcohol, because of its similar effects for promoting relaxation, relieving muscle tension and inducing social 
interaction (Clough, 2003; Mathews et al., 1988).  Kava herb extracts are available as a dietary supplement 
in U.S.A. In Europe, purified extracts or synthetic kavain can be prescribed as an antidepressant and muscle 
relaxant (Baselt, 2017).  The Australian Therapeutic Goods Administration (TGA) has recommended that no 
more than 250 mg of kavalactones should be taken in a 24-hour period (Kava Fact Sheet, TGA).   
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The primary bioactive compounds in kava are kavalactones (KLT). Eighteen KLTs have been identified; six 
major KLTs constitute about 96% of the lipid extract of dried roots and rhizomes.  
These are kavain, dihydrokavain desmethoxyyangonin, yangonin, methysticin, and dihydromethysticin (Fu 
et al., 2009). A single oral 400 mg dose of kavain given to healthy subjects resulted in average peak plasma 
concentration of 0.05 mg/L at 1.5 hours (Baselt,  2017). In a fatal kava overdose case, the deceased post 
mortem femoral blood kavalactones’ concentrations were detected as:  kavain 1.4 mg/L; 7,8-dihydrokavain 
2.7 mg/L; methysticin  0.46 mg/L; 7,8-dihydromethysticin 1.6 mg/L and desmethoxyyangonin 0.13 mg/L 
(Ketola et al., 2015). In the case we are reporting, Mr A’s blood kavain concentration was approximately 3.0 
mg/L, which is 60 times more than the TGA recommended dose and about double the kavain concentration 
in the reported fatal intoxication case.   
         
Scientific studies demonstrated that the physical effects of kava include muscle relaxation and analgesia. 
The psychoactive effects of kava include euphoria, anxiolytic, sedation or stimulation, and a tendency 
toward being very talkative or introspective (Baselt, 2017). The similar effects of kava to alcohol and 
benzodiazepines have raised the concern over the possibility that kava could adversely influence driving 
performance and increase the risk of road collisions (Wainiqolo et al., 2015).   
    
A study examining the saccade (a rapid movement of eyes) and cognitive impairment associated with kava 
intoxication, concluded that intoxicated kava drinkers (who had each consumed 205 grams of kava powder) 
displayed specific abnormalities of movement coordination and visual attention, but normal performance of 
complex cognitive functions (Cairney et al., 2003).   
   
A study carried out by Wainiqolo et al in Fiji showed that in motor vehicle collision incidents 23% of 
drivers reported having consumed kava 12 hours prior to the incidents. In contrast, 4% of drivers reported 
having consumed kava 12 hours prior to non-crashed vehicles. Also, nearly twice the number of drivers of 
crashed vehicles reported drinking kava several times a week to daily in the preceding 12 months as 
compared to non-crashed vehicles. This study concluded that driving following the use of kava was 
associated with a significant risk of being involved in a serious motor vehicle collision. It suggested that 
drinking kava in the six hours prior to driving was a major contributing factor to being involved in a serious 
injury motor vehicle collision in Fiji.  The study also suggested that road safety strategies should explicitly 
recommend avoiding driving following kava ingestion (Wainiqolo et al., 2012 and 2016).   
  
Limitations   
In New South Wales, Australia, while there is mandatory blood and urine testing of drivers suspected of 
DUI, the drugs included in the spectrum of the analysis is limited to a defined list of illicit and medicinal 
drugs for which there is scientific evidence of psychomotor effects. Some new medications and recreational 
drugs are not currently in the spectrum of the analysis. Kava was not included in the analytical spectrum of 
drugs at the time of the incidents reported in these case reports. Confirmation of kava use in case 2 was on 
the basis of targeted drug analysis due to information provided at the time of the incident.    
   
Conclusions   
According to the nature of the reported collisions, the admission of high dose ingestion of kava hours prior 
to the collisions, the significant amount of kavain detected (Case 2) and no detection of alcohol and other 
drug in Mr A’s blood / urine samples, as well as the physical and behavioural signs displayed by Mr A 
which are consistent with the effects of kava, we conclude that Mr A was under the influence of kava and 
had impaired driving ability at the time of the collisions.  Such cases have identified emerging new 
recreational drugs, a changing pattern of drug usage by drivers, such as kava use and new medications with 
potentially impairing effects.   
We highly recommend:   
avoidance of recreational high doses of kava ingestion if driving or operating heavy machinery, and    
inclusion of kavalactone in mandatory blood testing of suspected impaired drivers in  
Australia.      
  
Note: Submissions to traffic policy authorities resulted in an amendment to legislation in New South Wales 
in December 2018 to include a much broader analytical spectrum of drugs.      
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Next Steps: Currently only kavian, one of the six major KLTs, is targeted in the blood sample analysis. The 
six major KLTs are going to be targeted analysis for a more accurate and broad range evaluation of the 
suspected drivers’ impairment in future studies. 
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Abstract 
Keywords. medication, impaired driving, self-report, survey 
Background. Drug-impaired driving is a prominent road safety concern and research surrounding this issue 
is being conducted at an unprecedented pace. However much less is known about driving under the 
influence of medication, and how to manage this road safety issue, especially in light of an aging population. 
Further research to support the development of tailored enforcement strategies and educational campaigns 
that address the risks associated with medication use and driving is needed. 
Objectives. The objective of this study was to compare the rates of drivers in Canada, the United States, and 
Europe who self-declare driving after taking medication with a warning that it may influence driving ability 
to determine what quantitative differences exist between these three regions. The effects of demographics 
and personal beliefs on this self-reported behaviour were also examined. 
Methods. Self-reported use of medication with a warning that it may influence driving ability, and personal 
acceptability of this behaviour were measured as part of the E-Survey of Road Users’ Attitudes (ESRA 2; 
www.esranet.eu). ESRA 2 is a joint international initiative of 26 research centres and road safety institutes; 
the project has surveyed road users in 38 countries on 5 continents. The descriptive analysis compared rates 
of this self-reported behaviour and opinions regarding personal acceptability by region. A multivariate 
model predicting driver’s self-reported use of medication with a warning that it may influence driving ability 
was estimated. 
Results. At the time of submission of this abstract, data collection for the cross-sectional online survey is 
ongoing. Data collection will begin in December 2018; final analysis results will be available in February, 
2019. 
Discussion. To be completed when the survey data is available and analyses are finalized. 
Disclosure. No relevant affiliations or conflicts of interest exist. 
 
Introduction 
Driving under the influence of medications, both prescription and over-the-counter (OTC) drugs, is a 
growing road safety concern. Certain medications can impair cognitive and psychomotor performance, and 
their effect on driving ability have been documented in both experimental and epidemiological studies 
(Verstraete et al., 2014; Strand, Gjerde, & Mørland, 2016; Rudisill et al. 2016; Gjerde, Strand, & Mørland, 
2015). Some of the drug classes with the potential to impair driving include stimulants, opioids, 
benzodiazepines and other central nervous system (CNS) depressants, antihistamines, antiemetics, and cold 
and flu medications (Smith, Turturici & Camden, 2018).  
Studies examining the prevalence of prescription and OTC medications in various populations offer 
valuable insight into the magnitude of the issue. In Canada, the Traffic Injury Research Foundation (TIRF) 
produces the Road Safety Monitor (RSM) which is based upon an online survey of drivers’ attitudes and 
behaviours. The RSM measured the self-reported behaviour of driving within 2 hours of taking a medication 
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that may affect driving ability within the last 12 months. Results showed that 15.4% of drivers in Canada 
reported driving within two hours of using OTC medications for allergies, hay fever, cold, flu, cough or 
insomnia. In addition, 3.1% of drivers reported driving within two hours of taking prescription drugs 
carrying a warning that it may affect their driving (Robertson, Hing, Woods-Fry & Vanlaar, 2018).  
In the United States, the 2013-2014 National Roadside Survey (NRS) measured the prevalence of 
prescription and OTC medications at the roadside. Results showed that 10.7% of daytime drivers and 7.4% 
of nighttime drivers tested positive for prescription and OTC medications (Berning, Compton, & 
Wochinger, 2015). Furthermore, data from the FARS database demonstrate an increasing prevalence of 
prescription drugs in fatally injured drivers from 1999 to 2010 (Rudisill et al., 2014).  
In Europe, results from the first edition of the European Survey of Road users’ safety Attitudes (ESRA1, 
now called ‘E-Survey of Road users’ Attitudes) measured the self-reported behaviour of medication use and 
driving. Drivers across Europe were asked if they had driven while taking a medication that carries a 
warning about its potential to influence driving ability. Results showed that 22% of drivers reported to have 
done so within the last 12 months (Achermann, 2016). In addition, the average prevalence of medications in 
fatally injured drivers across European countries was 1.4%, with benzodiazepines being the second most 
frequently detected substance in fatally injured drivers after alcohol (Schulze, Schumacher, Urmeew, & 
Auerbach, 2012). 
Although various individual studies have measured the prevalence of medication use and driving in Canada, 
the U.S. and Europe, research comparing this issue across these regions has not, to the best of our 
knowledge, been conducted. The objective of this paper is to determine what differences exist between these 
three regions by comparing the rates of drivers in Canada, the U.S., and Europe, who self-report driving 
after taking medications that have a warning that it may influence driving ability, and the personal 
acceptability of this behaviour.  
Methods 
ESRA 2 survey 
The ESRA project (E-Survey of Road users’ Attitudes) is a joint initiative of road safety institutes, research 
organisations, public services, and private sponsors, aiming at collecting comparable international and 
national data on road users’ opinions, attitudes and behaviour with respect to road traffic risks. The project is 
funded by the partners’ own resources and covers countries all over the world.  
ESRA is an extensive online panel survey, using a representative sample (at least N=1,000) of the national 
adult populations in each participating country. A common questionnaire was developed and translated into 
national language versions. The themes covered are e.g. ‘self-declared behaviour’, ‘attitudes and opinions on 
unsafe traffic behaviour’, ‘enforcement experiences’, and ‘support for policy measures’. The survey addresses 
different road safety topics (e.g. DUI of alcohol, drugs and medicines, speeding, distraction) and targets all 
types of road users (car drivers, moped drivers and motorcyclists, cyclists, pedestrians). The first edition of 
the ESRA survey (ESRA1) was carried out in three waves between 2015-2017. Data were gathered from 
almost 40,000 road users in 38 countries across 5 continents (Meesmann, Torfs, Nguyen, Van den Berghe, 
2018). 
The present paper is based on the second edition of this global survey (ESRA2_2018). It was conducted in 32 
countries in 2018. In total, this survey collected data from more than 35,000 road users (Meesmann, & Torfs, 
2019). 
Data analysis 
Descriptive analyses were conducted to compare the self-reported behaviour of driving after taking a 
medication carrying a warning that it may influence driving ability, and the attitudes surrounding the 
acceptability of drivers who drive after taking medications that may affect driving ability. Proportions were 
compared across all three regions (Canada, United States, and Europe) to determine if there were significant 
differences between them. Note that a weighting of the data was applied to the descriptive analyses. This 
weighting took into account small corrections with respect to national representativeness of the sample based 
on gender and six age groups: 18-24y, 25-34y, 35-44y, 45-54y, 55-64y, 65y+; based on population statistics 
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from United Nations data (United Nations Statistics Division, 2019). For Europe, the weighting also took into 
account the population size of each country in the total set of 20 countries (Austria, Belgium, Czech Republic, 
Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Norway, Poland, Portugal, Slovenia, 
Spain, Sweden, Switzerland, The Netherlands and United Kingdom). SPSS 25.0 was used for all analyses 
(IMB corp, 2017). 
Results 
As part of the ESRA2_2018 questionnaire, respondents in each region were asked questions about medications 
and driving. Results are grouped into two sections: self-reported behaviour of driving after taking a medication 
carrying a warning that it may influence driving ability, and the personal acceptability of this behaviour. More 
results from the ESRA2_2018 survey on driving under influence of alcohol, drugs and medication can be 
found in Achermann, Stürmer & Meesmann (2019). 
Self-reported behaviour 
Rates of the self-reported behaviour of driving after taking medication carrying a warning that it may influence 
driving ability within the last 30 days are reported by region in Table 1. Self-reported behaviour was measured 
on a five-point rating scale ranging from never to (almost) always. For the purpose of the analysis, the value 
of 1 was coded as never, and values 2 to 5 were coded as at least once. 
Table 1: Proportions of self-reported behaviour for all three regions.  
Over the last 30 days, how often did you as a 
CAR DRIVER drive after taking medication 
that carries a warning that it may influence 
your driving ability? 
 Canada United States Europe 
Never  83,3%a 85,0%a 84,9%a 
At least once  16,7%a 15,0%a 15,1%a 
Note. (1) When the superscript letter is different, then the row proportions are significantly different from each 
other at the 0.05 level.  
Regional differences in the proportion of drivers who drove at least once in the past 30 days after taking a 
medication that carries a warning that it may influence driving ability were not found to be significant (chi-
squared = 1.50; df = 2; p-value= 0.471). 
Personal acceptability 
The proportions of personal acceptability of drivers who drive after taking medication that may influence 
ability to drive are reported by region in Table 2. Personal acceptability was measured on a five-point rating 
scale ranging from unacceptable to acceptable. For the purpose of the analysis, values 1 to 3 were coded as 
unacceptable/neutral, and values 4 and 5 were coded as acceptable 
Table 2: Proportions of personal acceptability for all three regions.  
How acceptable do you, personally, feel it 
is for a CAR DRIVER to drive after taking 
a medication that may influence the ability 
to drive? 
 Canada United States Europe 
Unacceptable/ne
utral 
96,2%a 99,4%b 97,6%c 
Acceptable 3,8%a 0,6%b 2,4%c 
Note. (1) When the superscript letter is different, then the row proportions are significantly different from each other 
at the 0.05 level.  
When asked whether respondents felt it to be personally acceptable for a driver to drive after taking 
medications that may influence ability to drive, the proportions of those that found it acceptable were 
significantly different between regions (3.8% for Canada, 0.6% for U.S., and 2.4% for Europe) (chi-squared 
= 18.54; df = 2; p-value =0.000).   
Conclusions 
Taking medications and driving is not always perceived as dangerous. However, there are a number of 
medications, both prescribed and over-the-counter, that significantly impair driving. Across the three 
regions, we found that 15% or more of respondents candidly responded they had taken these medications 
and driven, yet no more than 3.8% indicated that it was an acceptable behaviour. The discordance between 
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beliefs and behaviour is concerning. Although motorists may recognize using these potentially impairing 
medications as unacceptable, they may also feel there is little option (i.e., some medications are life saving) 
and that the risk is minimal. For example, in a recent study conducted in the U.S., only 42.5% of drivers 
reported that people driving after using prescription drugs was a very serious threat to their personal safety 
on the roadway (AAA Foundation for Traffic Safety, 2018).  
These results speak to the need to develop and revaluate our current practices for educating the public about 
using medications and driving. Drivers may not always distinguish between impairing and non-impairing 
medications, nor understand potential interactive effects among medications. As such, health professionals 
are instrumental in better identifying and informing drivers about the potential dangers through counseling 
and improved prescription labeling (i.e., warnings). More specifically, pharmacists, doctors and other 
healthcare practitioners require evidence-based tools and training that facilitates their ability to screen and 
effectively communicate to patients the impact that certain medications may have on driving ability. A study 
by Hill, Rybar and Styer (2013), demonstrated that the implementation of a training curriculum for 
healthcare professionals resulted in increased knowledge about medications and driving impairment, as well 
as increased confidence in screening patients about their medication use and driving. Medication labeling is 
also important. Although all three of the study regions have policies on prescription warning labels, not all 
clearly communicate the potential driving risk.  Improvements may include warnings presented in larger 
font, brighter in color, or displaying a signal word (i.e., “danger”). Pictorial aids can also enhance 
understanding (Katz, Kripalani, & Weiss, 2006). In the European research project DRUID (Driving under 
the Influence of Drugs, Alcohol and Medicines) a warning label using a rating pictogram on medicines and 
driving (ranging for risk categories from green, yellow, orange to red), proved to be effective in risk 
communication (Meesmann et al., 2011).   
Finally, although still low, it is interesting to note that acceptability of driving after using a potentially 
impairing medication is significantly lower in the United States than Europe and Canada (Canada having the 
highest acceptable reports). This warrants further examination as it suggests differences in how drivers 
perceive risks, both crash and injury, as well as enforcement and apprehension for driving and using 
potentially impairing medications. These differences may relate to how information is relayed to drivers, 
and what might be the most effective educational delivery mechanisms. 
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Abstract 
Background: Theoretical concepts from the social cognition literature have proven valuable in 
understanding and developing countermeasures for driving under the influence of alcohol. Yet, these 
concepts have rarely been applied to inform understanding of driving under the influence of cannabis 
(DUIC).  
Objectives: This study aimed to expand knowledge of perceived collision risk and social influences 
associated with DUIC and driving after other substance use.  
Methods: Semi-structured interviews were conducted with 20 participants of a remedial program for 
impaired drivers. Two independent coders initiated thematic analysis. Early discussion of emergent themes 
led to the identification of applicable social cognition concepts, resulting in selective coding and 
interpretation.  
Results: Many participants identified DUIC as less risky than driving under the influence of alcohol or other 
drugs. Mixed perceptions regarding the dangerousness of DUIC were expressed, with some participants 
denying increased collision risk except among novice cannabis users. Comparative optimism bias was also 
expressed by participants who perceived themselves as less likely than others to be involved in a collision 
when DUIC. In view of normative influence, participants perceived friends to be more accepting of DUIC 
than family, and there were indications that fellow users’ opinions were viewed as more credible than those 
who did not use cannabis.  
Discussion, Conclusions and Implications: Comparative optimism bias and normative influence may 
contribute to perceived risks associated with DUIC and may, therefore, be useful concepts to employ to 
increase the effectiveness of intervention initiatives. Important implications for public health and road safety 
campaigns including the source and focus of the message are discussed.  
 
Introduction  
According to international roadside survey studies, cannabis is often the illicit drug most commonly used 
prior to driving (Beirness & Beasley, 2010; Berning et al., 2015; Davey et al., 2007; Verstraete & Legrand, 
2014) and, after alcohol, the substance most frequently detected in seriously and fatally injured drivers 
(Drummer et al., 2004; Verstraete & Legrant, 2014; Woodall et al., 2015). The magnitude of collision risk 
associated with cannabis-related impairment is difficult to measure and varies between studies (Asbridge et 
al., 2012; Elvik, 2013; Li et al., 2012; Rogeberg & Elvik, 2016). While legal and other efforts to reduce 
impaired driving have predominantly focused on driving under the influence of alcohol (DUIA), now efforts 
to reduce drug-driving, especially driving under the influence of cannabis (DUIC), are garnering substantial 
policy and research attention (Watson & Mann, 2016).  
Studies on DUIA provide insights helpful for advancing understanding of DUIC (Asbridge et al., 2016; 
Watson & Mann, 2016). Key topic areas of DUIA research have included driver attitudes, perceived risks, 
and normative influence such as the role of perceived peer disapproval (Baum, 2000; Davey et al., 2005; 
McCarthy et al., 2007). Earlier research identified a widespread lack of recognition of DUIA as a high-risk 
behaviour; personal judgments of responsibility and appropriate sanctions for DUIA, for example, were 
highly sensitive to situational context and minimal in the absence of adverse consequences such as serious 
injury or property damage (DeJoy, 1989; DeJoy & Klippel, 1984; Pliner & Cappell, 1977). However, 
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knowledge and beliefs regarding DUIA have changed over time and the behaviour is now widely regarded 
as a major collision risk factor and met with strong social disapproval (Berger & Marelich, 1997; Danton et 
al., 2003; Greenberg et al., 2005), a shift accompanied by significantly reduced DUIA prevalence (Berger & 
Marelich, 1997; Elder et al., 2004; Fell & Voas, 2014; Mann et al., 2001; Wickens et al., 2013; Yanovitzky  
& Bennett, 1999).  
Evidence shows that engaging in DUIA is influenced, in part, by safety-related perceptions, with lower 
likelihood of DUIA among those who perceive the behaviour to increase collision risk (Greenfield & 
Rogers, 1999; Harbeck & Glendon, 2013; Harbeck et al., 2017). Drink-drivers also demonstrate a 
comparative optimism bias that leads individuals to estimate their own risk of a negative event as lower than 
that of someone else (Shepperd et al., 2002). Drink-drivers tend to perceive themselves as less likely than 
the average driver to have a collision when DUIA; and this bias represents a means to self-justify engaging 
in DUIA (Albery & Guppy, 1996).  
Understanding DUIC has rarely been informed by relevant concepts from social cognition literature, such as 
comparative optimism bias and normative influence (see Aston et al., 2016; Barrie et al., 2011; Danton et 
al., 2003; Greene, 2018). We used qualitative interviews to assess perceived collision risk and social 
influences associated with DUIC.  
Methods 
We extracted from the transcribed dataset responses to questions about perceptions related to: the effects of 
cannabis use on collision risk (i.e., increases risk, decreases risk, or has no effect); driving skills most 
affected by cannabis use; and beliefs of friends and family regarding whether and how cannabis use affects 
collision risk. 
The data were co-coded by the interviewer and first author. Thematic analysis began with independent 
coding of all extracted transcript text for emergent themes without preconceived hypotheses (Glaser, 2004) 
and we followed coding steps found in standard qualitative research guides (Coffey & Atkinson, 1996; 
Corbin & Strauss, 2008; Denzin & Lincoln, 1994; Rubin & Rubin, 2005). While openly coding data, the 
first author observed applicable concepts from the social cognition literature. We re-read the data multiple 
times and prepared a table containing narrower themes of interest with illustrative quotations. We then 
discussed any outstanding discrepancies and how to present our findings, including how to address any 
uncommon examples we observed. Thus, while our coding began inductively, observation of and mutual 
interest in applicable social cognition concepts led to selective coding and interpretation, moving us away 
from grounded theory techniques (Glaser, 2004).   
Results 
Sample characteristics 
Participant ages ranged from 21 to 53 years (mean = 32). Self-reported length of time with a driver’s license 
ranged from five to 31 years. Table 1 presents other sample characteristics, including past-year DUIC 
frequency and substance use. All participants who reported daily past-year occurrences of DUIC also 
reported daily cannabis use. A majority (65%) reported having driven in the past year after drinking, while 
15% reported driving after use of other drugs. All participants indicated that the impaired driving offence 
that brought them to BOT was related to alcohol; only one reported being charged for DUIC at the same 
time as their alcohol-related charge. 
Only 15% of participants reported having been involved in a collision as a driver after using cannabis; in one 
case, alcohol was also reported to be involved. Two participants reported ever having been in a collision as a 
passenger with a driver who had used cannabis, and again one noted that alcohol was also involved.   
Perceived effects of cannabis use on collision risk and driving skill 
While some participants believed that cannabis use impairs driving and increases collision risk, this was 
often qualified by statements regarding the amount consumed or level of personal experience with the drug.  
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[I]t’s not a good idea for people who haven’t smoked weed[…]it would endanger others because 
I feel like if you’re doing it first, like for your first couple of times, it’ll boost your anxiety up, 
then probably create a car crash on the road. (participant 12) 
Table 1. Sample characteristics  
 % reporting [n] 
Gender 
Male 
Female 
 
 
90 [18] 
10 [2] 
BOT workshop type in which participant was enrolled 
Education workshop 
Treatment workshop 
 
 
65 [13] 
35 [7] 
Past-year DUIC [within hour of cannabis use] 
Daily 
Weekly 
Monthly  
Less than monthly 
 
 
20 [4] 
25 [5] 
15 [3] 
40 [8] 
Past-year cannabis use 
Daily 
Weekly 
Monthly 
Less than monthly 
 
 
55 [11] 
15 [3] 
20 [4] 
10 [2] 
Past-year alcohol use 
Daily 
Weekly 
Monthly 
Less than monthly 
 
 
5 [1] 
70 [14] 
20 [4] 
5 [1] 
Past-year other drug use [not cannabis or alcohol] 
Monthly use 
Less than monthly use 
No use 
 
 
25 [5] 
20 [4] 
55 [11] 
 
Commonly drawing on personal experiences, participants identified varied skills related to driving that could 
be negatively impacted by cannabis use including judgement (e.g., misjudging speed or distance between 
vehicles), reaction time, and peripheral vision. Paranoia and anxiety or panic induced by cannabis use were 
mentioned as feeling states that could disrupt driving. Many reported varied attention-related effects that 
could impair driving such as distracted concentration, focusing on other details (e.g., “tunnel vision”, 
“hyper-focusing”), and decreased alertness or being too “relaxed”. 
Despite acknowledging driving-related abilities that could be negatively affected, some participants did not 
believe that cannabis use increases collision risk. Several participants who reported experiencing effects on 
concentration, alertness, and paranoia considered these effects as having a positive impact.   
My attention span is there. I’m not driving anything dangerous. I’m driving very, like, 
cautiously[…]I’m checking, I’m aware. I’m like, in fact, I’m extremely alert. So there’s really 
nothing that’s going to happen that I’m going to do on the road. (participant 13) 
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A few participants believed that cannabis use improves their overall driving ability: e.g., “I drive 
perfectly fine. It made me drive better, to be honest with you.” (participant 4)  
 
Comparative optimism bias 
Many participants demonstrated a comparative optimism bias, expressed as lower estimates of personal risk 
for a negative outcome (i.e., collision) compared to others’ risk. These participants often believed that while 
cannabis use did not affect or no longer affected (e.g., due to drug tolerance) their own driving, it likely 
could or does affect someone else’s driving, especially in reference to novice or less frequent cannabis users. 
I’ve really been smoking for years now and I’m always driving. It’s never affected me, like not 
even the slightest. But I’ve heard people tell me that, ‘Oh, I’ve smoked, I can’t drive’, ‘Oh, I get 
paranoid’ and stuff like that. (participant 2) 
These participants identified effects of cannabis use that they themselves do not experience as the primary 
cause of possible driving-related impairment, allowing them to perceive themselves as different from drivers 
who experience a collision after cannabis use. 
Several participants compared their DUIC to DUIA while identifying the latter behaviour as far riskier.  
Honestly, I think it’s [DUIC] better than drinking[…]when you drink, like, you don’t even 
remember the things that you do the next day, but when you smoke you actually, like, you 
focus. You focus on the road, even if you’re driving, you focus. (participant 7) 
Again, this type of cognitive bias allows drivers to rationalize and legitimize their choice to engage 
in DUIC. 
Normative influences 
Normative influences may also impact DUIC risk perceptions. When asked about what their friends or 
family think regarding the effects of cannabis use on collision risk, many recalled having conversations 
about the issue. Overall, friends were seen as more accepting of DUIC compared to family members.  
My parents definitely think that it would increase it [collision risk], but my friends, no. My 
friends, they smoke often, as often as I do, and they drive as often as I do and they don’t feel it 
impairs their driving. (participant 2) 
Participant responses revealed that some may regard as more credible the opinions of fellow cannabis users 
than the opinions of non-users regardless of whether they were friends or family.  
Some participants expressed a sense that DUIC is socially accepted or generally “not frowned upon” and 
connected this sense to viewing cannabis use and DUIC as commonplace, and to beliefs that DUIC is 
relatively benign in terms of collision risk.  
I think my friends are of the same mind[…]I don’t think that any one of them would argue that 
it’s [cannabis use is] not a hindrance. But I’m sure there would be a couple that would be like, 
‘Whatever, it’s no big deal’, you know. I think there’s[…]been a long underground belief that 
marijuana’s not a big deal and that it’s not really a drug and all that sort of stuff. So I think 
people my age, like between twenty-five and thirty-five or twenty-five and forty, they’ve just 
kinda been working through that[…]the government’s actions and their willingness to look at 
legalisation and stuff is kind of representative of that. (participant 19) 
This participant and several others, based on their own and others’ anecdotal experiences, suggested 
that many Canadians now view cannabis use as low risk for driving-related and other harms. In these 
instances, impending cannabis legalisation was viewed as confirmation that cannabis use poses 
minimal health and safety risks (statements that can be contrasted with growing evidence (Fischer et 
al., 2017)). 
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Discussion 
Our study has several limitations. Interviews generate self-reported data that may be subject to recall issues 
and social desirability bias. The latter is perhaps a larger concern because participants were recruited from a 
program they must complete to have their driving licenses reinstated. That said, participants were assured 
that study participation was confidential and would not impact their program status. Most spoke comfortably 
during their interviews. As we consulted a group of known at-risk drivers, it is unclear to what extent our 
findings may transfer to the broader population, including medical and non-medical cannabis users. 
Additionally, as most who volunteered to participate in our study identified as male, our findings may have 
limited transferability to female drivers.   
Consideration of how comparative optimism bias and normative influence may contribute to perceived risks 
associated with DUIC may well inform future intervention efforts. The wide spectrum of beliefs about the 
dangerousness of DUIC poses a significant challenge to the delivery of effective prevention messaging to a 
diverse driving public. Our results lead to recommendations for developing new public health and road 
safety campaigns: 1) consistently base messaging on up-to-date evidence of the impairing effects of 
cannabis use on driving (Brands et al., submitted; Downey et al., 2013; Hartman et al., 2015); 2) provide 
information on the limited utility of personal efforts to compensate for cannabis-related impairment while 
driving [e.g., slowing driving speed (Brands et al., submitted; Young & Regan, 2007); and 3) aim for a wide 
audience in an effort to decrease the perceived social acceptability of DUIC. Finally, our findings also 
suggest considering the perceived credibility of the source of prevention messaging. If individuals who 
engage in DUIC are more influenced by fellow cannabis users than others, it may be important that public 
campaigns are endorsed or delivered by those with relevant lived experience.  
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Abstract 
Background: While alcohol-impaired driving has declined for more than a decade in Canada, drugged 
driving seems to be rising, at least among fatally injured drivers (Brown et al. 2017). Objectives: To describe 
the state of drugged driving in Canada. 
Methods: Data from the Road Safety Monitor (RSMs 2002-2018) and the National Fatality Database (2000-
2015) maintained by the Traffic Injury Research Foundation (TIRF) were used. Data from 2016 will be 
included by the time of paper submission. Two sample tests of proportions, logistic regression analysis and 
piece-wise linear regression were used to analyze the data.  
Results: There have been some changes in the prevalence of some drug types among drivers. There was a 
106% increase from the 1.6% of drivers reporting driving within two hours of using marijuana in 2013 to 
3.3% in 2018. There were also increases in the percentage of fatally injured drivers testing positive for all 
drugs (see table 3.13, page 44 for data up to 2014). Results showed varying characteristics based upon 
gender and age among self-reported and fatally injured drugged drivers.  
Discussion, Conclusions and Implications: Drugged driving behaviours remain prevalent among Canadian 
drivers and drugs were in over one-third of tested fatally injured drivers. Of concern are the increasing 
trends of this risky behaviour on the road. These findings highlight the need for increased public awareness 
about the risks associated with drugs and driving.  
Keywords: drugged driving; trends; impaired-driving  
Disclosure: Data from the TIRF National Fatality Database have been collected with financial support from 
the Canadian Council of Motor Transport Administrators, Transport Canada, the Public Health Agency of 
Canada and Desjardins (previously State Farm). Data from TIRF’s RSMs have been collected with financial 
support from Desjardins, Transport Canada, Beer Canada and Aviva. The authors declare no ethical conflict 
of interest.  
Introduction 
In Canada, the prevalence of drugs found in drivers has been shown to rival that of alcohol (Jonah, 2013; 
Robertson et al. 2017). In fact, while alcohol-impaired driving has declined for more than a decade in 
Canada, drugged driving seems to be increasing (Brown et al. 2017).  
Our understanding of how drugs affect driving behaviours is limited compared to what we know about 
alcohol. Cannabis, one of the most common substances found in drivers, has been shown to increase the risk 
of collision (Asbridge et al., 2012). However, tolerance to cannabis can also result in less impairment in 
drivers (Wolff et al., 2013), reaffirming that setting standardized per se limits for drugs in drivers is more 
complicated than limits for alcohol. Other illicit psychoactive drugs and prescription drugs have been shown 
to cause side-effects which could impair driving abilities (Stoduto et al., 2012; Wolff et al., 2013).  
Self-report studies are useful in ascertaining the prevalence of specific driving behaviours and attitudes 
among drugged drivers. As drug testing of fatally injured drivers increases, the percentage of fatally injured 
drivers positive for drugs becomes a relatively reliable measure of the drugged driving problem (Brown et 
al., 2017). 
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The objectives of this paper are to identify the state of drugged driving in Canada, compare recent data with 
those from previous years to determine possible changes, and characterize drugged drivers with respect to 
gender and age. 
Methods 
Data Sources 
Data on drugged driving behaviours and attitudes have been collected as part of the Traffic Injury Research 
Foundation (TIRF) series of Road Safety Monitors (RSM) since 2002, specifically in the years 2002, 2004, 
2005, and from 2010 onward. The survey is administered annually to a sample of Canadian drivers who had 
driven in the past 30 days and held a valid driver’s licence (see Table 1 for the sample sizes). 
Table 1: Number of participants (N) in the RSM, 2002-2018 
Year N 
2002 1,212 
2004 1,221 
2005 1,218 
2010 1,195 
2011 1,208 
2012 903 
2013 1,201 
2014 1,031 
2015 1,204 
2016 2,009 
2017 2,018 
2018  1,203 
 
Data from TIRF’s National Fatality Database were also used to identify the percentage of fatally injured 
drivers in Canada who tested positive for drugs between 2000 and 2015. The TIRF National Fatality Database 
includes data from coroners and medical examiners on fatally injured motor vehicle collision victims in all 
Canadian jurisdictions. In this study we included the 19,654 drivers of highway vehicles who died within 30 
days in crashes on public roads. The data in this study exclude British Columbia whose data have not been 
available since 2011. The drug types are broadly classified into seven groups according to the Drug Evaluation 
and Classification categories (i.e., cannabis, depressants, stimulants, narcotic analgesics, hallucinogens, 
dissociative anesthetics, and inhalants) (Jonah, 2012). 
Further details about RSM data and the TIRF National Fatality Database can be found in Robertson et al. 
(2017). 
Data Analysis 
All analyses were conducted using Stata 14.2 (StataCorp., 2015). The data from the RSM were analyzed, 
considering the stratified and weighted sampling design to avoid bias. Two-sample tests of proportions, 
piecewise linear regression and logistic regression analyses were conducted to evaluate statistical significance 
of results and possible trends while also controlling for gender and age differences within the population. 
Results 
Self-reported Drugged Driving in Canada 
Figure 1 shows the prevalence of self-reported drugged driving in Canada since 2002, for all years in which 
related items were included in the survey.  
163 
 
Figure 5. Percentage who drove within two hours of taking drugs in the past 12 months: 2002-2018. 
Prescription drugs have been the most prevalent drug type compared to marijuana/hashish and other illegal 
drugs. Although there was a decreasing trend (coef.=-0.44, p<0.001) from the 3.9% of drivers reporting they 
drove within two hours of using prescription drugs in 2011, to the 2.5% in 2014, this was followed by an 
increasing trend (coef.=0.17, p<0.001) up to 3.0% in 2018. 
A smaller percentage of drivers have consistently reported to driving under the influence of marijuana or 
hashish compared to prescription drugs, except in 2018 when 3.3% reported doing so. A piecewise regression 
model for the use of marijuana or hashish before driving revealed an increasing trend (coef.=0.15, p=0.001) 
between 2002 and 2010, followed by a decreasing trend (coef.=-0.38, p=0.001) until 2013, and increasing 
again (coef.=0.30, p<0.001) between 2013 and 2018. 
An even smaller percentage of drivers reported driving while under the influence of other illegal drugs. In 
2002, 0.9% of Canadian drivers admitted to driving within two hours of taking an illegal drug at least once in 
the previous 12 months. In 2012, a low of 0.4% was reported, however, a piecewise regression model revealed 
a small but significant increasing trend from 2012 to 1.1% in 2018 (coef.=0.09, p=0.02). 
Only six years of data were collected from the RSM with respect to the prevalence of marijuana or hashish 
combined with alcohol while driving. The percentage of drivers who indicated they drove within two hours 
of taking marijuana or hashish combined with alcohol did not change significantly from 1.3% in 2015 to 1.7% 
in 2018. 
Analyses of RSM data from 2002 to 2018 revealed significant sex and age differences in the prevalence of 
drugged driving (see Table 2). 
Table 2: Percentage and odds ratios (OR) for drivers reporting driving within two hours of taking drugs in 
the past 12 months: 2002-2018 by sex and age. *p-value<0.05 
 Sex Age 
 Female Male 16- 24 25-44 45-64 
65 or 
older 
Illegal drugs 0.5* 
(1.0) 
1.5* 
(2.7*) 
2.2* (7.8*) 
1.4* 
(5.3*) 
0.6* 
(2.5) 
0.2* 
(1.0) 
Marijuana/hashish 1.5* 
(1.0) 
3.3* 
(2.1*) 
6.4* 
(24.7*) 
3.2* 
(12.6*) 
1.2* 
(5.1*) 
0.2* 
(1.0) 
Prescription drugs 
2.7 (1.0) 3.3 (1.2) 3.8* (1.6) 
3.6* 
(1.6*) 
2.5* 
(1.1) 
2.2* 
(1.0) 
Marijuana/hashish 
/alcohol 
0.8* 
(1.0) 
1.6* 
(2.2*) 
1.7*(5.3*) 
2.0* 
(7.1*) 
0.8* 
(2.8) 
0.2* 
(1.0) 
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Overall, 1.5% of male drivers versus 0.5% of female drivers reported driving within two hours of taking an 
illegal drug at least once in the previous 12 months. Regarding marijuana use, 3.3% of male drivers versus 
1.5% of female drivers reported driving within two hours of using this substance. No significant sex 
differences were found with respect to the prevalence of prescription drugs. Male drivers were also more 
likely than female drivers to drive after consuming marijuana combined with alcohol (1.6% vs. 0.8%). 
Drivers aged 16 to 24 years, were more likely to report driving within two hours of taking an illegal drug 
(2.2%) or marijuana (6.4%), or prescription drugs (3.8%) in comparison to older age groups. Furthermore, the 
prevalence of use of these drugs before driving decreased with age. Drivers aged 25 to 44 years were more 
likely (2.0%) to report driving after consuming marijuana combined with alcohol than drivers in other age 
groups. 
Logistic regression models controlling for sex and age confirmed the above results. 
 
Drug use among fatally injured drivers 
Figure 2 shows the percentage of fatally injured drivers who were tested for drugs in Canada (except British 
Columbia) from 2000 to 2015, and the total percentage of drug-positive drivers among those who were tested.  
 
Figure 6: Percentage of fatally injured drivers tested for drugs, and the percentage of fatally injured drivers 
testing positive for any substance: 2000-2015. 
The testing rates among fatally injured drivers have significantly increased by 117.5% from 37.0% in 2000 to 
80.5% in 2015 (z=-21.3; trend: coef.=3.2, p<0.001). The percentage of drug-positive drivers has significantly 
increased by 43.9% from 34.4% of drivers in 2000 to 49.5% in 2015 (z=-7.5; trend: coef.=0.69, p=0.002). 
Figure 3 depicts the percentage of fatally injured drivers from 2000 to 2015 that were drug positive for four 
drug categories. Overall, between 2000 and 2015, 17.1% of fatally injured drivers who were tested for drugs 
were positive for cannabis, 14.2% for depressants, 8.9% for stimulants and 7.8% for narcotic analgesics. Since 
the percentages of drivers testing positive for hallucinogens, dissociative anesthetics, or inhalants were below 
1%, they are not included in this figure. 
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Figure 7: Percentage of fatally injured drivers who were positive for drugs: 2000-2015. 
 
The figure shows an overall increase in the percent of fatally injured drivers that were positive for cannabis, 
depressants, stimulants and narcotic analgesics from 2000 to 2015 (cannabis: 16.1% to 21.0%, depressants: 
14.0% to 20.7%, stimulants: 4.3% to 13.5% and narcotic analgesics: 5.1% to 10.4%). A test of proportions 
revealed that these increases (cannabis: 30.5%, depressants: 47.9%, stimulants: 217.1%, narcotic analgesics: 
105.9%) were statistically significant (p<0.05). Regression analyses confirmed that there were statistically 
significant increasing trends from 2000 to 2015 in the percent of fatally injured drivers that were positive for 
cannabis (coef.=0.4, p=0.002), stimulants (coef.=0.44, p<0.001) and narcotic analgesics (coef.=0.44, 
p<0.001). In the case of depressants, there was a decreasing trend from 2000 to 2008 (coef.=-0.5, p=0.04) 
followed by an increasing trend from 2008 to 2015 (coef.=1.02, p=0.001). 
Sex differences among all drug-positive fatally injured drivers correspond with the RSM data which showed 
differences between males and females. Between 2000 and 2015, 39.7% of fatally injured male drivers were 
positive for any type of drug, slightly but significantly larger than the 36% of females (z=-3.2, p=0.001). 
Among those drivers tested, fatally injured males were more likely to test positive for cannabis (18.8% versus 
10.3%, OR=2.1) and stimulants (9.7% versus 5.7, OR=1.8) than females (see Table 3). Conversely, fatally 
injured female drivers were more likely to test positive for depressants (18.8% versus 10.3%, OR=2.1) and 
narcotic analgesics (18.8% versus 10.3%, OR=2.1) than males.  
 
Table 3: Percentage and odds ratios (OR) testing positive for drugs among fatally injured drivers who were 
tested: 2000-2015. All p-values<0.05 
 Sex Age 
 Female Male 14-24* 25-44 45-64 
65 or 
older 
Cannabis 10.3 (1) 18.8 (2.1) 27.5 (63) 21.3 (43.6) 10.4 (17.9) 0.6 (1) 
Depressants 19.6 (1) 13.4 (0.6) 5.4 (0.2) 13.6 (0.5) 19.8 (0.8) 23.7 (1) 
Stimulants 5.7 (1) 9.7 (1.8) 9.0 (7.8) 14.5 (13.1) 5.3 (4.1) 1.4 (1) 
Narcotic 
analgesics 
8.8 (1) 7.2 (0.8) 3.3 (0.3) 6.9 (0.6) 10.1 (0.9) 11.5 (1) 
*Drivers aged 14 and 15 years represented 0.23% of all fatally injured drivers tested for drugs 
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Regarding the influence of age on the drug use of fatally injured drivers, a larger percentage (27.5%) of drivers 
aged 14 to 24 years tested positive for cannabis than any other age group, and the prevalence for this drug 
decreased with the increase in age (see Table 3). In the case of stimulants, drivers aged 25 to 44 had the largest 
prevalence (14.5%), followed by drivers under 25 years (9.0%). The oldest drivers (65 and older) had the 
larger prevalence of depressants (23.7%) and narcotic analgesics (11.5%). For these two drug categories, 
prevalence increased with age. Logistic regression models controlling for sex, age and victim’s year of death 
confirmed the above results (see odds ratios in Table 3). 
Conclusions 
Analyses of the RSM data and the National Fatality Database showed that drugged driving continues to be a 
prevalent issue among Canadians. Of concern are the increasing trends in the percentages of drivers that report 
driving within two hours of using prescription drugs, marijuana or hashish and other illegal drugs over the 
past four years. Furthermore, the percentage of fatally injured drivers testing positive for any drug type has 
also significantly increased. By comparison, other studies have shown decreases in the percentage of fatally 
injured drivers testing positive for alcohol (Brown et al., 2017).  
When combining the RSM data from 2002 to 2018, young (aged 16 to 24 years) and male drivers were more 
likely to admit to driving within two hours after using illegal drugs including marijuana or hashish. Male 
drivers were also more likely to report driving when combining alcohol and marijuana and drivers aged 25 to 
44 years were more likely to report this behaviour. 
 Among fatally injured drivers who were tested for drugs, male and young drivers were also more likely to 
test positive for cannabis and stimulants while female and older drivers were more likely to test positive for 
depressants and narcotic analgesics. 
These findings highlight the need for increased public awareness about the risks associated with drugs and 
driving. 
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Abstract 
 
Traffic Medicine is one of the Swiss legal entities that contribute to minimizing traffic casualties. But has 
pertaining Swiss legislation adequately incorporated developments in medicine, science, society and politics 
to attain this goal? Moreover, is the field in general sufficiently prepared and agile to react timely to 
heralding mega-trends such as legalization and medical use of cannabis, automation and overaging of 
drivers?  
 
Our objective is to reflect roughly a decade of measures affecting Swiss traffic medicine. With a focus on 
medically relevant measures, we review origin, implementation and – wherever already ascertainable – 
resulting effects, both from the practical and scientific perspective of a traffic medicine expert.  
 
After parliamentary debate since 2008, the Swiss parliament passed the project “Via sicura” in 2012 
comprising 22 measures. Since 2013, 19 of these were put into law. We will discuss five measures, the latter 
not being part of Via sicura: 1.) quality measures for traffic medicine experts (Stufensystem), 2.) compulsory 
exams after DUI above 1.6 ‰ alcohol, 3.) Evidential detection of alcohol levels via blood vs. breath 4.) 
factual no-alcohol-rule (<0.1 ‰) for learning drivers and chauffeurs, 5.) raising the age for regular 
compulsory exams from 70 to 75.  
 
Despite ever increasing traffic, the number of traffic deaths has dropped from 544 in 2001 to 216 in 2016. 
Particularly in the light of the WHO decade of action, his gratifying reduction is partly due to “Via sicura”. 
However, we find some of the measures (3 and 5) to be justified on a weak and rather political basis, 
ultimately even conflicting hard evidence (3).  
 
Particularly in the light of the above mentioned challenges we call for more fully integrated clinical research 
in traffic medicine: collected evidence, evaluated by interdisciplinary expert teams, should form the basis for 
creative and pragmatic future bills. 
 
Switzerland registered a close to record low number of street-traffic casualties in 2017 (230 (BFS, 2019)) 
and will most likely report even lower numbers for 2018 (first 6 months: 100 (ASTRA, 2019)). According to 
the European Transport safety Council’s (ETSC) 11th Road Safety Performance Index (PIN) Report 
(council, 2017), this equals to 26 casualties per million inhabitants in 2016. As compared to the reference 
years 2010 and 2001, this reflects a reduction of 19% or 60% reduction in road casualties, respectively. 
Surpassed only by the Baltic and Scandinavian states, this corresponds to a yearly reduction of 5.9% (2007-
2016). Also in relation to bmd (billion miles driven, 3.7 casualties/bmd), Switzerland is only surpassed by 
Norway, Sweden and the UK with each 3.0, 3.3 and 3.5 casualties/bmd, respectively.  
 
A very illustrative differentiation by kind of accident can be found in (Helfenberger, 2018): roughly 50 % of 
traffic casualties stem from accidents which involve no other party. Casualties originating from car-
accidents involving other cars, bicycles, pedestrians or motorized 2-wheelers sum up to about 40 % of 
casualties, while the predominant number of all accidents (also w/o casualties) are still caused by young and 
senior drivers. Further detailed reference may be found in the Annual Road Safety Report, Sinus 2018 
(Unfallverhütung, 2018).  
 
This development can be seen as an overall success and Sitzerland’s leading role resulted in ETCS’s Road 
Safety PIN Award in 2017. But what are the reasons for this success and on what basis can the numbers be 
even more reduced or prevented from rising again?  
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The fundamental European safety attitude to put precautionary principle first (exquisitely elaborated in 
(Fisher, 2011), Section 3) results in ambitious joint visions and EU Frameworks which have consistently 
been worked on in the last decades. With the overall long-term “Vision zero” to avoid any traffic deaths by 
2050, the EU’s intermediate pragmatic framework goals from 2000/2001 and the subsequent 2011 
“Transport White Paper” aim at a 50% reduction of traffic casualties within a decade.  
 
In 2002, Switzerland adopted and extended this EU Framework and between 2005 and 2012 a set of 60 
individual actions was formulated and most of which, grouped in 22 legislative measures, have been put into 
law by 2016. This concerted federal effort - labeled “Via sicura”, for “safe ways” - involved all institutions 
with responsibilities in traffic regulation and safety: the federal ASTRA (road safety), the cantonal STVAs 
(Road traffic offices), the BFU and BFS (Federal Office for Accident Prevention and Federal Bureau for 
Statistics), the law enforcement and, finally, Traffic Medicine (TM) as the subject field that services the 
medical and forensic expertise forming the basis for legal repressions, fines and regulation for offenders or 
applicants for driving licenses by the STVAs.  
 
In short, traffic medicine ensures the medically defined short- and long-term fitness to drive, based on 
comprehensive medical exams and closed-mesh follow-up examinations after any DUI involving drugs or 
alcohol.  
 
Assuming a self-critical perspective, we here want to review TM-related developments and their effects 
within the project “Via sicura” throughout roughly the last decade. Within the context of a strategic 
repositioning of our own institution – but maybe also Swiss Traffic Medicine in general - , we want the put 
these developments in context and in perspective to imminent societal and scientific developments.  
 
Outcomes – Origin, implementation and effects of TM-related measures of Via sicura  
 
Measure 1 – Quality Management of Traffic medicine  
 
The first and most important development for Traffic Medicine was the federation-wide harmonization and 
structuring of traffic medicine as an organizational and professional body. This originated in part in pre-“Via 
sicura”-efforts to establish a professionalized medical title specific for higher level exams within the section 
of traffic medicine of the Swiss society for Legal Medicine (SSLM) starting in the late 2000s, finally agreed 
upon in 2011 and anchored in the law by 2013. Concomitant with an increasingly apparent need to re-
evaluate and update medical examination standards stemming mainly form the 1970, a concerted 
restructuring and alignment of the professional regulations and responsibilities with the law were at hand: 
fragmented cantonal responsibilities and well-executed but informally performed appointments and 
educational programs were harmonized into a federation-wide graduated system of qualification 
(Stufensystem). As a result, traffic medical exams are open to any qualified person and there is no separation 
between a general practitioner and a medical officer (e.g. cantonally appointed). Four levels of qualification 
are matched with the graduated categories of driving licenses and complexity of medical conditions in 
question: for example, the basic criteria for drivers of individual vehicles above and age of – until the end of 
2018 - 70 years (see below) can be confirmed by an (self-)educated general practitioner (level 1, Module 1-3 
or confirmed self-study of the contents thereof). Examining the criteria to obtain or keep higher category 
driving licenses (including trucks, taxis and coaches) requires a 1 day qualification (level 2, Module 4-5). 
Level 3 professionals are qualified by an additional one-day course (module 6) to exam - for example – 
applicants who are disabled, aged >65a, or after serious injury or illness. Level 4 requires the above 
mentioned professional title “Verkehrsmediziner, SSLM” and enables for exams clarifying the long term 
fitness to drive (Chronic diseases, behavioral problems). In doubt, level 1 and 2 can escalate to level 3 or 4 
in order to obtain a clarifying second opinion.  
 
The harmonization of qualification has led to improved quality management and much improved clarity in 
relation to STVAs and jurisdiction. Also, detaching the qualification from (previously in part obligatory 
cantonal) institutions has allowed for a market diversification and a better coverage and more focused choice 
for the patients, reducing the overall time needed for obtaining examination results  
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Measures 2-4 – Alcohol related measures:  
The following three measures deal with the “evergreen” of traffic medicine, alcohol.  
The first measure lowers limits at which a full traffic medicine exam becomes compulsory from 2.5 ‰ to 
1.6 ‰ (1.25 mg/l to 0.8 mg/l). In line with internal findings and reports form our own and other groups in 
Switzerland, the SSLM as a whole argued that the likelihood of alcohol related subsequent offenses and 
problems is similarly elevated at DUIs at <2.5 ‰ and DUIs at 1.6 ‰ -2.5‰, with a distinct increase from 
DUIs below 1.6 ‰. To prevent serious events, a compulsory full exam after a DUI above 1.6 ‰ should 
encompass a strong focus on determining the likelihood of alcohol abuse and dependencies with stricter 
abstinence obligations (Baumann, 2014; Höhn, 2015a, 2015b). The effect of this measure, which was put 
into law in July 2014, is currently analyzed in two separate retrospective analyses. A first tendency shows 
that postulated positive effects began to show (manuscripts in preparation).  
 
A second adjustment strengthened total alcohol abstinence (<0.1‰) while driving for professional drivers 
(trucks, coach, taxi) and novice drives (preliminary license). This call for total abstinence while driving was 
put into law in January 2014 and also covers driving teachers, learning drivers and persons accompanying 
novice drivers holding a preliminary license. The law stems predominantly from the above mentioned 
maximizing of precautionary principles for passengers (coach, taxi), massive impact potential (trucks), and 
the particularly error prone novice drivers. According to a statistical overview of administrative measures by 
way of the ASTRA, this measure is the cause for a 16.5% reduction in license-suspensions on the basis of 
DUIs in 2017 (N =617) as compared to 2016 (739). However, this measure might have accelerated the 
continuously decreasing yearly numbers of license suspensions since 2012-2015 (N= 891, 849, 806, 742) 
and the effect of the law might thus have shown with a delay (ASTRA, 2018).  
 
In October 2016, the last alcohol-related measure within Via sicura established that blood alcohol levels 
could be determined evidentiary on site by using breath alcohol measurements (evBrAC) using validated 
instrumentation (predominantly Dräger7110 Evidential). First established as an aiding initial road-side test 
in the 1960s in the US, the current evidentiary measurement systems use two independent measures to 
determine BAC within approx. 1 minute and promise to be mouth-alcohol insensitive. Concomitantly, the 
unit description was harmonized to mg/l. In line with the “rule of thumb” mg/l = ½ ‰ and the conversion 
factor used in Switzerland from evBrAC to BAC was fixed to 2000 l/mg. With whole blood based BAC 
being the only evidentiary accepted method previously, evBrAC promised to accelerate determination at the 
point-of-care (POC) and provide a timed value not requiring any back-calculation: previously, and initial 
qualitative detection of alcohol needed to be confirmed in a hospital by qualified personnel, often resulting 
in delays and dispute, never mind substantial costs. Thus it was argued that evBrAC would streamline 
securing proof for the benefit of all parties, also avoiding the taking of blood as a medical intervention. Here 
it needs to be stated, that – on the one hand – the suspected offender can demand an additional BAC for 
confirmation, and – on the other hand – law enforcement might require taking a blood sample if they 
observe sings for additional substance abuse.  
 
Measure 5 – Increasing the age limit  
 
In contrast to the four measures describe previously, a last change in legislation was not part of Via sicura: 
with effect Jan 1st 2019, the age for compulsory and regular traffic medicine exams at level 1 or higher) for 
the elderly drivers of lower categories was raised from 70 to 75 years of age. Also the qualified doctor’s 
maximal age was raised from 70 to 75 years of age. While a politically motivated argument that senior 
drivers are in general in much better overall health nowadays as compared to 30 years ago might be factual, 
this loosening of established and proven procedure was not supported by the representative bodies of Traffic 
Medicine and represents a surprising breach with a long term-proven principle of maximal precautionary 
principles in Switzerland. This method will not be discussed in further detail in the following section, as 
there is no data are present as of now.  
 
Discussion 
 
The establishments of a federally harmonized quality management for Traffic Medicine – including the 
level-system and education as well as the continuous harmonized updating of standard to scientific 
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knowledge – have to be welcomed in total from our perspective. Above all, the positive effects of this 
professionalization effort for the patient/customer show in faster results and improved communication 
between TM, STVAs and TM and customer. Together with the SSLM as the professional body of expertise, 
this “leap” also releases capacities for much better reactivity to incumbent fundamental challenges in traffic 
medicine with respect to automated driving and such. 
  
The three alcohol-related measures of Via sicura exemplify the possibilities and restrictions of fact based 
decisions in Traffic medicine regulation in total, especially the relation between measure 2 and 4 show 
conflict potential and added rather than reduced certainty and control: while compulsory TM-exams after a 
DUI <1.6‰ were well reasoned for ahead of the legislation and positive effects began to show, the 
introduction of evBrAC seems to partially thwarts the potential long-term positive effects or at least makes it 
difficult to observe these consistently: BrAC and evBrAC are and were criticized and contested for two 
reasons. First, it is argued that the determination of BAC vs evBrAC relies of a plethora of individual 
physiological factors and might over or underestimate the BAC within a wide range (partition, lung volume, 
metabolism; (Iten & Wüst, 2009; Wüst, 2009)). The standard BAC blood sample determination allowed for 
a additional screening for substance abuse, allowed reanalysis of samples if results were in doubt and 
provided clearer back-calculation to the time of offense. More systematic studies display in part largely 
diverging comparative values with an underestimation of on average 0.3 mg/l or 0.18 mg/ml (Roiu et al., 
2013; Weinmann, Disch, Längin, Nussbaumer, & Jackowski, 2016). Still, evBrAC is reality in most 
European states (Jones, 2016).  
 
In relation to measure 2, it needs to be discussed and evaluated if the introduction of evBrAC does not lead 
to a factual erosion and masking of the positive security effects resulting from measure 2: for example 
(Weinmann et al., 2016) does argue that based on a comparison of 1059 cases 48% less drivers reached the 
critical 0.8 mg/ml (i.e. 1.6 ‰) based on evBrAC, strongly favoring the driver. In only 12% of the cases a 
disadvantage for the driver could be deduced. In fact we, do see a reduction of >1.6 cases in our institution 
albeit this might be also the result of measure 1. In total, variability , dependence and use of BrAC and/or of 
fixed and dose-dependent conversion factors between evBrAC and BAC has been discussed repeatedly and 
at length (e.g. (Hartung et al., 2016; Iten & Wüst, 2009; Jones, 2016; Roiu et al., 2013; Wilske, 
Eisenmenger, & Liebhardt, 1991; Wüst, 2009)) on the scientific level.  
 
We see independent and additional real-life problems which thwart the best intentions: a large fraction of 
offenders do demand a traditional test. Law enforcement does order very often additional blood sample for 
drug testing based on behavioral cues (Zürich, 2014). Despite the legal claim to have broad coverage, most 
law enforcement vehicles do not allow housing the instrumentation, so that the real on-road coverage of this 
method is factually very low and tests are performed at the police station without reliable back-calculation. 
To our view, this approach – while per se advantageous and beneficial – faces expected and predicted real-
life challenges that do serve neither scientific robustness nor economic criteria. It needs to be evaluated in 
the coming years, whether case data allow for consistent trends.  
 
Albeit there has been a 25-year-“promise” from the fields of microfluidics and biomedical engineering 
concepts for hand-held POC-blood testing devices with strong or even fully evidentiary character, have not 
yet been proven to be robust. With venous blood seems still the best analyte reporting both substance and 
concentration, it would however be highly desirable to have such POC-devices for standard finger blood 
testing at hand (Aymerich et al., 2018).  
 
Conclusion – Repercautions for future challenges 
 
Overall, the discussed measures show organizational, scientific and political origins with postulated and or 
reported effects ranging from – to our view – very positive (Measure 1 and 2) to conflicting or at least 
questionable (measure 4 and 5). We observe a tendency to (unwillingly) revert positive and evidence based 
measures due to political and/or seemingly economic reasons (economy and police).  
Moreover, three of the five discussed measures deal with changes in alcohol legislation. This strong and 
continued fixation combined with partially crab-like developments ( see above) is surprising in so far, as to 
Swiss Traffic Medicine per se and – to the best of our knowledge - also other related institutions - have no 
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foresighted work-program in place (or in discussion) to prepare and address incumbent societal and 
scientific changes such as, for example, more widespread Cannabis-use and aging drivers.  
 
With the incoming remarks about the success in the reduction of traffic casualties, we see an urgent need to 
address these challenges ahead of time to – above all - maintain these record low numbers of casualties. 
While Switzerland is a small country with particular challenges to topography and traffic composition (high 
density , public transport, developing cyclists movement, high and powerful motorization), we call for a 
more integrated effort within Swiss traffic medicine to define and advertise for systematic clinical studies of 
the holistic system “man” in the context of the system “machine”. We find, it would be negligent for Swiss 
Traffic Medicine to either just rely on other country’s research-efforts and -findings and/or not to take 
advantage of being mostly part of a striving academic setting.  
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Abstract 
Background: Exposure to traffic risk behaviors differs according to sociodemographic characteristics. 
However, little is known about the profile of risky drivers in Brazil, which could help develop effective 
measures in terms of traffic safety.  
Objective: To investigate different driving risk behaviors according to gender, level of education and age 
groups among Brazilian drivers.  
Methods: 9,724 drivers from five Brazilian capitals were interviewed through a KAP survey on traffic 
behavior. Variables analyzed were: drinking and driving, speeding tickets and seat belt use. The association 
between the variables was verified using the Chi-Square test.  
Results: The sample comprised mostly men (67.2%), between 30 and 59 years old (62.1%), with a college 
degree (38.8%). Men were more involved in risky behaviors, with less seat belt use (81.60% vs. 89.11% p < 
0 .001), more speeding tickets (19% vs 11%, p < 0 .001), and more driving under the influence of alcohol 
(56% vs 33%, p < 0 .001). Individuals with higher education and a degree had more speeding tickets than 
the overall sample (18% and 23% vs. 16%, p < 0 .001). 43.9% and 38.3% of those who were fined for non-
use of seatbelts had high schooling and college degrees. Acollege degree was associated with higher 
prevalence of driving under the influence of alcohol. Drivers between 18 and 29 years had a high prevalence 
of drinking and driving (57%).  
Conclusions: Male drivers are more exposed to risky situations. Higher educational levels may be a 
vulnerability to risky driving behavior. Our data also indicate that younger drivers are more prone to the 
influence of alcohol when compared to other age groups. Our results are in line with international data, 
suggesting that adapting measures that are being used - and already known to be effective - in other 
locations for drivers who engage in traffic risky situations in Brazil is appropriate.  
Introduction 
Brazilian data indicates that around 47 thousand people die annually due to traffic crashes (Ministério da 
Saúde – MS, 2017). In terms of public health, traffic injuries generate health expenses, since emergency 
treatments have a high cost, in addition to the infrastructure damage caused by these events (Word Health 
Organization – WHO, 2018). 
 
The leading cause of traffic crashes is human behavior to include drunk driving and speeding (Word Health 
Organization – WHO, 2005). Recent findings indicate that the profile of traffic offenders is heterogeneous 
and that aspects such as sociodemographic characteristics influence driver behavior (Brown et al., 2016; 2015; 
Dedovic et al., 2016; Zhao et al., 2017). International studies indicate that engaging in risk behavior can be 
associated with certain gender and age profiles (Rhodes & Pivik, 2011). Therefore, it appears that there is a 
driver profile with a more risk-oriented behavioral repertoire.  
 
Despite the regulations, inspections and preventive measures in Brazilian traffic, the exposure to these risk 
behaviors is still significant. Data indicates that the number of people who driver under the influence of alcohol 
increases each year (MS, 2017) and this results in physical, psychological and economic dame to both the 
173 
victims and the perpetrator (WHO, 2005). This scenario shows that drivers of higher risk may not be benefiting 
from the preventive interventions implemented in Brazil. 
 
International data on driver profiles is more consolidated; however, there is a gap in the literature in terms of 
a broader understanding of driver profiles in Brazil. Comprehending this scenario could help in the 
development of effective traffic safety measures, since Brazilian intervention actions are not directed to 
specific driver profiles and seem to be ineffective in terms of reducing traffic injury. 
 
Objective 
To investigate different driving risk behaviors according to gender, level of education and age groups among 
Brazilian drivers. 
 
Method 
A cross-sectional study recruited drivers from five Brazilian cities, that were chosen by the road safety 
program "Vida no Trânsito" [Life in Traffic] based on convenience. The chosen cities were initially divided 
into regions along the existing municipal divisions. The choice of these regions was based on the assumption 
that the distribution of drivers at that location was equal to that of the driver population throughout the city 
and the number of regions sampled varied according to the size of the intervention city. In each region, data 
collection teams identified locations that were easily accessible and where they could safely approach drivers, 
such as supermarkets, gas stations, shopping malls and public parks. 
 
Data was collected from August 2011 to July 2013 by researchers from the Federal University of Rio Grande 
do Sul in collaboration with the Johns Hopkins International Injury Research Unit. Individuals who had 
reported not driving in the past 12 months and under the age of 18 were excluded from the study, totaling 
9.724 drivers in our sample. The selected drivers were interviewed through a KAP (knowledge, attitudes and 
practices) survey on issues pertinent to high risk behavior (“In the last year, have you been fined for 
speeding?”, “In the last year, did you drive within an hour of consuming alcohol?”, “In the last year, have you 
been fined for not wearing a belt while driving?”). The World Health Organization indicates that the 
previously listed behaviors were the main traffic risk behaviors in Brazil (WHO, 2015). Sociodemographic 
information was also collected from participants, such as gender, age and level of education. 
 
Data analysis was performed through the SPSS program and the association between risk behavior and 
sociodemographic variables was verified using the Chi-Square test. 
 
Results 
Table 1 shows the sociodemographic data of the analyzed sample. The majority of drivers interviewed were 
men (67.2%), between 30 and 59 years old (62.1%), with a college degree (38.8%).  
 
Table 1. Sociodemographic data  
    
Total                                  
n = 9724  
(100%) 
Male                             
n = 6532  
(67,2%) 
Female                         
n = 3192  
(32,8%) 
p-value 
Age (years) ¹ 38 [29;65] 38 [30;66] 36 [28;66]  <0,005 
            
Education ²         
Elementary school  1114 (11.5) 999 (15.3) 115 (3.6)   
High school 3735 (38.4) 2758 (42.2) 977 (30.6)   
College degree 3772 (38.8) 2179 (33.4) 1593 (49.9)  <0,005 
Post-graduation  929 (9.6) 484 (7.4) 445 (13.9)   
            
Income ¹ 
                                                               
2200  
[1300;10000] 
2400 
[1500;10000] 
2000 
[1100;8000] 
 <0,005 
¹ Values expressed by median [Interquartile range], Mann Whitney test;    
² Values expressed by n (%), Chi-Square test.      
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When analyzing the association between traffic risk behaviors and socio-demographic characteristics of 
drivers (Table 2), considering gender, it was verified that men are more involved in traffic risk behaviors 
compared to women, evidenced by the higher prevalence of tickets for not seat belt use (77% vs. 23% p 
<0.001), higher prevalence of speeding tickets (19% vs 11%, p <0.001), and higher occurrence of driving 
under the influence of alcohol (56% vs 33%, p <0.001). Regarding level of education, individuals with higher 
education and post-graduation had a higher prevalence of speeding tickets than the general prevalence of the 
sample (18% and 23% vs. 16%, p <0.001). Regarding the history of tickets for not wearing seat belts, 43.9% 
of those who were fined had higher education. College degrees were associated with a higher prevalence of 
driving under the influence of alcohol. Drivers between 18 and 29 years old had higher prevalence of drinking 
and driving (57%); while drivers older than 60 years had a lower prevalence (31%) when compared to the 
general mean of the sample (50%, p <0.001). 
 
Table 2. Traffic risk behaviors and sociodemographic characteristics 
    
Tickets for not  
wearing  seat belts 
Tickets for 
speeding 
Driving under the 
influence of alcohol  
Gender        
Male  5029 (77%)* 1245 (19%)* 2308 (56%)* 
Female   734 (23%) 353 (11%) 486 (33%) 
      
Age (years)       
18 - 29   144 (5.7%)* 382 (15%) 927 (57%)* 
30 - 59   241 (3.9%) 1015 (17%) 1712 (49%) 
≥ 60   39 (3.3%) 201 (17%) 155 (31%) 
          
Education       
Elementary school  89 (8%) 156 (14%) 479 (43%) 
High school 1643 (43.9%)* 523 (14%) 1942 (52%) 
College degree 1433 (38.3%) 679 (18%)* 1923 (51%) 
Post-graduation  74 (8%) 213 (23%)* 455 (49%) 
 
Values expressed by absolute frequency (%) Chi-Square test 
Prevalence of variable in the columns within the categories in 
the rows 
* Significant at p<0,001 level.     
 
 
Discussion and Conclusion 
 
The results show that men and women have different behaviors in traffic, with male drivers tending to engage 
more in risk taking behaviors. Specifically, drinking and driving behavior seems to be associated with young 
male drivers (between 18 and 29 years old) and college or advanced degrees, unlike the profile of drivers who 
do not use seat belts, for example, which tend to have less education. In this sense, our results corroborate 
what the characteristics of drivers that drink and drive reported in international studies, showing heterogeneity 
of the profile of drivers linked to different risk behaviors.  
 
Regarding gender, previous studies corroborate our results, which show that men tend to drive in a more 
dangerous way compared to women (Oltedal & Rundmo, 2006; Whissell & Bigelow, 2003). Likewise, 
research has found that male drivers have a higher tendency to drive under the influence of alcohol and exceed 
the speed limit  (Pechansky et. al., 2009; Rhodes & Pivik, 2011), which may reflect the high mortality rates 
of men, consistently higher than women (WHO, 2005). These results seem to demonstrate that sex-related 
factors may play an important role in the behavior of drivers in traffic, which suggests that prevention 
measures in Brazil should target this riskier group. Another interesting point of our findings is that, although 
women presented lower rates of drinking and driving behavior when compared to men, the prevalence of this 
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risk behavior was still significant. Few studies have been carried out exclusively with female drivers, most of 
them are predominantly male or compared between genders (Lapham et. al 2000; Welsh & Lenard, 2001). 
Therefore, little is known about the characteristics of women who drink and drive, which in the Brazilian 
context seems to be relevant in terms of traffic injury prevention. 
 
Our results indicated that the prevalence of driving under the influence of alcohol was higher among young 
drivers compared to other age groups. Studies conducted with young drivers associate factors related to age 
to the increased risk of traffic injury, such as lack of driving practice and their ability to recognize hazards 
(Borowsky, Shinar, & Oron-Gilad, 2010; McKnight & McKnight, 2003). In addition, other factors are 
associated with this age group, like higher levels of impulsivity and sensations seeking (Brown et al., 2017; 
Clarke & Robertson, 2005), which may lead to an increase in risk behavior in traffic, such as drinking and 
driving. Therefore, the need for interventions directed to this age group is significant, since traffic accidents 
are cited as the primary cause of death among men in the youngest age group (WHO, 2018). 
 
Another variable associated with risk behavior in traffic is the level of education of drivers - our results showed 
that drivers with high levels of education tend to engage in risky traffic behaviors: drinking and driving and 
speeding. On the other hand, less educated drivers had a higher prevalence of non-use of seat belts, which 
seems to indicate that drivers with lower levels of education present more passive risk behaviors when 
compared to more aggressive traffic behaviors such as drinking and driving and excess of speed, which were 
more prevalent in higher education levels. 
 
It is suggested that adapting measures, which are currently in place - and already known to be effective - in 
other locations for drivers who engage in traffic risky situations in Brazil is appropriate. A systematic review 
pointed out that interventions such as ignition interlock systems, implementing compulsory blood-alcohol 
content testing in traffic injury cases, alcohol safety education, and use of designated driver and safe ride 
programs are effective in reducing alcohol-related accidents/ or associated fatal and nonfatal injuries (Shults 
et al., 2001). In addition to sociodemographic characteristics, studies indicate that other factors seem to 
influence the engagement of risk behaviors in traffic, such as cognitive and personality aspects (Beanland, 
Sellbom, & Johnson, 2014; Lev, Hershkovitz, & Yechiam, 2008; Ulleberg & Rundmo, 2003). Therefore, it is 
recommended that other variables be analyzed for a better understanding of the profile of the high risk drivers 
in Brazilian traffic. 
 
It is important to highlight some limitations of the study: our data cannot be generalized, because the sample 
was collected for convenience, despite the attempt to randomly select the drivers for the interview. Another 
point is the fact that the interviews had the presence of an interviewer which may have generated a bias of 
social desirability, which may have influenced the responses. In addition, the approaches were performed in 
public places, which may have hampered the accuracy of the individuals' responses, due to external factors 
such as lack of time, for example. Finally, our analyzes were not controlled by kilometers driven by the 
participants, which could interfere in the found findings. However, despite the limitations, our study is the 
first study to analyze the profile of Brazilian drivers according to sociodemographic characteristics using a 
significant sample size.  
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 State of Texas Ignition Interlock Laws  
Jena Prescott, MPSA, Texas A&M Transportation Institute. 
Abstract 
Current Texas statutes mandate Driving While Intoxicated (DWI) offenders install an ignition interlock 
device (IID) as a condition of bond and/or probation. To fully understand how Texas’ IID statutes may be 
improved, it is critical to examine the statutes for strengths, weaknesses, and opportunities for enhancement. 
This paper undertakes a comparative analysis between the IID programs of Texas and other states to identify 
strengths, weaknesses, and opportunities for improvement to the Texas’ ignition interlock program.  
 
Introduction 
 
According to the National Highway Traffic Safety Administration (NHTSA), IIDs designed to detect breath 
alcohol and prevent motor vehicle use while under the influence of alcohol, are effective in reducing 
recidivism among impaired driving offenders (Goodwin et. al, 2015). Currently, all 50 states have laws that 
require IID installation for impaired driving offenders. Further, 37 states have made IIDs mandatory or 
highly incentivized for all impaired driving offenders, including requiring IIDs even for first-time offenders 
(Dong et al., 2016).  
To reduce impaired driving on Texas roadways, legislative statutes mandate that DWI offenders install an 
IID as a condition of bond and/or probation if they meet certain criteria. Each biennium, when the Texas 
legislature meets, stakeholders work to strengthen Texas’ ignition interlock policies. To better understand 
ways in which Texas’ ignition interlock statutes may be improved, the researchers conducted a multifaceted 
evaluation and examined the current statutes for strengths, weaknesses, and opportunities for improvement.  
 
Methodology 
 
Researchers first reviewed Texas’ ignition interlock statutes to provide a foundation for analysis. Next, 
researchers reviewed the ignition interlock statutes of three comparison states, and conducted a comparative 
analysis that identified similarities and differences in relation to Texas’ IID program. The selection of 
comparison states was based on NHTSA’s Evaluation of State Ignition Interlock Programs: Interlock Use 
Analyses from 28 States, 2006-2011. This document evaluates and rates the quality of interlock program in 
28 states on eight categories (Casanova-Powell et. al, 2015). Researchers averaged and ranked the ratings, 
and selected three states with the strongest IID programs: Colorado, New Mexico, and Washington.  
 
Comparative Analysis of Ignition Interlock Laws Between Texas and Comparison States  
 
Texas’ ignition interlock laws are found in the Penal Code (PC), Code of Criminal Procedure (CCP), as well 
as the Transportation Code (TC), and work together to form a comprehensive IID program. As part of the 
comparative analysis Texas’ IID program was compared with the IID programs of Colorado, New Mexico, 
and Washington, the three comparison states identified by researchers. The applicable ignition interlock 
statutes of all four states are summarized in Table 1 (see pg. 3).  
 
Texas law requires an IID to be ordered as a condition of bond for all second and subsequent offenders. 
Additionally, Texas law mandates an IID be installed as a condition of probation first offenders with a blood 
alcohol concentration (BAC) ≥ 0.15 or under the age of 21, and all second or subsequent offenders. In 2015, 
Texas also passed a law allowing offenders with a suspended license to receive an unrestricted occupational 
driver’s license if they show proof of IID installation. Currently, Texas does not utilize compliance-based 
removal, which requires offenders to be violation-free for a period prior to removal of the IID.  
 
Due to the nature of its IID statutes and program size, Texas utilizes a decentralized system that allows each 
jurisdiction discretion on ordering and supervising IIDs. Additionally, the policies and procedures related to 
IIDs depend on county size, and whether it is being ordered as a condition of bond or probation. On the 
regulatory side, the Texas ignition interlock industry is overseen by the Texas Department of Public Safety 
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(TxDPS). TxDPS issues and maintains standards for IID manufacturers, and undertakes approvals, 
maintenance, and calibration of IIDs.  
From the comparative analysis, the key characteristics that contribute to the overall strength of the 
comparison states’ IID programs are:  
 
Employ centralized administration of the IID program in the state: All three comparison states employ 
a centralized agency to administer IID programs in their state, ensuring consistent application of state 
statutes and reducing tendency of offenders to avoid their IID requirement. In all comparison states, the 
same departments that are responsible for administrative oversight are also responsible for issuing state 
standards for ignition interlock manufacturers and the approval of all devices (see Table 1, pg. 3). However, 
the courts maintain the authority to order offenders to install an IID as part of their disposition.  
 
Require IID installation for all convicted offenders: Studies show that the average first offender drives 
impaired 87 times before getting caught (Advocates for Highway & Auto Safety, 2010). In New Mexico and 
Washington, a first DWI conviction results in license revocation and an IID installation requirement for one 
year. Subsequent DWI convictions result in additional time of license revocation and IID installation 
requirement. Mandatory IID for first offenders have been found to be effective in lowering recidivism rates 
(Marques et al., 2010) and lowering the number of alcohol-related fatalities (Ullman, 2016; McGinty et al., 
2017). For example, New Mexico saw a 25 percent drop in alcohol-related fatalities the first year that it 
enacted this mandatory law (Marutollo, 2009)  
 
Table 1 also summarizes the key attributes of the IID programs in Texas, Colorado, New Mexico and 
Washington (see pg 3).  
 
Incentivize IID installation: Colorado and Washington incentivize IID installation that enable offenders to 
legally get back on the road sooner. Colorado allows offenders access to an Ignition Interlock Restricted 
License during the period of their license suspension, after a one to two month waiting period. In 
Washington, an offender is eligible for early removal of their IID through day-for-day credit, if the IID is 
installed prior to conviction. 
Utilize compliance-based removal: All comparison states employ compliance-based removal, whose key 
features require offenders to complete a mandated period on the IID without alcohol violations, and 
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tampering or circumvention of the IID. Compliance-based removal is favored due to its effectiveness in 
encouraging behavior change and decreasing recidivism (Marques et al. 2010; Bailey et al. 2013). In both 
Colorado and Washington, failure to meet the IID program conditions are subject to additional penalty. 
Penalize those who tamper with or circumvent their IID or fail to install IIDs when required: All three 
comparison states have enhanced penalties for offenders who drive without installing a required IID or 
attempt to tamper with or circumvent their IID which ensures offenders successfully fulfill their IID 
requirement and to generate compliance from them.  
 
Recommendations and Conclusion 
 
For ways to improve its current IID program, Texas should look to comparison states with strong ignition 
interlock programs, as well as consider recommendations from NHTSA and Mothers Against Drunk Driving 
(MADD). Moreover, MADD advocates 12 model ignition interlock law provisions that could provide strong 
incentives for interlock use and compliance by impaired driving offenders (MADD, 2018); Texas should 
consider incorporating these provisions. Researchers recommend the following changes to improve Texas’ 
ignition interlock program:  
 
Simplify the Transportation Code and other laws related to IIDs: IID statutes of comparison states are 
streamlined and located in one place, making them easier to implement.  
 
Implement IID mandate for first offenders. NHTSA’s model guidelines encourage all states to  
adopt IID provisions for first offenders (NHTSA, 2013) which all comparison states have.  
 
Penalize those who tamper with or circumvent their IID or operate a motor vehicle without an IID 
when ordered: Also recommended by MADD (2018) in their model provisions, the comparison states have 
specific penalty for tampering with or circumventing IIDs which all comparison states have.  
 
Apply ignition interlock statutes across the state consistently: Comparison states with strong ignition 
interlock programs have one centralized agency which oversees their IID programs. Additionally, MADD 
(2018) makes a similar recommendation in their model provisions. Consistent application of IID statutes 
allow for improved supervision of offenders.  
 
Move to a compliance-based removal system: Compliance-based removal system is utilized by all 
comparison states and is also recommended by MADD (2018).  
 
Limitations 
 
One limitation to the described methodology is that the comparison states’ selection was based on 28 states 
evaluated in the NHTSA document (Casanova-Powell et. al, 2015). Had this document considered all 50 
states, the comparison states would have potentially been different.  
 
Despite, this limitation, the incorporation of the recommended changes will strengthen Texas’ current 
ignition interlock statutes, simplify implementation, reduce alcohol impaired driving, and ultimately make 
Texas’ roadways safer. 
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Abstract 
Background: Synthetic cannabinoid (SC) mixtures have become very popular over the last years but can 
cause serious intoxications, resulting in impaired driving performance. In 2 controlled experimental studies 
we previously demonstrated that low doses of the SC JWH-018 impair cognitive and psychomotor 
functioning. Strikingly however, half of the participants did not feel intoxicated after administration, which 
hampers the interpretation of the results.  
Objective: In the current study, we are looking at the effects on driving related skills of JWH-018 after 
acute administration, in participants who feel intoxicated.  
Methods: 24 healthy cannabis-experienced participants take part in this placebo controlled, cross-over 
study. Participants inhale the smoke of 75µg JWH-018/kg bodyweight, and are given a booster dose if 
needed to induce feelings of subjective high. They are subsequently monitored for 4 hours, during which 
psychomotor and cognitive performance, vital signs and subjective experience are measured. In addition, 
blood samples are taken regularly to determine JWH-018 levels.  
Results: Previously we demonstrated that subjective high scores showed a large variability in the subjective 
intoxication experienced by the participants. Serum concentrations of JWH-018 were found to be 
significantly higher in responders (participants who showed subjective intoxication). JWH-018 significantly 
impaired critical tracking performance in all participants. Responders had slower reaction times in the stop 
signal task and impaired performance in the spatial memory task after JWH-018 administration. Drug effects 
were also found on several subjective measures. Data collection of the new study is expected to end soon, 
and the results will be incorporated in the presentation.  
Conclusion: In our previous two studies we demonstrated psychomotor, cognitive and subjective effects of 
low doses of JWH-018 even though not all participants reported feelings of intoxication. We expect to see 
stronger effects in participants in whom we first confirmed subjective intoxication. Keywords: Synthetic 
cannabinoid, psychomotor performance, inhibition, tracking performance, attention  
Introduction 
Synthetic cannabinoid (SC) mixtures were originally portrayed as natural and harmless and were easily 
accessible, which made them a very popular alternative for cannabis. Nevertheless, SCs can have severe side 
effects such as tachycardia, aggression and psychosis, and an increasing number of users end up in hospital 
(Auwärter et al., 2009; WHO, 2014). Controlled studies on the effects of SCs on human performance are 
scarce. We therefore assessed the safety pharmacology of the SC JWH-018 after acute administration in 2 
controlled experimental studies (E. L. Theunissen et al., In press; Eef L Theunissen et al., 2018). Participants 
inhaled the vapor of JWH-018 (doses between 2 and 6,2 mg) using a crack pipe. Vital signs, cognitive 
performance and subjective experience were monitored for 12 hours. Subjective high scores showed that there 
is a large variability in the subjective experience of participants, with half of the participants not feeling 
intoxicated after administration. The group that experienced intoxication (i.e. subjective high score > 2), hence 
‘responders’, showed significantly higher serum concentrations of JWH-018. Responders also performed 
more poorly in tests measuring reaction time and showed increased levels of confusion, amnesia, dissociation, 
derealisation and depersonalisation and increased drug liking after JWH-018. In both responder and non-
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responder groups, JWH-018 increased heart rate within the first hour, and significantly impaired critical 
tracking and memory performance. From these studies it was concluded that fluctuations in drug delivery 
probably contributed to the variation in drug response as JWH-018’s impairing effects on cognition and 
subjective measures were mainly demonstrated in participants who experienced a subjective intoxication of 
the drug. In addition, a higher dose of JWH-018 or better administration procedure would be needed to achieve 
a behavioral impairment profile that is similar to a typical cannabis dose. Interpretation of the results of our 
studies with JWH-018 is challenging as half of the participants did not feel intoxicated after administration. 
Therefore, in a follow-up study, we   used an improved method for drug administration to reliably induce 
JWH-018 induced intoxication.   
Methods 
Twenty-four healthy cannabis-experienced participants took part in this placebo controlled, cross-over study. 
Participants inhaled the smoke of 75µg JWH-018/kg bodyweight. JWH-018 powder was heated via a 
vaporizer pen, which reaches temperatures of approximately 380°C. Participants inhaled the vapor in 5 
intakes, according to a strict inhalation regimen. In case participants did not show a subjective response within 
15 minutes after administration (i.e. a subjective high score <3), a booster dose of 50µg /kg bodyweight was 
administered. This was repeated a second time if needed. Participants were subsequently monitored for 4 
hours, during which driving related skills, subjective experience and vital signs are measured. Driving related 
skills included measures of eye-hand coordination (Critical Tracking Task (CTT), processing speed (Digit 
Symbol Substitution Task), divided attention, response inhibition (Stop Signal Task and Matching Familiar 
Figures test), spatial memory and executive functioning (Tower of London). In addition, blood samples are 
taken regularly to determine JWH-018 levels.  
Preliminary Results 
 
Twenty one participants completed the study at the moment of writing this working paper. On 6 occasions it 
was needed to give the participant a booster dose. Preliminary data of this dataset show that the maximum 
subjective high is reached 15 minutes after administration of JWH-018 (average 5.98 cm) (fig.1). Eye-hand 
coordination performance (CTT) also shows a one-sided significant difference between the two treatments 
(p=.032), at 15 minutes after administration (fig. 2). 
 
     
 
 
 
 
Conclusion 
 
Data collection of the present study is currently still ongoing. In our previous two studies we demonstrated 
psychomotor, cognitive and subjective effects of low doses of JWH-018 even though not all participants 
reported feelings of intoxication (E. L. Theunissen et al., In press; Eef L Theunissen et al., 2018). Based on 
the preliminary data we expect to see more and stronger effects of JWH-018 on driving related skills in the 
current study, which should be more representative for users of SCs in real life settings. 
  
Figure 1. Average (SE) subjective high score 
for placebo and JWH-018 over time (min) 
Figure 2. Average (SE) CTT score for placebo 
and JWH-018 over time (min) 
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Abstract 
Pakistan is a Muslim majority country and the use of drugs or alcohol is legally prohibited.  However, both 
have seen a considerable increase in use across various social strata in the past decade. In the case of illicit 
drug use, the Ministry of Narcotics Control Pakistan has reported that every year at least 50,000 new people 
become addicted to different kinds of illegal drugs in Pakistan, adding to the 6.9 million already addicted. 
Pakistan is more susceptible to drug use as it has the world’s main transit corridors for opiates and cannabis 
from Afghanistan, the world’s top producer of such substances. Though direct evidence-based information 
about the utilisation of drugs or alcohol among Pakistani drivers is scarce, indirect evidence suggests that a 
large number of drivers use alcohol or drugs while driving. This study explores the involvement of alcohol 
and drugs in road crashes across Pakistan in road crashes reported by police and subsequent judicial 
enforcement of criminal laws. Five years’ of crash and court data (2013- 2017) was obtained manually from 
different government departments across Pakistan. A total of 41,789 reported road crashes (involving deaths 
or/and injuries) are examined. Not a single driver in the five year period has been imprisoned in relation to 
their involvement in road crashes as a result of alcohol or drug consumption. The data indicate little judicial 
action of any kind. The mechanism of criminal justice system in Pakistan exhibits significant shortcomings 
in administering penalties and is therefore unlikely to contribute to deterrence of alcohol and drug use by 
road users. Road safety policy leaders in Pakistan need to think strategically to introduce interventions in the 
legal and enforcement systems to enhance the detection and conviction of such drivers. This study helps to 
address shortcomings in Pakistan’s road safety enforcement and legal system.  
Introduction 
Pakistan is strategically located, lying astride the world’s busiest drug trafficking corridors, largely due to the 
cultivation of opium poppy and cannabis in neighbouring Afghanistan, one of the world’s largest producers 
of such illicit drugs. The Narcotics Control Strategy Report, 2016 released by the Bureau for International 
Narcotics and Law Enforcement Affairs International (INCSR) of United States Department of State identified 
Pakistan as one of major illicit drug producing and/or drug-transit countries (INCSR, 2016).  
Pakistan is a Muslim country and despite being legally prohibited, alcohol and illicit drugs remain widely 
available and abuse has become a significant social problem. Illiteracy/low education level, peer pressure, age, 
social and family stress are influencing and contributing factors to high illegal drug use, while drug distribution 
routes provide an ease of access to drugs at very low prices (Aslam, Kamal & Ahmed, 2011; Aslam, 2015; 
Jabeen et al., 2017). UNODC’s 2013 nationwide drug user survey indicated that 6.7 million Pakistanis aged 
15 to 64 – about 6 percent of the population – used drugs illegally. Cannabis and opioids were the most 
prevalent drugs consumed, with four million and 2.7 million users, respectively. Around 860,000 people used 
heroin regularly, approximately 19,000 people reported they had used methamphetamine. Overall, the survey 
indicated that 4.25 million drug users aged 15 to 64 were suffering from substance use disorders. The trend of 
drug use is continuing to rise (every year, almost 50,000 more drug addicted people are added to the existing 
numbers), whereas the capacity of Pakistan to align its resources to treat those with substance use disorders 
and educate its people about the dangers of illicit drugs has been questioned (UNODC, 2013; INCSR, 2016). 
In Pakistan, the road safety problem has registered a very sharp increase during recent years and more than 
27,000 people die in road crashes annually (WHO, 2018). Among many factors responsible for the increasing 
trend of road crashes worldwide, driving under the influence of drugs or alcohol poses a significant threat to 
road safety by increasing the risk of a crash that results in death or serious injuries (WHO, 2018). Drug and 
alcohol use in the field of road safety has attracted little attention in Pakistan. Information on common drugs 
used among drivers (mostly professional) is available through media, police, and government/non-government 
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organisation reports and studies in other fields and general population drug use (i.e. Khawaja et. al., 1997; 
Ahmed et. al., 2003; Haque et. al., 2004; Aslam, Kamal & Ahmed, 2011; Aslam, 2015; Kayani, King & 
Fleiter, 2013, Jabeen et al., 2017).  Only a few studies (i.e. Mir et al., 2012, Kayani, King & Fleiter, 2013) 
provide information on the widespread use of drugs by professional drivers. Notably, no study has yet been 
conducted to investigate illegal drink and drug driving among general drivers. A study in Rawalpindi and 
Islamabad by Mir et al. (2012) on a sample of 857 commercial bus and truck drivers reported that alcohol was 
used by almost 10% of drivers while driving, whereas 30% of drivers used marijuana. The use of both 
substances was reported by 4.6% of the sample. A qualitative study in Lahore, Rawalpindi and Islamabad 
(Kayani, King & Fleiter, 2013) found accounts of widespread use of illicit drugs among bus, truck and taxi 
drivers for recreational purposes and to combat fatigue. It also revealed that police are well aware of 
widespread drug use among drivers, however lack the resources and legal framework to conduct formal 
drink/drug driver testing. A case study in Lahore (Batool, Carsten & Jopson, 2011) noted the use of drugs and 
alcohol predominantly among and public transport drivers as contributing to the exacerbation of aberrant 
behaviours.  
The constitution of Pakistan is one of the only constitutions of the world which prohibits its citizens the use 
of injurious drugs and consumption of alcohol under Article 37 (g) and (h). An exemption is provided for the 
consumption of alcoholic liquor for medical and, in the case of non-Muslims, religious purposes. The Pakistan 
penal code, under the Prohibition (Enforcement of Had) Order of 1979, awards punishment to those convicted 
of consuming prohibited intoxicants such as alcohol and drugs. However, this law is not applicable to non- 
Muslims who have a permit issued to them by the government for the use of alcohol under prescribed 
conditions. The “Control of Narcotic Substances Act, 1997” is a special law which the legislature had enacted 
mainly for awarding deterrent punishment to the persons involved in the cultivation, possession, trafficking, 
and trade of narcotics in any manner. Under this law, any such act is punishable by imprisonment up to two 
years to death or imprisonment to life. 
Aims 
- Examine and  develop an understanding of the overall legal framework, situation and nature of drug and 
alcohol related registered (reported) road crashes; 
- Understand the overall situation of road crashes across Pakistan in terms of each road crash registered 
(reported) by police, casualties in each registered case, numbers and characteristics of those subsequently 
subject to judicial procedures, trends in recent years and legal consequences of such registered road 
crashes after police investigations and court trial; 
- Understand the mechanisms underpinning crash reporting, investigation and court proceedings.  
Methods 
This study was undertaken via secondary source analysis of de-identified data from 2013-2017 obtained all 
over Pakistan (including all provinces and districts) including government organisations – provincial police 
(district police, traffic police), National Highways and Motorways Police, National Police Bureau, Statistics 
Bureau of Pakistan, provincial Home, Prison and Prosecution departments, and Emergency Services 1122. 
Ethics approval for this study was granted by the Queensland University of Technology Human Research 
Ethics Committee (QUT UHREC).  Different crash datasets are examined to understand the characteristics of 
the problem. For example, the mechanisms of reporting, investigation and court proceedings; collection and 
analysis of the road crash data reported to police and emergency departments; the cases transferred to courts 
and legal outcomes of trials in courts in particular of those that involved a death or injury. About 55,000 fatal 
(involving death) and non-fatal (involving injury) reported cases were examined in this study.  
A verbal and written request was made to the different organisations to collect the data. Different data 
collection formats were developed through a prescribed pro forma as per data needs and the organisation’s 
scope of work. An extensive exercise was launched for the manual collection of required information from all 
over Pakistan by disseminating the prescribed pro formas in police stations (a primary unit of policing in a 
specified local area). After collection of manual information on papers, Excel spreadsheets were created to 
digitalise the data.  Different crash datasets were examined to understand the characteristics of problem. For 
example the mechanisms of reporting, investigation and court proceedings: collection and analysis of the road 
crash data reported to police and transferred to courts. Descriptive analysis was used to understand the 
characteristics of registered road crashes. Data variables include: police station, case registration number, fatal or 
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non- fatal, number of casualties involved, cases registered under sections of Pakistan Penal Code (classification in 
each section), cause of road crash, type of vehicle (s) involved, driving with/ without a license, and outcome of 
cases after a court trial (i.e. completed, under court trial, under police investigations, conviction (imprisonment/ 
fine/ or both)). 
The details of provincial population, total districts in provinces and total number of police stations covered in 
the study are given in Table below.  
 
Details of provincial population, total districts in provinces and total number of police stations 
Province Population Total Districts Total Police Stations 
Punjab 110,012,442 36 705 
Sindh 47,886,051 27 562 
KPK 30,523,371 25 273 
Baluchistan 12,344,408 26 120 
Jammu & Kashmir 4,045,366 10 47 
Gilgit Baltistan 922,745 10 66 
Federal Capital Area,    
Islamabad. 
2,006,572 1 22 
Total  135 1795 
 
Results 
The analysis of data exposed many inaccuracies, shortcomings and inconsistencies in the reporting of road 
crash cases, police investigations, court proceedings and legislation.  Manifestly, driving under the influence 
of drug or alcohol has not been identified as specific driving behaviours or as cause of a road crash in all 
reported cases during the period of study. The legal procedure for collecting evidence of drug and drink driving 
is very lengthy and complicated and requires that the driver be taken to a doctor and a medical laboratory. 
Moreover, police investigations are not scientific and do not specify drug and alcohol use as a behaviour, 
attributing almost all the road crashes to general causes, such as negligent driving, speeding, careless driving, 
etc. Such general findings in police investigations are almost impossible to prove in the court proceedings. 
For that reason, the analysis revealed that in all reported road crashes (during 2013- 2017), not a single driver 
has been reported and convicted in relation to their involvement in road crashes in connection with alcohol or 
drug driving. Enforcement and investigation is considered necessary to evaluate the deterrent impact of in 
practice countermeasures; however it seems no mechanism of targeted and intelligence-led enforcement 
methods on road or fatally injured driver’s alcohol and drug testing system.  
Discussion and Conclusions 
Analyses indicates that the performance of criminal justice system is not at its optimal level in Pakistan in 
detection and conviction of drivers who use illicit drugs or alcohol during driving, which has serious 
repercussions in undermining the deterrent effect of road safety laws and regulations. The inefficient reporting, 
investigations and penalties or deterrent mechanism provided in the existing enforcement and legal system 
appear manifestly negligible if intended to instil any considerable change in driver’s illicit drink or drug 
driving behaviour. Effective legislation, enforcement and the judicial system play an important role and are a 
prerequisite for deterrence of road user behaviour through the establishment and detection of offences, and 
imposition of penalties and sanctions.  However the impact of legal sanctions is weakened if they are not 
187 
applied automatically and consistently. The analysis shows that there is no investigation initiated by police to 
investigate the factors associated with road crashes. Inadequate investigations from police that fail to identify 
the responsibility, grounds and circumstances of road crashes, coupled with a lack of knowledge and 
awareness among road users, can give rise to misunderstandings about crash causation and may lead people 
to attribute crashes to other factors such as fate or predestined (Kayani et al,. 2012, 2013, 2014). 
This study provides comprehensive information on the existing road safety enforcement and legal system 
situation in Pakistan, and suggests that the structure of the road safety enforcement and legal system in 
Pakistan requires reform to address the inadequacies and to improve the system of accountability to make it 
more responsive to illegal driving behaviours including illicit drug use or drinking. Inadequacies and 
inefficiencies in Pakistan’s complex criminal justice structure are embedded in interconnected systems and 
interventions may include all spheres of improvements: the police reforms in improvement of reporting and 
investigative procedures, strengthening prosecution and judiciary, alignment of legislative and regulatory 
frameworks.  
The police reports analysed provided very little information regarding examination of the presence of different 
human conditions and states (i.e. drug or alcohol use). Police road crash reports are perhaps the most important 
source of road crash databases and analysis. There is a need to develop a comprehensive reporting and 
investigation system and to monitor the quality of police-reported road crash data. WHO and number of other 
road safety experts have repeatedly emphasised that inaccurate crash data is a significant problem faced by all 
developing countries such as Pakistan, most importantly when assessment of full‐scale and nature, and 
priorities for attention and funding are made (Kayani et al., 2014). WHO (2018) has asserted that “without the 
ability to assess progress and the effectiveness of efforts to reduce fatalities and injuries, countries will not be 
able to identify gaps in the system and deliver tailored improvements. As a result of the differences in 
definitions, reporting, and coding practices adopted by health, police, and insurance, the individual sources of 
data often provide an incomplete view of the actual situation” (page 79). Quality data and appropriate 
investigation are critical in reducing the road toll that is rapidly growing to pandemic proportions in much of 
the developing world, including Pakistan. Many factors may contribute to inaccurate reporting and 
investigations of road crashes. There is need to investigate such factors to identify the shortcomings and 
achievement of future targets. 
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The Effects of Recent Drug Driving Legislation in Great Britain 
Rob Tunbridge, Ph.D., BSc., RJT Associates 
Abstract 
Statuary drug driving limits were introduced in England and Wales in March 2015, whereby it became an 
offence to drive above specific limits for 17 proscribed drugs in blood. Eight of these drugs were nominally 
illicit and 8 nominally medicinal, plus amphetamine. At the same time roadside screening devices based on 
saliva samples were introduced. These however only test for THC and Cocaine. 
Despite this limitation, within the first year of legislation prosecutions for drug driving offences increased by a 
factor of eight over pre legislation numbers. Subsequent to this, prosecutions for drug driving offences have 
continued to rise steeply. There are now in excess of 25,000 per year compared with around 1000 pre 
legislation. Only two devices are currently approved for roadside screening. A DrugWipe device produced by 
Securetec and one produced by Drager. The vast majority of tests are conducted using the DrugWipe device. 
Approximately two thirds of drivers who are roadside screened are positive and then only 50% are eventually 
confirmed positive in blood with successful prosecutions, due to procedural issues. This paper will present the 
latest figures for drug driving prosecutions and also address how the very successful legislation can be further 
improved. In particular possible extension to screening for Methamphetamines, principally MDMA, the next 
most commonly used and impairing illicit drug, and  importantly, creation of legislation allowing the option for 
the collection of evidential saliva samples at the roadside. The latter procedure would not only most likely 
significantly reduce the cost and time for sample analysis, but also likely increase in the number of successful 
prosecutions for drug driving offences. 
Keywords: Drug driving, Illicit, Great Britain 
Background 
In 1985 the Department for Transport (DfT) commissioned the then Transport Research Laboratory (TRL) to 
undertake a study of the incidence of drugs in driver fatalities. The results of this research were published in 
1989 (Everest et al,, 1989) and showed that 6% of fatally injured drivers had traces of medicinal drugs and 
3% had traces of illicit drugs.  
The topic then remained relatively dormant until 1995 when increasing evidence of illicit drug use in the 
community, mainly cannabis, was giving rise to concern. The DfT then undertook its own repeat study of 
drugs in road user fatalities between 1995 and 2000. The results of this work showed a massive 6 fold increase 
in illicit use in drivers, 3% to 18%, but virtually no change in medicinal use at 6%, (Tunbridge et al, 2001). 
These results prompted the Government to fund a large programme of work into the issue of drug driving 
including experimental studies on the effect of cannabis on driving (Sexton et al, 2000) and how best to detect 
drug impaired drivers at the roadside (Tunbridge et al, 2000). 
The evidence for an increased drug driving problem resulted in the Government bringing in new legislation 
under the Railways and Transport Safety Act 2003 (RATS). This allowed police to conduct roadside screening 
tests with ‘Type Approved’ devices testing for drugs in saliva or sweat. However, 11 years on, no such devices 
had received government approval. The RATS Act also allowed police to conduct, so called, Field Impairment 
Tests (FIT) under Section 4 of the Road Traffic Act 1988, to assess whether a driver might be impaired through 
drugs. Such tests, however, can only give a subjective indication of impairment, but not prove impairment. 
The latter is extremely complex. In practice these tests have been used spasmodically. 
During the mid-2000's more research was carried out on the increase of recreational drug use in the community 
and associated likely increase in illicit drug use amongst drivers. The British Crime Survey (BCS) of admitted 
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drug use, published annually, consistently shows around 20% of 16 -25 year olds, the key road safety group, 
admitting to taking illicit drugs in the previous year. In addition, the most popular Clubbing magazine, 
Mixmag, showed that of regular clubbers around 75% admitted cannabis and ecstasy (MDMA) use in the past 
year. By 2010, the general population was consuming cocaine in proportions heading towards those of 
Cannabis consumption. 
The IMMORTAL Project (2005; www.immortal.org.at) showed that of over 1300 drivers in Glasgow, who 
had been stopped at random and had a saliva sample taken, 10% were positive for illicit drugs; mainly cannabis 
and ecstasy (MDMA). 
In addition, other non government funded studies showed around 20% of young drivers admitting to DUID. 
Following this research the then-Government announced a Review of Drink and Drug Driving Policy to be 
carried out by Sir Peter North, (North, 2010). North and a House of Commons Transport Select Committee  
concluded that drug screening of drivers should be introduced as soon as practically possible. In early 2012 
an ‘expert’ panel was be set up to consider the technical aspects of introducing an offence of driving after 
taking illegal drugs and the possibility of identifying impairing levels for these drugs. The expert panel 
reported in March 2013 and recommended limits based on road accident ‘Risk’. The vast majority of the 
panel's evidence was based on a re-reading of the Pan European study DRUID (DRiving Under the Influence 
of Drugs, alcohol and medicines) www.druid-project.eu. 
Soon after, a new law was introduced as the Crime and Courts Act 2013. Under this new law the basic 
offence became: ‘Driving or being in charge of a motor vehicle with a concentration of a specified drug 
above a specified limit’ 
The law applies only to controlled drugs i.e. those controlled under the Misuse of Drugs Act 1971.These 
basically comprise the most commonly taken illicit drugs plus some CNS active prescription-only drugs. 
The illicit drugs covered are cannabis, cocaine, benzoylecgonine, heroin metabolite (6MAM), ketamine, 
LSD, methamphetamine and ecstasy. The main medicinal drugs are primarily six benzodiazepine 
tranquillizers and hypnotics, plus methadone and morphine. Amphetamine is also included and can be seen 
as either a medicinal or illicit drug depending on use. 
Drug driving limits or levels in blood for the drugs outlined above where finally set in law in March 2015. 
At the same time devices detecting 2 of the 17 drugs proscribed in the Act ( Cannabis and Cocaine) received 
‘Type Approval’ for use in roadside drug screening. The proscribed drug levels in blood are available at 
www.gov.uk/government/collections/drug-driving#table-of-drugs-and-limits. 
Aims 
This paper aims to review the background to the drug driving situation in Great Britain over the past 30 plus 
years, the results of research and the consequent anti drug driving legislation and its effects. The current 
paper updates the presentation given to T 2016 with developments over the past 3 years. 
Method 
This is a review paper on drug driving in GB covering background, research undertaken, development of 
government policy subsequent change in drug driving legislation and the results of this. This paper is an 
update of the one delivered at T2016 with the latest developments in GB drug driving policy since then and 
up to date drug driving prosecution statistics. 
Results 
The Crime and Courts Act 2013 has been a major step forward; for the first time setting in law drug drive 
limits for specific drugs. 
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Since the law was enacted in March 2015, there has been a massive increase in the enforcement of drug 
driving, with convictions increasing, in the police forces of England and Wales, by up to a factor of 8 in the 
first year subsequent to the act, from around 1000 to nearly 8000.  
In subsequent years the availability of roadside screening devices for the two most commonly used illicit drugs 
in Great Britain, Cannabis  (THC) and Cocaine has lead to a massive increase in drug drive prosecutions under 
the new act. Over the past 3 years with the availability of drug screening devices for THC and cocaine 
prosecutions are estimated to be approaching 33,000 per annum and still growing! 
Latest results (December 2018) suggest that around 65% of screening tests performed on drivers at the roadside 
are positive for drugs. But only 50% are successfully prosecuted following confirmation in blood. Of the 20% 
that aren't, the loss is principally due to the failure to get an evidential blood sample (Needle phobia issues are 
significant and constricted veins post Cocaine consumption are also important) or the time delay in getting to a 
Doctor or Health Care Professional to take a sample. 
One force, North Wales, shows an average level of drug driver prosecution before the new law of 30 drivers, 
where as their current 2018 results indicate nearly 800 drug driver prosecutions per year, a 25 fold increase. 
The England and Wales drug driving legislation allows arrest under the 1988 Road Traffic Act 1988 under two 
Sections. Section 4 which requires the demonstration of Impairment at the point of the driving offence; or Section 
5a which requires provision of a roadside screening sample for one of the two currently proscribed drugs, 
Cannabis (THC) or Cocaine. At present around 95% of prosecutions in England and Wales are under Section 5a. 
The devices currently approved for roadside screening are illustrated below. 
 
 
 
 DrugWipe 3S Cannabis and Cocaine Keyboard.     Drager DDT 5000 with printer and keyboard. 
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Discussion / Conclusions 
Following on from the initial results presented at T2016, it is clear that drug driving prosecutions have increased 
massively, estimated at over 25 fold, due to clear legislation and the availability of a simple to use, portable and 
reliable roadside saliva screening device. The issue is clearly a major road safety problem in Great Britain as 
many forces are now reporting more prosecutions for  drug drive  than drink driving.  
After more than 20 years of campaigning we have at long last seen a major success in this important area of 
road safety!  
To take this road safety improvement to the next and readily achievable level, it is recommended to take several 
relatively simple steps. In particular, the screening for MDMA, the next most commonly used illicit drug, and 
legislation for the option to collect evidential saliva samples at the roadside. 
Epidemiological evidence on drug use in the general population suggests that MDMA (Ecstasy) use is the 
next most common illicit drug to cocaine and as a first step, roadside screening devices need approval for 
testing of Methamphetamines principally MDMA along with Cannabis and Cocaine.  
The procedure to introduce evidential saliva collection at the roadside would not only reduce the cost and time of 
sample analysis but also increase successful drug drive prosecutions. Best estimates from current drug analysis 
practice in GB suggest that evidential saliva test results could be made available in one or two days compared to 
3 to 4 weeks for evidential blood samples! 
Furthermore, the cost of individual analyses could be reduced from around £400 - 500 GB to around £ 50 GB per 
saliva analysis! A great saving in time, effort and cost and likely increase in drug driving enforcement building 
the necessary deterrent to save lives and reduce injury. 
 
The latter procedure has already had successful application in France and other European countries as well as 
Australia. 
To counter this very significant road safety issue, the Department for Transport needs to improve and extend its 
anti-drug drive campaign, but this must come with more focus from the Home Office in assisting with legislative 
changes and to maintain, at least, the current number of specialist Road Traffic Police. 
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Abstract 
Context: Drink driving is a serious problem in New Zealand (NZ). Over the years 2014–2016, 
alcohol/drugs were a factor in 29 percent of fatal crashes (Ministry of Transport 2017). From 2009-2012, 47 
percent of detected drink drivers were repeat or recidivist offenders who had at least one previous historical 
drink driving conviction (Waters, 2013). 
Objectives: One for the Road (OFTR) is a New Zealand based group intervention targeting behaviour 
change in repeat drink/ drugged drivers. This programme has been active since 2008 and has been developed 
to achieve both best- practice and achieve a unique approach appropriate to a New Zealand context. Group 
therapy is the key, seeking exploration of deeper underlying issues and using a relational approach to engage 
with Maori and Pacific Islander people who make up 45% of participants. Attendees are mixture of those 
referred prior to sentencing, as part of a court ordered sentencing programme, or towards the end of an 
‘indefinite’ licence disqualification period. 
Key Outcomes: A recent independent evaluation by RIDNZ (Waters, 2019) has supported programme 
effectiveness for the longer version of the programme (20 hours), with an overall 7.5% re-offending rate, 
and a 20.2% reduction in reoffending over 3 years, when compared to a well matched control group. 
However the earlier 10 hour version of OFTR (last implemented in 2013) was not supported for 
effectiveness. 
Discussion and Conclusions The evaluation by RIDNZ has been an opportunity for reflective practice, and 
valuable in highlighting the effectiveness, strengths and limitations of OFTR.  Harmony Trust have gained 
validation for programme integrity, and the developments in lengthening and updating OFTR to it’s current 
version. Subsequent to this study there have been some further changes to the style, structure, and length of 
the programme in order to achieve best practice. 
 
Introduction- Background to drink driving in NZ- why focus on repeat drink drivers? 
Drinking and driving behaviour has long been of concern in NZ, with reports indicating 31% of road deaths 
being alcohol-related (Ministry of Transport, 2009).  Dawe (2010) has found that 36% of drink drivers were 
reconvicted over the 10 year period 1999 to 2008 in New Zealand, which appears to be high compared to 
overseas examples, and Waters (2013) has reported that from 2009-2012, 47 percent of detected drink 
drivers were repeat or recidivist offenders who had at least one previous historical drink driving conviction. 
It is generally acknowledged that preventing recidivists from re-offending is likely to have the greatest 
impact on alcohol-related crashes (Campbell, 2000; Joyce, 2000; Roadsafe Auckland, 2001).  
 
Methods of social change to reduce drink driving have been attempted such as increased police presence and 
breath testing, tougher sentencing, media shock tactics, and lowering the drink-driving limit from .08 
(80mgs per 100 mls of blood) to .05 (50mgs). However there remains a concern about the high number and 
cost of people receiving a custodial sentence for traffic and vehicle related offences making up 19% of the 
total number of custodial sentences passed in 2009 (Statistics New Zealand, 2010). There appear to be 
persistent drink-drivers who appear immune to these interventions and who appear to feel their behaviour is 
justified as ‘normal’ as ‘thousands do it’. The OFTR programme focuses on group work with repeat 
offenders, using engagement, empathy, challenging to world views, eliciting commitment to change, and 
promoting a zero drink/drugged driving limit.   
 
The One for the Road Programme- Background and Development: 
The OFTR programme was first implemented by Harmony Trust in 2008 as a pilot initiative to test whether 
a ‘brief intervention’ model would show any effectiveness with repeat drink/drugged drivers. Initial funding 
was from The New Zealand Transport Agency via The Auckland Council/Auckland Transport. To date 
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some 250 individual groups have been completed across the Auckland region and the Central North Island 
of NZ, with in excess of 2000 people completing. During these 10 years there has been a continuous process 
of experimentation, trial and error, reflection, review and development.  
 
OFTR Version 1: From 2008-2013 OFTR consisted of a 10 hour programme run over 2 days workshop 
style (6 hours and 4 hours). This was typically on a Friday and Sunday afternoon to ‘capture’ the weekend 
binge drinking times and give a chance to practice group challenge in situ. This version which could be 
described as condensed, was based on the assertion of Bill Miller that ‘there is much that can be done in 
even a single session to initiate change in alcohol use’ (Miller and Rollnick, 2002), and was adopted to 
facilitate engagement (attendance and completion rates) in what is often a resistant and pre-contemplative 
population referred through the justice system. To this end also meal catering and end of group gifts were 
provided (a OFTR key ring and fridge magnet). The group was also designed to reduce barriers and 
resistance to change, have an emotional impact, create cognitive dissonance, and develop a discomfort 
(aversion) for drink-driving. The process was based on a central victim empathy session, sensitive and 
careful use of guilt and shame, peer group feedback and accountability, emotional insight and moral 
development, and planning for change.  
 
OFTR Version 2: From 2013-2018 (with additional national funding from the Ministry of Health) a 20 hour 
programme was developed which included the original 2 day workshop plus 5x 2 hour weekly sessions. The 
additional 10 hours run over 6 weeks offered a greater change for group participants to demonstrate change 
and commitment through practice with a group action challenge set each week focusing on behaviour 
change, completion of an AOD log to monitor use during the week including triggers and coping skills, an 
increased opportunity for process therapy, peer feedback, development in communication styles, awareness 
of cognitions and consequential thinking, and relapse prevention. In this time Harmony Trust had also 
produced a brief video ‘Be Back Soon’, which was used in group to promote awareness of impact of 
behaviour on others. 
 
OFTR Version 3: With preliminary information gained from the evaluation by Waters (2019) an 
opportunity for reflection and review was created. In August 2018 OFTR was extended to the current a 22 
hour version run over 8 weeks. Version 3 features the same content and process of the previous version but 
with an extended time frame consisting of an initial 1 day (6 hour) workshop, plus 8 x 2 hr closed weekly 
sessions. This lengthening of the programme was an acknowledgement that, while still a brief intervention, 
OFTR would benefit from the extra time needed for repeat impaired drivers to consolidate learnings and 
demonstrate commitment to change over time. We were aware that some graduates of the earlier 10 hour 
programme would have been able to ‘fake’ change more easily or avoid a more thorough exploration of their 
offending. 
 
The Typical Group Member Profile: 
Referrals have generally come from defence lawyers (clients who have court cases pending), probation (as 
part of a court order), Alcohol and Drug Services, or via the NZTA from those applying to have a licence 
disqualification lifted.  
 
The following points are based on demographic data gathered by Harmony Trust and from data received 
from the Ministry of Justice on 142 OFTR programmes run between July 2009 and March 2015, some 1437 
particpants. This data has indicated the ‘typical’ One for the Road group member is: male (88%), on average 
is between 35-39 years old, may equally be Pakeha (NZ European) or Polynesian, has 3 plus ‘excess breath 
alcohol’ convictions, shows a tendency to binge drink and alcohol ‘abuse’ (moderate, rather than meet the 
criteria for dependency (less than 10% scoring medium or high on the LDQ), is ‘pre-contemplative’ (does 
see a need to change) and likely to have ways of justifying their behaviour, may be guarded or defensive, 
show stored anger and a tendency to blame other. 
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Repeat offenders have developed a particular ‘mindset’ or attitude with strong and compelling reasons for 
rationalising and continuing with their behaviour. These justifications assist the drink driver to ‘cope’ with 
potential feelings of guilt, shame, hurt, victimisation, alienation, and anger.  One group member described 
having a ‘book’ of justifications he could draw upon at any point in order to ‘feel’ better about his 
behaviour. These are often statements (beliefs) such as: “I only had a few…I drive better when I’m 
drunk…I’m the least drunk so I had to drive…It’s only around the corner… Where’s the victim, I haven’t 
hurt anybody…There’s thousands out there that drink and drive”. 
 
Current Evaluation by RIDNZ 2019: 
OFTR was subjected to a matched control group outcome comparison, with up to 3 matches per OFTR 
offender, undertaken by RIDNZ (Repeat Impaired Drivers New Zealand- Waters, 2019)). Findings from this 
study indicate: 
• The OFTR 20hr programme appears to be an effective intervention for repeat and high level first time 
detected drink drivers. This is encouraging given the group is often delivered as a ‘stand-alone’ 
intervention. However the previous OFTR 10 hour programme (by itself) appears not to be effective 
intervention, with no reduction in re-offending.  
• Participants who completed the full programme were 20 per cent less likely to reoffend over the 3-
year period when compared with the control groups (7.5 per cent recidivism rate among 20hr 
programme participants compared to 9.4 for the matched control group and 10.6 per cent unmatched 
‘other’ drink drive offenders among the controls). However an important caveat of this study is that 
the actual numbers involved are quite low and future research would be needed to be replicate and 
confirm.  
• Those who re-offended were just more likely to do so in the first year post group. 
• The RODD – ‘Risk of Drink Driving’ Screening Tool used by Harmony Trust appears to be an 
effective assessment of risk. 
• Future evaluations should not rely on just post programme detected reoffending alone without the use 
of any comparison control group to indicate reduction in re-offending. 
 
Conclusions, Findings and /or Recommendations: 
Initial results for One for the Road are promising in terms of the reduction in re-offending and relatively low 
reconviction rates. The low reconviction rate is more impressive given the relatively high previous drink-
drive convictions and low motivation to change compared to overseas programmes. The relatively 
inexpensive cost of the programme indicates that the programme is likely to be cost-effective relative to 
custodial sentences. 
 
Key Features / Learnings for OFTR- What we have learnt through this review process: 
1. Brief Intervention  
OFTR has always been a brief and intensive, and this has assisted with engagement and client retention 
in group, as the task of attending appears more manageable to clients. This helps with retention but the 
evaluation has shown that there is a cost to brief intervention in terms of programme integrity and 
outcomes, and the learning is ‘brief, but not too brief’.  
2. Motivational Enhancement 
Alcohol and other drug intervention studies support the effectiveness of a brief intervention model in 
motivating a client towards behaviour change (Bill Miller, 1996; Miller and Taylor, 1980).The essential 
process followed in group parallels the work of Bill Miller (2002) with the ‘motivational interviewing 
process of working towards change in a) Expressing Empathy b) Rolling with Resistance c) Developing 
Discrepancy and d) Supporting Self Efficacy. One OFTR client remarked in end of group feedback: “I 
knew I had to change, but meeting you has made me want to change”. 
3. Group Therapy 
OFTR is a true closed therapy group which can be described as experiential (action, emotion, and 
activity based) rather than educational. To assist with this process numbers should be capped at 14.This 
is more about ‘being in’ a situation than talking about a situation. There is a group resource booklet 
given to clients, and videos are shown but these are secondary to group process, where the group 
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members are regarded as the ‘guest speakers’. One exception is the ‘Be Back Soon’ video created by 
Harmony Trust to elicit feelings for family and support people of repeat impaired drivers. Feedback from 
group participant: “I have stood before the just 3 times but never felt as guilty as I do right now”. 
4. The Anti-Drink Driving Peer Group  
Human beings have a strong drive for affiliation and we typically live in groups, work in groups, and 
tend to drink alcohol in groups (ie ‘social drinkers’). Drink Drivers who don’t believe they have an 
‘alcohol’ problem, are more likely to attend a group for ‘drink drivers’ than one for ‘alcoholics’. One of 
the most important objectives of One for the Road is then to establish an ‘anti drink driving’ peer group 
amongst the group members, where the person who remains ‘pro’ drink driving and begins to feel 
‘abnormal’. Group feedback: “I ‘enjoyed’ being confronted and challenged rather than a room full of 
people smiling and agreeing with me”. 
5. Connecting with Maori Pacific Island People- whakawhanaungatanga  
The group is designed specifically to cater for people of Maori and Pacific Islander origin (approx. 45%) 
and a feature of this is the focus on hospitality- a cooked kai (food) is provided to participants, use of 
karaka, observance of tikanga (protocol). Both Maori and Pacific cultures are reflected in group leaders, 
and  the attendance of ‘drink-driver crash survivor’, Tamati Paul, Ngati Porou, and who has been 
through a process of rehabilitation and recovery, provides an important catalyst for change.  
 
In conclusion, over 10 years, through trial and error, the OFTR programme has been continually reviewed 
and developed. The programme has evolved a distinctive NZ flavour, innovative practice, and a true 
therapeutic focus. With the more rigorous scrutiny offered by the recent matched control group evaluation 
by Waters (2019), there has been a further chance to reflective and improve. The outcomes indicate a 
qualified success in reducing re-offending in this ‘hard to engage’ and resistant population, who, without 
intervention, are highly likely to reoffend causing harm to themselves or others.  
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